Diabetes & Endocrinology

Our aim is to understand more fully the mechanisms underpinning links between metabolic, endocrine and cardiovascular diseases, and their implications for the wider population and subgroups of interest. 

Staff

Publications

2024

Zhang, M., Ward, J., Strawbridge, R. J., Celis Morales, C., Pell, J. P., Lyall, D. M., Ho, F. K. (2024) How do lifestyle factors modify the association between genetic predisposition and obesity-related phenotypes? A 4-way decomposition analysis using UK Biobank. BMC Medicine,

Al-Ozairi, E., Irshad, M., Al-Ozairi, A., Al-Kandari, J., Taghadom, E., Varghese, A., Megahed, A., Abdullah, A., Murad, S., Gray, S. (2024) Seasonal differences in physical activity, sedentary behaviour, and sleep patterns in people with type 1 diabetes in Kuwait. Diabetes and Metabolic Syndrome: Clinical Research and Reviews,

Sattar, N., Neeland, I. J., McGuire, D. K. (2024) Obesity and cardiovascular disease: a new dawn. Circulation, 149, pp. 1621-1623. (doi: 10.1161/CIRCULATIONAHA.123.065485)

Mezincescu, A. M., Rudd, A., Cheyne, L., Horgan, G., Philip, S., Cameron, D., van Loon, L., Whitfield, P., Gribbin, R., Khei Hu, M., Delibegovic, M., Fielding, B., Lobley, G., Thies, F., Newby, D. E., Gray, S., Henning, A., Dawson, D. (2024) Comparison of intramyocellular lipid metabolism in patients with diabetes and male athletes. Nature Communications, 15, (doi: 10.1038/s41467-024-47843-y)

Docherty, N. G., Delles, C., López-Hernández, F. J. (2024) Reframing acute kidney injury as a pathophysiological continuum of disrupted renal excretory function. Acta Physiologica,

Al-Ozairi, A., Irshad, M., AlSarraf, H., AlKandari, J., Al-Ozairi, E., Gray, S. R. (2024) Association of physical activity and sleep metrics with depression in people with type 1 diabetes. Psychology Research and Behavior Management,

Yu, Y.-L. et al. (2024) Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart, (doi: 10.1136/heartjnl-2023-323796)

Jones, D. J., Celis-Morales, C., Gray, S. R., Morrison, D. J., Ozanne, S. E., Jain, M., Mattin, L. R., Burden, S. (2024) Effect of sustainably sourced protein consumption on nutrient intake and gut health in older adults: a systematic review. Nutrients, 16, (doi: 10.3390/nu16091398)

Curtain, J. P., Talebi, A., McIntosh, A., McConnachie, A., O’Donnell, J., Welsh, P., Osmanska, J., Lee, M. M.Y., Sonecki, P., Akl, T., Seo, J., Gopinathan, V., Hurwitz, J., Thiagarajan, S., Pettit, S., Kalra, P. R., Patel, R. K., Mark, P. B., Lang, N. N., McMurray, J. J.V., Petrie, M. C., Gardner, R. S., Jhund, P. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure,

Carrasco-Marín, F., Parra-Soto, S., Boonpor, J., Phillips, N., Talebi, A., Petermann-Rocha, F., Pell, J., Ho, F. K., Martínez-Maturana, N., Celis-Morales, C. A., Molina-Luque, R., Molina-Recio, G. (2024) Adherence to dietary recommendations by socioeconomic status in the United Kingdom biobank cohort study. Frontiers in Nutrition, 11, (doi: 10.3389/fnut.2024.1349538)

Cardoso, P., Young, K. G., Nair, A. T. N., Hopkins, R., McGovern, A. P., Haider, E., Karunaratne, P., Donnelly, L., Mateen, B. A., Sattar, N., Holman, R. R., Bowden, J., Hattersley, A. T., Pearson, E. R., Jones, A. G., Shields, B. M., McKinley, T. J., Dennis, J. M. (2024) Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia, 67, pp. 822-836. (doi: 10.1007/s00125-024-06099-3)

Butler, J. et al. (2024) Empagliflozin after acute myocardial infarction. New England Journal of Medicine, 390, pp. 1455-1466. (doi: 10.1056/NEJMoa2314051)

Cleland, J. G.F., Kalra, P. A., Pellicori, P., Graham, F. J., Foley, P. W.X., Squire, I. B., Cowburn, P. J., Seed, A., Clark, A. L., Szwejkowski, B., Banerjee, P., Cooke, J., Francis, M., Clifford, P., Wong, A., Petrie, C., McMurray, J. J.V., Thomson, E. A., Wetherall, K., Robertson, M., Ford, I., Kalra, P. R., the IRONMAN Study Group, (2024) Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. European Heart Journal, 45, pp. 1410-1426. (doi: 10.1093/eurheartj/ehae086)

Kosiborod, M. N. et al. (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes. New England Journal of Medicine, 390, pp. 1394-1407. (doi: 10.1056/NEJMoa2313917)

Lang, N., Rankin, S., Elyan, B., Jones, R., Venugopal, B., Mark, P. B., Lees, J., Petrie, M., Lang, N. (2024) Cardiovascular eligibility criteria and adverse event reporting in combined immune checkpoint and VEGF inhibitors trials. JACC: CardioOncology, 6, pp. 267-279. (doi: 10.1016/j.jaccao.2023.12.010)

Glen, C., Morrow, A., Roditi, G., Hopkins, T., Macpherson, I., Stewart, P., Petrie, M. C., Berry, C., Epstein, F., Lang, N. N., Mangion, K. (2024) Cardiovascular sequalae of trastuzumab and anthracycline in long-term survivors of breast cancer. Heart, 110, pp. 650-656. (doi: 10.1136/heartjnl-2023-323437)

Carberry, J., Petrie, M. C., Lee, M. M.Y., Brooksbank, K., Campbell, R. T., Good, R., Jhund, P. S., Kellman, P., Lang, N. N., Mangion, K., Mark, P. B., McConnachie, A., McMurray, J. J.V., Meyer, B., Orchard, V., Shaukat, A., Watkins, S., Welsh, P., Sattar, N., Berry, C., Docherty, K. F. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure,

Hernandez, A. F. et al. (2024) Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial. Circulation, (doi: 10.1161/circulationaha.124.069217)

Rastogi, T., Gargani, L., Pellicori, P., Lamiral, Z., Ambrosio, G., Bayés-Genis, A., Domingo, M., Lupon, J., Simonovic, D., Riccardo Pugliese, N., Ruocco, G., Duarte, K., Coiro, S., Palazzuoli, A., Girerd, N. (2024) Prognostic implication of lung ultrasound in heart failure: pooled analysis of international cohorts. European Heart Journal: Cardiovascular Imaging,

Sattar, N., Butler, J., Lee, M. M.Y., Harrington, J., Sharma, A., Zannad, F., Filippatos, G., Verma, S., Januzzi, J. L., Ferreira, J. P., Pocock, S. J., Pfarr, E., Ofstad, A. P., Brueckmann, M., Packer, M., Anker, S. D. (2024) Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: principal findings and meta-analysis with the DELIVER trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3221)

Sattar, N., Presslie, C., Rutter, M. K., McGuire,, D. K. (2024) Cardiovascular and kidney risks in individuals with type 2 diabetes: contemporary understanding with greater emphasis on excess adiposity. Diabetes Care, 47, pp. 531-543. (doi: 10.2337/dci23-0041)

Udell, J. A. et al. (2024) Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction. Journal of the American College of Cardiology, (doi: 10.1016/j.jacc.2024.03.405)

Lean, M. E.J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., Hollingsworth, K. G., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., McIlvenna, Y., Welsh, P., McConnachie, A., McIntosh, A., Sattar, N., Taylor, R. (2024) 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes and Endocrinology, 12, pp. 233-246. (doi: 10.1016/S2213-8587(23)00385-6)

Jackson, A. M., Goland, S., Farhan, H. A., Yaseen, I. F., Prameswari, H. S., Böhm, M., Jhund, P. S., Maggioni, A. P., van der Meer, P., Sliwa, K., Bauersachs, J., Petrie, M. C. (2024) A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry. European Heart Journal, 45, pp. 1430-1439. (doi: 10.1093/eurheartj/ehad888)

Lim, M. W. S., Lucas-Herald, A. K., Mason, A., Delles, C., Connelly, P. J. (2024) Sex differences in the cardiovascular effects of GnRH analogues. Journal of Endocrinology, 261, (doi: 10.1530/JOE-23-0309)

Docherty, K. F., McMurray, J. J.V., Kalra, P., Cleland, J. G.F., Lang, N. N., Petrie, M. C., Robertson, M., Ford, I. (2024) Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction. ESC Heart Failure, (doi: 10.1002/ehf2.14742)

Savarese, G., Lindberg, F., Christodorescu, R. M., Ferrini, M., Kumler, T., Toutoutzas, K., Dattilo, G., Bayes-Genis, A., Moura, B., Amir, O., Petrie, M. C., Seferovic, P., Chioncel, O., Metra, M., Coats, A. J.S., Rosano, G. M.C. (2024) Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice. European Journal of Heart Failure, (doi: 10.1002/ejhf.3214)

Manyara, A., Mwanik, E., Gill, J. M.R., Gray, C. M. (2024) Knowledge, perceptions, and practices towards diabetes risk in sub-Saharan Africa: a mixed methods scoping review. Public Health Nutrition,

Knigge, P., Lundberg, S., Strange, J. E., Malik, M. E., Nouhravesh, N., Wagner, A. K., Gislason, G., Fosbøl, E. L., Carlson, N., Zahir, D., Andersson, C., Butt, J. H., Jhund, P., Petrie, M. C., McMurray, J. J.V., Køber, L., Schou, M. (2024) Temporal trends in the initiation of dialysis among patients with heart failure with or without diabetes: a nationwide study from 2002 to 2016. Journal of the American Heart Association, 13, (doi: 10.1161/JAHA.123.032539)

Carrasco-Marín, F., Zhao, L., Hébert, J. R., Wirth, M. D., Petermann-Rocha, F., Phillips, N., Malcomson, F. C., Mathers, J. C., Ferguson, L. D., Ho, F., Pell, J., Celis-Morales, C., Molina-Recio, G., Molina-Luque, R. (2024) Association of a dietary inflammatory index with cardiometabolic, endocrine, liver, renal and bones biomarkers: cross-sectional analysis of the UK Biobank study. Nutrition, Metabolism and Cardiovascular Diseases, (doi: 10.1016/j.numecd.2024.03.010)

Suzuki, K. et al. (2024) Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature, 627, pp. 347-357. (doi: 10.1038/s41586-024-07019-6)

Campbell, P., Rutten, F. H., Lee, M. M. Y., Hawkins, N. M., Petrie, M. C. (2024) Heart failure with preserved ejection fraction: Everything the clinician needs to know. Lancet, 403, pp. 1083-1092. (doi: 10.1016/S0140-6736(23)02756-3)

Hageman, S. H..J. et al. (2024) Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions. European Journal of Preventive Cardiology,

Cleland, J. G.F. (2024) Nature and magnitude of the benefits of dapagliflozin and empagliflozin for heart failure. Circulation, 149, pp. 839-842. (doi: 10.1161/circulationaha.123.068089)

Kobayashi, M., Ferreira, J. P., Kevin, D., Bresso, E., Huttin, O., Bozec, E., Brunner La Rocca, H.-P., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A.J., Rossignol, P., Cleland, J. G.F., Zannad, F., Girerd, N. (2024) Proteomic profiles of left atrial volume and its influence on response to spironolactone: findings from the HOMAGE trial and STANISLAS cohort. European Journal of Heart Failure,

Haag, L., Richardson, J., Haig, C., Cunningham, Y., Fraser, H., Brosnahan, N., Ibbotson, T., Omerod, J., White, C., McIntosh, E., O'Donnell, K., Sattar, N., McConnachie, A., Lean, M., Blane, D., Combet, E. (2024) Baseline characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT) NIHR Open Research, 4, (doi: 10.3310/nihropenres.13522.1)

Nakada, S., Ho, F. K., Celis-Morales, C., Pell, J. P. (2024) Schizophrenia and types of stroke: A Mendelian randomization study. Journal of the American Heart Association, 13, (doi: 10.1161/JAHA.123.032011)

Ferreira, J. P., Packer, M., Sattar, N., Butler, J., Pocock, S. J., Anker, S. D., Maldonado, S. G., Panova‐Noeva, M., Sumin, M., Masson, S., Zannad, F., Januzzi, J. L. (2024) Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: the EMPEROR programme. European Journal of Heart Failure, (doi: 10.1002/ejhf.3166)

Grobbee, D. E., Filippatos, G., Desai, N. R., Coats, A. J.S., Pinto, F., Rosano, G. M.C., Cleland, J., Kammerer, J., Ramirez de Arellano, A. (2024) Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Failure, (doi: 10.1002/ehf2.14661)

Cleland, J. G.F., Pellicori, P., Lakhal-Littleton, S. (2024) Low serum ferritin might predict incident heart failure but why and is it clinically useful? JACC: Heart Failure, 12, pp. 549-551. (doi: 10.1016/j.jchf.2023.12.012)

Sliwa, K., van der Meer, P., Viljoen, C., Jackson, A. M., Petrie, M. C., Mebazaa, A., Hilfiker-Kleiner, D., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Tavazzi, L., Roos-Hesselink, J. W., Hamdan, R., Frogoudaki, A., Ibrahim, B., Farhan, H. A. F., Mbakwem, A., Seferovic, P., Böhm, M., Pieske, B., Johnson, M. R., Bauersachs, J. (2024) Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry. International Journal of Cardiology, 398, (doi: 10.1016/j.ijcard.2023.131596)

Olowoyo, P. et al. (2024) ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa. Journal of Human Hypertension, 38, pp. 193-199. (doi: 10.1038/s41371-024-00903-8)

Ferguson, L. D., Molenberghs, G., Verbeke, G., Rahimi, K., Rao, S., McInnes, I. B., McMurray, J. J.V., Sattar, N., Conrad, N. (2024) Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatology, 6, pp. e156-e167. (doi: 10.1016/S2665-9913(23)00338-7)

Deo, S. V., Al-Kindi, S., Motairek, I., McAllister, D., Shah, A. S.V., Elgudin, Y. E., Gorodeski, E. Z., Virani, S., Petrie, M. C., Rajagopalan, S., Sattar, N. (2024) Impact of residential social deprivation on prediction of heart failure in patients with type 2 diabetes: External validation and recalibration of the WATCH-DM score using real world data. Circulation: Cardiovascular Quality and Outcomes, 17, pp. 267-276. (doi: 10.1161/circoutcomes.123.010166)

Bosserdt, M. et al. (2024) Age and computed tomography and invasive coronary angiography in stable chest pain: a prespecified secondary analysis of the discharge randomized clinical trial. JAMA Cardiology, 9, pp. 346-356. (doi: 10.1001/jamacardio.2024.0001)

Rudd, A. E., Horgan, G., Khan, H., Gamble, D. T., McGowan, J., Sood, A., McGeoch, R., Irving, J., Watt, J., Leslie, S. J., Petrie, M., Lang, C., Mills, N. L., Newby, D. E., Dawson, D. K. (2024) Cardiovascular and noncardiovascular prescribing and mortality after takotsubo comparison with myocardial infarction and general population. JACC: Advances, 3, (doi: 10.1016/j.jacadv.2023.100797)

Osmanska, J., Petrie, M. C., Campbell, R. T. (2024) Reply: subcutaneous furosemide patch: heart failure decongestion "from the comfort of your home" European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvae015)

Mellbin, L. G., Bhatt, D. L., David, J.-P., Ekström, K., Petrie, M. C., Rasmussen, S., Vilsbøll, T. (2024) Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials. European Heart Journal, 45, pp. 1371-1374. (doi: 10.1093/eurheartj/ehae028)

Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, (doi: 10.1038/s43856-024-00455-5)

Rossitto, G., Bertoldi, G., Rutkowski, J. M., Mitchell, B. M., Delles, C. (2024) Sodium, interstitium, lymphatics, and hypertension - A tale of hydraulics: Salt series. Hypertension, (doi: 10.1161/HYPERTENSIONAHA.123.17942)

Pellicori, P., Felker, G. M., Cleland, J. G.F. (2024) Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’ European Journal of Heart Failure, 26, pp. 528-528. (doi: 10.1002/ejhf.3159)

Al Kandari, J., Al Ozairi, E., Irshad, M., Varghese, A., Gray, S. R. (2024) Association of physical activity metrics with glucose variability in people with type 1 diabetes: a cross sectional study. European Journal of Sport Science, 24, pp. 210-216. (doi: 10.1002/ejsc.12062)

Friedman, D. J., Olivas-Martinez, A., Dalgaard, F., Fudim, M., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Ali-Ahmed, F., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Relationship between sex, body size, and cardiac resynchronization therapy benefit: a patient level meta-analysis of randomized controlled trials. Heart Rhythm, (doi: 10.1016/j.hrthm.2024.01.058)

Manyara, A. M., Mwaniki, E., Gill, J. M.R., Gray, C. M. (2024) Perceptions of diabetes risk and prevention in Nairobi, Kenya: a qualitative and theory of change development study. PLoS ONE, 19, (doi: 10.1371/journal.pone.0297779)

UK HFpEF Collaborative Group, , , (2024) Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry. Heart, 110, pp. 359-365. (doi: 10.1136/heartjnl-2023-323049)

Black, N., Bradley, J., Lewis, G., Lagan, J., Orsborne, C., Soltani, F., Farrant, J. P., McDonagh, T., Schmitt, M., Cavalcante, J. L., Ugander, M., Butler, J., Petrie, M. C., Miller, C. A., Schelbert, E. B. (2024) Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials. medRxiv, (doi: 10.1101/2024.02.07.24302443)

Lakhal-Littleton, S., Cleland, J. G. F. (2024) Iron deficiency and supplementation in heart failure. Nature Reviews Cardiology, (doi: 10.1038/s41569-024-00988-1)

Goldie, F. C., Lee, M. M. Y., Coats, C. J., Nordin, S. (2024) Advances in multi-modality imaging in hypertrophic cardiomyopathy. Journal of Clinical Medicine, 13, (doi: 10.3390/jcm13030842)

Raisi, A., Boonpor, J., Breheny, M., Vasquez, J., Matus, C., Diaz-Martinez, X., Pell, J. P., Ho, F. H., Celis-Morales, C. (2024) Association of stair use with risk of major chronic diseases. American Journal of Preventive Medicine, 66, pp. 324-332. (doi: 10.1016/j.amepre.2023.10.007)

Welsh, P., Al Zabiby, A., Byrne, H., Benbow, H. R., Itani, T., Farries, G., Costa-Scharplatz, M., Ferber, P., Martin, L., Brown, R., Fonseca, A. F., Sattar, N. (2024) Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: a cohort study from the UK biobank. Atherosclerosis, 389, (doi: 10.1016/j.atherosclerosis.2023.117437)

Chybowska, A. D., Gadd, D. A., Cheng, Y., Bernabeu, E., Campbell, A., Walker, R. M., McIntosh, A. M., Wrobel, N., Murphy, L., Welsh, P., Sattar, N., Price, J. F., McCartney, D. L., Evans, K. L., Marioni, R. E. (2024) Epigenetic contributions to clinical risk prediction of cardiovascular disease. Circulation: Genomic and Precision Medicine, 17, (doi: 10.1161/CIRCGEN.123.004265)

Ammirati, E., Marchetti, D., Colombo, G., Pellicori, P., Gentile, P., D’Angelo, L., Masciocco, G., Verde, A., Macera, F., Brunelli, D., Occhi, L., Musca, F., Perna, E., Bernasconi, D. P., Moreo, A., Camici, P., Metra, M., Oliva, F., Garascia, A. (2024) Estimation of right atrial pressure by ultrasound-assessed jugular vein distensibility in patients with heart failure. Circulation: Heart Failure, 17, (doi: 10.1161/CIRCHEARTFAILURE.123.010973)

Butt, J. H., McDowell, K., Kondo, T., Desai, A. S., Lefkowitz, M. P., Packer, M., Petrie, M. C., Pfeffer, M. A., Rouleau, J. L., Vaduganathan, M., Zile, M. R., Jhund, P. S., Køber, L., Solomon, S., McMurray, J. J.V. (2024) Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan. ESC Heart Failure, 11, pp. 65-77. (doi: 10.1002/ehf2.14558)

Bull, C. J. et al. (2024) Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine, 100, (doi: 10.1016/j.ebiom.2024.104977)

Olowoyo, P. et al. (2024) Priorities to reduce the burden of hypertension in Africa through ACHIEVE. Lancet Global Health, 12, pp. e192-e193. (doi: 10.1016/S2214-109X(23)00540-5)

Pellicori, P., Cleland, J. G.F. (2024) Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good? European Journal of Heart Failure, (doi: 10.1002/ejhf.3148)

Omerovic, E., Petrie, M., Redfors, B., Fremes, S., Murphy, G., Marquis-Gravel, G., Lansky, A., Velazquez, E., Perera, D., Reid, C., Smith, J., van der Meer, P., Lipsic, E., Juni, P., McMurray, J., Bauersachs, J., Køber, L., Rouleau, J. L., Doenst, T. (2024) Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-pragmatic research and innovation through multinational experimentation. Trials, 25, (doi: 10.1186/s13063-024-07935-y)

Petrie, M. C., Rouleau, J. L., Claggett, B., Jering, K., van der Meer, P., Køber, L., Miao, Z. M., Lewis, E., Granger, C., De Pasqulae, C. G., Mann, D., Steg, P. G., Maggioni, A., Amir, O., Lefkowitz, M., Braunwald, E., Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A. (2024) Pulmonary congestion and left ventricular dysfunction after myocardial infarction: insights from the PARADISE-MI trial. Circulation, 149, pp. 335-38. (doi: 10.1161/CIRCULATIONAHA.123.066163)

Farhat, G., Mellor, D. D., Sattar, N., Harvie, M., Issa, B., Rutter, M. K. (2024) Effectiveness of lifestyle interventions/culturally bespoke programmes in South Asian ethnic groups targeting weight loss for prevention and/or remission of type 2 diabetes: A systematic review and meta‐analysis of intervention trials. Journal of Human Nutrition and Dietetics, (doi: 10.1111/jhn.13279)

Mary, S., Conti-Ramsden, F., Boder, P., Parveen, H., Setjiadi, D., Fleminger, J., Brockbank, A., Graham, D., Bramham, K., Chappell, L. C., Delles, C. (2024) Pregnancy-associated changes in urinary uromodulin excretion in chronic hypertension. Journal of Nephrology, (doi: 10.1007/s40620-023-01830-6)

Kosiborod, M. N., Verma, S., Borlaug, B. A., Butler, J., Davies, M. J., Jon Jensen, T., Rasmussen, S., Erlang Marstrand, P., Petrie, M. C., Shah, S. J., Ito, H., Schou, M., Melenovský, V., Abhayaratna, W., Kitzman, D. W., STEP-HFpEF Trial Committees and Investigators, (2024) Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial. Circulation, 149, pp. 204-216. (doi: 10.1161/circulationaha.123.067505)

Cuthbert, J. J., Brown, O. I., Pellicori, P., Dobbs, K., Bulemfu, J., Kazmi, S., Sokoreli, I., Pauws, S. C., Riistama, J. M., Cleland, J. G.F., Clark, A. L. (2024) Medicines optimization prior to discharge in patients admitted to hospital with heart failure. ESC Heart Failure, (doi: 10.1002/ehf2.14638)

Pellicori, P., Hunter, D., Khin, H. H. E., Cleland, J. G.F. (2024) How to diagnose and treat venous congestion in heart failure. European Heart Journal, (doi: 10.1093/eurheartj/ehad883)

Kharlamov, A., Sherriff, N., Delles, C., van der Harst, P. (2024) Tackling cardiovascular healthcare disparities for LGBTQIA+ population: a call to action in the European Society of Cardiology. European Heart Journal, (doi: 10.1093/eurheartj/ehad882)

Pellicori, P., Cleland, J. G.F. (2024) Atrial myopathy and HFpEF - when a label does more harm than good. European Journal of Heart Failure,

Osmanska, J., Brooksbank, K., Docherty, K. F., Robertson, S., Wetherall, K., McConnachie, A., Hu, J., Gardner, R. S., Clark, A. L., Squire, I. B., Kalra, P. R., Jhund, P. S., Muntendam, P., McMurray, J. J.V., Petrie, M. C., Campbell, R. T. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073)

Zeitler, E. P., Dalgaard, F., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Friedman, D. J., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D., Al-Khatib, S. M. (2024) Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis. American Heart Journal, 267, pp. 81-90. (doi: 10.1016/j.ahj.2023.11.002)

Cleland, J. G. F. (2024) Defining iron deficiency in patients with heart failure. Nature Reviews Cardiology, 21, pp. 1-2. (doi: 10.1038/s41569-023-00951-6)

Lee, M. M.Y., Kondo, T., Campbell, R. T., Petrie, M. C., Sattar, N., Solomon, S. D., Vaduganathan, M., Jhund, P. S., McMurray, J. J.V. (2024) Effects of Renin-Angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomised controlled trials. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 68-80. (doi: 10.1093/ehjcvp/pvad067)

Sofianopoulou, E. et al. (2024) Estimating dose—response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and revised Mendelian randomization analyses. Lancet Diabetes and Endocrinology, 12, pp. E2-E11. (doi: 10.1016/S2213-8587(23)00287-5)

Chivardi, C. et al. (2024) Percutaneous revascularization for ischemic left ventricular dysfunction: Cost-effectiveness analysis of the REVIVED-BCIS2 trial. Circulation: Cardiovascular Quality and Outcomes, 17, (doi: 10.1161/circoutcomes.123.010533)

Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W.-Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., Jouravskaya, I., Murphy, M. A. (2024) Continued treatment with Tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA: Journal of the American Medical Association, 331, pp. 38-48. (doi: 10.1001/jama.2023.24945)

Monzo, L., Girerd, N., Ferreira, J. P., Lamiral, Z., Anker, S. D., Cleland, J. G. F., Kondo, T., McMurray, J. J. V., Lam, C. S. P., Mehra, M. R., van Veldhuisen, D. J., Greenberg, B., Zannad, F. (2024) High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm: risk prediction score analysis from the COMMANDER-HF trial. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2023.11.020)

2023

Caiazzo, E., Sharma, M., Rezig, A. O.M., Morsay, M. I., Czesnikiewicz-Guzik, M., Ialenti, A., Sulicka-Grodzicka, J., Pellicori, P., Crouch, S. H., Schutte, A. E., Bruzzese, D., Maffia, P., Guzik, T. J. (2023) Circulating cytokines and risk of developing hypertension: a systematic review and meta-analysis. Pharmacological Research, 200, (doi: 10.1016/j.phrs.2023.107050)

Lee, M. M.Y., Lean, M. E.J., Sattar, N., Petrie, M. C. (2023) Appetite and its regulation: Are there palatable interventions for heart failure? Current Heart Failure Reports, 21, pp. 1-4. (doi: 10.1007/s11897-023-00637-7)

Kosiborod, M. N., Borlaug, B. A., Petrie, M. C. (2023) Semaglutide and heart failure with preserved ejection fraction and obesity. Reply. New England Journal of Medicine, 389, pp. 2398-2399. (doi: 10.1056/NEJMc2312296)

Nazar, G., Díaz-Toro, F., Concha-Cisternas, Y., Leiva-Ordoñez, A. M., Troncoso-Pantoja, C., Celis-Morales, C., Petermann-Rocha, F. (2023) Latent class analyses of multimorbidity and all-cause mortality: A prospective study in Chilean adults. PLoS ONE, 18, (doi: 10.1371/journal.pone.0295958)

Bagordo, D., Rossi, G. P., Delles, C., Wiig, H., Rossitto, G. (2023) The tangram of sodium and fluid balance: salt series. Hypertension, (doi: 10.1161/HYPERTENSIONAHA.123.19569)

Donin, A., Nightingale, C. M., Sattar, N., Fraser, W. D., Owen, C. G., Cook, D. G., Whincup, P. H. (2023) Cross-sectional study of the associations between circulating vitamin D concentrations and insulin resistance in children aged 9-10 years of South Asian, black African Caribbean and white European origins. Journal of Epidemiology and Community Health, (doi: 10.1136/jech-2023-220626)

Neupane, D., Mukhtar, Q., Krajan Pardo, E. K., Acharya, S. D., Delles, C., Sharman, J. E., Cobb, L., Lackland, D. T., Moran, A., Weber, M. A., Olsen, M. H. (2023) Emerging Authors Program for building cardiovascular disease prevention and management research capacity in low- and middle-income countries: a collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League. Journal of Human Hypertension, pp. -023. (doi: 10.1038/s41371-023-00880-4)

Welsh, P., Kimenai, D. M., Shah, A. S.V., Gadd, D. A., Marioni, R. E., Woodward, M., Sudlow, C. L.M., Campbell, A., Cleland, J. G.F., Pellicori, P., Hayward, C., Mills, N. L., Sattar, N. (2023) Multiple cardiac biomarkers to improve prediction of cardiovascular events: findings from the Generation Scotland Scottish Family Health Study. Clinical Chemistry, 70, pp. 403-413. (doi: 10.1093/clinchem/hvad205)

Foster, H. M.E., Polz, P., Gill, J. M.R., Celis-Morales, C., Mair, F. S., O'Donnell, C. A. (2023) The influence of socioeconomic status on the association between unhealthy lifestyle factors and adverse health outcomes: A systematic review. Wellcome Open Research, 8, (doi: 10.12688/wellcomeopenres.18708.2)

Lee, M. M.Y., Masri, A. (2023) Correction to: Differentiating cardiac troponin levels during cardiac myosin inhibition or cardiac myosin activation treatments: drug effect or the canary in the coal mine? Current Heart Failure Reports, (doi: 10.1007/s11897-023-00639-5)

Connelly, P., Osmanska, J., Lee, M. M.Y., Delles, C., McEntegart, M. B., Byrne, J. (2023) A case report of myocardial infarction in a young transgender man with testosterone therapy? raising awareness on healthcare issues in the transgender community and a call for further research. European Heart Journal: Case Reports, 7, (doi: 10.1093/ehjcr/ytad562)

Chong, H. Y., McNamee, P., Bachmair, E.-M., Martin, K., Aucott, L., Dhaun, N., Dures, E., Emsley, R., Gray, S. R., Kidd, E., Kumar, V., Lovell, K., MacLennan, G., Norrie, J., Paul, L., Packham, J., Ralston, S. H., Siebert, S., Wearden, A., LIFT study group, , Macfarlane, G., Basu, N. (2023) Cost-effectiveness of cognitive behavioural and personalised exercise interventions for reducing fatigue in inflammatory rheumatic diseases. Rheumatology, 62, pp. 3819-3827. (doi: 10.1093/rheumatology/kead157)

Lee, M. M. Y., Masri, A. (2023) Differentiating cardiac troponin levels during cardiac myosin inhibition or cardiac myosin activation treatments: drug effect or the canary in the coal mine? Current Heart Failure Reports, 20, pp. 504-518. (doi: 10.1007/s11897-023-00620-2)

Zahir Anjum, D., Strange, J. E., Fosbøl, E., Garred, C. H., Malik, M. E., Andersson, C., Jhund, P. S., McMurray, J. J.V., Petrie, M. C., Kober, L., Schou, M. (2023) Initiation of medical therapy for heart failure patients according to kidney function: a Danish nationwide study. Clinical Epidemiology, 15, pp. 855-866. (doi: 10.2147/clep.s412787)

Nazar, G., Díaz-Toro, F., Petermann-Rocha, F., Lanuza, F., Troncoso, C., Leiva-Ordóñez, A. M., Concha-Cisternas, Y., Celis, C. M. (2023) Multimorbidity and 11-year mortality in adults: a prospective analysis using the Chilean National Health Survey. Health Promotion International, 38, (doi: 10.1093/heapro/daad176)

Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7, pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)

Petermann-Rocha, F., Carrasco-Marín, F., Boonpor, J., Parra-Soto, S., Shannon, O., Malcomson, F., Phillips, N., Jain, M., Deo, S., Livingstone, K. M., Dingle, S. E., Mathers, J. C., Forrest, E., Ho, F. K., Pell, J. P., Celis-Morales, C. (2023) Association of five diet scores with severe NAFLD incidence: a prospective study from UK Biobank. Diabetes, Obesity and Metabolism, (doi: 10.1111/dom.15378)

Pellicori, P., Cleland, J. G.F., Borentain, M., Taubel, J., Graham, F., Khan, J., Bruzzese, D., Kessler, P., McMurray, J. J.V., Voors, A. A., O’Connor, C. M., Teerlink, J. R., Felker, G. M. (2023) Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS‐986231) European Journal of Heart Failure, (doi: 10.1002/ejhf.3077)

Malcomson, F. C., Parra-Soto, S., Lu, L., Ho, F., Celis-Morales, C., Sharp, L., Mathers, J. C. (2023) Socio-demographic variation in adherence to the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations within the UK Biobank prospective cohort study. Journal of Public Health, (doi: 10.1093/pubmed/fdad218)

Foster, H. M.E., Gill, J. M.R., Mair, F. S., Celis-Morales, C. A., Jani, B. D., Nicholl, B. I., Lee, D., O'Donnell, C. A. (2023) Social connection and mortality in UK Biobank: a prospective cohort analysis. BMC Medicine, 21, (doi: 10.1186/s12916-023-03055-7)

Ferguson, L., McInnes, I.B., Sattar, N., Conrad, N. (2023) Gout is Associated with Increased Cardiovascular Risk: Results from Analysis of the CPRD Dataset. (doi: 10.1093/eurheartj/ehad655.2771)

Desson, Z., Sharman, J. E., Searles, A., Schutte, A. E., Delles, C., Olsen, M. H., Ordunez, P., Hure, A., Morton, R., Figtree, G., Webster, J., Jennings, G., Redfern, J., Nicolls, S., McNamara, M., Deeming, S., Doyle, K., Ramanathan, S. (2023) Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study. Journal of Human Hypertension, (doi: 10.1038/s41371-023-00866-2)

McDowell, K., Adamson, C., Jackson, C., Campbell, R., Welsh, P., Petrie, M. C., McMurray, J. J.V., Jhund, P., Herring, N. (2023) Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes. European Journal of Heart Failure, (doi: 10.1002/ejhf.3085)

Ray, R., Ford, I., Cleland, J. G.F., Graham, F., Ahmed, F. Z., Al-Mohammad, A., Cowburn, P. J., Critoph, C., Kalra, P. A., Lane, R. E., Ludman, A., Pellicori, P., Petrie, M. C., Robertson, M., Seed, A., Squire, I., Kalra, P. R. (2023) The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2023.10.006)

Malcomson, F. C., Parra-Soto, S., Ho, F., Celis-Morales, C., Sharp, L., Mathers, J. C. (2023) Abbreviated score to assess adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations and risk of cancer in the UK Biobank. Cancer Epidemiology, Biomarkers and Prevention, (doi: 10.1158/1055-9965.EPI-23-0923)

Petermann-Rocha, F., Deo, S., Lyall, D., Orkaby, A. R., Quinn, T. J., Sattar, N., Celis-Morales, C., Pell, J. P., Ho, F. K. (2023) Association between the AHA Life's Essential 8 score and incident all-cause dementia: a prospective cohort study from UK Biobank. Current Problems in Cardiology, 48, (doi: 10.1016/j.cpcardiol.2023.101934)

Murphy, C. N., Delles, C., Davies, E., Connelly, P. J. (2023) Cardiovascular disease in transgender individuals. Atherosclerosis, 384, (doi: 10.1016/j.atherosclerosis.2023.117282)

Purcell, C., Purvis, A., Cleland, J. G.F., Cowie, A., Dalal, H. M., Ibbotson, T., Murphy, C., Taylor, R. S. (2023) Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study) European Journal of Cardiovascular Nursing, 22, pp. 804-813. (doi: 10.1093/eurjcn/zvad004)

Sattar, N., Taheri, S., Astling, D. P., Chadwick, J., Hinterberg, M. A., Holmes, M. V., Troth, E. V., Welsh, P., Zaghloul, H., Chagoury, O., Lean, M., Taylor, R., Williams, S. (2023) Prediction of cardiometabolic health through changes in plasma proteins with intentional weight loss in the DiRECT and DIADEM-I randomised clinical trials of type 2 diabetes remission. Diabetes Care, 46, pp. 1949-1957. (doi: 10.2337/dc23-0602)

Ranglani, S., Ward, J., Sattar, N., Strawbridge, R. J., Lyall, D. M. (2023) Testing for associations between HbA1c levels, polygenic risk and brain health in UK Biobank (N = 39 283) Diabetes, Obesity and Metabolism, 25, pp. 3136-3143. (doi: 10.1111/dom.15207)

Irshad, Z., Lund, J., Sillars, A., Løvsletten, N. G., Gharanei, S., Salt, I. P., Freeman, D. J., Gill, J. M.R., Thoresen, G. H., Rustan, A. C., Zammit, V. A. (2023) The roles of DGAT1 and DGAT2 in human myotubes are dependent on donor patho-physiological background. FASEB Journal, 37, (doi: 10.1096/fj.202300960RR)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2023) Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study. European Heart Journal: Quality of Care and Clinical Outcomes, 9, pp. 731-739. (doi: 10.1093/ehjqcco/qcac073)

Boonpor, J., Pell, J. P., Ho, F. K., Celis-Morales, C., Gray, S. R. (2023) In people with type 2 diabetes sarcopenia is associated with the incidence of cardiovascular disease: a prospective cohort study from the UK Biobank. Diabetes, Obesity and Metabolism, (doi: 10.1111/dom.15338)

Roberts, C., Phillips, L., Cooper, C., Gray, S., Soiza, R., Allan, J. (2023) Classifying the non-metabolic demands of different physical activity types: the Physical Activity Demand (PAD) typology. PLoS ONE, 18, (doi: 10.1371/journal.pone.0291782)

Parra-Soto, S., Araya, C., Knight, K., Livingstone, K. M., Malcomson, F. C., Sharp, L., Mathers, J. C., Ho, F. K., Celis-Morales, C., Pell, J. P. (2023) Different sources of fiber intake and risk of 17 specific cancers and all cancers combined: prospective study of 364,877 participants in UK Biobank. American Journal of Epidemiology, (doi: 10.1093/aje/kwad202)

Phillips, N., Gray, S. R., Combet, E., Witard, O. C. (2023) Long-chain n-3 polyunsaturated fatty acids for the management of age- and disease- related declines in skeletal muscle mass, strength and physical function. Current Opinion in Clinical Nutrition and Metabolic Care,

Glen, C., Adam, S., McDowell, K., Waterston, A., Tan, Y. Y., Petrie, M. C., Coats, C. J., Lang, N. N. (2023) Cardiotoxicity of BRAF/MEK inhibitors: a longitudinal study incorporating contemporary definitions and risk scores. JACC: CardioOncology, 5, pp. 628-637. (doi: 10.1016/j.jaccao.2023.04.004)

Jackson, A., Bauersachs, J., Petrie, M. C., van der Meer, P., Laroche, C., Farhan, H. A., Frogoudaki, A., Ibrahim, B., Fouad, D. A., Damasceno, A., Karaye, K., Goland, S., Maggioni, A. P., Briton, O., Sliwa, K. (2023) Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM Registry. European Journal of Heart Failure, (doi: 10.1002/ejhf.3055)

Jackson, A. M., Macartney, M., Brooksbank, K., Brown, C., Dawson, D., Francis, M., Japp, A., Lennie, V., Leslie, S. J., Martin, T., Neary, P., Venakatasubramanian, S., Vickers, D., Weir, R. A., McMurray, J. J.V., Jhund, P. S., Petrie, M. C. (2023) A 20-year population study of peripartum cardiomyopathy. European Heart Journal, (doi: 10.1093/eurheartj/ehad626)

Chico, T. J., Stamatakis, E., Ciravegna, F., Dunn, J., Redwood, S., Al-lamee, R., Sofat, R., Gill, J. (2023) Device-based measurement of physical activity in cardiovascular healthcare: possibilities and challenges. British Journal of Sports Medicine, 57, pp. 1225-1226. (doi: 10.1136/bjsports-2022-106460)

Stamatakis, E., Ahmadi, M., Murphy, M. H., Chico, T. J., Milton, K., Del Pozo Cruz, B., Katzmarzyk, P. T., Lee, I.-M., Gill, J. (2023) Journey of a thousand miles: from ‘Manpo-Kei’ to the first steps-based physical activity recommendations. British Journal of Sports Medicine, 57, pp. 1227-1228. (doi: 10.1136/bjsports-2023-106869)

Gill, J. M. R., Chico, T. J., Doherty, A., Dunn, J., Ekelund, U., Katzmarzyk, P. T., Milton, K., Murphy, M. H., Stamatakis, E. (2023) Potential impact of wearables on physical activity guidelines and interventions: Opportunities and challenges. British Journal of Sports Medicine, 57, pp. 1223-1225. (doi: 10.1136/bjsports-2023-106822)

McDonagh, T. A. et al. (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 44, pp. 3627-3639. (doi: 10.1093/eurheartj/ehad195)

Boonpor, J., Parra-Soto, S., Talebi, A., Zhou, Z., Carrasco-Marín, F., Petermann-Rocha, F., Welsh, P., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R., Celis-Morales, C., Ho, F. K. (2023) Associations and predictive performance of eleven anthropometric measures with incident type 2 diabetes: a prospective cohort study from the UK Biobank. Obesity, 31, pp. 2648-2657. (doi: 10.1002/oby.23849)

Ahmadi, M. N., Hamer, M., Gill, J., Murphy, M., Sanders, J. P., Doherty, A., Stamatakis, E. (2023) Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality in people who do not exercise: a prospective cohort study. Lancet Public Health, 8, pp. e800-e810. (doi: 10.1016/S2468-2667(23)00183-4)

Malik, M. E., Butt, J. H., Strange, J. E., Falkentoft, A. C., Jensen, J., Andersson, C., Zahir, D., Fosbøl, E., Petrie, M. C., Sattar, N., McMurray, J. J.V., Køber, L., Schou, M. (2023) Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study. Lancet Healthy Longevity, 4, pp. e552-e560. (doi: 10.1016/S2666-7568(23)00164-2)

Cuthbert, J. J., Cleland, J. G.F. (2023) Should we resurrect acetazolamide as a diuretic for congestion due to heart failure? Cardiovascular Research, 119, pp. e149-e151. (doi: 10.1093/cvr/cvad148)

Wei, L., Phillippo, D. M., Shah, A., Cleland, J. G.F., Lewsey, J., McAllister, D. A. (2023) Transportability of two heart failure trials to a disease registry using individual patient data. Journal of Clinical Epidemiology, 162, pp. 160-168. (doi: 10.1016/j.jclinepi.2023.08.019)

Meyer, B. J., Cortie, C., Dekker-Nitert, M., Barrett, H. L., Freeman, D. J. (2023) Women with gestational diabetes mellitus, controlled for plasma glucose level, exhibit maternal and fetal dyslipidaemia that may warrant treatment. Diabetes Research and Clinical Practice, 204, (doi: 10.1016/j.diabres.2023.110929)

Flett, A., Cebula, A., Nicholas, Z., Adam, R., Ewings, S., Prasad, S., Cleland, J. G.F., Eminton, Z., Curzen, N. (2023) Rationale and study protocol for the BRITISH randomised trial (using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with non-ischaemic cardiomyopathy and severe systolic heart failure) American Heart Journal, (doi: 10.1016/j.ahj.2023.09.008)

Logan, G., Somers, C., Baker, G., Connell, H., Gray, S., Kelly, P., McIntosh, E., Welsh, P., Gray, C., Gill, J. M. (2023) Benefits, risks, barriers, and facilitators to cycling: a narrative review. Frontiers in Sports and Active Living, 5, (doi: 10.3389/fspor.2023.1168357)

Krasuska, M., Davidson, E. M., Beune, E., Jenum, A. K., Gill, J. M.R., Stronks, K., van Valkengoed, I. G.M., Diaz, E., Sheikh, A. (2023) A culturally adapted diet and physical activity text message intervention to prevent Type 2 diabetes mellitus for women of Pakistani origin living in Scotland: formative study. JMIR Formative Research, 7, pp. e33810. (doi: 10.2196/33810)

Richardson, J., Sattar, N., AlOzairi, E., Dawwas, B., Raj, J., Nappoe, A., Alshammari, S., Patil, S. (2023) Within an International Research Project, Visits to Collaborator Sites Informs Staff Training Needs, and Contributes to Successful Project Delivery.

Perera, D. et al. (2023) Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: Prespecified analyses from the REVIVED-BCIS2 trial. Circulation: Heart Failure, 148, pp. 862-871. (doi: 10.1161/circulationaha.123.065300)

de Beer, D., MC. Mels, C., Schutte, A., Delles, C., Mary, S., Mullen, W., Mischak, H., Kruger, R. (2023) Urinary peptidomics and pulse wave velocity: The African-PREDICT study. Journal of Proteome Research, 22, pp. 3282-3289. (doi: 10.1021/acs.jproteome.3c00347)

Fudim, M., Dalgaard, F., Friedman, D. J., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Ali-Ahmed, F., Tang, A., Olivas-Martinez, A., Inoue, L. Y.T., Al-Khatib, S. M., Sanders, G. D. (2023) Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trials. European Journal of Heart Failure, (doi: 10.1002/ejhf.3029)

Malcomson, F. C., Wiggins, C., Parra‐Soto, S., Ho, F. K., Celis‐Morales, C., Sharp, L., Mathers, J. C. (2023) Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and cancer risk: a systematic review and meta‐analysis. Cancer, 129, pp. 2655-2670. (doi: 10.1002/cncr.34842)

Graham, F. J., Friday, J., Pellicori, P., Greenlaw, N., Cleland, J. G.F. (2023) Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart, 109, pp. 1294-1301. (doi: 10.1136/heartjnl-2022-322145)

Ho, F. K., Wirth, M. D., Parra-Soto, S., Boonpor, J., Zhou, Z., Petermann-Rocha, F., Nakada, S., Livingstone, K. M., Mathers, J. C., Pell, J. P., Hébert, J. R., Celis-Morales, C. (2023) Dose-response associations of dietary inflammatory potential with health outcomes: a prospective cohort study of 198,265 UK Biobank participants. Current Problems in Cardiology, 48, (doi: 10.1016/j.cpcardiol.2023.101774)

Tromp, J., Ezekowitz, J. A., Ouwerkerk, W., Chandramouli, C., Yiu, K. H., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Collins, S. P., Filippatos, G., Cleland, J. G. F., Lam, C. S. P. (2023) Global variations according to sex in patients hospitalized for heart failure in the REPORT-HF registry. JACC: Heart Failure, 11, pp. 1262-1271. (doi: 10.1016/j.jchf.2023.06.028)

Brennan, A. C., Campbell, R. T., Lee, M. M.Y. (2023) Influenza vaccination: a simple, safe, and effective treatment for patients with ischaemic heart disease and heart failure. European Journal of Heart Failure, 25, pp. 1693-1695. (doi: 10.1002/ejhf.2993)

Osadnik, K. et al. (2023) Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies. European Journal of Preventive Cardiology, 30, pp. 1195-1204. (doi: 10.1093/eurjpc/zwad101)

Morris, A., Bright, C., Cocks, M., Gibson, N., Goff, L., Greaves, C., Griffin, S., Jane, B., Kinnafick, F., Robb, P., Roberts, M., Salman, D., Saxton, J., Taylor, A., West, D., Yates, T., Andrews, R. C., Gill, J. M.R. (2023) Recommendations from Diabetes UK's 2022 diabetes and physical activity workshop. Diabetic Medicine, 40, (doi: 10.1111/dme.15169)

Al Ozairi, E., ElSamad, A., Al Kandari, J., Hamdan, Y., Taliping, D., Gray, S. R. (2023) The effect of timing of remotely supervised exercise on glucose control in people with type 1 diabetes during Ramadan: a randomised crossover study. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 17, (doi: 10.1016/j.dsx.2023.102845)

Taquet, M. et al. (2023) Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nature Medicine, (doi: 10.1038/s41591-023-02525-y)

Borlaug, B. A. et al. (2023) Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature Medicine, 29, pp. 2358-2365. (doi: 10.1038/s41591-023-02526-x)

Harrington, J., Udell, J. A., Jones, W. S., Anker, S. D., Bhatt, D. L., Petrie, M. C., Andersen, K. R., Sumin, M., Zwiener, I., Hernandez, A. F., Butler, J. (2023) Baseline characteristics of patients enrolled in the EMPACT‐MI trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2990)

Ioannou, A. et al. (2023) Conventional heart failure therapy in cardiac ATTR amyloidosis. European Heart Journal, 44, pp. 2893-2907. (doi: 10.1093/eurheartj/ehad347)

Yeoh, S. E., Osmanska, J., Petrie, M. C., Brooksbank, K. J.M., Clark, A. L., Docherty, K. F., Foley, P. W.X., Guha, K., Halliday, C. A., Jhund, P. S., Kalra, P. R., McKinley, G., Lang, N. N., Lee, M. M.Y., McConnachie, A., McDermott, J. J., Platz, E., Sartipy, P., Seed, A., Stanley, B., Weir, R. A.P., Welsh, P., McMurray, J. J.V., Campbell, R. T. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44, pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341)

Gray, S., Binmahfoz, A., Timraz, M., Quinn, T. J., Combet Aspray, E., Gray, S. R. (2023) The effect of long chain n-3 fatty acid supplementation on muscle strength in older adults: a systematic review and meta-analysis. Nutrients, 15, (doi: 10.3390/nu15163579)

AI Abel, A., Samuel, N. A., Cuthbert, J. J., Brown, O. I., Pellicori, P., Kazmi, S., Cleland, J. G.F., Johnson, M. J., Clark, A. L. (2023) Hospital admissions in the last year of life of patients with heart failure. European Heart Journal: Quality of Care and Clinical Outcomes, (doi: 10.1093/ehjqcco/qcad047)

Mangion, K., Morrow, A. J., Sykes, R., Kamdar, A., Bagot, C., Bruce, G., Connelly, P., Delles, C., Gibson, V. B., Gillespie, L., Hall Barrientos, P., Lennie, V., Roditi, G., Sattar, N., Stobo, D., Allwood-Spiers, S., McConnachie, A., Berry, C., CISCO-19 investigators, (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, (doi: 10.1186/s12872-023-03412-7)

Haag, L., Richardson, J., Cunningham, Y., Fraser, H., Brosnahan, N., Ibbotson, T., Ormerod, J., White, C., O'Donnell, K., Sattar, N., McConnachie, A., Lean, M. E. J., Blane, D. N., Combet, E. (2023) The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT): protocol for a randomised controlled trial to determine the effectiveness and cost-effectiveness of a remotely delivered supported weight management programme for people with Long COVID and excess weight, with personalised improvement goals. NIHR Open Research, 2, (doi: 10.3310/nihropenres.13315.2)

Jones, R. E. et al. (2023) Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery disease. Nature Cardiovascular Research, 2, pp. 733-745. (doi: 10.1038/s44161-023-00312-z)

Karusheva, Y., Petry, C. J., Yasara, N., Kottahachchi, D., Premawardhena, A., Barker, P., Burling, K., Sattar, N., Welsh, P., Mettananda, S., O'Rahilly, S. (2023) Association of GDF15 levels with body mass index and endocrine status in β-thalassaemia. Clinical Endocrinology, 99, pp. 182-189. (doi: 10.1111/cen.14897)

Docherty, K. F., Jackson, A. M., Macartney, M., Campbell, R. T., Petrie, M. C., Pfeffer, M. A., McMurray, J. J.V., Jhund, P. S. (2023) Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016. European Journal of Heart Failure, 25, pp. 1213-1224. (doi: 10.1002/ejhf.2965)

Zhou, Z., Parra-Soto, S., Boonpor, J., Petermann-Rocha, F., Welsh, P., Mark, P. B., Sattar, N., Pell, J. P., Celis-Morales, C., Ho, F. K. (2023) Exploring the underlying mechanisms linking adiposity and cardiovascular disease: a prospective cohort study of 404,332 UK Biobank participants. Current Problems in Cardiology, 48, (doi: 10.1016/j.cpcardiol.2023.101715)

Docherty, K. F., Lam, C. S.P., Rakisheva, A., Coats, A. J.S., Greenhalgh, T., Metra, M., Petrie, M. C., Rosano, G. M.C. (2023) Heart failure diagnosis in the general community - who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 25, pp. 1185-1198. (doi: 10.1002/ejhf.2946)

Brown, C. E., Casey, H., Dominiczak, A. F., Kerr, S., Campbell, A., Delles, C. (2023) Impact of preeclampsia on cardiovascular events: an analysis of the Generation Scotland: Scottish family health study. Journal of Human Hypertension, 37, pp. 735-741. (doi: 10.1038/s41371-023-00812-2)

Iaconelli, A., Pellicori, P., Caiazzo, E., Rezig, A. O. M., Bruzzese, D., Maffia, P., Cleland, J. G. F. (2023) Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials. Clinical Research in Cardiology, 112, pp. 1007-1019. (doi: 10.1007/s00392-022-02104-0)

Iaconelli, A., Cuthbert, J., Kazmi, S., Maffia, P., Clark, A. L., Cleland, J. G.F., Pellicori, P. (2023) Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity. Clinical Research in Cardiology, 112, pp. 1077-1086. (doi: 10.1007/s00392-023-02178-4)

Connelly, P. J., Delles, C. (2023) Journal of Human Hypertension special issue on sex and gender differences in hypertension. Journal of Human Hypertension, 37, pp. 587-588. (doi: 10.1038/s41371-023-00847-5)

Casey, H., Dennehy, N., Fraser, A., Lees, C., McEniery, C. M., Scott, K., Wilkinson, I. B., Delles, C. (2023) Placental syndromes and maternal cardiovascular health. Clinical Science, 137, pp. 1211-1224. (doi: 10.1042/CS20211130)

de Koning, M.-S. L.Y., Emmens, J. E., Romero-Hernández, E., Bourgonje, A. R., Assa, S., Figarska, S. M., Cleland, J. G.F., Samani, N. J., Ng, L. L., Lang, C. C., Metra, M., Filippatos, G. S., van Veldhuisen, D. J., Anker, S. D., Dickstein, K., Voors, A. A., Lipsic, E., van Goor, H., van der Harst, P. (2023) Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. Clinical Research in Cardiology, 112, pp. 1056-1066. (doi: 10.1007/s00392-023-02171-x)

Gargani, L., Girerd, N., Platz, E., Pellicori, P., Stankovic, I., Palazzuoli, A., Pivetta, E., Miglioranza, M. H., Soliman-Aboumarie, H., Agricola, E., Volpicelli, G., Price, S., Donal, E., Cosyns, B., Neskovic, A. N. (2023) Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) European Heart Journal, (doi: 10.1093/ehjci/jead169)

Mohebi, R., Liu, Y., Hansen, M. K., Yavin, Y., Sattar, N., Pollock, C. A., Butler, J., Jardine, M., Masson, S., Heerspink, H. J. L., Januzzi Jr, J. L. (2023) Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial. Cardiovascular Diabetology, 22, (doi: 10.1186/s12933-023-01916-2)

Docherty, K. F., McDowell, K., Welsh, P., Osmanska, J., Anand, I., de Boer, R. A., Køber, L., Kosiborod, M. N., Martinez, F. A., O’Meara, E., Ponikowski, P., Schou, M., Berg, D. D., Sabatine, M. S., Morrow, D. A., Jarolim, P., Hammarstedt, A., Sjöstrand, M., Langkilde, A. M., Solomon, S. D., Sattar, N., Jhund, P. S., McMurray, J. J.V. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82, pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011)

Nadarajah, R., Younsi, T., Romer, E., Raveendra, K., Nakao, Y., Nakao, K., Shuweidhi, F., Hogg, D., Arbel, R., Zahger, D., Iakobishvili, Z., Fonarow, G. C., Petrie, M. C., Wu, J., Gale, C. P. (2023) Prediction models for heart failure in the community: a systematic review and meta‐analysis. European Journal of Heart Failure, (doi: 10.1002/ejhf.2970)

Graham, F. J., Pellicori, P., Masini, G., Cuthbert, J. J., Clark, A. L., Cleland, J. G.F. (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Failure, (doi: 10.1002/ehf2.14438)

Lee, M. M.Y., Sattar, N. (2023) A review of current key guidelines for managing high risk patients with diabetes and heart failure and future prospects. Diabetes, Obesity and Metabolism, 25, pp. 33-47. (doi: 10.1111/dom.15085)

Boonpor, J., Parra-Soto, S., Gore, J., Talebi, A., Lynskey, N., Raisi, A., Welsh, P., Sattar, N., Pell, J. P., Gill, J. M.R., Gray, S. R., Ho, F. K., Celis-Morales, C. A. (2023) Association between walking pace and incident type 2 diabetes by adiposity levels – a prospective cohort study from the UK Biobank. Diabetes, Obesity and Metabolism, 25, pp. 1900-1910. (doi: 10.1111/dom.15053)

Soltanisarvestani, M., Lynskey, N., Gray, S., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P., Ho, F. K., Celis-Morales, C., Petermann-Rocha, F. (2023) Associations of grip strength and walking pace with mortality in stroke survivors: a prospective study from UK Biobank. Scandinavian Journal of Medicine and Science in Sports, 33, pp. 1190-1200. (doi: 10.1111/sms.14352)

Dowsett, L., Duluc, L., Higgins, E., Alghamdi, F., Fast, W., Salt, I. P., Leiper, J. (2023) Asymmetric dimethylarginine positively modulates calcium-sensing receptor signalling to promote lipid accumulation. Cellular Signalling, 107, (doi: 10.1016/j.cellsig.2023.110676)

Iaconelli, A., Pellicori, P., Dolce, P., Busti, M., Ruggio, A., Aspromonte, N., D'Amario, D., Galli, M., Princi, G., Caiazzo, E., Rezig, A. O.M., Maffia, P., Pecorini, G., Crea, F., Cleland, J. G.F. (2023) Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials. European Journal of Heart Failure, 25, pp. 1170-1175. (doi: 10.1002/ejhf.2911)

Caiazzo, E., Sharma, M., Rezig, A. O., Morsy, M., Ialenti, A., Pellicori, P., Bruzzese, D., Maffia, P., Guzik, T. J. (2023) Inflammatory Cytokines and Risk of Developing Hypertension: A Systematic Review and Meta-Analysis. (doi: 10.1111/bph.16105)

Kondo, T., Jering, K. S., Jhund, P. S., Anand, I. S., Desai, A. S., Lam, C. S.P., Maggioni, A. P., Martinez, F. A., Packer, M., Petrie, M. C., Pfeffer, M. A., Redfield, M. M., Rouleau, J. L., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Solomon, S. D., McMurray, J. J.V. (2023) Predicting stroke in heart failure and preserved ejection fraction without atrial fibrillation. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.010377)

Verma, S., Dhingra, N. K., Bonaca, M. P., Butler, J., Anker, S. D., Ferreira, J. P., Filippatos, G., Januzzi, J. L., Lam, C. S.P., Sattar, N., Iwata, T., Nordaby, M., Brueckmann, M., Pocock, S. J., Packer, M. (2023) Presence of peripheral artery disease is associated with increased risk of heart failure events: insights from EMPEROR-Pooled. Arteriosclerosis, Thrombosis, and Vascular Biology, 43, pp. 1334-1337. (doi: 10.1161/ATVBAHA.123.319156)

Araki, T., Kondo, T., Imaizumi, T., Sumita, Y., Nakai, M., Tanaka, A., Okumura, T., Yang, M., Butt, J. H., Petrie, M. C., Murohara, T. (2023) Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support. American Heart Journal, 261, pp. 109-123. (doi: 10.1016/j.ahj.2023.03.017)

Pugliese, N. R., Pellicori, P., Filidei, F., Del Punta, L., De Biase, N., Balletti, A., Di Fiore, V., Mengozzi, A., Taddei, S., Gargani, L., Mullens, W., Cleland, J. G.F., Masi, S. (2023) The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure. European Heart Journal: Cardiovascular Imaging, 24, pp. 961-971. (doi: 10.1093/ehjci/jeac254)

Bozkurt, B., Savarese, G., Adamsson Eryd, S., Bodegård, J., Cleland, J. G.F., Khordoc, C., Kishi, T., Thuresson, M., Vardeny, O., Zhang, R., Lund, L. H. (2023) Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization: EVOLUTION HF. JACC: Heart Failure, (doi: 10.1016/j.jchf.2023.04.017)

Sattar, N., McMurray, J., Boren, J., Rawshani, A., Omerovic, E., Berg, N., Holminen, J., Skoglund, K., Eliasson, B., Gerstein, H. C., McGuire, D. K., Bhatt, D., Rawshani, A. (2023) Years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study. Circulation, 147, pp. 1872-1886. (doi: 10.1161/CIRCULATIONAHA.122.063374)

Al Ozairi, E., Alsaeed, D., Al Rhoudan, D., Jalali, M., Mashankar, A., Taliping, D., Abdulla, A., Gill, J. M.R., Sattar, N., Welsh, P., Gray, S. R. (2023) The effect of home-based resistance exercise training in people with type 2 diabetes: a randomized controlled trial. Diabetes/Metabolism Research and Reviews, (doi: 10.1002/dmrr.3677)

Cleland, J. G.F., Pellicori, P., Graham, F. J. (2023) Redefining both iron deficiency and anaemia in cardiovascular disease. European Heart Journal, 44, pp. 1992-1994. (doi: 10.1093/eurheartj/ehad154)

Conrad, N., Misra, S., Verbakel, J. Y., Verbeke, G., Molenberghs, G., Taylor, P. N., Mason, J., Sattar, N., McMurray, J. J.V., McInnes, I. B., Khunti, K., Cambridge, G. (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet, 401, pp. 1878-1890. (doi: 10.1016/S0140-6736(23)00457-9)

Markousis-Mavrogenis, G., Minich, W. B., Al-Mubarak, A. A., Anker, S. D., Cleland, J. G.F., Dickstein, K., Lang, C. C., Ng, L. L., Samani, N. J., Zannad, F., Metra, M., Seemann, P., Hoeg, A., Lopez, P., van Veldhuisen, D. J., de Boer, R. A., Voors, A. A., van der Meer, P., Schomburg, L., Bomer, N., The BIOSTAT-CHF Consortium, (2023) Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. Cardiovascular Research, 119, pp. 1690-1705. (doi: 10.1093/cvr/cvad042)

Graham, F., Iaconelli, A., Sonecki, P., Campbell, R. T., Hunter, D., Cleland, J. G.F., Pellicori, P. (2023) Defining heart failure based on imaging the heart and beyond. Cardiac Failure Review, 9, (doi: 10.15420/cfr.2022.29)

Curtain, J. P., Lee, M. M.Y., McMurray, J. J.V., Gardner, R. S., Petrie, M. C., Jhund, P. S. (2023) Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis. Heart, 109, pp. 823-831. (doi: 10.1136/heartjnl-2022-321885)

De Beer, D., Mels, C. M.C., Schutte, A. E., Delles, C., Mary, S., Mullen, W., Latosinska, A., Mischak, H., Kruger, R. (2023) Identifying a urinary peptidomics profile for hypertension in young adults: the African-PREDICT study. Proteomics, 23, (doi: 10.1002/pmic.202200444)

Schreiner, A. D., Sattar, N. (2023) Identifying patients with nonalcoholic fatty liver disease in primary care: how and for what benefit? Journal of Clinical Medicine, 12, (doi: 10.3390/jcm12124001)

Farmakis, D., Tromp, J., Marinaki, S., Ouwerkerk, W., Angermann, C. E., Bistola, V., Dahlstrom, U., Dickstein, K., Ertl, G., Ghadanfar, M., Hassanein, M., Obergfell, A., Perrone, S. V., Polyzogopoulou, E., Schweizer, A., Boletis, I., Cleland, J. G.F., Collins, S. P., Lam, C. S.P., FIlippatos, G. (2023) Impact of left ventricular ejection fraction phenotypes on healthcare-resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. European Journal of Heart Failure, 25, pp. 818-828. (doi: 10.1002/ejhf.2833)

Gard, E. K., Beale, A. L., Telles, F., Silvestry, F. E., Hanff, T., Hummel, S. L., Litwin, S. E., Petrie, M. C., Shah, S. J., Borlaug, B. A., Burkhoff, D., Komtebedde, J., Kaye, D. M., Nanayakkara, S. (2023) Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction. European Journal of Heart Failure, 25, pp. 806-814. (doi: 10.1002/ejhf.2805)

Angelov, A., Connelly, P. J., Delles, C., Kararigas, G. (2023) Sex-biased and sex hormone-dependent regulation of apolipoprotein A1. Current Opinion in Physiology, 33, (doi: 10.1016/j.cophys.2023.100654)

Butcher, C.J.T., Cantor, E., Sohaib, S.M.A., Shun-Shin, M., Haynes, R., Khan, H., Kyriacou, A., Shi, R., Chen, Z., Haldar, S., Cleland, J., Hussain, W., Markides, V., Jones, D., Lane, R.E., Mason, M.J., Whinnett, Z., Francis, D., Wong, T. (2023) Variation in optimal hemodynamic atrio-ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics. Journal of Cardiovascular Electrophysiology, 34, pp. 1431-1440. (doi: 10.1111/jce.15862)

Metra, M. et al. (2023) Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 25, pp. 776-791. (doi: 10.1002/ejhf.2874)

Yeoh, S. E., Docherty, K. F., Campbell, R. T., Jhund, P. S., Hammarstedt, A., Heerspink, H. J.L., Jarolim, P., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Solomon, S. D., Sjöstrand, M., Bengtsson, O., Greasley, P. J., Sattar, N., Welsh, P., Sabatine, M. S., Morrow, D. A., McMurray, J. J.V. (2023) Endothelin-1, outcomes in patients with heart failure and reduced ejection fraction, and effects of dapagliflozin: findings from DAPA-HF. Circulation, 147, pp. 1670-1683. (doi: 10.1161/CIRCULATIONAHA.122.063327)

Lam, C. S. P., Harding, E., Bains, M., Chin, A., Kanumilli, N., Petrie, M. C., Pohja-Hutchison, P., Yang, J., Butler, J. (2023) Identification of urgent gaps in public and policymaker knowledge of heart failure: results of a global survey. BMC Public Health, 23, (doi: 10.1186/s12889-023-15405-4)

Arisido, M. W., Foco, L., Shoemaker, R., Melotti, R., Delles, C., Gögele, M., Barolo, S., Baron, S., Azizi, M., Dominiczak, A. F., Zennaro, M.-C., P. Pramstaller, P., Poglitsch, M., Pattaro, C. (2023) Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies. BMC Medical Research Methodology, 23, (doi: 10.1186/s12874-023-01930-8)

Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Lynskey, N., Cabanas-Sánchez, V., Sattar, N., Gill, J. M.R., Welsh, P., Pell, J. P., Gray, S. R., Ho, F. K., Celis-Morales, C. (2023) Dose–response relationship between device-measured physical activity and incident type 2 diabetes: findings from the UK Biobank prospective cohort study. BMC Medicine, 21, (doi: 10.1186/s12916-023-02851-5)

Aletaha, D. et al. (2023) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases, 82, pp. 773-787. (doi: 10.1136/ard-2022-222784)

Morris, J. G., Celis-Morales, C. A. (2023) Editorial: highlights in physical activity in the prevention and management of disease 2021/22. Frontiers in Sports and Active Living, 5, (doi: 10.3389/fspor.2023.1207393)

Wang, H. et al. (2023) Cardiovascular safety in type 2 diabetes with sulfonylureas as second-line drugs: a nation-wide population-based comparative safety study. Diabetes Care, 46, pp. 967-977. (doi: 10.2337/dc22-1238)

Khan, J., Graham, F. J., Masini, G., Iaconelli, A., Friday, J. M., Lang, C. C., Pellicori, P. (2023) Congestion and use of diuretics in heart failure and cardiomyopathies: a practical guide. Current Cardiology Reports, 25, pp. 411-420. (doi: 10.1007/s11886-023-01865-y)

Wang, Y. et al. (2023) Early-life cardiovascular risk factor trajectories and vascular aging in midlife: a 30-year prospective cohort study. Hypertension, 80, pp. 1057-1066. (doi: 10.1161/HYPERTENSIONAHA.122.20518)

Dewan, P., Ferreira, J. P., Butt, J. H., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Stewart, S., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2023) Impact of multimorbidity on mortality in HFrEF : which comorbidities matter most? – an analysis of PARADIGM‐HF and ATMOSPHERE. European Journal of Heart Failure, 25, pp. 687-697. (doi: 10.1002/ejhf.2856)

Girerd, N. et al. (2023) Protein biomarkers of new-onset heart failure: insights from the Heart Omics and Ageing cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation: Heart Failure, 16, pp. 426-441. (doi: 10.1161/CIRCHEARTFAILURE.122.009694)

Sattar, N. (2023) Statins and diabetes: what are the connections? Best Practice and Research: Clinical Endocrinology and Metabolism, 37, (doi: 10.1016/j.beem.2023.101749)

Tromp, J., Jackson, A. M., Abdelhamid, M., Fouad, D., Youssef, G., Petrie, M. C., Bauersachs, J., Sliwa, K., van der Meer, P. (2023) Thrombo‐embolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. European Journal of Heart Failure, (doi: 10.1002/ejhf.2871)

Kobayashi, M., Huttin, O., Ferreira, J. P., Duarte, K., González, A., Heymans, S., Verdonschot, J. A.J., Brunner-La Rocca, H.-P., Pellicori, P., Clark, A. L., Petutschnigg, J., Edelmann, F., Cleland, J. G., Rossignol, P., Zannad, F., Girerd, N. (2023) A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2859)

Ferreira, J. P., Cleland, J. G., Girerd, N., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., González, A., Diez, J., Solomon, S. D., Claggett, B., Pfeffer, M. A., Pitt, B., Petutschnigg, J., Pieske, B., Edelmann, F., Zannad, F. (2023) Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: pooled analysis of three randomized trials. International Journal of Cardiology, 377, pp. 86-88. (doi: 10.1016/j.ijcard.2023.01.088)

Degenaar, A., Jacobs, A., Kruger, R., Delles, C., Mischak, H., Mels, C.M.C. (2023) Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study. BMC Nephrology, 24, (doi: 10.1186/s12882-023-03100-w)

Butler, J., Petrie, M. C., Bains, M., Bawtinheimer, T., Code, J., Levitch, T., Malvolti, E., Monteleone, P., Stevens, P., Vafeiadou, J., Lam, C. S. P. (2023) Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post–hospital discharge period. Research Involvement and Engagement, 9, (doi: 10.1186/s40900-023-00412-x)

Lee, M. M. Y., McMurray, J. J. V. (2023) Lack of benefit of renin-angiotensin system inhibitors in COVID-19. JAMA: Journal of the American Medical Association, 329, pp. 1155-1156. (doi: 10.1001/jama.2023.4405)

Petermann-Rocha, F., Wirth, M. D., Boonpor, J., Parra-Soto, S., Zhou, Z., Mathers, J. C., Livingstone, K., Forrest, E., Pell, J. P., Ho, F. K., Hébert, J. R., Celis, C.-M. (2023) Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants. BMC Medicine, 21, (doi: 10.1186/s12916-023-02793-y)

Butt, J. H., Petrie, M. C., Jhund, P. S., Sattar, N., Desai, A. S., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J.V. (2023) Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. European Heart Journal, 44, pp. 1136-1153. (doi: 10.1093/eurheartj/ehad083)

Bruhn, J., Malmborg, M., Garred, C. H., Ravn, P., Zahir, D., Andersson, C., Gislason, G., Torp-Pedersen, C., Kragholm, K., Fosbol, E., Butt, J. H., Lang, N. N., Petrie, M. C., McMurray, J., Kober, L., Schou, M. (2023) Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study. European Heart Journal, 44, pp. 1124-1132. (doi: 10.1093/eurheartj/ehac797)

Mooney, L., Jackson, C. E., Adamson, C., McConnachie, A., Welsh, P., Myles, R. C., McMurray, J. J.V., Jhund, P. S., Petrie, M. C., Lang, N. N. (2023) Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction. Circulation: Heart Failure, 16, (doi: 10.1161/CIRCHEARTFAILURE.122.010051)

Petermann-Rocha, F., Deo, S., Celis-Morales, C., Ho, F. K., Bahuguna, P., McAllister, D., Sattar, N., Pell, J. P. (2023) An opportunity for prevention: associations between the Life's Essential 8 score and cardiovascular incidence using prospective data from UK Biobank. Current Problems in Cardiology, 48, (doi: 10.1016/j.cpcardiol.2022.101540)

Cuthbert, J.J., Pellicori, P., Rigby, A.S., Abel, A.A.I., Kalvickbacka-Bennet, A., Shah, P., Kearsley, J.W., Kazmi, S., Cleland, J.G.F., Clark, A.L. (2023) Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 9, pp. 281-292. (doi: 10.1093/ehjqcco/qcac035)

Parra-Soto, S., Tumblety, C., Araya, C., Rezende, L. F. M., Ho, F. K., Pell, J. P., Celis-Morales, C. (2023) Associations of physical activity with breast cancer risk: findings from the UK Biobank prospective cohort study. Journal of Physical Activity and Health, 20, pp. 272-278. (doi: 10.1123/jpah.2022-0437)

Al-Sawaf, O. et al. (2023) Body composition and lung cancer-associated cachexia in TRACERx. Nature Medicine, 29, pp. 846-858. (doi: 10.1038/s41591-023-02232-8)

Cigarroa, I., Bravo-Leal, M., Petermann-Rocha, F., Parra-Soto, S., Concha-Cisternas, Y., Matus-Castillo, C., Vásquez-Gómez, J., Zapata-Lamana, R., Parra-Rizo, M. A., Álvarez, C., Celis-Morales, C. (2023) Brisk walking pace is associated with better cardiometabolic health in adults: findings from the Chilean National Health Survey 2016–2017. International Journal of Environmental Research and Public Health, 20, (doi: 10.3390/ijerph20085490)

Desai, A. S., Petrie, M. C. (2023) Centrally adjudicated heart failure outcomes are needed in clinical trials. JACC: Heart Failure, 11, pp. 418-421. (doi: 10.1016/j.jchf.2023.01.028)

Dobbin, S. J.H., Shen, L., Petrie, M. C., Packer, M., Solomon, S. D., McMurray, J. J.V., Lang, N. N., Jhund, P. S. (2023) Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials. European Journal of Heart Failure, 25, pp. 488-496. (doi: 10.1002/ejhf.2818)

Concha-Cisternas, Y., Castro-Piñero, J., Leiva-Ordóñez, A. M., Valdés-Badilla, P., Celis-Morales, C., Guzmán-Muñoz, E. (2023) Effects of neuromuscular training on physical performance in older people: a systematic review. Life, 13, (doi: 10.3390/life13040869)

Leo, V. C., Kazmi, S., Brownrigg, J., Araghi, M., Sarna, H. S., Pellicori, P., Cuthbert, J., Cleland, J. G.F., Clark, A. L. (2023) Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis. ESC Heart Failure, 10, pp. 1492-1496. (doi: 10.1002/ehf2.14315)

Graham, F. J., Pellicori, P., Kalra, P. R., Ford, I., Bruzzese, D., Cleland, J. G.F. (2023) Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. European Journal of Heart Failure, 25, pp. 528-537. (doi: 10.1002/ejhf.2810)

Conrad, N., McInnes, I. B., Mcmurray, J. J.V., Sattar, N. (2023) Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)'s recommendations for cardiovascular risk management? Annals of the Rheumatic Diseases, 82, pp. 457-459. (doi: 10.1136/ard-2022-223315)

Rotbain Curovic, V. et al. (2023) Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – a post-hoc analysis of the PRIORITY randomized clinical trial. Journal of Diabetes and its Complications, 37, (doi: 10.1016/j.jdiacomp.2023.108433)

Edgar, B., Pearson, R., Kasthuri, R., Gillis, K., Geddes, C., Rostron, M., Brady, A., Hussey, K., Roditi, G., Delles, C., Kingsmore, D. (2023) The impact of renal artery stenting on therapeutic aims. Journal of Human Hypertension, 37, pp. 265-272. (doi: 10.1038/s41371-022-00785-8)

Gerstein, H. C., Li, Z., Ramasundarahettige, C., Baek, S., Branch, K. R.H., Del Prato, S., Lam, C. S.P., Lopes, R. D., Pratley, R., Rosenstock, J., Sattar, N. (2023) Exploring the relationship between efpeglenatide dose and cardiovascular outcomes in type 2 diabetes: insights from the AMPLITUDE-O trial. Circulation, 147, pp. 1004-1013. (doi: 10.1161/CIRCULATIONAHA.122.063716)

Tabák, A. G., Sattar, N., Kivimäki, M. (2023) Response by Tabák et al to letters regarding article, “Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study” Circulation, 147, pp. 988-989. (doi: 10.1161/CIRCULATIONAHA.123.063545)

Ferreira, J. P., Cleland, J. G.F., Girerd, N., Pellicori, P., Hazebroek, M. R., Verdonschot, J., Collier, T. J., Retutschnigg, J., Clark, A. L., Staessen, J. A., Heymans, S., Rossignol, P., Zannad, F. (2023) Effect of spironolactone on QRS duration in patients at risk for heart failure (from the HOMAGE trial) American Journal of Cardiology, 191, pp. 39-42. (doi: 10.1016/j.amjcard.2022.12.016)

Talebi, A., Celis‑Morales, C., Borumandnia, N., Abbasi, S., Pourhoseingholi, M. A., Akbari, A., Yousefi, J. (2023) Predicting metastasis in gastric cancer patients: machine learning-based approaches. Scientific Reports, 13, (doi: 10.1038/s41598-023-31272-w)

Friedman, D. J., Al-Khatib, S. M., Dalgaard, F., Fudim, M., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Tang, A. S., Ali-Ahmed, F., Olivas-Martinez, A., Inoue, L. Y.T., Sanders, G. D. (2023) Cardiac resynchronization therapy improves outcomes in patients with intraventricular conduction delay but not right bundle branch block: a patient-level meta-analysis of randomized controlled trials. Circulation, 147, pp. 812-823. (doi: 10.1161/CIRCULATIONAHA.122.062124)

Nakada, S., Ho, F. K., Celis-Morales, C., Pell, J. P. (2023) Association between being breastfed and cardiovascular disease: a population cohort study of 320 249 participants. Journal of Public Health, (doi: 10.1093/pubmed/fdad016)

Ochoa-Rosales, C., Mardones, L., Villagrán, M., Aguayo, C., Martorell, M., Celis-Morales, C., Ulloa, N. (2023) Body adiposity partially mediates the association between FTO rs9939609 and lower adiponectin levels in Chilean children. Children, 10, (doi: 10.3390/children10030426)

Holman, N., Khunti, K., Wild, S. H., Sattar, N., Knighton, P., Young, B., Gregg, E. W., Bakhai, C., Valabhji, J. (2023) Care processes in people in remission from type 2 diabetes: a cohort study using the National Diabetes Audit. Diabetic Medicine, 40, (doi: 10.1111/dme.15016)

Packer, M., Cleland, J. G.F. (2023) Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events? Journal of Cardiac Failure, 29, pp. 403-406. (doi: 10.1016/j.cardfail.2022.12.007)

Nuzzi, V., Cannatà, A., Pellicori, P., Manca, P., Stolfo, D., Gregorio, C., Barbati, G., Bromage, D. I., McDonagh, T., Cleland, J. G.F., Merlo, M., Sinagra, G. (2023) Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. Clinical Research in Cardiology, 112, pp. 419-430. (doi: 10.1007/s00392-022-02126-8)

Petermann-Rocha, F., Celis-Morales, C., Pell, J. P., Ho, F. K. (2023) Do all vegetarians have a lower cardiovascular risk? A prospective study. Clinical Nutrition, 42, pp. 269-276. (doi: 10.1016/j.clnu.2023.01.010)

Adamson, C., Welsh, P., Docherty, K. F., de Boer, R. A., Diez, M., Drożdż, J., Dukát, A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ljungman, C. E.A., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Morrow, D. A., Lindholm, D., Hammarstedt, A., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Solomon, S. D., Sattar, N., McMurray, J. J.V., Jhund, P. S. (2023) IGFBP-7 and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF. JACC: Heart Failure, 11, pp. 291-304. (doi: 10.1016/j.jchf.2022.09.004)

Kimera, I. D., Namugenyi, C., Schwartz, J. I., Musimbaggo, D. J., Ssenyonjo, R., Atukunda, P., Mutungi, G., Mugabe, F., Ambangira, F., Mbuliro, M., Katwesigye, R., Neupane, D., Ssinabulya, I., Semitala, F. C., Delles, C., Muddu, M. (2023) Integrated multi-month dispensing of antihypertensive and antiretroviral therapy to sustain hypertension and HIV control. Journal of Human Hypertension, 37, pp. 213-219. (doi: 10.1038/s41371-022-00655-3)

Picone, D. S., Peterson, G. M., Jackson, S. L., Campbell, N. R.C., Delles, C., Olsen, M. H., Padwal, R., Schutte, A. E., Sharman, J. E. (2023) Perceptions of pharmacists on the quality of automated blood pressure devices: a national survey. Journal of Human Hypertension, 37, pp. 235-240. (doi: 10.1038/s41371-022-00670-4)

Cassidy, S., Trenell, M., Stefanetti, R. J., Charman, S. J., Barnes, A. C., Brosnahan, N., McCombie, L., Thom, G., Peters, C., Zhyzhneuskaya, S., Leslie, W. S., Catt, C., Catt, M., McConnachie, A., Sattar, N., Sniehotta, F. F., Lean, M. E.J., Taylor, R. (2023) Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT) Diabetic Medicine, 40, (doi: 10.1111/dme.15010)

Curtain, J. P., Adamson, C., Kondo, T., Butt, J., Desai, A. S., Zannad, F., Rouleau, J. L., Rohde, L. E., Kober, L., Anand, I. S., van Veldhuisen, D. J., Zile, M. R., Lefkowitz, M. P., Solomon, S. D., Packer, M., Petrie, M. C., Jhund, P. S., McMurray, J. J.V. (2023) Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction. European Heart Journal, 44, pp. 668-677. (doi: 10.1093/eurheartj/ehac801)

Malcomson, F. C., Parra-Soto, S., Lu, L., Ho, F. K., Perez-Cornago, A., Shams-White, M. M., van Zutphen, M., Kampman, E., Winkels, R. M., Mitrou, P., Wiseman, M., Romaguera, D., Celis-Morales, C., Sharp, L., Mathers, J. C. (2023) Operationalisation of a standardised scoring system to assess adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations in the UK biobank. Frontiers in Nutrition, 10, (doi: 10.3389/fnut.2023.1011786)

Zhao, L., Wirth, M. D., Petermann-Rocha, F., Parra-Soto, S., Mathers, J. C., Pell, J. P., Ho, F. K., Celis-Morales, C. A., Hebert, J. R. (2023) Diet-related inflammation is associated with worse COVID-19 outcomes in the UK biobank cohort. Nutrients, 15, (doi: 10.3390/nu15040884)

Gladysheva, I. P., Sullivan, R. D., Pellicori, P. (2023) Editorial: Edema in heart failure with reduced ejection fraction. Frontiers in Cardiovascular Medicine, 10, (doi: 10.3389/fcvm.2023.1141937)

Boorsma, E. M., ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., Lang, C. C., Ng, L., Anker, S. D., Cleland, J. G., Pellicori, P., Gansevoort, R.T., Heerspink, H. J.L., Voors, A. A., Emmens, J. E. (2023) Albuminuria as a marker of systemic congestion in patients with heart failure. European Heart Journal, 44, pp. 368-380. (doi: 10.1093/eurheartj/ehac528)

Pathak, S., Lai, F. Y., Miksza, J., Petrie, M. C., Roman, M., Murray, S., Dearling, J., Perera, D., Murphy, G. J. (2023) Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial. European Heart Journal, 44, pp. 351-364. (doi: 10.1093/eurheartj/ehac670)

de Beer, D., Mels, C. M. C., Schutte, A. E., Delles, C., Mary, S., Mullen, W., Mischak, H., Kruger, R. (2023) A urinary peptidomics approach for early stages of cardiovascular disease risk: the African-PREDICT study. Hypertension Research, 46, pp. 485-494. (doi: 10.1038/s41440-022-01097-7)

Chua, S. Y.L., Welsh, P., Sun, Z., Balaskas, K., Warwick, A., Steel, D., Sivaprasad, S., Channa, R., Ko, T., Sattar, N., Khawaja, A. P., Foster, P. J., Patel, P. J. (2023) Associations between HbA1c across the normal range, diagnosed, and undiagnosed diabetes and retinal layer thickness in UK Biobank cohort. Translational Vision Science and Technology, 12, (doi: 10.1167/tvst.12.2.25)

Malik, M. E., Andersson, C., Blanche, P., D’Souza, M., Madelaire, C., Zareini, B., Lamberts, M., Kristensen, S. L., Sattar, N., McMurray, J., Køber, L., Torp-Pedersen, C., Gislason, G., Schou, M. (2023) Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes. Clinical Research in Cardiology, 112, pp. 215-226. (doi: 10.1007/s00392-022-02016-z)

Sattar, N., Welsh, P., Leslie, W. S., Thom, G., McCombie, L., Brosnahan, N., Richardson, J., Gill, J. M. R., Crawford, L., Lean, M. E. J. (2023) Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby) Lancet Regional Health – Southeast Asia, 9, (doi: 10.1016/j.lansea.2022.100111)

Whinnett, Z. I. et al. (2023) Effects of haemodynamically atrio‐ventricular optimized His‐pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) randomised, double‐blind, cross‐over trial. European Journal of Heart Failure, 25, pp. 274-283. (doi: 10.1002/ejhf.2736)

Docherty, K. F., McMurray, J. J.V., Claggett, B. L., Miao, Z. M., Adams, K. F., Arias‐Mendoza, A., Cleland, J. G.F., Diaz, R., Echeverría Correa, L. E., Felker, G. M., Fonseca, C., Li, J., Metra, M., Sliwa‐Hahnle, K., Solomon, S. D., Vandekerckhove, H. J., Vinereanu, D., Voors, A. A., Heitner, S. B., Kupfer, S., Malik, F. I., Meng, L., Teerlink, J. R. (2023) Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B ‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. European Journal of Heart Failure, 25, pp. 248-259. (doi: 10.1002/ejhf.2763)

Chu, W., Lynskey, N., Iain-Ross, J., Pell, J. P., Sattar, N., Ho, F. K., Welsh, P., Celis-Morales, C., Petermann-Rocha, F. (2023) Identifying the biomarker profile of pre-frail and frail people: a cross-sectional analysis from UK Biobank. International Journal of Environmental Research and Public Health, 20, (doi: 10.3390/ijerph20032421)

Deo, S., Ueda, P., Sheikh, A. M., Altarabsheh, S., Elgudin, Y., Rubelowsky, J., Cmolik, B., Hawkins, N., McAllister, D., Ruel, M., Sattar, N., Pell, J. (2023) Lipid-lowering in ‘very high risk’ patients undergoing coronary artery bypass surgery and its projected reduction in risk for recurrent vascular events: A Monte Carlo stepwise simulation approach. Journal of Cardiovascular Pharmacology, 81, pp. 120-128. (doi: 10.1097/FJC.0000000000001374)

Lim, M. W.S., Setjiadi, D., Dobbin, S. J.H., Lang, N. N., Delles, C., Connelly, P. J. (2023) Nailfold video-capillaroscopy in the study of cardiovascular disease: a systematic review. Blood Pressure Monitoring, 28, pp. 24-32. (doi: 10.1097/MBP.0000000000000624)

Shields, B. M., Angwin, C. D., Shepherd, M. H., Britten, N., Jones, A. G., Sattar, N., Holman, R., Pearson, E. R., Hattersley, A. T. (2023) Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study. Nature Medicine, 29, pp. 384-391. (doi: 10.1038/s41591-022-02121-6)

Rushworth, L. K., Loveridge, C., Salji, M., MacLeod, M., Mui, E., Sumpton, D., Neilson, M., Hedley, A., Alexander, L., McCartney, E., Patel, R., Wallace, J., Delles, C., Jones, R., Leung, H. Y. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131, pp. 236-243. (doi: 10.1111/bju.15851)

Sullivan, M. K., Jani, B. D., Rutherford, E., Welsh, P., McConnachie, A., Major, R. W., McAllister, D., Nitsch, D., Mair, F. S., Mark, P. B., Lees, J. S. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73, pp. e141-e147. (doi: 10.3399/BJGP.2022.0145)

Kondo, T., Araki, T., Imaizumi, T., Sumita, Y., Nakai, M., Tanaka, A., Okumura, T., Butt, J. H., Petrie, M. C., McMurray, J. J.V., Murohara, T. (2023) Prognosis in patients with cardiogenic shock who received temporary mechanical circulatory support. JACC: Asia, 3, pp. 122-134. (doi: 10.1016/j.jacasi.2022.10.004)

Chen, J. Y., Chew, K. S., Mary, S., Boder, P., Bagordo, D., Rossi, G. P., Touyz, R. M., Delles, C., Rossitto, G. (2023) Skin-specific mechanisms of body fluid regulation in hypertension. Clinical Science, 137, pp. 239-250. (doi: 10.1042/CS20220609)

Ward, J., Lyall, L. M., Strawbridge, R. J., Stanciu, I., Veldsman, M., Garfield, V., Celis Morales, C., Newby, D., Stewart, W., Pell, J. P., Sattar, N., Lyall, D. M. (2023) Testing for association between exonic glucagon-like peptide 1 receptor mutation with physical and brain health traits in UK Biobank. Diabetes, Obesity and Metabolism, 25, pp. 623-627. (doi: 10.1111/dom.14879)

Sharman, J. E., Ordunez, P., Brady, T., Parati, G., Stergiou, G., Whelton, P. K., Padwal, R., Olsen, M. H., Delles, C., Schutte, A. E., Tomaszewski, M., Lackland, D. T., Khan, N., McManus, R. J., Tsuyuki, R. T., Zhang, X.-H., Murphy, L. D., Moran, A. E., Schlaich, M. P., Campbell, N. R.C. (2023) The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league. Journal of Human Hypertension, 37, pp. 155-159. (doi: 10.1038/s41371-022-00747-0)

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. (doi: 10.1136/heartjnl-2022-BSCMR.26)

Sattar, N., Deanfield, J., Delles, C. (2023) Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes? Cardiovascular Research, (doi: 10.1093/cvr/cvac186)

Rawshani, A., McGuire, D. K., Omerovic, E., Sattar, N., McMurray, J. J.V., Smith, U., Redfors, B., Bergfeldt, L., Eliasson, B., Borén, J., Bhatt, D. L., Bergstrom, G., Rawshani, A. (2023) Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetes. Scientific Reports, 13, (doi: 10.1038/s41598-023-27941-5)

Holman, N., Barron, E., Young, B., Gregg, E. W., Khunti, K., Valabhji, J., Sattar, N. (2023) Comparative incidence of diabetes following hospital admission for COVID-19 and pneumonia: a cohort study. Diabetes Care, (doi: 10.2337/dc22-0670)

Verma, S., Dhingra, N. K., Butler, J., Anker, S. D., Ferreira, J. P., Filippatos, G., Januzzi, J. L., Lam, C. S.P., Sattar, N., Pfarr, E., Nordaby, M., Brueckmann, M., Pocock, S. J., Zannad, F., Packer, M. (2023) Empagliflozin in black versus white patients with heart failure: analysis of EMPEROR-pooled. Circulation, 147, pp. 101-104. (doi: 10.1161/circulationaha.122.062644)

Savarese, G., von Haehling, S., Butler, J., Cleland, J. G.F., Ponikowski, P., Anker, S. D. (2023) Iron deficiency and cardiovascular disease. European Heart Journal, 44, pp. 14-27. (doi: 10.1093/eurheartj/ehac569)

Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10, (doi: 10.1136/openhrt-2022-002192)

Ouwerkerk, W., Tromp, J., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Filippatos, G., Collins, S. P., Lam, C. S. (2023) Association of time‐to‐IV ‐furosemide with mortality in acute heart failure: data from REPORT‐HF. European Journal of Heart Failure, 25, pp. 43-51. (doi: 10.1002/ejhf.2708)

Hastie, C. E., Foster, H. M.E., Jani, B. D., O'Donnell, C. A., Ho, F. K., Pell, J. P., Sattar, N., Katikireddi, S. V., Mair, F. S., Nicholl, B. I. (2023) Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study. Pain, 164, pp. 84-90. (doi: 10.1097/j.pain.0000000000002663)

Bleken Østergaard, H., Hageman, S. H. J., Read, S. H., Taylor, O., Pennells, L., Kaptoge, S., Petitjean, C., Xu, Z., Shi, F., McEvoy, J. W., Herrington, W., Visseren, F. L. J., Wood, A., Eliasson, B., Sattar, N., Wild, S., Di Angelantonio, E., Dorresteijn, J. A. N. (2023) Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2) European Journal of Preventive Cardiology, 30, pp. 61-69. (doi: 10.1093/eurjpc/zwac232)

Diaz-Toro, F., Nazar, G., Troncoso, C., Concha-Cisternas, Y., Leiva-Ordoñez, A. M., Martinez-Sanguinetti, M. A., Parra-Soto, S., Lasserre-Laso, N., Cigarroa, I., Mardones, L., Vásquez-Gómez, J., Petermann-Rocha, F., Diaz-Martinez, X., Celis-Morales, C. (2023) Frailty index as a predictor of mortality in middle-aged and older people: a prospective analysis of Chilean adults. International Journal of Environmental Research and Public Health, 20, (doi: 10.3390/ijerph20021195)

Lee, M. M.Y., Campbell, R. T., Claggett, B. L., Lewis, E. F., Docherty, K. F., Lindner, M., Liu, J., Solomon, S. D., McMurray, J. J.V., Platz, E. (2023) Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion. European Journal of Heart Failure, 25, pp. 54-60. (doi: 10.1002/ejhf.2699)

Petrie, M. C., Jhund, P. S., Connolly, E., Mark, P. B., MacDonald, M. R., Robertson, M., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Wheeler, D. C., Tomson, C. R.V., Ford, I., McMurray, J. J.V., Macdougall, I. C. (2023) High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. Cardiovascular Research, 119, pp. 213-220. (doi: 10.1093/cvr/cvab317)

Inciardi, R., Pellicori, P., Chandra, A. (2023) Identification and quantification of congestion in heart failure: a work in progress. European Journal of Heart Failure, 25, pp. 61-62. (doi: 10.1002/ejhf.2751)

Manla, Y., Kuan, W., Clark, A. L., Cleland, J. G. F., Pellicori, P. (2023) Ketone bodies in acute heart failure: fuel for thought. Journal of Cardiac Failure, 29, pp. 42-44. (doi: 10.1016/j.cardfail.2022.11.002)

Iliodromiti, S., McLaren, J., Ghouri, N., Miller, M. R., Dahlqvist Leinhard, O., Linge, J., Ballantyne, S., Platt, J., Foster, J., Hanvey, S., Gujral, U. P., Kanaya, A., Sattar, N., Lumsden, M. A., Gill, J. M.R. (2023) Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data. Diabetologia, 66, pp. 44-56. (doi: 10.1007/s00125-022-05803-5)

Banda, J., Bunn, C., Crampin, A. C., Gill, J. M.R., Gray, C. M. (2023) Qualitative study of practices and attitudes towards physical activity among prediabetic men and women in urban and rural Malawi. BMJ Open, 13, (doi: 10.1136/bmjopen-2021-058261)

Ferreira, J. P., Cleland, J. G., Girerd, N., Bozec, E., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., Solomon, S. D., Pitt, B., Pfeffer, M. A., Shah, A. M., Petutschnigg, J., Pieske, B., Edelmann, F., Zannad, F. (2023) Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials. European Journal of Heart Failure, 25, pp. 108-113. (doi: 10.1002/ejhf.2726)

Welsh, P., Sattar, N. (2023) To apoB or not to apoB: new arguments, but basis for widespread implementation remains elusive. Clinical Chemistry, 69, pp. 3-5. (doi: 10.1093/clinchem/hvac183)

Sattar, N., McMurray, J. J. V., McInnes, I. B., Aroda, V. R., Lean, M. E. J. (2023) Treating chronic diseases without tackling excess adiposity promotes multimorbidity. Lancet Diabetes and Endocrinology, 11, pp. 58-62. (doi: 10.1016/S2213-8587(22)00317-5)

Anker, S. D., Khan, M. S., Butler, J., Ofstad, A. P., Peil, B., Pfarr, E., Doehner, W., Sattar, N., Coats, A. J.S., Filippatos, G., Ferreira, J. P., Zannad, F., Pocock, S., Packer, M. (2023) Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced. European Journal of Heart Failure, 25, pp. 117-127. (doi: 10.1002/ejhf.2728)

Zonneveld, M. H., Noordam, R., Sabayan, B., Stott, D. J., Mooijaart, S. P., Blauw, G. J., Jukema, J. W., Sattar, N., Trompet, S. (2023) Weight loss, visit-to-visit body weight variability and cognitive function in older individuals. Age and Ageing, 52, (doi: 10.1093/ageing/afac312)

Lanuza, F., Zamora-Ros, R., Petermann-Rocha, F., Martínez-Sanguinetti, M.A., Troncoso-Pantoja, C., Labraña, A.M., Leiva-Ordoñez, A.M., Nazar, G., Ramírez-Alarcón, K., Ulloa, N., Lasserre-Laso, N., Parra-Soto, S., Martorell, M., Villagrán, M., Garcia-Diaz, D.F., Andrés-Lacueva, C., Celis-Morales, C. (2023) Advances in polyphenol research from Chile: a literature review. Food Reviews International, 39, pp. 3134-3171. (doi: 10.1080/87559129.2021.2009508)

Nazar, G., Díaz-Toro, F., Roa, P., Petermann-Rocha, F., Troncoso-Pantoja, C., Leiva-Ordóñez, A. M., Cigarroa, I., Celis-Morales, C. (2023) Asociación entre salud oral y deterioro cognitivo en personas mayores chilenas = Association between oral health and cognitive decline in older Chileans. Gaceta Sanitaria, 37, (doi: 10.1016/j.gaceta.2023.102303)

Lean, M. E.J., Taylor, R., Sattar, N. (2023) Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter] Diabetologia, 66, pp. 958-959. (doi: 10.1007/s00125-022-05863-7)

Nakada, S., Ho, F. K., Celis-Morales, C., Jackson, C. A., Pell, J. P. (2023) Individual and joint associations of anxiety disorder and depression with cardiovascular disease: a UK Biobank prospective cohort study. European Psychiatry, 66, (doi: 10.1192/j.eurpsy.2023.2425)

Kulkarni, S., Glover, M., Kapil, V., Abrams, S. M. L., Partridge, S., McCormack, T., Sever, P., Delles, C., Wilkinson, I. B. (2023) Management of hypertensive crisis: British and Irish Hypertension Society position document. Journal of Human Hypertension, (doi: 10.1038/s41371-022-00776-9)

Perera, D., Ryan, M., Morgan, H. P., Greenwood, J. P., Petrie, M. C., Dodd, M., Weerackody, R., O'Kane, P. D., Masci, P. G., Nazir, M. S., Papachristidis, A., Chahal, N., Khattar, R., Ezad, S. M., Kapetanakis, S., Dixon, L. J., De Silva, K., McDiarmid, A. K., Marber, M. S., McDonagh, T., McCann, G. P., Clayton, T. C., Senior, R., Chiribiri, A. (2023) Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 Trial. JAMA Cardiology, 8, pp. 1154-1161. (doi: 10.1001/jamacardio.2023.3803)

2022

White, S. L., Pasupathy, D., Begum, S., Sattar, N., Nelson, S. M., Seed, P., Poston, L. (2022) Gestational diabetes in women with obesity; an analysis of clinical history and simple clinical/anthropometric measures. PLoS ONE, 17, (doi: 10.1371/journal.pone.0279642)

Aman, A., Slob, E. A.W., Ward, J., Cullen, B., Graham, N., Lyall, D. M., Sattar, N., Strawbridge, R. J. (2022) Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization. PLoS ONE, 17, (doi: 10.1371/journal.pone.0279381)

Bissett, M., Gray, C. M., Abdulla, S., Bunn, C., Crampin, A. C., Dillip, A., Gill, J. M.R., Kaare, H. C., Kalima, S., Kambulu, E., Lwanda, J., Makoye, H. F., Mtema, O., Perry, M., Strachan, Z., Todd, H., Mtenga, S. M. (2022) "I see salt everywhere": a qualitative examination of the utility of arts-based participatory workshops to study noncommunicable diseases in Tanzania and Malawi. PLoS Global Public Health, 2, (doi: 10.1371/journal.pgph.0000927)

Zannad, F., Ferreira, J. P., Butler, J., Filippatos, G., Januzzi, J. L., Sumin, M., Zwick, M., Saadati, M., Pocock, S. J., Sattar, N., Anker, S. D., Packer, M. (2022) Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights from the EMPEROR program. European Heart Journal, 43, pp. 4991-5002. (doi: 10.1093/eurheartj/ehac495)

Lithgow, H., Johnston, L., Ho, F. K., Celis-Morales, C., Cobley, J., Raastad, T., Hunter, A. M., Lees, J. S., Mark, P. B., Quinn, T. J., Gray, S. R. (2022) Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults—the TAKEOVER study. Trials, 23, (doi: 10.1186/s13063-022-06937-y)

Kalra, P. R., Cleland, J. G.F., Petrie, M. C., Thomson, E. A., Kalra, P. A., Squire, I. B., Ahmed, F. Z., Al-Mohammad, A., Cowburn, P. J., Foley, P. W.X., Graham, F. J., Japp, A. G., Lane, R. E., Lang, N. N., Ludman, A. J., Macdougall, I. C., Pellicori, P., Ray, R., Robertson, M., Seed, A., Ford, I. (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400, pp. 2199-2209. (doi: 10.1016/S0140-6736(22)02083-9)

Murray, E. C., Delles, C., Orzechowski, P., Renc, P., Sitek, A., Wagenaar, J., Guzik, T. J. (2022) Vascular phenotypes in early hypertension. Journal of Human Hypertension, (doi: 10.1038/s41371-022-00794-7)

Marx, N., Husain, M., Lehrke, M., Verma, S., Sattar, N. (2022) GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes. Circulation, 146, pp. 1882-1894. (doi: 10.1161/CIRCULATIONAHA.122.059595)

Al Ozairi, E., Al Saeed, D., AlRoudhan, D., Voase, N., Pell, J., Ho, F. K., Abdulla, M., Gray, S. R. (2022) A comparison of physical activity, muscle strength and sleep between people with type 2 diabetes in Kuwait and the UK: a cross sectional study. Frontiers in Endocrinology, 13, (doi: 10.3389/fendo.2022.1067227)

Stamatakis, E., Ahmadi, M. N., Gill, J. M. R., Thøgersen-Ntoumani, C., Gibala, M. J., Doherty, A., Hamer, M. (2022) Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. Nature Medicine, 28, pp. 2521-2529. (doi: 10.1038/s41591-022-02100-x)

Mehran, R., Steg, P. G., Pfeffer, M. A., Jering, K., Claggett, B., Lewis, E. F., Granger, C., Køber, L., Maggioni, A., Mann, D. L., McMurray, J. J.V., Rouleau, J.-L., Solomon, S. D., Ducrocq, G., Berwanger, O., De Pasquale, C. G., Landmesser, U., Petrie, M., Leng, D. S. K., van der Meer, P., Lefkowitz, M., Zhou, Y., Braunwald, E. (2022) The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial. Circulation, 146, pp. 1749-1757. (doi: 10.1161/CIRCULATIONAHA.122.060841)

Bhandari, S., Mehta, S., Khwaja, A., Cleland, J. G.F., Ives, N., Brettell, E., Chadburn, M., Cockwell, P. (2022) Renin-angiotensin system inhibition in advanced chronic kidney disease. New England Journal of Medicine, 387, pp. 2021-2032. (doi: 10.1056/NEJMoa2210639)

Ahmed, A., Sattar, N., Yaghootkar, H. (2022) Advancing a causal role of type 2 diabetes and its components in developing macro‐ and microvascular complications via genetic studies. Diabetic Medicine, 39, (doi: 10.1111/dme.14982)

Wang, J., Kuang, Y., Shen, S., Price, M. J., Lu, J., Sattar, N., He, J., Pittavino, M., Xia, H., Thomas, G.N., Qiu, X., Cheng, K. K., Nirantharakumar, K. (2022) Association of maternal lipid levels with birth weight and cord blood insulin: a Bayesian network analysis. BMJ Open, 12, (doi: 10.1136/bmjopen-2022-064122)

Sharma, A., Lee-Ødegård, S., Qvigstad, E., Sommer, C., Sattar, N., Gill, J. M.R., Gulseth, H. L., Sollid, S. T., Nermoen, I., Birkeland, K. I. (2022) Beta cell function, hepatic insulin clearance, and insulin sensitivity in South Asian and Nordic women after gestational diabetes mellitus. Diabetes, 71, pp. 2530-2538. (doi: 10.2337/db22-0622)

Rosengren, A., Söderberg, M., Lundberg, C. E., Lindgren, M., Santosa, A., Edqvist, J., Åberg, M., Gisslén, M., Robertson, J., Cronie, O., Sattar, N., Lagergren, J., Brandén, M., Björk, J., Adiels, M. (2022) COVID-19 in people aged 18-64 in Sweden in the first year of the pandemic: Key factors for severe disease and death. Global Epidemiology, 4, (doi: 10.1016/j.gloepi.2022.100095)

Østergaard, H. B., Read, S. H., Sattar, N., Franzén, S., Halbesma, N., Dorresteijn, J. A.N., Westerink, J., Visseren, F. L.J., Wild, S. H., Eliasson, B., van der Leeuw, J. (2022) Development and validation of a lifetime risk model for kidney failure and treatment benefit in type 2 diabetes: 10-year and lifetime risk prediction models. Clinical Journal of the American Society of Nephrology, 17, pp. 1783-1791. (doi: 10.2215/CJN.05020422)

Dennis, J. M., Young, K. G., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., Henley, W. E., Holman, R. R., Sattar, N., Pearson, E. R., Hattersley, A. T., Jones, A. G., Shields, B. M. (2022) Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digital Health, 4, pp. e873-e883. (doi: 10.1016/S2589-7500(22)00174-1)

Gregers, M. C. T., Schou, M., Jensen, M. T., Jensen, J., Petrie, M. C., Vilsbøll, T., Goetze, J. P., Rossing, P., Jørgensen, P. G. (2022) Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes. Scandinavian Cardiovascular Journal, 56, pp. 256-263. (doi: 10.1080/14017431.2022.2095435)

Monzo, L., Ferreira, J. P., Cleland, J. G.F., Pellicori, P., Mariottoni, B., Hazebroek, M. R., Collier, T. J., Cuthbert, J. J., Pieske, B., Petutschnigg, J., Ahmed, F. Z., Girerd, N., Clark, A. L., Cosmi, F., Staessen, J. A., Heymans, S., Rossignol, P., Zannad, F. (2022) Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial. ESC Heart Failure, 9, pp. 4352-4357. (doi: 10.1002/ehf2.14086)

Pugliese, N. R., Pellicori, P., Filidei, F., De Biase, N., Maffia, P., Guzik, T. J., Masi, S., Taddei, S., Cleland, J. G.F. (2022) Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. Cardiovascular Research, 118, pp. 3536-3555. (doi: 10.1093/cvr/cvac133)

Bracun, V., van Essen, B., Voors, A. A., van Veldhuisen, D. J., Dickstein, K., Zannad, F., Metra, M., Anker, S., Samani, N. J., Ponikowski, P., Filippatos, G., Cleland, J. G.F., Lang, C. C., Ng, L. L., Shi, C., de Wit, S., About Msallem, J. P., Meijers, W. C., Klip, I. T., van der Meer, P., de Boer, R. A. (2022) Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. ESC Heart Failure, 9, pp. 4167-4176. (doi: 10.1002/ehf2.14120)

Mark, P. B., Mangion, K., Rankin, A. J., Rutherford, E., Lang, N. N., Petrie, M. C., Stoumpos, S., Patel, R. K. (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clinical Kidney Journal, 15, pp. 2186-2199. (doi: 10.1093/ckj/sfac146)

Rossitto, G., Delles, C. (2022) Mechanisms of sodium-mediated injury in cardiovascular disease: old play, new scripts. FEBS Journal, 289, pp. 7260-7273. (doi: 10.1111/febs.16155)

Kalra, P. R., Cleland, J. G. F., Petrie, M. C., Ahmed, F. Z., Foley, P. W. X., Kalra, P. A., Lang, N. N., Lane, R. E., Macdougall, I. C., Pellicori, P., Pope, M. T. B., Robertson, M., Squire, I. B., Thomson, E. A., Ford, I. (2022) Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart, 108, pp. 1979-1985. (doi: 10.1136/heartjnl-2022-321304)

Gerstein, H. C., Sattar, N. (2022) Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status. Lancet Diabetes and Endocrinology, 10, pp. 831-832. (doi: 10.1016/S2213-8587(22)00313-8)

Deo, S. V., McAllister, D. A., Al-Kindi, S., Elgudin, Y., Chu, D., Pell, J., Sattar, N. (2022) Trends in prescriptions of cardioprotective diabetic agents after coronary artery bypass grafting among U.S. veterans. Diabetes Care, 45, pp. 3054-3057. (doi: 10.2337/dc22-0570)

Kilpi, F., Soares, A. G., Clayton, G. L., Fraser, A., Welsh, P., Sattar, N., Nelson, S. M., Tilling, K., Lawlor, D. A. (2022) Changes in women’s physical function in mid-life by reproductive age and hormones: a longitudinal study. BMC Women's Health, 22, (doi: 10.1186/s12905-022-02070-9)

Mark, P. B., Sattar, N. (2022) Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease. Lancet, 400, pp. 1745-1747. (doi: 10.1016/S0140-6736(22)02164-X)

Tromp, J., Bauer, D., Claggett, B. L., Frost, M., Iversen, M. B., Prasad, N., Petrie, M. C., Larson, M. G., Ezekowitz, J. A., Solomon, S. D. (2022) A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram. Nature Communications, 13, (doi: 10.1038/s41467-022-34245-1)

Paterson, C., Hinterberg, M. A., Morrow, A. J., Sykes, R., Mangion, K., Welsh, P., McConnachie, A., Sattar, N., Berry, C., Williams, S. A. (2022) Utility of a Proteomic Surrogate for Cardiovascular Outcomes to Predict and Monitor COVID-19 Induced Myocarditis. (doi: 10.1161/circ.146.suppl_1.12132)

Kondo, T., Abdul-Rahim, A. H., Talebi, A., Abraham, W. T., Desai, A. S., Dickstein, K., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Packer, M., Petrie, M., Ponikowski, P., Rouleau, J. L., Sabatine, M. S., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. European Heart Journal, 43, pp. 4469-4479. (doi: 10.1093/eurheartj/ehac487)

Butler, J. et al. (2022) Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European Heart Journal, 43, pp. 4362-4373. (doi: 10.1093/eurheartj/ehac401)

Pellicori, P., Kalra, P. R., Clark, A. L., Friday, J., Cleland, J. G. F. (2022) Chronic kidney disease (CKD) and CKD-ism in heart failure – what a mess! European Journal of Heart Failure, 24, pp. 2196-2198. (doi: 10.1002/ejhf.2696)

Inciardi, R. M., Pagnesi, M., Lombardi, C. M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Pellicori, P., Ponikowski, P., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Solomon, S. D., Voors, A. A., Metra, M. (2022) Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure. European Journal of Heart Failure, 24, pp. 2131-2139. (doi: 10.1002/ejhf.2593)

Karusheva, Y., Ratcliff, M., Mörseburg, A., Barker, P., Melvin, A., Sattar, N., Burling, K., Backmark, A., Roth, R., Jermutus, L., Guiu-Jurado, E., Blueher, M., Welsh, P., Hyvönen, M., O’Rahilly, S. (2022) Common H202D variant in GDF-15 does not affect its bioactivity but can significantly interfere with measurement of its circulating levels. Journal of Applied Laboratory Medicine, 7, pp. 1388-1400. (doi: 10.1093/jalm/jfac055)

Harrington, J., Udell, J. A., Jones, W. S., Anker, S. D., Bhatt, D. L., Petrie, M. C., Vedin, O., Sumin, M., Zwiener, I., Hernandez, A. F., Butler, J. (2022) Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. American Heart Journal, 253, pp. 86-98. (doi: 10.1016/j.ahj.2022.05.010)

Arulmurugananthavadivel, A., Holt, A., Parveen, S., Lamberts, M., Gislason, G. H., Torp-Pedersen, C., Madelaire, C., Andersson, C., Zahir, D., Butt, J. H., Petrie, M. C., McMurray, J., Fosbol, E. L., Kober, L., Schou, M. (2022) Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark 1997–2017. European Heart Journal: Quality of Care and Clinical Outcomes, 8, pp. 750-760. (doi: 10.1093/ehjqcco/qcab073)

Lopez-Jimenez, F., Almahmeed, W., Bays, H., Cuevas, A., Di Angelantonio, E., le Roux, C. W., Sattar, N., Sun, M. C., Wittert, G., Pinto, F. J., Wilding, J. P.H. (2022) Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. European Journal of Preventive Cardiology, 29, pp. 2218-2237. (doi: 10.1093/eurjpc/zwac187)

Mary, S., Boder, P., Padmanabhan, S., McBride, M. W., Graham, D., Delles, C., Dominiczak, A. F. (2022) The role of uromodulin in salt-sensitive hypertension. Hypertension, 79, pp. 2419-2429. (doi: 10.1161/HYPERTENSIONAHA.122.19888)

Yengo, L. et al. (2022) A saturated map of common genetic variants associated with human height. Nature Communications, 610, pp. 704-712. (doi: 10.1038/s41586-022-05275-y)

Seckin, M., Johnston, B., Petrie, M. C., Stewart, S., Chan, Y.-K. (2022) Characteristics of symptoms and symptom change across different heart failure subtypes: a sex-stratified analysis. European Journal of Cardiovascular Nursing, (doi: 10.1093/eurjcn/zvac099)

Connell, H., Logan, G., Somers, C., Baker, G., Broadfield, S., Bunn, C., Harper, L. D., Kelly, P., McIntosh, E., Pell, J. P., Puttnam, J., Robson, S., Gill, J. M. R., Gray, C. M. (2022) Development and optimisation of a multi-component workplace intervention to increase cycling for the Cycle Nation Project. Frontiers in Sports and Active Living, 4, (doi: 10.3389/fspor.2022.857554)

Salah, H. M., Goldberg, L. R., Molinger, J., Felker, G. M., Applefeld, W., Rassaf, T., Tedford, R. J., Mirro, M., Cleland, J. G.F., Fudim, M. (2022) Diaphragmatic function in cardiovascular disease: JACC review topic of the week. Journal of the American College of Cardiology, 80, pp. 1647-1659. (doi: 10.1016/j.jacc.2022.08.760)

Lota, A. S. et al. (2022) Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation, 146, pp. 1123-1134. (doi: 10.1161/CIRCULATIONAHA.121.058457)

Garred, C. H., Zahir, D., Butt, J. H., Ravn, P. B., Bruhn, J., Gislason, G. H., Fosbøl, E. L., Torp‐Pedersen, C., Petrie, M. C., McMurray, J. J.V., Køber, L., Schou, M. (2022) Adherence and discontinuation of optimal heart failure therapies according to age: a Danish nationwide study. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.122.026187)

Desai, A. S., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Miao, Z. M., Kondo, T., Barkoudah, E., Brahimi, A., Connolly, E., Finn, P., Lang, N. N., Mc Causland, F. R., McGrath, M., Petrie, M. C., McMurray, J. J.V., Solomon, S. D. (2022) Effect of dapagliflozin on cause-specific mortality in patients with heart failure across the spectrum of ejection fraction. JAMA Cardiology, 7, pp. 1227-1234. (doi: 10.1001/jamacardio.2022.3736)

Baumhove, L., Tromp, J., Figarska, S., van Essen, B. J., Anker, S. D., Dickstein, K., Cleland, J. G., Lang, C. C., Filippatos, G., Ng, L. L., Samani, N. J., Metra, M., van Veldhuisen, D. J., Lam, C. S.P., Voors, A. A., van der Meer, P. (2022) Heart failure with normal LVEF in BIOSTAT-CHF. International Journal of Cardiology, 364, pp. 85-90. (doi: 10.1016/j.ijcard.2022.05.054)

Butterly, E., Wei, L., Adler, A. I., Almazam, S. A.M., Alsallumi, K., Blackbourn, L. A.K., Dias, S., Hanlon, P., Hughes, K., Lewsey, J., Lindsay, R., McGurnaghan, S., Petrie, J., Phillippo, D., Sattar, N., Tomlinson, L. A., Welton, N., Wild, S., McAllister, D. (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol. BMJ Open, 12, (doi: 10.1136/bmjopen-2022-066491)

McGurnaghan, S. J., Blackbourn, L. A. K., Caparrotta, T. M., Mellor, J., Barnett, A., Collier, A., Sattar, N., McKnight, J., Petrie, J., Philip, S., Lindsay, R., Hughes, K., McAllister, D., Leese, G. P., Pearson, E. R., Wild, S., McKeigue, P. M., Colhoun, H. M. (2022) Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland. BMJ Open, 12, (doi: 10.1136/bmjopen-2022-063046)

Kazmi, S., Kambhampati, C., Cleland, J. G.F., Cuthbert, J., Kazmi, K. S., Pellicori, P., Rigby, A. S., Clark, A. L. (2022) Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure. ESC Heart Failure, 9, pp. 3009-3018. (doi: 10.1002/ehf2.14028)

Harrington, J., Petrie, M. C., Anker, S. D., Bhatt, D. L., Jones, S. W., Udell, J. A., Hernandez, A. F., Butler, J. (2022) Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction. JAMA Cardiology, 7, pp. 1067-1075. (doi: 10.1001/jamacardio.2022.2847)

McMurray, J. J. V., Sattar, N. (2022) Heart failure: now centre-stage in diabetes. Lancet Diabetes and Endocrinology, 10, pp. 689-691. (doi: 10.1016/S2213-8587(22)00249-2)

Welsh, P., Campbell, R. T., Mooney, L., Kimenai, D. M., Hayward, C., Campbell, A., Porteous, D., Mills, N., Lang, N. N., Petrie, M. C., Januzzi, J. L., McMurray, J. J.V., Sattar, N. (2022) Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circulation: Heart Failure, 15, pp. 957-967. (doi: 10.1161/CIRCHEARTFAILURE.121.009427)

Cooper, T. J., Pellicori, P., Ushakov, A., Dickstein, K. (2022) Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease' European Journal of Heart Failure, 24, pp. 1990-1992. (doi: 10.1002/ejhf.2690)

Rosengren, A., Lundberg, C. E., Söderberg, M., Santosa, A., Edqvist, J., Lindgren, M., Åberg, M., Gisslén, M., Robertson, J., Cronie, O., Sattar, N., Lagergren, J., Brandén, M., Björk, J., Adiels, M. (2022) Severe COVID‐19 in people 55 and older during the first year of the pandemic in Sweden. Journal of Internal Medicine, 292, pp. 641-653. (doi: 10.1111/joim.13522)

Nazar, G., Alcover, C.-M., Lanuza, F., Labraña, A. M., Ramírez-Alarcón, K., Troncoso-Pantoja, C., Leiva, A. M., Celis-Morales, C., Petermann-Rocha, F. (2022) Association between bodyweight perception, nutritional status, and weight control practices: a cross-sectional analysis from the Chilean Health Survey 2016–2017. Frontiers in Psychology, 13, (doi: 10.3389/fpsyg.2022.984106)

Docherty, K. F., Welsh, P., Verma, S., De Boer, R. A., O'Meara, E., Bengtsson, O., Køber, L., Kosiborod, M. N., Hammarstedt, A., Langkilde, A. M., Lindholm, D., Little, D. J., Sjöstrand, M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Morrow, D. A., Schou, M., Solomon, S. D., Sattar, N., Jhund, P. S., McMurray, J. J.V. (2022) Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF. Circulation, 146, pp. 980-994. (doi: 10.1161/CIRCULATIONAHA.122.060511)

Tabák, A. G., Brunner, E. J., Lindbohm, J. V., Singh-Manoux, A., Shipley, M. J., Sattar, N., Kivimäki, M. (2022) Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study. Circulation, 146, pp. 995-1005. (doi: 10.1161/CIRCULATIONAHA.122.059430)

Sharma, A., Nermoen, I., Qvigstad, E., Tran, A. T., Sommer, C., Sattar, N., Gill, J. M.R., Gulseth, H. L., Sollid, S. T., Birkeland, K. I. (2022) High prevalence and significant ethnic differences in actionable HbA 1C after gestational diabetes mellitus in women living in Norway. BMC Medicine, 20, (doi: 10.1186/s12916-022-02515-w)

Ho, F. K., Zhou, Z., Petermann-Rocha, F., Parra-Soto, S., Boonpor, J., Welsh, P., Gill, J. M.R., Gray, S. R., Sattar, N., Pell, J. P., Celis-Morales, C. (2022) Association between device-measured physical activity and incident heart failure: a prospective cohort study of 94 739 UK Biobank participants. Circulation, 146, pp. 883-891. (doi: 10.1161/CIRCULATIONAHA.122.059663)

Toth, P. P., Bray, S., Villa, G., Palagashvili, T., Sattar, N., Stroes, E. S. G., Worth, G. M. (2022) Network meta‐analysis of randomized trials evaluating the comparative efficacy of lipid‐lowering therapies added to maximally tolerated statins for the reduction of low‐density lipoprotein cholesterol. Journal of the American Heart Association, 11, (doi: 10.1161/JAHA.122.025551)

Ho, F. K., Petermann-Rocha, F., Parra-Soto, S., Boonpor, J., Gill, J. M.R., Gray, S. R., Pell, J. P., Celis-Morales, C. (2022) Device-measured physical activity and incident affective disorders. BMC Medicine, 20, (doi: 10.1186/s12916-022-02484-0)

Boonpor, J., Ho, F. K., Gray, S. R., Celis-Morales, C. A. (2022) Association of self-reported walking pace with type 2 diabetes incidence in the UK Biobank prospective cohort study. Mayo Clinic Proceedings, 97, pp. 1631-1640. (doi: 10.1016/j.mayocp.2022.02.028)

Livingstone, K. M., Brayner, B., Celis-Morales, C., Moschonis, G., Manios, Y., Traczyk, I., Drevon, C. A., Daniel, H., Saris, W. H. M., Lovegrove, J. A., Gibney, M., Gibney, E. R., Brennan, L., Martinez, J. A., Mathers, J. C. (2022) Associations between dietary patterns, FTO genotype and obesity in adults from seven European countries. European Journal of Nutrition, 61, pp. 2953-2965. (doi: 10.1007/s00394-022-02858-3)

Nazarzadeh, M., Bidel, Z., Canoy, D., Copland, E., Bennett, D. A., Dehghan, A., Davey Smith, G., Holman, R. R., Woodward, M., Gupta, A., Adler, A. I., Wamil, M., Sattar, N., Cushman, W. C., McManus, R. J., Teo, K., Davis, B. R., Chalmers, J., Pepine, C. J., Rahimi, K. (2022) Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis. Lancet Diabetes and Endocrinology, 10, pp. 645-654. (doi: 10.1016/S2213-8587(22)00172-3)

Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Ho, F., Celis-Morales, C., Gray, S. R. (2022) Combined association of walking pace and grip strength with incident type 2 diabetes. Scandinavian Journal of Medicine and Science in Sports, 32, pp. 1356-1365. (doi: 10.1111/sms.14197)

Ravera, A., Santema, B. T., de Boer, R. A., Anker, S. D., Samani, N. J., Lang, C. C., Ng, L., Cleland, J. G.F., Dickstein, K., Lam, C. S.P., Van Spall, H., Filippatos, G., van Veldhuisen, D. J., Metra, M., Voors, A. A., Sama, I. E. (2022) Distinct pathophysiological pathways in women and men with heart failure. European Journal of Heart Failure, 24, pp. 1532-1544. (doi: 10.1002/ejhf.2534)

Kobayashi, M., Girerd, N., Ferreira, J. P., Kevin, D., Huttin, O., González, A., Bozec, E., Clark, A. L., Cosmi, F., Cuthbert, J., Diez, J., Edelmann, F., Hazebroek, M., Heymans, S., Mariottoni, B., Pellicori, P., Petutschnigg, J., Pieske, B., Staessen, J. A., Verdonschot, J. A.J., Rossignol, P., Cleland, J. G.F., Zannad, F. (2022) The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24, pp. 1559-1568. (doi: 10.1002/ejhf.2579)

Madjedi, K. M., Stuart, K. V., Chua, S. Y.L., Luben, R. N., Warwick, A., Pasquale, L. R., Kang, J. H., Wiggs, J. L., Lentjes, M. A.H., Aschard, H., Sattar, N., Foster, P. J., Khawaja, A. P. (2022) The association between serum lipids and intraocular pressure in two large UK cohorts. Ophthalmology, 129, pp. 986-996. (doi: 10.1016/j.ophtha.2022.04.023)

Clayton, G. L., Soares, A. G., Kilpi, F., Fraser, A., Welsh, P., Sattar, N., Nelson, S. M., Tilling, K., Lawlor, D. A. (2022) Cardiovascular health in the menopause transition: a longitudinal study of up to 3892 women with up to four repeated measures of risk factors. BMC Medicine, 20, (doi: 10.1186/s12916-022-02454-6)

Sattar, N., Anker, S. D., Butler, J., Verma, S. (2022) Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights. European Heart Journal, 43, pp. 2968-2970. (doi: 10.1093/eurheartj/ehab709)

Höhn, A., McGurnaghan, S. J., Caparrotta, T. M., Jeyam, A., O'Reilly, J. E., Blackbourn, L. A. K., Hatam, S., Dudel, C., Seaman, R. J., Mellor, J., Sattar, N., McCrimmon, R. J., Kennon, B., Petrie, J. R., Wild, S., McKeigue, P. M., Colhoun, H. M., on behalf of the SDRN-Epi Group, (2022) Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018. PLoS ONE, 17, (doi: 10.1371/journal.pone.0271110)

Adamson, C., Docherty, K. F., Heerspink, H. J.L., de Boer, R. A., Damman, K., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Solomon, S. D., Verma, S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Jhund, P. S., McMurray, J. J.V. (2022) Initial decline ("dip") in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF. Circulation, 146, pp. 438-449. (doi: 10.1161/CIRCULATIONAHA.121.058910)

Valabhji, J., Barron, E., Gorton, T., Bakhai, C., Kar, P., Young, B., Khunti, K., Holman, N., Sattar, N., Wareham, N. J. (2022) Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study. Lancet Diabetes and Endocrinology, 10, pp. 561-570. (doi: 10.1016/S2213-8587(22)00131-0)

Savarese, G., Uijl, A., Ouwerkerk, W., Tromp, J., Anker, S. D., Dickstein, K., Hage, C., Lam, C. S.P., Lang, C. C., Metra, M., Ng, L. L., Orsini, N., Samani, N. J., van Veldhuisen, D. J., Cleland, J. G.F., Voors, A. A., Lund, L. H. (2022) Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction. ESC Heart Failure, 9, pp. 2107-2118. (doi: 10.1002/ehf2.13917)

Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G. S., Inciardi, R. M., Lang, C. C., Lombardi, C. M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Voors, A. A., Metra, M. (2022) Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. Clinical Research in Cardiology, 111, pp. 912-923. (doi: 10.1007/s00392-022-01991-7)

Cabanas‐Sánchez, V., Esteban‐Cornejo, I., Parra-Soto, S., Petermann-Rocha, F., Gray, S. R., Rodríguez‐Artalejo, F., Ho, F. K., Pell, J. P., Martínez‐Gómez, D., Celis-Morales, C. (2022) Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 1983-1994. (doi: 10.1002/jcsm.12963)

Hoes, M. F., Arany, Z., Bauersachs, J., Hilfiker-Kleiner, D., Petrie, M. C., Sliwa, K., van der Meer, P. (2022) Pathophysiology and risk factors of peripartum cardiomyopathy. Nature Reviews Cardiology, 19, pp. 555-565. (doi: 10.1038/s41569-021-00664-8)

Rossignol, P., Silva-Cardoso, J., Kosiborod, M.N., Brandenburg, V., Cleland, J.G., Hadimeri, H., Hullin, R., Makela, S., Mörtl, D., Paoletti, E., Pollock, C., Vogt, L., Jadoul, M., Butler, J. (2022) Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease. Pharmacological Research, 182, (doi: 10.1016/j.phrs.2022.106277)

Bachmair, E.-M., Martin, K., Aucott, L., Dhaun, N., Dures, E., Emsley, R., Gray, S. R., Kidd, E., Kumar, V., Lovell, K., MacLennan, G., McNamee, P., Norrie, J., Paul, L., Packham, J., Ralston, S. H., Siebert, S., Wearden, A., Macfarlane, G., Basu, N., on behalf of the LIFT study group, (2022) Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial. Lancet Rheumatology, 4, pp. e534-e545. (doi: 10.1016/S2665-9913(22)00156-4)

Ryan, M., Perera, D., Petrie, M. C. (2022) Revascularisation and HFpEF – time for randomised trials. European Journal of Heart Failure, 24, pp. 1439-1440. (doi: 10.1002/ejhf.2583)

Deo, S. V., Reddy, Y. N.V., Zakeri, R., Karnib, M., Selvaganesan, P., Elgudin, Y., Kilic, A., Rubelowsky, J., Altarabsheh, S. E., Osman, M. N., Josephson, R. A., Mohan, S. K. M., Cmolik, B., Simon, D. I., Rajagopalan, S., Cleland, J. G.F., Sahadevan, J., Sundaram, V. (2022) Revascularization in ischemic heart failure with preserved ejection fraction: a nationwide cohort study. European Journal of Heart Failure, 24, pp. 1427-1438. (doi: 10.1002/ejhf.2446)

Jorbendaze, A., Young, R., Shaburishvili, T., Demyanchuk, V., Buriak, R., Todurov, B., Rudenko, K., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P., Mirro, M., Fudim, M., Goldberg, L. R., Cleland, J. G.F. (2022) Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first‐in‐patient study. ESC Heart Failure, 9, pp. 2207-2214. (doi: 10.1002/ehf2.13984)

Deo, S. V., Marsia, S., McAllister, D. A., Elgudin, Y., Sattar, N., Pell, J. P. (2022) The time-varying cardiovascular benefits of glucagon like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus: evidence from large multinational trials. Diabetes, Obesity and Metabolism, 24, pp. 1607-1616. (doi: 10.1111/dom.14738)

Girerd, N., Von Hunolstein, J.-J., Pellicori, P., Bayés-Genís, A., Jaarsma, T., Lund, L. H., Bilbault, P., Boivin, J.-M., Chouihed, T., Costa, J., Eicher, J.-C., Fall, E., Kenizou, D., Maillier, B., Nazeyrollas, P., Roul, G., Zannad, N., Rossignol, P., Seronde, M.-F. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, 9, pp. 2063-2069. (doi: 10.1002/ehf2.13929)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) Circulation, 146, pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851)

Kimenai, D. M., Pirondini, L., Gregson, J., Prieto, D., Pocock, S. J., Perel, P., Hamilton, T., Welsh, P., Campbell, A., Porteous, D. J., Hayward, C., Sattar, N., Mills, N. L., Shah, A. S.V. (2022) Socioeconomic deprivation: an important, largely unrecognized risk factor in primary prevention of cardiovascular disease. Circulation, 146, pp. 240-248. (doi: 10.1161/CIRCULATIONAHA.122.060042)

Lewinter, C., Nielsen, T. H., Edfors, L. R., Linde, C., Bland, J. M., LeWinter, M., Cleland, J. G.F., Køber, L., Braunschweig, F., Mansson-Broberg, A. (2022) A systematic review and meta-analysis of beta-blockers and inhibitors of the renin-angiotensin system for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. European Heart Journal, 43, pp. 2562-2569. (doi: 10.1093/eurheartj/ehab843)

Shen, L., Jhund, P. S., Docherty, K. F., Vaduganathan, M., Petrie, M. C., Desai, A. S., Køber, L., Schou, M., Packer, M., Solomon, S. D., Zhang, X., McMurray, J. J. V. (2022) Accelerated and personalized therapy for heart failure with reduced ejection fraction. European Heart Journal, 43, pp. 2573-2587. (doi: 10.1093/eurheartj/ehac210)

Cowie, M., Cleland, J. G.F. (2022) The COVID-19 pandemic and heart failure: lessons from GUIDE-HF. European Heart Journal, 43, pp. 2619-2621. (doi: 10.1093/eurheartj/ehac226)

Sattar, N., McGuire, D. K., Gill, J. M.R. (2022) High circulating triglycerides are most commonly a marker of ectopic fat accumulation: connecting the clues to advance lifestyle interventions. Circulation, 146, pp. 77-79. (doi: 10.1161/CIRCULATIONAHA.122.060411)

Cester, L., Starshynov, I., Jones, Y., Pellicori, P., Cleland, J. G.F., Faccio, D. (2022) Remote laser-speckle sensing of heart sounds for health assessment and biometric identification. Biomedical Optics Express, 13, pp. 3743-3750. (doi: 10.1364/BOE.451416)

Rao, S., Li, Y., Ramakrishnan, R., Hassaine, A., Canoy, D., Cleland, J. G., Lukasiewicz, T., Salimi-Khorshidi, G., Rahimi, K. (2022) An explainable transformer-based deep learning model for the prediction of incident heart failure. IEEE Journal of Biomedical and Health Informatics, 26, pp. 3362-3372. (doi: 10.1109/JBHI.2022.3148820)

Colaço, K., Lee, K.‐A., Akhtari, S., Winer, R., Welsh, P., Sattar, N., McInnes, I. B., Chandran, V., Harvey, P., Cook, R. J., Gladman, D. D., Piguet, V., Eder, L. (2022) Association of cardiac biomarkers with cardiovascular outcomes in patients with psoriatic arthritis and psoriasis: a longitudinal cohort study. Arthritis and Rheumatology, 74, pp. 1184-1192. (doi: 10.1002/art.42079)

Thygesen, J. H., Tomlinson, C., Hollings, S., Mizani, M. A., Handy, A., Akbari, A., Banerjee, A., Cooper, J., Lai, A. G., Li, K., Mateen, B. A., Sattar, N., Sofat, R., Torralbo, A., Wu, H., Wood, A., Sterne, J. A. C., Pagel, C., Whiteley, W. N., Sudlow, C., Hemingway, H., Denaxas, S. (2022) COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records. Lancet Digital Health, 7, pp. e542-e557. (doi: 10.1016/S2589-7500(22)00091-7)

Cooper, T. J., Cleland, J. G.F., Guazzi, M., Pellicori, P., Ben Gal, T., Amir, O., Al‐Mohammad, A., Clark, A. L., McConnachie, A., Steine, K., Dickstein, K. (2022) Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomised placebo‐controlled multicentre trial. European Journal of Heart Failure, 24, pp. 1239-1248. (doi: 10.1002/ejhf.2527)

Santema, B. T., Artola Arita, V., Sama, I. E., Kloosterman, M., van den Berg, M. P., Nienhuis, H. L.A., Van Gelder, I. C., van der Meer, P., Zannad, F., Metra, M., Ter Maaten, J. M., Cleland, J. G., Ng, L. L., Anker, S. D., Lang, C. C., Samani, N. J., Dickstein, K., Filippatos, G., van Veldhuisen, D. J., Lam, C. S.P., Rienstra, M., Voors, A. A. (2022) Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovascular Research, 118, pp. 2478-2487. (doi: 10.1093/cvr/cvab331)

Cohen, D. J., Magnuson, E., Stone, G. W., Cleland, J. G.F. (2022) Response to: correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock. Heart, 108, (doi: 10.1136/heartjnl-2022-321180)

Boonpor, J., Petermann-Rocha, F., Parra-Soto, S., Pell, J. P., Gray, S. R., Celis-Morales, C., Ho, F. K. (2022) Types of diet, obesity, and incident type 2 diabetes: findings from the UK Biobank prospective cohort study. Diabetes, Obesity and Metabolism, 24, pp. 1351-1359. (doi: 10.1111/dom.14711)

Paul, L., Barclay, A., Rooney, S., Gray, S. (2022) The effects of cycling using lower limb active passive trainers in people with neurological conditions: a systematic review. International Journal of Therapy and Rehabilitation, 29, (doi: 10.12968/ijtr.2020.0171)

Davis, T. M. E., Giczewska, A., Lokhnygina, Y., Mentz, R. J., Sattar, N., Holman, R. R. (2022) Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) Cardiovascular Diabetology, 21, (doi: 10.1186/s12933-022-01555-z)

Lip, S., McCallum, L., Delles, C., McClure, J. D., Guzik, T., Berry, C., Touyz, R., Padmanabhan, S. (2022) Rationale and design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR) Open Heart, 9, (doi: 10.1136/openhrt-2022-002057)

Aktaa, S., Batra, G., Cleland, J. G.F., Coats, A., Lund, L. H., McDonagh, T., Rosano, G., Seferovic, P., Vasko, P., Wallentin, L., Maggioni, A. P., Casadei, B., Gale, C. P. (2022) Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) European Heart Journal, 43, pp. 2185-2195. (doi: 10.1093/eurheartj/ehac151)

Tromp, J., Ouwerkerk, W., Teng, T.-H. K., Cleland, J. G.F., Bamadhaj, S., Angermann, C. E., Dahlstrom, U., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Collins, S. P., Filippatos, G., Lam, C. S.P. (2022) Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. European Heart Journal, 43, pp. 2224-2234. (doi: 10.1093/eurheartj/ehac103)

Fernando, J., Lee, M., Quinn, D., Corcoran, D., Connolly, E. (2022) Assessing the Impact of the Covid-19 Pandemic on Rapid Access Chest Pain Clinics: A Retrospective Audit in Glasgow. (doi: 10.1136/heartjnl-2022-BCS.70)

Tayal, U. et al. (2022) Precision phenotyping of dilated cardiomyopathy using multidimensional data. Journal of the American College of Cardiology, 79, pp. 2219-2232. (doi: 10.1016/j.jacc.2022.03.375)

Mangion, K. et al. (2022) Multi-system investigation of COVID-19 illness. (doi: 10.1136/heartjnl-2022-BCS.157)

Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28, pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9)

Craig, A., Delles, C., Murray, E. C. (2022) A review of vascular traits and assessment techniques, and their heritability. Artery Research, 28, pp. 61-78. (doi: 10.1007/s44200-022-00016-y)

Kastrati, K., Aletaha, D., Burmester, G. R., Chwala, E., Dejaco, C., Dougados, M., McInnes, I. B., Ravelli, A., Sattar, N., Stamm, T. A., Takeuchi, T., Trauner, M., van der Heijde, D., Voshaar, M. J.H., Winthrop, K., Smolen, J. S., Kerschbaumer, A. (2022) A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD Open, 8, (doi: 10.1136/rmdopen-2022-002359)

Jackson, A. M., Benson, L., Savarese, G., Hage, C., Jhund, P. S., Petrie, M. C., Dahlström, U., McMurray, J. J.V., Lund, L. H. (2022) Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry. JACC: Heart Failure, 10, pp. 380-392. (doi: 10.1016/j.jchf.2022.04.006)

Ho, F. K., Ferguson, L. D., Celis-Morales, C. A., Gray, S. R., Forrest, E., Alazawi, W., Gill, J. M.R., Katikireddi, S. V., Cleland, J. G.F., Welsh, P., Pell, J. P., Sattar, N. (2022) Association of gamma-glutamyltransferase levels with total mortality, liver-related, and cardiovascular outcomes: a prospective cohort study in the UK Biobank. EClinicalMedicine, 48, (doi: 10.1016/j.eclinm.2022.101435)

Wang, Y. et al. (2022) Associations of long-term visit-to-visit blood pressure variability with subclinical kidney damage and albuminuria in adulthood: a 30-year prospective cohort study. Hypertension, 79, pp. 1247-1256. (doi: 10.1161/HYPERTENSIONAHA.121.18658)

Boyalla, V., Harling, L., Snell, A., Kralj-Hans, I., Barradas-Pires, A., Haldar, S., Khan, H. R., Cleland, J. G.F., Athanasiou, T., Harding, S. E., Wong, T. (2022) Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis. Clinical Research in Cardiology, 111, pp. 680-691. (doi: 10.1007/s00392-021-01978-w)

Lucas-Herald, A. K., Delles, C. (2022) Carotid intima-media thickness is associated with obesity and hypertension in young people. Hypertension, 79, pp. 1177-1179. (doi: 10.1161/hypertensionaha.122.19163)

Halliday, B. P., Owen, R., Gregson, J., Vazir, A., Wassall, R., Khalique, Z., Lota, A. S., Tayal, U., Hammersley, D. J., Jones, R. E., Pennell, D. J., Cowie, M. R., Cleland, J. G.F., Prasad, S. K. (2022) Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy. ESC Heart Failure, 9, pp. 1616-1624. (doi: 10.1002/ehf2.13872)

Streng, K. W., Hillege, H. L., Maaten, J. M., Veldhuisen, D. J., Dickstein, K., Ng, L. L., Samani, N. J., Metra, M., Ponikowski, P., Cleland, J. G., Anker, S. D., Romaine, S. P.R., Damman, K., Meer, P., Lang, C. C., Voors, A. A. (2022) Clinical implications of low estimated protein intake in patients with heart failure. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 1762-1770. (doi: 10.1002/jcsm.12973)

Curtain, J. P., Campbell, R. T., Petrie, M. C., Jackson, A. M., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Jhund, P. S., McMurray, J. J.V. (2022) Clinical outcomes related to background diuretic use and new diuretic initiation in patients with HFrEF. JACC: Heart Failure, 10, pp. 415-427. (doi: 10.1016/j.jchf.2022.01.020)

Rastogi, T., Ho, F. K., Rossignol, P., Merkling, T., Butler, J., Clark, A., Collier, T., Delles, C., Jukema, J. W., Heymans, S., Latini, R., Mebazaa, A., Pellicori, P., Sever, P., Staessen, J. A., Thijs, L., Cleland, J. G., Sattar, N., Zannad, F., Girerd, N. (2022) Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. European Journal of Heart Failure, 24, pp. 976-984. (doi: 10.1002/ejhf.2495)

McDowell, K., Welsh, P., Docherty, K. F., Morrow, D. A., Jhund, P. S., De Boer, R. A., O’Meara, E., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Hammarstedt, A., Langkilde, A. M., Sjöstrand, M., Lindholm, D., Solomon, S. D., Sattar, N., Sabatine, M. S., McMurray, J. J.V. (2022) Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF. European Journal of Heart Failure, 24, pp. 1066-1076. (doi: 10.1002/ejhf.2433)

Kahl, S., Ofstad, A. P., Zinman, B., Wanner, C., Schüler, E., Sattar, N., Inzucchi, S. E., Roden, M. (2022) Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes. Diabetes, Obesity and Metabolism, 24, pp. 1061-1071. (doi: 10.1111/dom.14670)

Petermann-Rocha, F., Pell, J. P., Celis-Morales, C., Ho, F. K. (2022) Frailty, sarcopenia, cachexia and malnutrition as comorbid conditions and their associations with mortality: a prospective study from UK Biobank. Journal of Public Health, 44, pp. e172-e180. (doi: 10.1093/pubmed/fdaa226)

Esteban-Cornejo, I., Ho, F., Petermann-Rocha, F., Lyall, D. M., Martinez-Gomez, D., Cabanas-Sanchez, V., Ortega, F. B., Hillman, C. H., Gill, J. M.R., Quinn, T. J., Sattar, N., Pell, J. P., Gray, S. R., Celis-Morales, C. (2022) Handgrip strength and all-cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 1514-1525. (doi: 10.1002/jcsm.12857)

Pellicori, P., Cleland, J. G. F. (2022) Heart failure: age is no excuse for complacency. European Journal of Heart Failure, 24, pp. 1063-1065. (doi: 10.1002/ejhf.2517)

Bomer, N., Pavez-Giani, M. G., Grote Beverborg, N., Cleland, J. G.F., van Veldhuisen, D. J., van der Meer, P. (2022) Micronutrient deficiencies in heart failure: mitochondrial dysfunction as a common pathophysiological mechanism? Journal of Internal Medicine, 291, pp. 713-731. (doi: 10.1111/joim.13456)

Du Puy, R. S., Poortvliet, R. K. E., Mooijaart, S. P., Stott, D. J., Quinn, T., Sattar, N., Westendorp, R. G. J., Kearney, P. M., McCarthy, V. J. C., Byrne, S., Rodondi, N., Baretella, O., Collet, T.-H., van Heemst, D., Dekkers, O. M., Jukema, J. W., Smit, J. W. A., Gussekloo, J., den Elzen, W. P. J. (2022) No effect of levothyroxine on hemoglobin in older adults with subclinical hypothyroidism: pooled results from 2 randomized controlled trials. Journal of Clinical Endocrinology and Metabolism, 107, pp. e2339-e2347. (doi: 10.1210/clinem/dgac106)

McNaughton, C. D., McConnachie, A., Cleland, J. G., Spertus, J. A., Angermann, C. E., Duklas, P., Tromp, J., Lam, C. S.P., Filippatos, G., Dahlstrom, U., Dickstein, K., Schweizer, A., Perrone, S. V., Hassanein, M., Ertl, G., Obergfell, A., Ghadanfar, M., Collins, S. P. (2022) Quality of life assessed six months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) European Journal of Heart Failure, 24, pp. 1020-1029. (doi: 10.1002/ejhf.2508)

Connelly, P. J., Currie, G., Delles, C. (2022) Sex differences in the prevalence, outcomes and management of hypertension. Current Hypertension Reports, 24, pp. 185-192. (doi: 10.1007/s11906-022-01183-8)

Israr, M. Z., Zhan, H., Salzano, A., Voors, A. A., Cleland, J. G.F., Anker, S. D., Metra, M., van Veldhuisen, D. J., Lang, C. C., Zannad, F., Samani, N. J., Ng, L. L., Suzuki, T. (2022) Surrogate markers of gut dysfunction are related to heart failure severity and outcome - from the BIOSTAT-CHF consortium. American Heart Journal, 248, pp. 108-119. (doi: 10.1016/j.ahj.2022.03.002)

Goldberg, L. R., Jorbenadze, A., Shaburishvilli, T., Mirro, M. J., Fudim, M., Zuber, M., Stämpfli, S. F., Tanner, F. C., Erne, P., Cleland, J. G. (2022) Synchronized diaphragmatic stimulation: a case report of a novel extra-cardiac intervention for chronic heart failure. ESC Heart Failure, 9, pp. 1677-1681. (doi: 10.1002/ehf2.13882)

Cleland, J. G.F., Bristow, M. R., Freemantle, N., Olshansk, B., Gras, D., Saxon, L., Tavazzi, L., Boehmer, J., Ghio, S., Feldman, A. M., Daubert, J.-C., deMets, D. (2022) The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual-patient-data meta-analysis of COMPANION and CARE-HF. European Journal of Heart Failure, 24, pp. 1080-1090. (doi: 10.1002/ejhf.2524)

Alkhedhairi, S. A.A., Aba Alkhayl, F. F., Ismail, A. D., Rozendaal, A., German, M., MacLean, B., Johnston, L., Miller, A.A., Hunter, A.M., Macgregor, L.J., Combet, E., Quinn, T.J., Gray, S.R. (2022) The effect of krill oil supplementation on skeletal muscle function and size in older adults: a randomised controlled trial. Clinical Nutrition, 41, pp. 1228-1235. (doi: 10.1016/j.clnu.2022.04.007)

Nath, M., Romaine, S. P.R., Koekemoer, A., Hamby, S., Webb, T. R., Nelson, C. P., Castellanos-Uribe, M., Papakonstantinou, M., Anker, S. D., Lang, C. C., Metra, M., Zannad, F., Filippatos, G., van Veldhuisen, D. J., Cleland, J. G., Ng, L. L., May, S. T., Marelli-Berg, F., Voors, A. A., Timmons, J. A., Samani, N. J. (2022) Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure. European Journal of Heart Failure, 24, pp. 1009-1019. (doi: 10.1002/ejhf.2540)

Siddiqui, M., Anjana, R.M., Dawed, A. Y., Martoeau, C., Srinivasan, S., Saravanan, J., Madanagopal, S. K., Taylor, A., Bell, S., Veluchamy, A., Pradeepa, R., Sattar, N., Venkatesan, R., Palmer, C. N.A., Pearson, E. R., Mohan, V. (2022) Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function. Diabetologia, 65, pp. 973-983. (doi: 10.1007/s00125-022-05671-z)

Borlaug, B. A. et al. (2022) Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation, 145, pp. 1592-1604. (doi: 10.1161/CIRCULATIONAHA.122.059486)

Udell, J. A., Jones, W. S., Petrie, M. C., Harrington, J., Anker, S. D., Bhatt, D. L., Hernandez, A. F., Butler, J. (2022) Sodium glucose cotransporter-2 inhibition for acute myocardial infarction: JACC Review Topic of the Week. Journal of the American College of Cardiology, 79, pp. 2058-2068. (doi: 10.1016/j.jacc.2022.03.353)

Girerd, N., Cleland, J., Anker, S. D., Byra, W., Lam, C. S.P., Lapolice, D., Mehra, M. R., van Veldhuisen, D. J., Bresso, E., Lamiral, Z., Greenberg, B., Zannad, F. (2022) Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Scientific Reports, 12, (doi: 10.1038/s41598-022-12385-0)

Fairbairn, T. et al. (2022) Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. JAMA: Journal of the American Medical Association, 327, pp. 1875-1887. (doi: 10.1001/jama.2022.5776)

Lucas-Herald, A. K., Montezano, A. C., Alves-Lopes, R., Haddow, L., Alimussina, M., O’Toole, S., Flett, M., Lee, B., Amjad, S. B., Steven, M., Brooksbank, K., McCallum, L., Delles, C., Padmanabhan, S., Ahmed, S. F., Touyz, R. M. (2022) Vascular dysfunction and increased cardiovascular risk in hypospadias. European Heart Journal, 43, pp. 1832-1845. (doi: 10.1093/eurheartj/ehac112)

Sattar, N., Welsh, P. (2022) Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatments. European Heart Journal, 43, pp. 1728-1730. (doi: 10.1093/eurheartj/ehac125)

Ahmadi, M. N., Gill, J. M.R., Stamatakis, E. (2022) Association of changes in physical activity and adiposity with mortality and incidence of cardiovascular disease: longitudinal findings from the UK Biobank. Mayo Clinic Proceedings, 97, pp. 847-861. (doi: 10.1016/j.mayocp.2021.11.026)

Petermann-Rocha, F., Gray, S. R., Forrest, E., Welsh, P., Sattar, N., Celis-Morales, C., Ho, F. K., Pell, J. P. (2022) Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK Biobank participants. Journal of Hepatology, 76, pp. 1021-1029. (doi: 10.1016/j.jhep.2022.01.010)

Cohen, D. J., Wang, K., Magnuson, E. A., Smith, R. D., Petrie, M. C., Buch, M. H., Abraham, W. T., Lindenfeld, J., Mack, M. J., Stone, G. W., Cleland, J. G. F. (2022) Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation. Heart, 108, pp. 717-724. (doi: 10.1136/heartjnl-2021-320005)

Livingstone, K. M., Brayner, B., Celis-Morales, C., Ward, J., Mathers, J. C., Bowe, S. J. (2022) Dietary patterns, genetic risk, and incidence of obesity: Application of reduced rank regression in 11,735 adults from the UK Biobank study. Preventive Medicine, 158, (doi: 10.1016/j.ypmed.2022.107035)

Rossitto, G., Delles, C. (2022) Does excess tissue sodium storage regulate blood pressure? Current Hypertension Reports, 24, pp. 115-122. (doi: 10.1007/s11906-022-01180-x)

Westerink, J., Matthiessen, K. S., Nuhoho, S., Fainberg, U., Lyng Wolden, M., Østergaard, H. B., Visseren, F., Sattar, N. (2022) Estimated life-years gained free of new or recurrent major cardiovascular events with the addition of semaglutide to standard of care in people with type 2 diabetes and high cardiovascular risk. Diabetes Care, 45, pp. 1211-1218. (doi: 10.2337/dc21-1138)

Beazer, J. D., Freeman, D. J. (2022) Estradiol and HDL function in women – a partnership for life. Journal of Clinical Endocrinology and Metabolism, 107, pp. e2192-2194. (doi: 10.1210/clinem/dgab811)

McBride, P., Yates, T., Henson, J., Davies, M., Gill, J., Celis-Morales, C., Khunti, K., Maylor, B., Rowlands, A., Edwardson, C. (2022) Ethnic differences in the relationship between step cadence and physical function in older adults. Journal of Sports Sciences, 40, pp. 1183-1190. (doi: 10.1080/02640414.2022.2057013)

Holman, N., Wild, S. H., Khunti, K., Knighton, P., O'Keefe, J., Bakhai, C., Young, B., Sattar, N., Valabhji, J., Gregg, E. W. (2022) Incidence and characteristics of remission of type 2 diabetes in England: a cohort study using the National Diabetes Audit. Diabetes Care, 45, pp. 1151-1161. (doi: 10.2337/dc21-2136)

Ferreira, J. P., Verdonschot, J. A.J., Girerd, N., Bozec, E., Pellicori, P., Collier, T., Mariottoni, B., Cosmi, F., Hazebroek, M., Cuthbert, J., Petutschnigg, J., Heymans, S., Staessen, J. A., Pieske, B., Edelman, F., Clark, A. L., Díez, J., González, A., Rossignol, P., Cleland, J. G., Zannad, F. (2022) Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, 24, pp. 771-778. (doi: 10.1002/ejhf.2455)

He, W. et al. (2022) Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size. Cardiovascular Research, 118, pp. 1535-1547. (doi: 10.1093/cvr/cvab204)

Cleland, J. G.F. (2022) Maintaining public trust in medical advice—could less be more? JAMA Network Open, 5, (doi: 10.1001/jamanetworkopen.2022.11113)

Halliday, B. P., Cleland, J. G. F. (2022) Maintaining success for patients with dilated cardiomyopathy and remission of heart failure. JACC: Basic to Translational Science, 7, pp. 500-503. (doi: 10.1016/j.jacbts.2022.03.008)

Blüher, M., Ceriello, A., Davies, M., Rodbard, H., Sattar, N., Schnell, O., Tonchevska, E., Giorgino, F. (2022) Managing weight and glycaemic targets in people with type 2 diabetes—how far have we come? Endocrinology, Diabetes and Metabolism, 5, (doi: 10.1002/edm2.330)

Mahajan, A. et al. (2022) Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nature Genetics, 54, pp. 560-572. (doi: 10.1038/s41588-022-01058-3)

Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Fereirra, J. P., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., Lang, C.C., Metra, M., Samani, N.J., de Boer, R.A., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2022) Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovascular Research, 118, pp. 1964-1977. (doi: 10.1093/cvr/cvab235)

Graham, F. J., Masini, G., Pellicori, P., Cleland, J. G.F., Greenlaw, N., Friday, J., Kazmi, S., Clark, A. L. (2022) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure, 24, pp. 807-817. (doi: 10.1002/ejhf.2251)

Girerd, N., Newton, N., Tartière, J.-M., Guijarro, D., Jourdain, P., Damy, T., Lamblin, N., Bayes-Génis, A., Pellicori, P., Januzzi, J., Rossignol, P., Roubille, F. (2022) Practical outpatient management of worsening chronic heart failure. European Journal of Heart Failure, 24, pp. 750-761. (doi: 10.1002/ejhf.2503)

Pellicori, P., McConnachie, A., Carlin, C., Wales, A., Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, (doi: 10.1016/j.phrs.2022.106199)

Rastogi, T., Bozec, E., Pellicori, P., Bayes Genis, A., Coiro, S., Domingo, M., Gargani, L., Palazzuoli, A., Girerd, N. (2022) Prognostic value and therapeutic utility of lung ultrasound in acute and chronic heart failure: a meta-analysis. JACC: Cardiovascular Imaging, 15, pp. 950-952. (doi: 10.1016/j.jcmg.2021.11.024)

Yeoh, S. E., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Boulton, D. W., Greasley, P. J., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2022) Relationship of dapagliflozin with serum sodium: findings from the DAPA-HF trial. JACC: Heart Failure, 10, pp. 306-318. (doi: 10.1016/j.jchf.2022.01.019)

Lee, M. M.Y., Docherty, K. F., Jhund, P. S. (2022) Sodium–glucose co-transporter-2 inhibitors. Oxford University Press

Verdonschot, J. A.J., Ferreira, J. P., Pizard, A., Pellicori, P., Brunner La Rocca, H.-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Waring, O. J., Henkens, M. H.T.M., Mariottoni, B., Petutschnigg, J., Rossignol, P., Hazebroek, M. R., Cleland, J. G.F., Zannad, F., Heymans, S. R.B. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28, pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005)

Maurovich-Horvat, P. et al. (2022) CT or invasive coronary angiography in stable chest pain. New England Journal of Medicine, 386, pp. 1591-1602. (doi: 10.1056/NEJMoa2200963)

Ho, F., Gray, S. R., Welsh, P., Gill, J. M.R., Sattar, N., Pell, J. P., Celis-Morales, C. (2022) Ethnic differences in cardiovascular risk: examining differential exposure and susceptibility to risk factors. BMC Medicine, 20, (doi: 10.1186/s12916-022-02337-w)

Kohli-Lynch, C. N., Lewsey, J., Boyd, K. A., French, D. D., Jordan, N., Moran, A. E., Sattar, N., Preiss, D., Briggs, A. H. (2022) Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease. Circulation, 145, pp. 1312-1323. (doi: 10.1161/CIRCULATIONAHA.121.057631)

Said, S., Pazoki, R., Karhunen, V., Võsa, U., Ligthart, S., Bodinier, B., Koskeridis, F., Welsh, P., Alizadeh, B. Z., Chasman, D. I., Sattar, N., Chadeau-Hyam, M., Evangelou, E., Jarvelin, M.-R., Elliott, P., Tzoulaki, I., Dehghan, A. (2022) Genetic analysis of over half a million people characterises C-reactive protein loci. Nature Communications, 13, (doi: 10.1038/s41467-022-29650-5)

Sani, R. N., Connelly, P. J., Toft, M., Rowa-Dewar, N., Delles, C., Gasevic, D., Karaye, K. M. (2022) Rural-urban difference in the prevalence of hypertension in West Africa: a systematic review and meta-analysis. Journal of Human Hypertension, (doi: 10.1038/s41371-022-00688-8)

Cotton, S. et al. (2022) Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS) Trials, 23, (doi: 10.1186/s13063-022-06226-8)

Livingstone, K. M., Celis-Morales, C., Mathers, J. C. (2022) Can personalized nutrition improve people’s diets? Frontiers for Young Minds, 10, (doi: 10.3389/frym.2022.718748)

Williams, S. A. et al. (2022) A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk. Science Translational Medicine, 14, (doi: 10.1126/scitranslmed.abj9625)

Aune, E., McMurray, J., Lundgren, P., Sattar, N., Israelsson, J., Nordberg, P., Herlitz, J., Rawshani, A. (2022) Clinical characteristics and survival in patients with heart failure experiencing in hospital cardiac arrest. Scientific Reports, 12, (doi: 10.1038/s41598-022-09510-4)

Ho, F. K., Celis-Morales, C., Gray, S. R., Demou, E., Mackay, D., Welsh, P., Katikireddi, S. V., Sattar, N., Pell, J. P. (2022) Association and pathways between shift work and cardiovascular disease: a prospective cohort study of 238 661 participants from UK Biobank. International Journal of Epidemiology, 51, pp. 579-590. (doi: 10.1093/ije/dyab144)

Toloza, F. J. K. et al. (2022) Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes and Endocrinology, 10, pp. 243-252. (doi: 10.1016/S2213-8587(22)00007-9)

Täger, T., Frankenstein, L., Atar, D., Agewall, S., Frey, N., Grundtvig, M., Clark, A. L., Cleland, J. G.F., Fröhlich, H. (2022) Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical Research in Cardiology, 111, pp. 428-439. (doi: 10.1007/s00392-021-01913-z)

Tayal, U., Gregson, J., Buchan, R., Whiffin, N., Halliday, B. P., Lota, A., Roberts, A. M., Baksi, A. J., Voges, I., Jarman, J. W.E., Baruah, R., Frenneaux, M., Cleland, J. G., Barton, P. J., Pennell, D. J., Ware, J. S., Cook, S. A., Prasad, S. K. (2022) Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy. Heart, 108, pp. 619-625. (doi: 10.1136/heartjnl-2021-319418)

Cleland, J. G.F., Butler, J., Januzzi, J. L., Pellicori, P., McDonagh, T. (2022) Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. European Journal of Heart Failure, 24, pp. 678-680. (doi: 10.1002/ejhf.2488)

Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., Buchan, I., Mamas, M. A., van Staa, T. P., Sattar, N., Ashcroft, D. M., Rutter, M. K. (2022) Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes. Diabetes Care, 45, pp. 909-918. (doi: 10.2337/dc21-1113)

Tromp, J., Beusekamp, J. C., Ouwerkerk, W., Meer, P., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Dickstein, K., Collins, S. P., Lam, C. S.P. (2022) Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry. European Journal of Heart Failure, 24, pp. 645-652. (doi: 10.1002/ejhf.2431)

Foster, H. M.E., Ho, F. K., Mair, F. S., Jani, B. D., Sattar, N., Katikireddi, S. V., Pell, J. P., Niedzwiedz, C. L., Hastie, C. E., Anderson, J. J., Nicholl, B. I., Gill, J. M.R., Celis-Morales, C., O'Donnell, C. A. (2022) The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort. BMC Infectious Diseases, 22, (doi: 10.1186/s12879-022-07132-9)

Dritsoula, A., Dowsett, L., Pilotti, C., O'Connor, M. N., Moss, S. E., Greenwood, J. (2022) Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway. Scientific Reports, 12, (doi: 10.1038/s41598-022-08516-2)

Coats, A. J. S. et al. (2022) Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. European Heart Journal, 43, pp. 863-867. (doi: 10.1093/eurheartj/ehab834)

Cleland, J. G.F. (2022) Aspirin for primary and secondary prevention of cardiovascular disease: time to stop? Thrombosis and Haemostasis, 122, pp. 311-314. (doi: 10.1055/s-0041-1740639)

Montoye, A. H.K., Vondrasek, J. D., Neph, S. E., Basu, N., Paul, L., Bachmair, E.-M., Stefanov, K., Gray, S. R. (2022) Comparison of the activPAL CREA and VANE algorithms for characterization of posture and activity in free-living adults. Journal for the Measurement of Physical Behaviour, 5, pp. 49-57. (doi: 10.1123/jmpb.2021-0053)

Pellicori, P., Vaduganathan, M., Ferreira, J. P., Zannad, F., Sanyal, A. J. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes and Metabolism, 48, (doi: 10.1016/j.diabet.2021.101281)

Butt, J. H., Docherty, K. F., Jhund, P. S., De Boer, R. A., Böhm, M., Desai, A. S., Howlett, J. G., Inzucchi, S. E., Kosiborod, M. N., Martinez, F. A., Nicolau, J. C., Petrie, M. C., Ponikowski, P., Bengtsson, O., Langkilde, A. M., Schou, M., Sjöstrand, M., Solomon, S. D., Sabatine, M. S., McMurray, J. J.V., Køber, L. (2022) Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF. European Journal of Heart Failure, 24, pp. 513-525. (doi: 10.1002/ejhf.2381)

Jackson, A. M. et al. (2022) Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 24, pp. 497-509. (doi: 10.1002/ejhf.2403)

Curtain, J. P., Jackson, A., Shen, L., Jhund, P. S., Docherty, K. F., Petrie, M. C., Castagno, D., Desai, A. S., Rohde, L. E., Lefkowitz, M. P., Rouleau, J.-L., Zile, M. R., Solomon, S. D., Swedberg, K., Packer, M., McMurray, J. J.V. (2022) Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. European Journal of Heart Failure, 24, pp. 551-561. (doi: 10.1002/ejhf.2419)

Ferguson, L. D., Cathcart, S., Rimmer, D., Semple, G., Brooksbank, K., Paterson, C., Brown, R., Harvie, J., Gao, X., Radjenovic, A., Welsh, P., McInnes, I. B., Sattar, N., Siebert, S. (2022) Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease – results of the Immune Metabolic Associations in Psoriatic Arthritis study. Rheumatology, 61, pp. 1026-1034. (doi: 10.1093/rheumatology/keab474)

Sundaram, V., Nagai, T., Chiang, C.-E., Reddy, Y. N.V., Chao, T.-F., Zakeri, R., Bloom, C., Nakai, M., Nishimura, K., Hung, C.-L., Miyamoto, Y., Yasuda, S., Banerjee, A., Anzai, T., Simon, D. I., Rajagopalan, S., Cleland, J. G.F., Sahadevan, J., Quint, J. K. (2022) Hospitalization for heart failure in the USA, UK, Taiwan and Japan: an international comparison of administrative health records on 417,385 individual patients. Journal of Cardiac Failure, 28, pp. 353-366. (doi: 10.1016/j.cardfail.2021.08.024)

Glen, C., Tan, Y. Y., Waterston, A., Evans, T. R. J., Jones, R. J., Petrie, M. C., Lang, N. N. (2022) Mechanistic and clinical overview cardiovascular toxicity of BRAF and MEK inhibitors: JACC: CardioOncology state-of-the-art review. JACC: CardioOncology, 4, pp. 1-18. (doi: 10.1016/j.jaccao.2022.01.096)

Lee, M. M.Y., Docherty, K. F., Sattar, N., Mehta, N., Kalra, A., Nowacki, A. S., Solomon, S. D., Vaduganathan, M., Petrie, M. C., Jhund, P. S., McMurray, J. J.V. (2022) Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 165-178. (doi: 10.1093/ehjcvp/pvaa138)

Ferreira, J. P., Collier, T., Clark, A. L., Mamas, M. A., Rocca, H.-P. B.-L., Heymans, S., González, A., Ahmed, F. Z., Petutschnigg, J., Mujaj, B., Cuthbert, J., Rouet, P., Pellicori, P., Mariottoni, B., Cosmi, F., Edelmann, F., Thijs, L., Staessen, J. A., Hazebroek, M., Verdonschot, J., Rossignol, P., Girerd, N., Cleland, J. G., Zannad, F. (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8, pp. 149-156. (doi: 10.1093/ehjcvp/pvab031)

Sattar, N., McGuire, D. K., Pavo, I., Weerakkody, G. J., Nishiyama, H., Wiese, R. J., Zoungas, S. (2022) Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis. Nature Medicine, 28, pp. 591-598. (doi: 10.1038/s41591-022-01707-4)

Beune, E., Muilwijk, M., Jelsma, J. G. M., van Valkengoed, I., Teitsma-Jansen, A. M., Kumar, B., Diaz, E., Gill, J. M.R., Jenum, A. K., Palaniappan, L., van der Ploeg, H. P., Sheikh, A., Davidson, E., Stronks, K. (2022) The acceptability and effect of a culturally-tailored dance intervention to promote physical activity in women of South Asian origin at risk of diabetes in the Netherlands—a mixed-methods feasibility study. PLoS ONE, 17, (doi: 10.1371/journal.pone.0264191)

Lam, C. S.P., Ramasundarahettige, C., Branch, K. R.H., Sattar, N., Rosenstock, J., Pratley, R., Del Prato, S., Lopes, R. D., Niemoeller, E., Khurmi, N. S., Baek, S., Gerstein, H. C. (2022) Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose co-transporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial. Circulation, 145, pp. 565-574. (doi: 10.1161/CIRCULATIONAHA.121.057934)

Aba Alkhayl, F. F., Ismail, A. D., Celis-Morales, C., Wilson, J., Radjenovic, A., Johnston, L., Welsh, P., Sattar, N., Gill, J. M.R., Preston, T., Gray, S. (2022) Muscle protein synthesis and muscle/metabolic responses to resistance exercise training in South Asian and White European men. Scientific Reports, 12, (doi: 10.1038/s41598-022-06446-7)

Vaduganathan, M., Sattar, N., Xu, J., Butler, J., Mahaffey, K. W., Neal, B., Shaw, W., Rosenthal, N., Pfeifer, M., Hansen, M. K., Januzzi, J. L. (2022) Stress cardiac biomarkers, cardiovascular and renal outcomes, and response to canagliflozin. Journal of the American College of Cardiology, 79, pp. 432-444. (doi: 10.1016/j.jacc.2021.11.027)

Parra-Soto, S., Malcomson, F. C., Ho, F. K., Pell, J. P., Sharp, L., Mathers, J. C., Celis-Morales, C. (2022) Associations of A Body Shape Index (ABSI) with cancer incidence, all-cause and at 23 sites- Findings from the UK Biobank prospective cohort study. Cancer Epidemiology, Biomarkers and Prevention, 31, pp. 315-324. (doi: 10.1158/1055-9965.EPI-21-0591)

Masini, G., Graham, F. J., Pellicori, P., Cleland, J. G.F., Cuthbert, J. J., Kazmi, S., Inciardi, R. M., Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology, 79, pp. 341-351. (doi: 10.1016/j.jacc.2021.11.039)

Parra Soto, S. L., Pell, J. P., Celis-Morales, C., Ho, F. (2022) Absolute and relative grip strength as predictors of cancer: prospective cohort study of 445 552 participants in UK Biobank. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 325-332. (doi: 10.1002/jcsm.12863)

Mujaj, B., ZHang, Z.-Y., Yang, W.-Y., Thijs, L., Wei, F.-F., Verhamme, P., Delles, C., Butler, J., Sever, P., Latini, R., Cleland, J. G. F., Zannad, F., Staessen, J. A. (2022) Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis. ESC Heart Failure, 9, pp. 685-694. (doi: 10.1002/ehf2.13688)

Parra-Soto, S., Tumblety, C., Ho, F. K., Pell, J. P., Celis-Morales, C. (2022) Associations between relative grip strength and risk of 15 cancer sites. American Journal of Preventive Medicine, 62, pp. e87-e95. (doi: 10.1016/j.amepre.2021.07.015)

Ravassa, S., López, B., Ferreira, J. P., Girerd, N., Bozec, E., Pellicori, P., Mariottoni, B., Cosmi, F., Hazebroek, M., Verdonschot, J. A.J., Cuthbert, J., Petutschnigg, J., Moreno, M. U., Heymans, S., Staessen, J. A., Pieske, B., Edelmann, F., Clark, A. L., Cleland, J. G.F., Zannad, F., Díez, J., González, A. (2022) Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial. European Journal of Heart Failure, 24, pp. 321-331. (doi: 10.1002/ejhf.2394)

Holman, N., Wild, S. H., Gregg, E. W., Valabhji, J., Sattar, N., Khunti, K. (2022) Comparison of mortality in people with type 1 and type 2 diabetes by age of diagnosis: an incident population-based study in England and Wales. Lancet Diabetes and Endocrinology, 10, pp. 95-97. (doi: 10.1016/S2213-8587(21)00293-X)

Mahe, G., Brodmann, M., Capodanno, D., Ceriello, A., Cuisset, T., Delgado, V., Espinola-Klein, C., Johnson, T. W., Sprynger, M., Sattar, N., Schnell, O., Valensi, P. (2022) Current management and screening of peripheral and coronary artery disease in people with diabetes mellitus in Europe. The PADDIA/CADDIA survey. Diabetes Research and Clinical Practice, 184, (doi: 10.1016/j.diabres.2022.109214)

Petermann-Rocha, F., Balntzi, V., Gray, S. R., Lara, J., Ho, F. K., Pell, J. P., Celis-Morales, C. (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 13, pp. 86-99. (doi: 10.1002/jcsm.12783)

Deis, T., Wolsk, E., Mujkanovic, J., Komtebedde, J., Burkhoff, D., Kaye, D., Hasenfuß, G., Hayward, C., Van der Heyden, J., Petrie, M.C., Shah, S.J., Borlaug, B.A., Kahwash, R., Litwin, S., Hoendermis, E., Hummel, S., Gustafsson, F. (2022) Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction. ESC Heart Failure, 9, pp. 186-195. (doi: 10.1002/ehf2.13697)

Connelly, P. J., Casey, H., Montezano, A. C., Touyz, R. M., Delles, C. (2022) Sex steroids receptors, hypertension and vascular ageing. Journal of Human Hypertension, 36, pp. 120-125. (doi: 10.1038/s41371-021-00576-7)

Docherty, K. F., Petrie, M. C. (2022) Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure. Heart, 108, pp. 312-320. (doi: 10.1136/heartjnl-2020-318658)

Caiazzo, E., Rezig, A. O.M., Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F., Guzik, T. J., Maffia, P., Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, (doi: 10.1016/j.phrs.2021.106053)

Emmens, J. E., ter Maaten, J. M., Matsue, Y., Figarska, S. M., Sama, I. E., Cotter, G., Cleland, J. G.F., Davison, B. A., Felker, G. M., Givertz, M. M., Greenberg, B., Pang, P. S., Severin, T., Gimpelewicz, C., Metra, M., Voors, A. A., Teerlink, J. R. (2022) Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure, 24, pp. 365-374. (doi: 10.1002/ejhf.2384)

Martin, S., Tyrrell, J., Thomas, E. L., Bown, M. J., Wood, A. R., Beaumont, R. N., Tsoi, L. C., Stuart, P. E., Elder, J. T., Law, P., Houlston, R., Kabrhel, C., Papadimitriou, N., Gunter, M. J., Bull, C. J., Bell, J. A., Vincent, E. E., Sattar, N., Dunlop, M. G., Tomlinson, I. P., Bell, J. D., Frayling, T. M., Yaghootkar, H. (2022) Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation. eLife, 11, (doi: 10.7554/elife.72452)

Parra-Soto, S., Ahumada, D., Petermann-Rocha, F., Boonpoor, J., Gallegos, J. L., Anderson, J., Sharp, L., Malcomson, F. C., Livingstone, K. M., Mathers, J. C., Pell, J. P., Ho, F. K., Celis-Morales, C. (2022) Association of meat, vegetarian, pescatarian, and fish-poultry diets with risk of 19 cancer sites and all cancer: Findings from the UK Biobank prospective cohort study and meta-analysis. BMC Medicine, 20, (doi: 10.1186/s12916-022-02257-9)

Mesin, L., Albani, S., Policastro, P., Pasquero, P., Porta, M., Melchiorri, C., Leonardi, G., Albera, C., Scacciatella, P., Pellicori, P., Stolfo, D., Grillo, A., Fabris, B., Bini, R., Giannoni, A., Pepe, A., Ermini, L., Seddone, S., Sinagra, G., Antonini-Canterin, F., Roatta, S. (2022) Assessment of phasic changes of vascular size by automated edge tracking-state of the art and clinical perspectives. Frontiers in Cardiovascular Medicine, 8, (doi: 10.3389/fcvm.2021.775635)

Berg, D. D., Docherty, K. F., Sattar, N., Jarolim, P., Welsh, P., Jhund, P. S., Anand, I. S., Chopra, V., de Boer, R. A., Kosiborod, M. N., Nicolau, J. C., O'Meara, E., Schou, M., Hammarstedt, A., Langkilde, A.-M., Lindholm, D., Sjöstrand, M., McMurray, J. J.V., Sabatine, M. S., Morrow, D. A. (2022) Serial assessment of high-sensitivity cardiac troponin and the effect of dapagliflozin in patients with heart failure with reduced ejection fraction: an analysis of the DAPA-HF trial. Circulation, 145, pp. 158-169. (doi: 10.1161/CIRCULATIONAHA.121.057852)

Ryan, M., Morgan, H., Chiribiri, A., Nagel, E., Cleland, J., Perera, D. (2022) Myocardial viability testing: all STICHed up, or about to be REVIVED? European Heart Journal, 43, pp. 118-126. (doi: 10.1093/eurheartj/ehab729)

Januzzi, J. L., Garasic, J. M., Kasner, S. E., McDonald, V., Petrie, M. C., Seltzer, J., Mauro, M., Croce, K., Berman, E., Deininger, M., Hochhaus, A., Pinilla-Ibarz, J., Nicolini, F., Kim, D.-W., DeAngelo, D. J., Kantarjian, H., Xu, J., Hall, T., Srivastava, S., Naranjo, D., Cortes, J. (2022) Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. Journal of Hematology and Oncology, 15, (doi: 10.1186/s13045-021-01221-z)

Pfeffer, M. A. et al. (2022) Impact of sacubitril/valsartan versus ramipril on total heart failure events in the PARADISE-MI trial. Circulation, 145, pp. 87-89. (doi: 10.1161/CIRCULATIONAHA.121.057429)

Krzemień, P. et al. (2022) Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress. Biomarker Insights, 17, (doi: 10.1177/11772719211066791)

Tromp, J., Ouwerkerk, W., Cleland, J. G.F., Chandramouli, C., Angermann, C. E., Dahlstrom, U., Ertl, G., Hassanein, M., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Dickstein, K., Collins, S. P., Filippatos, G., Lam, C. S. (2022) A global perspective of racial differences and outcomes in patients presenting with acute heart failure. American Heart Journal, 243, pp. 11-14. (doi: 10.1016/j.ahj.2021.09.001)

Alnuwaysir, R. I.S., Grote Beverborg, N., Hoes, M. F., Markousis‐Mavrogenis, G., Gomez, K. A., van der Wal, H. H., Cleland, J. G.F., Dickstein, K., Lang, C. C., Ng, L. L., Ponikowski, P., Anker, S. D., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2022) Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 24, pp. 192-204. (doi: 10.1002/ejhf.2393)

Lee, M. M.Y., Kristensen, S. L., Gerstein, H. C., McMurray, J. J.V., Sattar, N. (2022) Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 16, (doi: 10.1016/j.dsx.2021.102382)

Verma, S., Dhingra, N. K., Butler, J., Anker, S. D., Ferreira, J. P., Filippatos, G., Januzzi, J. L., Lam, C. S.P., Sattar, N., Peil, B., Nordaby, M., Brueckmann, M., Pocock, S. J., Zannad, F., Packer, M. (2022) Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Lancet Diabetes and Endocrinology, 10, pp. 35-45. (doi: 10.1016/S2213-8587(21)00292-8)

Jeyam, A., Gibb, F. W., McKnight, J. A., O’Reilly, J. E., Caparrotta, T. M., Höhn, A., McGurnaghan, S. J., Blackbourn, L. A. K., Hatam, S., Kennon, B., McCrimmon, R. J., Leese, G., Philip, S., Sattar, N., McKeigue, P. M., Colhoun, H. M. (2022) Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study. Diabetologia, 65, pp. 159-172. (doi: 10.1007/s00125-021-05578-1)

Chamberlain, R. C., Fleetwood, K., Wild, S. H., Colhoun, H. M., Lindsay, R. S., Petrie, J. R., McCrimmon, R. J., Gibb, F., Philip, S., Sattar, N., Kennon, B., Leese, G. P. (2022) Foot ulcer and risk of lower limb amputation or death in people with diabetes: a national population-based retrospective cohort study. Diabetes Care, 45, pp. 83-91. (doi: 10.2337/dc21-1596)

Cuthbert, J.J., Brown, O.I., Urbinati, A., Pan, D., Pellicori, P., Dobbs, K., Bulemfu, J., Kazmi, S., Sokoreli, I., Pauws, S.C., Riistama, J.M., Cleland, J.G.F., Clark, A.L. (2022) Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal: Acute Cardiovascular Care, 11, pp. 43-52. (doi: 10.1093/ehjacc/zuab097)

Delles, C. (2022) Maternally inherited essential hypertension: adding further complexity to an already complex condition. American Journal of Hypertension, 35, pp. 16-18. (doi: 10.1093/ajh/hpab133)

Ferreira, J. P., Cleland, J. G., Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., LaPolice, D. A., Greenberg, B., Zannad, F. (2022) New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clinical Research in Cardiology, 111, pp. 50-59. (doi: 10.1007/s00392-021-01891-2)

Rodríguez-Gómez, I., Gray, S. R., Ho, F. K., Petermann-Rocha, F., Welsh, P., Cleland, J., Iliodromiti, S., Ara, I., Pell, J., Sattar, N., Ferguson, L. D., Celis-Morales, C. (2022) Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank prospective cohort study. Mayo Clinic Proceedings, 97, pp. 110-121. (doi: 10.1016/j.mayocp.2021.07.019)

Lam, P. H., Keramida, K., Filippatos, G. S., Gupta, N., Faselis, C., Deedwania, P., George, B., Iskandrian, A., Cleland, J. G.F., Choudhary, G., Wu, W.-C., Morgan, C. J., Fonarow, G. C., Ahmed, A. (2022) Right ventricular ejection fraction and beta-blocker effect in heart failure with reduced ejection fraction: Beta-blocker and outcomes in HFrEF by RVEF. Journal of Cardiac Failure, 28, pp. 65-70. (doi: 10.1016/j.cardfail.2021.07.026)

Jesuthasan, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Hollingsworth, K. G., Sattar, N., Lean, M. E.J., Taylor, R., Al-Mrabeh, A. H. (2022) Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss. Diabetologia, 65, pp. 226-233. (doi: 10.1007/s00125-021-05583-4)

Romaine, S. P. R., Denniff, M., Codd, V., Nath, M., Koekemoer, A., Anker, S. D., Cleland, J. G., Filippatos, G., Levin, D., Metra, M., Mordi, I. R., Ouwerkerk, W., ter Maaten, J. M., van Veldhuisen, D. J., Zannad, F., Ng, L. L., van der Harst, P., Lang, C. C., Voors, A. A., Nelson, C. P., Samani, N. J. (2022) Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart, 108, pp. 124-129. (doi: 10.1136/heartjnl-2020-318654)

Petermann-Rocha, F., Rao, N., Pell, J. P., Celis-Morales, C., Wong, I. C. K., Ho, F. K., Ip, P. (2022) Weight-for-height, body fat, and development in children in the East Asia and Pacific Region. JAMA Network Open, 5, (doi: 10.1001/jamanetworkopen.2021.42458)

Sattar, N. (2022) Cardiovascular consequences. John Wiley & Sons

Chan, Y., Seckin, M., Johnston, B., Petrie, M., Stewart, S. (2022) Characteristics of symptom change in men and women with different heart failure subtypes. Heart, Lung and Circulation, 31, (doi: 10.1016/j.hlc.2022.06.074)

Delles, C., Rossitto, G. (2022) Of snails, earthworms, and men: insights into strategies to preserve water. Function, 3, (doi: 10.1093/function/zqab071)

Cuthbert, J. J., Pellicori, P., Clark, A. L. (2022) Optimal management of heart failure and chronic obstructive pulmonary disease: clinical challenges. International Journal of General Medicine, 15, pp. 7961-7975. (doi: 10.2147/IJGM.S295467)

Morrow, A., Gray, S. R., Bayes, H. K., Sykes, R., McGarry, E., Anderson, D., Boiskin, D., Burke, C., Cleland, J. G. F., Goodyear, C., Ibbotson, T., Lang, C. C., McConnachie, A., Mair, F., Mangion, K., Patel, M., Sattar, N., Taggart, D., Taylor, R., Dawkes, S., Berry, C. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, (doi: 10.1186/s13063-022-06632-y)

Welsh, P., Kimenai, D. M., Marioni, R. E., Hayward, C., Campbell, A., Porteous, D., Mills, N. L., O’Rahilly, S., Sattar, N. (2022) Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort. Clinical Chemistry and Laboratory Medicine, 60, pp. 1820-1829. (doi: 10.1515/cclm-2022-0135)

Bennett, S. E., Almeida, C., Bachmair, E.-M., Gray, S. R., Lovell, K., Paul, L., Wearden, A., Macfarlane, G. J., Basu, N., Dures, E. (2022) Remotely delivered cognitive-behavioural and personalised exercise interventions to lessen the impact of fatigue: a qualitative evaluation. Rheumatology Advances in Practice, 6, (doi: 10.1093/rap/rkac051)

Mazidi, M., Dehghan, A., Mikhailidis, D., Jóźwiak, J., Covic, A., Sattar, N., Banach, M., on behalf of the Lipid and Blood Pressure Meta-analysis Collab, , the International Lipid Expert Panel (ILEP), (2022) The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis. Archives of Medical Science, 18, pp. 900-911. (doi: 10.5114/aoms/144905)

Bennett, S. E., Almeida, C., Bachmair, E.-M., Gray, S. R., Lovell, K., Paul, L., Wearden, A., Macfarlane, G. J., Basu, N., Dures, E. (2022) Therapists’ experiences of remotely delivering cognitive-behavioural or graded-exercise interventions for fatigue: a qualitative evaluation. Rheumatology Advances in Practice, 6, (doi: 10.1093/rap/rkac083)

2021

Andersen, E., van der Ploeg, H. P., van Mechelen, W., Gray, C. M., Mutrie, N., van Nassau, F., Jelsma, J. G. M., Anderson, A. S., Silva, M. N., Pereira, H. V., McConnachie, A., Sattar, N., Sørensen, M., Røynesdal, Ø. B., Hunt, K., Roberts, G. C., Wyke, S., Gill, J. M.R. (2021) Contributions of changes in physical activity, sedentary time, diet and body weight to changes in cardiometabolic risk. International Journal of Behavioral Nutrition and Physical Activity, 18, (doi: 10.1186/s12966-021-01237-1)

Tikkanen, E., Jägerroos, V., Holmes, M. V., Sattar, N., Ala-Korpela, M., Jousilahti, P., Lundqvist, A., Perola, M., Salomaa, V., Würtz, P. (2021) Metabolic biomarker discovery for risk of peripheral artery disease compared with coronary artery disease: lipoprotein and metabolite profiling of 31 657 individuals from 5 prospective cohorts. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.121.021995)

Petermann-Rocha, F., Lyall, D. M., Gray, S. R., Gill, J. M.R., Sattar, N., Welsh, P., Quinn, T. J., Stewart, W., Pell, J. P., Ho, F. K., Celis-Morales, C. (2021) Dose-response association between device-measured physical activity and incident dementia: a prospective study from UK Biobank. BMC Medicine, 19, (doi: 10.1186/s12916-021-02172-5)

Connelly, P. J., Delles, C. (2021) Cardiovascular disease in transgender people: recent research and emerging evidence. Cardiovascular Research, 117, pp. e174-e176. (doi: 10.1093/cvr/cvab288)

Trivett, C., Lees, Z. J., Freeman, D. J. (2021) Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia. European Journal of Clinical Nutrition, 75, pp. 1745-1756. (doi: 10.1038/s41430-021-00948-9)

Macpherson, J. M., Gray, S. R., Ip, P., McCallum, M., Hanlon, P., Welsh, P., Chan, K. L., Mair, F. S., Celis-Morales, C., Minnis, H., Pell, J. P., Ho, F. K. (2021) Child maltreatment and incident mental disorders in middle and older ages: a retrospective UK Biobank cohort study. Lancet Regional Health - Europe, 11, (doi: 10.1016/j.lanepe.2021.100224)

Holman, N., Knighton, P., O'Keefe, J., Wild, S. H., Brewster, S., Price, H., Patel, K., Hanif, W., Patel, V., Gregg, E. W., Holt, R. I.G., Gadsby, R., Khunti, K., Valabhji, J., Young, B., Sattar, N. (2021) Completion of annual diabetes care processes and mortality: a cohort study using the National Diabetes Audit for England and Wales. Diabetes, Obesity and Metabolism, 23, pp. 2728-2740. (doi: 10.1111/dom.14528)

Vaduganathan, M., Inzucchi, S. E., Sattar, N., Fitchett, D. H., Ofstad, A. P., Brueckmann, M., George, J. T., Verma, S., Mattheus, M., Wanner, C., Zinman, B., Butler, J. (2021) Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: findings from the EMPA‐REG OUTCOME ® trial. Diabetes, Obesity and Metabolism, 23, pp. 2775-2784. (doi: 10.1111/dom.14535)

Butt, J. H., Adamson, C., Docherty, K. F., de Boer, R. A., Petrie, M. C., Inzucchi, S. E., Kosiborod, M. N., Maria Langkilde, A., Lindholm, D., Martinez, F. A., Bengtsson, O., Schou, M., O’Meara, E., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Jhund, P. S., McMurray, J. J.V., Køber, L. (2021) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide: insights from the DAPA-HF trial. Circulation: Heart Failure, 14, (doi: 10.1161/CIRCHEARTFAILURE.121.008837)

Drechsler, C. et al. (2021) Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes and Endocrinology, 9, pp. 837-846. (doi: 10.1016/S2213-8587(21)00263-1)

Diamant, M. J., Andrade, J. G., Virani, S. A., Jhund, P. S., Petrie, M. C., Hawkins, N. M. (2021) Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Failure, 8, pp. 4484-4496. (doi: 10.1002/ehf2.13526)

Jackson, A. M. et al. (2021) Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. European Journal of Heart Failure, 23, pp. 2058-2069. (doi: 10.1002/ejhf.2264)

Welsh, P., Welsh, C., Celis-Morales, C. A., Brown, R., Ho, F. K., Ferguson, L. D., Mark, P. B., Lewsey, J., Gray, S. R., Lyall, D. M., Gill, J. M.R., Pell, J. P., de Lemos, J. A., Willeit, P., Sattar, N. (2021) Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions. European Journal of Preventive Cardiology, 28, pp. 1991-2000. (doi: 10.1093/eurjpc/zwaa063)

Desai, A. S., Vaduganathan, M., Cleland, J. G., Claggett, B. L., Barkoudah, E., Finn, P., McCausland, F. R., Yilmaz, M. B., Lefkowitz, M., Shi, V., Pfeffer, M. A., McMurray, J. J.V., Soloman, S. D. (2021) Mode of death in patients with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation: Heart Failure, 14, (doi: 10.1161/CIRCHEARTFAILURE.121.008597)

Ferreira, J. P., Girerd, N., Rocca, H.-P. B.-L., Pellicori, P., Cleland, J. G., Rossignol, P., Zannad, F. (2021) No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial = Pas d’influence de la spironolactone sur les concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE. Archives of Cardiovascular Diseases, 114, pp. 814-817. (doi: 10.1016/j.acvd.2021.10.003)

Lund, S. S., Sattar, N., Salsali, A., Neubacher, D., Ginsberg, H. N. (2021) Potential contribution of haemoconcentration to changes in lipid parameters with empagliflozin in patients with type 2 diabetes mellitus – a post hoc analysis of pooled data from four phase III randomized clinical trials. Diabetes, Obesity and Metabolism, 23, pp. 2763-2774. (doi: 10.1111/dom.14534)

Lota, A. S., Tsao, A., Owen, R., Halliday, B. P., Auger, D., Vassiliou, V. S., Tayal, U., Almogheer, B., Vilches, S., Al-Balah, A., Patel, A., Mouy, F., Buchan, R., Newsome, S., Gregson, J., Ware, J. S., Cook, S. A., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2021) Prognostic significance of nonischaemic myocardial fibrosis in patients with normal left ventricular volumes and ejection-fraction. JACC: Cardiovascular Imaging, 14, pp. 2353-2365. (doi: 10.1016/j.jcmg.2021.05.016)

Kulkarni, S., Welsh, P., Ali, M., Petrie, J. R. (2021) Quality of life in people with type 2 diabetes; a study in a multi-ethnic clinical trial population. British Journal of Diabetes, 21, pp. 210-215. (doi: 10.15277/bjd.2021.315)

Mary, S., Boder, P., Rossitto, G., Graham, L., Scott, K., Flynn, A., Kipgen, D., Graham, D., Delles, C. (2021) Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats. Clinical Science, 135, pp. 2749-2761. (doi: 10.1042/CS20211017)

Studziński, K., Tomasik, T., Windak, A., Banach, M., Wójtowicz, E., Mastej, M., Tomaszewski, M., Mikhailidis, D. P., Toth, P. P., Catapano, A., Ray, K. K., Howard, G., Lip, G. Y.H., Charchar, F. J., Sattar, N., Williams, B., MacDonald, T. M., Penson, P. E., Jóźwiak, J. J., on behalf of the LIPIDOGRAM2015 Investigators, (2021) The differences in the prevalence of cardiovascular disease, its risk factors, and achievement of therapeutic goals among urban and rural primary care patients in Poland: results from the LIPIDOGRAM 2015 study. Journal of Clinical Medicine, 10, (doi: 10.3390/jcm10235656)

Lumbers, R. T. et al. (2021) The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Failure, 8, pp. 5531-5541. (doi: 10.1002/ehf2.13517)

Wannamethee, S. G., Welsh, P., Papacosta, O., Lennon, L., Whincup, P. (2021) Vitamin D deficiency, impaired lung function and total and respiratory mortality in a cohort of older men: cross-sectional and prospective findings from the British Regional Heart Study. BMJ Open, 11, (doi: 10.1136/bmjopen-2021-051560)

Mazidi, M., Katsiki, N., Webb, R., Lip, G., Sattar, N., Banach, M. (2021) Sleep duration may not have any effect on the risk of stroke: insights from Mendelian randomization and prospective cohort studies. Archives of Medical Science, (doi: 10.5114/aoms/144295)

Mark, P. B., Jhund, P. S., Walters, M. R., Petrie, M. C., Power, A., White, C., Robertson, M., Connolly, E., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Tomson, C. R.V., Wheeler, D. C., Winearls, C. G., McMurray, J. J.V., Macdougall, I. C., Ford, I. (2021) Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial. Kidney360, 2, pp. 1761-1769. (doi: 10.34067/KID.0004272021)

O'Connor, M. N., Kallenberg, D. M., Camilli, C., Pilotti, C., Dritsoula, A., Jackstadt, R., Bowers, C. E., Watson, H. A., Alatsatianos, M., Ohme, J., Dowsett, L., George, J., Blackburn, J. W.D., Wang, X., Singhal, M., Augustin, H. G., Ager, A., Sansom, O. J., Moss, S. E., Greenwood, J. (2021) LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency. Med, 2, pp. 1231-1252.e10. (doi: 10.1016/j.medj.2021.10.002)

Berry, C. et al. (2021) Post-COVID-19 illness trajectory: a multisystem investigation [Pre-print] Research Square, (doi: 10.21203/rs.3.rs-1053331/v1)

van Vliet, N. A. et al. (2021) Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling. BMC Medicine, 19, (doi: 10.1186/s12916-021-02130-1)

Morrow, A. et al. (2021) Rationale and design of the Medical Research Council Precision medicine with Zibotentan in microvascular angina (PRIZE) trial MRI sub-study. (doi: 10.1136/heartjnl-2021-BSCMR.3)

Wadt Hansen, K., Peytz, N., Blokstra, A., Bojesen, S. E., Celis-Morales, C., Chrysohoou, C., Clays, E., De Bacquer, D., Galatius, S., Gray, S. R., Ho, F., Kavousi, M., Koolhaas, C. M., Kouvari, M., Løchen, M.-L., Marques-Vida, P., Osler, M., Panagiotakos, D., Pell, J. P., Sulo, G., Tell, G. S., Vassiliou, V., Verschuren, W. M. M., Prescott, E. (2021) Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies. European Journal of Preventive Cardiology, 28, pp. 1590-1598. (doi: 10.1093/eurjpc/zwaa146)

Täger, T., Atar, D., Agewall, S., Katus, H. A., Grundtvig, M., Cleland, J. G.F., Clark, A. L., Fröhlich, H., Frankenstein, L. (2021) Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Failure Reviews, 26, pp. 1421-1435. (doi: 10.1007/s10741-020-09954-8)

Davidson, E. M., Krasuska, M., Jenum, A. K., Gill, J. M.R., Beune, E., Stronks, K., van Valkengoed, I. G.M., Diaz, E., Sheikh, A. (2021) Developing a realist informed framework for cultural adaptation of lifestyle interventions for the prevention of type 2 diabetes in South Asian populations in Europe. Diabetic Medicine, 38, (doi: 10.1111/dme.14584)

Captieux, M., Fleetwood, K., Kennon, B., Sattar, N., Lindsay, R., Guthrie, B., Wild, S. H. (2021) Epidemiology of type 2 diabetes remission in Scotland in 2019: a cross-sectional population-based study. PLoS Medicine, 18, (doi: 10.1371/journal.pmed.1003828)

Sullivan, M. K., Jani, B. D., Lees, J. S., Welsh, C. E., McConnachie, A., Stanley, B., Welsh, P., Nicholl, B. I., Lyall, D. M., Carrero, J.-J., Nitsch, D., Sattar, N., Mair, F. S., Mark, P. B. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14, pp. 2409-2419. (doi: 10.1093/ckj/sfab079)

Ghouri, N., Javed, H., Sattar, N. (2021) Pharmacological management of diabetes for reducing glucose levels and cardiovascular disease risk: what evidence in South Asians? Current Diabetes Reviews, 17, pp. e122820189511. (doi: 10.2174/1573399817666201228120725)

Pan, D., Pellicori, P., Dobbs, K., Bulemfu, J., Sokoreli, I., Urbinati, A., Brown, O., Sze, S., Rigby Cstat, A. R., Kazmi, S., Riistama, J. M., Cleland, J. G.F., Clark, A. L. (2021) Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology, 110, pp. 1743-1756. (doi: 10.1007/s00392-021-01836-9)

Colaco, K., Lee, K.-A., Akhtari, S., Winer, R., Welsh, P., Sattar, N., McInnes, I. B., Chandran, V., Harvey, P., Cook, R. J., Gladman, D. D., Piguet, V., Eder, L. (2021) Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Annals of the Rheumatic Diseases, 80, pp. 1429-1435. (doi: 10.1136/annrheumdis-2021-220168)

Cuthbert, J. J., Pellicori, P., Flockton, R., Kallvikbacka-Bennett, A., Khan, J., Rigby, A. S., Girerd, N., Zannad, F., Cleland, J. G.F., Clark, A. L. (2021) The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure. European Journal of Heart Failure, 23, pp. 1831-1840. (doi: 10.1002/ejhf.2353)

He, T. et al. (2021) Urinary peptides in heart failure: a link to molecular pathophysiology. European Journal of Heart Failure, 23, pp. 1875-1887. (doi: 10.1002/ejhf.2195)

Lee, M., Campbell, R. T., Claggett, B.L., Lewis, E.F., Groarke, J.D., Docherty, K. F., Lindner, M., Liu, J., Soloman, S.D., McMurray, J. J.V., Platz, E. (2021) Lung Ultrasound in Acute Heart Failure: Association Between Quality of Life, Symptoms and B-Lines. (doi: 10.1093/eurheartj/ehab724.1043)

Marshall-McKenna, R., Campbell, E., Ho, F., Banger, M., Ireland, J., Rowe, P., McAlpine, C., McArthur, K., Quinn, T. J., Gray, S. R. (2021) Resistance exercise training at different loads in frail and healthy older adults: a randomised feasibility trial. Experimental Gerontology, 153, (doi: 10.1016/j.exger.2021.111496)

Shah, P., Abel, A. A.I., Boyalla, V., Pellicori, P., Kallvikbacka-Bennett, A., Sze, S., Cleland, J. G.F., Clark, A. L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8, pp. 3929-3934. (doi: 10.1002/ehf2.13402)

Papageorgiou, V., Jones, K., Halliday, B. P., Mindham, R., Bruton, J., Wassall, R., Cleland, J. G.F., Prasad, S. K., Ward, H. (2021) A qualitative exploration of participant and investigator perspectives from the TRED-HF trial. ESC Heart Failure, 8, pp. 3760-3768. (doi: 10.1002/ehf2.13524)

Petermann-Rocha, F., Ferguson, L. D., Gray, S. R., Rodríguez-Gómez, I., Sattar, N., Siebert, S., Ho, F. K., Pell, J. P., Celis-Morales, C. (2021) Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants. Journal of Cachexia, Sarcopenia and Muscle, 12, pp. 1179-1188. (doi: 10.1002/jcsm.12757)

Touyz, R. M., Boyd, M. O.E., Guzik, T., Padmanabhan, S., McCallum, L., Delles, C., Mark, P. B., Petrie, J. R., Rios, F., Montezano, A. C., Sykes, R., Berry, C. (2021) Cardiovascular and renal risk factors and complications associated with COVID-19. CJC Open, 3, pp. 1257-1272. (doi: 10.1016/j.cjco.2021.05.020)

Sattar, N., Lee, M. M.Y., Kristensen, S. L., Branch, K. R.H., Del Prato, S., Khurmi, N. S., Lam, C. S.P., Lopes, R. D., McMurray, J. J.V., Pratley, R. E., Rosenstock, J., Gerstein, H. C. (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes and Endocrinology, 9, pp. 653-662. (doi: 10.1016/S2213-8587(21)00203-5)

Meijers, W. C., Bayes‐Genis, A., Mebazaa, A., Bauersachs, J., Cleland, J. J.G., Coats, A. J.S., Januzzi, J. L., Maisel, A. S., McDonald, K., Mueller, T., Richards, A. M., Seferovic, P., Mueller, C., de Boer, R. A. (2021) Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) European Journal of Heart Failure, 23, pp. 1610-1632. (doi: 10.1002/ejhf.2346)

Dalal, H., Taylor, R. S., Cleland, J. G. (2021) Correspondence to European Heart Journal—Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures. European Heart Journal: Quality of Care and Clinical Outcomes, 7, pp. e7. (doi: 10.1093/ehjqcco/qcab033)

Adamson, C., Jhund, P. S., Docherty, K. F., Bělohlávek, J., Chiang, C.‐E., Diez, M., Drożdż, J., Dukát, A., Howlett, J., Ljungman, C. E.A., Petrie, M. C., Schou, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Langkilde, A. M., Lindholm, D., Sjöstrand, M., McMurray, J. J.V. (2021) Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. European Journal of Heart Failure, 23, pp. 1662-1672. (doi: 10.1002/ejhf.2308)

Siebert, S., Sattar, N. (2021) Estimating cardiovascular impacts of drugs for psoriatic disease: a long way to go. Journal of Investigative Dermatology, 141, pp. 2322-2325. (doi: 10.1016/j.jid.2021.04.012)

Jani, B. D., Nicholl, B. I., Hanlon, P., Mair, F. S., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A., Ho, F. K., Lyall, D. M., Anderson, J. J., Hastie, C. E., Bailey, M. E.S., Foster, H., Pell, J. P., Welsh, P., Sattar, N. (2021) Family history of diabetes and risk of SARS-COV-2 in UK Biobank: a prospective cohort study. Endocrinology, Diabetes and Metabolism, 4, (doi: 10.1002/edm2.283)

Ferreira, J. P., Cleland, J. G., Lam, C. S.P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Pitt, B., Greenberg, B., Zannad, F. (2021) Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clinical Research in Cardiology, 110, pp. 1554-1563. (doi: 10.1007/s00392-021-01830-1)

Raafs, A. et al. (2021) Identification of sex‐specific biomarkers predicting new‐onset heart failure. ESC Heart Failure, 8, pp. 3512-3520. (doi: 10.1002/ehf2.13476)

Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Ponikowski, P., Ravera, A., Samani, N. J., Zannad, F., van Veldhuisen, D. J., Voors, A. A., Metra, M. (2021) Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. European Journal of Heart Failure, 23, pp. 1750-1758. (doi: 10.1002/ejhf.2276)

Weissler, E. H., Clare, R. M., Lokhnygina, Y., Buse, J. B., Goodman, S. G., Katona, B., Iqbal, N., Pagidipati, N. J., Sattar, N., Holman, R. R., Hernandez, A. F., Mentz, R. J., Patel, M. R., Jones, W. S. (2021) Predicting major adverse limb events in individuals with type 2 diabetes: insights from the EXSCEL trial. Diabetic Medicine, 38, (doi: 10.1111/dme.14552)

Rush, C. J., Berry, C., Oldroyd, K. G., Rocchiccioli, J. P., Lindsay, M. M., Touyz, R. M., Murphy, C. L., Ford, T. J., Sidik, N., McEntegart, M. B., Lang, N. N., Jhund, P. S., Campbell, R. T., McMurray, J. J.V., Petrie, M. C. (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiology, 6, pp. 1130-1143. (doi: 10.1001/jamacardio.2021.1825)

Anderson, J. J., Ho, F. K., Niedzwiedz, C. L., Katikireddi, V., Celis-Morales, C., Iliodromiti, S., Welsh, P., Pellicori, P., Demou, E., Hastie, C. E., Lyall, D. M., Gray, S. R., Forbes, J. F., Gill, J. M.R., Mackay, D. F., Berry, C., Cleland, J. G.F., Sattar, N., Pell, J. P. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19, pp. 2533-2538. (doi: 10.1111/jth.15452)

Graham, F. J., Pellicori, P., Cleland, J. G.F., Clark, A. L. (2021) Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure' European Journal of Heart Failure, 23, pp. 1800-1801. (doi: 10.1002/ejhf.2304)

Al-Ozairi, E., Brown, R., Hamdan, Y., Alabdullah, L., Voase, N., Al Kandari, J., Alsaeed, D., Al Ozairi, A., Hasan, A., Al-Mulla, F., Katikireddi, S. V., Gray, S. R., Gill, J. M.R., Celis-Morales, C. A., Sattar, N., Welsh, P. (2021) Risk of mortality among inpatients with COVID-19 and type 2 diabetes: national data from Kuwait. Endocrinology, Diabetes and Metabolism, 4, (doi: 10.1002/edm2.287)

Labuz-Roszak, B., Banach, M., Skrzypek, M., Windak, A., Tomasik, T., Mastej, M., Tomaszewski, M., Mikhailidis, D., Toth, P., Catapano, A., Ray, K., Howard, G., Lip, G., Charchar, F., Sattar, N., Williams, B., MacDonald, T., Penson, P., Jozwiak, J., on behalf of the LIPIDOGRAM2015 Investigators, (2021) Secondary stroke prevention in Polish adults: results from the LIPIDOGRAM2015 study. Journal of Clinical Medicine, 10, (doi: 10.3390/jcm10194472)

Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C., Wong, I. C.K., Berry, C., Sattar, N., Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96, pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002)

Brown, R., Lewsey, J., Wild, S., Logue, J., Welsh, P. (2021) Associations of statin adherence and lipid targets with adverse outcomes in myocardial infarction survivors: a retrospective cohort study. BMJ Open, 11, (doi: 10.1136/bmjopen-2021-054893)

Curtain, J. P., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Solomon, S. D., McMurray, J. J.V. (2021) Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. European Heart Journal, 42, pp. 3727-3738. (doi: 10.1093/eurheartj/ehab560)

Stoumpos, S., Rankin, A., Hall Barrientos, P., Mangion, K., McGregor, E., Thomson, P. C., Stevenson, K., Welsh, P., Kasthuri, R., Kingsmore, D., Roditi, G., Mark, P. B. (2021) Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function. Scientific Reports, 11, (doi: 10.1038/s41598-021-97625-5)

Cleland, J. G.F., Pellicori, P. (2021) To master heart failure, first master congestion. Lancet, 398, pp. 935-936. (doi: 10.1016/S0140-6736(21)01914-0)

Ferreira, J. P., Ouwerkerk, W., Santema, B. T., van Veldhuisen, D. J., Lang, C. C., Ng, L. L., Anker, S. D., Dickstein, K., Metra, M., Cleland, J. G.F., Nilesh, S. J., Filippatos, G., Aboumsallem, J.-P., de Boer, R. A., Figarska, S., Sama, I. E., Voors, A. A., Zannad, F. (2021) Differences in biomarkers and molecular pathways according to age for patients with HFrEF. Cardiovascular Research, 117, pp. 2228-2236. (doi: 10.1093/cvr/cvaa279)

Leslie, W. S., Ali, E., Harris, L., Messow, C. M., Brosnahan, N. T., Thom, G., McCombie, E. L., Barnes, A. C., Sattar, N., Taylor, R., Lean, M. E.J. (2021) Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT) Diabetologia, 64, pp. 1927-1938. (doi: 10.1007/s00125-021-05471-x)

Zhou, Z., Macpherson, J., Gray, S. R., Gill, J. M.R., Welsh, P., Celis-Morales, C., Sattar, N., Pell, J. P., Ho, F. K. (2021) Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia, 64, pp. 1963-1972. (doi: 10.1007/s00125-021-05484-6)

Kosyakovsky, L. B., Angriman, F., Katz, E., Adhikari, N. K., Godoy, L. C., Marshall, J. C., Ferreyro, B. L., Lee, D. S., Rosenson, R. S., Sattar, N., Verma, S., Toma, A., Englesakis, M., Burstein, B., Farkouh, M. E., Herridge, M., Ko, D. T., Scales, D. C., Detsky, M. E., Bibas, L., Lawler, P. R. (2021) Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis. Intensive Care Medicine, 47, pp. 931-942. (doi: 10.1007/s00134-021-06479-y)

Holman, N., Knighton, P., Wild, S. H., Sattar, N., Dew, C., Gregg, E. W., Khunti, K., Valabhji, J., Young, B. (2021) Cohort profile: National Diabetes Audit for England and Wales. Diabetic Medicine, 38, (doi: 10.1111/dme.14616)

Manyara, A. M., Mwaniki, E., Gray, C. M., Gill, J. M.R. (2021) Comparison of risk factors between people with type 2 diabetes and matched controls in Nairobi, Kenya. Tropical Medicine and International Health, 26, pp. 1075-1087. (doi: 10.1111/tmi.13629)

Docherty, N. G., Delles, C., D’Haese, P., Layton, A. T., Martínez-Salgado, C., Vervaet, B. A., López-Hernández, F. J. (2021) Haemodynamic frailty – A risk factor for acute kidney injury in the elderly. Ageing Research Reviews, 70, (doi: 10.1016/j.arr.2021.101408)

Mazidi, M., Valdes, A. M., Ordovas, J. M., Hall, W. L., Pujol, J. C., Wolf, J., Hadjigeorgiou, G., Segata, N., Sattar, N., Koivula, R., Spector, T. D., Franks, P. W., Berry, S. E. (2021) Meal-induced inflammation: postprandial insights from the Personalised REsponses to DIetary Composition Trial (PREDICT) study in 1000 participants. American Journal of Clinical Nutrition, 114, pp. 1028-1038. (doi: 10.1093/ajcn/nqab132)

Carter, J., Mathers, J., Fairweather‐Tait, S., Jebb, S., Sattar, N., Jennings, A., Minihane, A.‐M. (2021) Medical Research Council Hot Topic workshop report: planning a UK Nutrition and Healthy Life Expectancy Trial. Nutrition Bulletin, 46, pp. 395-408. (doi: 10.1111/nbu.12516)

Sattar, N., Valabhji, J. (2021) Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care. Current Obesity Reports, 10, pp. 282-289. (doi: 10.1007/s13679-021-00448-8)

Sattar, N. (2021) Prevention of diabetes macrovascular complications and heart failure. Endocrinology and Metabolism Clinics of North America, 50, pp. 415-430. (doi: 10.1016/j.ecl.2021.05.004)

Pellicori, P., Cleland, J. G.F. (2021) Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition. European Journal of Preventive Cardiology, 28, pp. 921-923. (doi: 10.1177/2047487320937135)

McDonagh, T. A. et al. (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42, pp. 3599-3726. (doi: 10.1093/eurheartj/ehab368)

Welsh, P., Welsh, C. E., Jhund, P. S., Woodward, M., Brown, R., Lewsey, J., Celis-Morales, C. A., Ho, F. K., MacKay, D. F., Gill, J. M.R., Gray, S. R., Katikireddi, S. V., Pell, J. P., Forbes, J., Sattar, N. (2021) Derivation and validation of a 10-year risk score for symptomatic abdominal aortic aneurysm: cohort study of nearly 500 000 individuals. Circulation, 144, pp. 604-614. (doi: 10.1161/CIRCULATIONAHA.120.053022)

Zakeri, R., Morgan, A. D., Sundaram, V., Bloom, C., Cleland, J. G.F., Quint, J. K. (2021) Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Medicine, 19, (doi: 10.1186/s12916-021-02048-8)

Verdonschot, J. A.J., Ferreira, J. P., Pellicori, P., Brunner La Rocca, H.-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Mariottoni, B., Petutschnigg, J., Rossignol, P., Cleland, J. G.F., Zannad, F., Heymans, S. R.B. (2021) Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial. Cardiovascular Diabetology, 20, (doi: 10.1186/s12933-021-01357-9)

Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Ferrari, G., Welsh, P., Pell, J. P., Sattar, N., Gill, J. M. R., Ho, F. K., Gray, S. R., Celis-Morales, C. (2021) Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank Prospective Cohort Study. BMJ Open Diabetes Research and Care, 9, (doi: 10.1136/bmjdrc-2020-001865)

Rørth, R., Clausen, M. F., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Jhund, P. S., Petrie, M. C., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2021) Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer. PLoS ONE, 16, (doi: 10.1371/journal.pone.0255364)

Boder, P., Mary, S., Mark, P. B., Leiper, J., Dominiczak, A. F., Padmanabhan, S., Rampold, L., Delles, C. (2021) Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension. Journal of Hypertension, 39, pp. 1490-1504. (doi: 10.1097/HJH.0000000000002861)

Ambrosy, A. P., von Haehling, S., Kalra, P. R., Court, E., Bhandari, S., McDonagh, T., Cleland, J. G.F. (2021) Safety and efficacy of intravenous ferric derisomaltose compared to iron sucrose for iron deficiency anemia in patients with chronic kidney disease with and without heart failure. American Journal of Cardiology, 152, pp. 138-145. (doi: 10.1016/j.amjcard.2021.04.042)

Cleland, J. G.F., Pellicori, P., González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27, pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9)

Kobayashi, M., Gargani, L., Palazzuoli, A., Ambrosio, G., Bayés-Genis, A., Lupon, J., Pellicori, P., Pugliese, N. R., Reddy, Y. N.V., Ruocco, G., Duarte, K., Huttin, O., Rossignol, P., Coiro, S., Girerd, N. (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure findings from a pooled analysis of four cohort studies. Clinical Research in Cardiology, 110, pp. 1181-1192. (doi: 10.1007/s00392-020-01724-8)

Jorbenadze, A., Fudim, M., Mahfoud, F., Adamson, P. B., Bekfani, T., Wachter, R., Sievert, H., Ponikowski, P. P., Cleland, J. G.F., Anker, S. D. (2021) Extra-cardiac targets in the management of cardiometabolic disease: device-based therapies. ESC Heart Failure, 8, pp. 3327-3338. (doi: 10.1002/ehf2.13361)

Graham, F. J., Pellicori, P., Ford, I., Petrie, M. C., Kalra, P. R., Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110, pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8)

Lees, J. S., Ho, F., Parra -Soto, S., Celis-Morales, C., Welsh, P., Sullivan, M. K., Jani, B. D., Sattar, N., Lang, N. N., Pell, J. P., Webster, A. C., Mark, P. B. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, (doi: 10.1016/j.eclinm.2021.101030)

Steell, L., Gray, S. R., Russell, R. K., MacDonald, J., Seenan, J. P., Wong, S. C., Gaya, D. R. (2021) Pathogenesis of musculoskeletal deficits in children and adults with inflammatory bowel disease. Nutrients, 13, (doi: 10.3390/nu13082899)

Thom, G., Messow, C.-M., Leslie, W.S., Barnes, A.C., Brosnahan, N., McCombie, L., Al-Mrabeh, A., Zhyzhneuskaya, S., Welsh, P., Sattar, N., Taylor, R., Lean, M.E.J. (2021) Predictors of type 2 diabetes in the Diabetes Remission Clinical Trial (DiRECT) Diabetic Medicine, 38, (doi: 10.1111/dme.14395)

Petrie, M. C., Lee, M. M.Y., Docherty, K. F. (2021) Sodium–glucose co-transporter 2 inhibitors—the first successful treatment for heart failure with preserved ejection fraction? European Journal of Heart Failure, 23, pp. 1256-1259. (doi: 10.1002/ejhf.2108)

Patanapirunhakit, P., Karlsson, H., Mulder, M., Ljunggren, S., Graham, D., Freeman, D. (2021) Sphingolipids in HDL – potential markers for adaptation to pregnancy? Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids, 1866, (doi: 10.1016/j.bbalip.2021.158955)

Mackenzie, R. M., Greenlaw, N., Ali, A., Bruce, D., Bruce, J., Grieve, E., Lean, M., Lindsay, R., Sattar, N., Stewart, S., Ford, I., Logue, J. (2021) SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UK. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-046441)

Tank, R., Ward, J., Celis-Morales, C., Smith, D. J., Flegal, K. E., Lyall, D. M. (2021) Testing for interactions between APOE and Klotho genotypes on cognitive, dementia, and brain imaging metrics in UK Biobank. Journal of Alzheimer's Disease, 83, pp. 51-55. (doi: 10.3233/JAD-210181)

Castrichini, M., Nuzzi, V., Sinagra, G., Cleland, J., Pellicori, P. (2021) Use of social media by cardiovascular health care professionals: is patient privacy respected? JACC: Cardiovascular Imaging, 14, pp. 1680-1682. (doi: 10.1016/j.jcmg.2021.02.012)

Riquelme, R., Rezende, L. F. M., Guzmán-Habinger, J., Chávez, J. L., Celis-Morales, C., Ferreccio, C., Ferrari, G. (2021) Non-communicable diseases deaths attributable to high body mass index in Chile. Scientific Reports, 11, (doi: 10.1038/s41598-021-94974-z)

Lee, M. M.Y., McMurray, J. J.V., Jhund, P. S., Petrie, M. C., Sattar, N. (2021) Response by Lee et al to letter regarding article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)" Circulation, 144, pp. e40. (doi: 10.1161/CIRCULATIONAHA.121.055067)

Docherty, K. F., Campbell, R. T., Brooksbank, K. J.M., Dreisbach, J. G., Forsyth, P., Godeseth, R., Hopkins, T., Jackson, A. M., Lee, M. M.Y., McConnachie, A., Roditi, G., Squire, I. B., Stanley, B., Welsh, P., Jhund, P. S., Petrie, M., McMurray, J. J.V. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144, pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892)

Sattar, N., McGuire, D. K. (2021) Prevention of CV outcomes in antihyperglycemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, atherosclerotic cardiovascular disease: to start or not to start with metformin. European Heart Journal, 42, pp. 2574-2576. (doi: 10.1093/eurheartj/ehaa879)

Simpson, J., Jackson, C. E., Haig, C., Jhund, P. S., Tomaszewski, M., Gardner, R. S., Tsorlalis, Y., Petrie, M. C., McMurray, J. J.V., Squire, I. B., Gupta, P. (2021) Adherence to prescribed medications in patients with heart failure – insights from liquid chromatography-tandem mass spectrometry-based urine analysis. European Heart Journal: Cardiovascular Pharmacotherapy, 7, pp. 296-301. (doi: 10.1093/ehjcvp/pvaa071)

Bistola, V., Simitsis, P., Parissis, J., Ouwerkerk, W., van Veldhuisen, D. J., Cleland, J. G., Anker, S. D., Samani, N. J., Metra, M., Zannad, F., Polyzogopoulou, E., Keramida, K., Farmakis, D., Voors, A. A., Filippatos, G. (2021) Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum. European Journal of Heart Failure, 23, pp. 1170-1181. (doi: 10.1002/ejhf.2219)

Lang, N. N., Ahmad, F. A., Cleland, J. G., O'Connor, C. M., Teerlink, J. R., Voors, A. A., Taubel, J., Hodes, A. R., Anwar, M., Karra, R., Sakata, Y., Ishihara, S., Senior, R., Khemka, A., Prasad, N. G., DeSouza, M. M., Seiffert, D., Ye, J. Y., Kessler, P. D., Borentain, M., Solomon, S. D., Felker, G. M., McMurray, J. J.V. (2021) Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. European Journal of Heart Failure, 23, pp. 1147-1155. (doi: 10.1002/ejhf.2138)

Jhund, P. S., Petrie, M. C., Robertson, M., Mark, P. B., MacDonald, M. R., Connolly, E., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., Wheeler, D. C., Tomson, C. R.V., Ford, I., McMurray, J. J.V., Macdougall, I. C. (2021) Heart failure hospitalization in adults receiving maintenance hemodialysis and effect of intravenous iron therapy: A report from PIVOTAL. JACC: Heart Failure, 9, pp. 518-527. (doi: 10.1016/j.jchf.2021.04.005)

Halliday, B. P., Vazir, A., Owen, R., Gregson, J., Wassall, R., Lota, A. S., Khalique, Z., Tayal, U., Jones, R. E., Hammersley, D., Pantazis, A., Baksi, A. J., Rosen, S., Pennell, D. J., Cowie, M. R., Cleland, J. G.F., Prasad, S. K. (2021) Heart rate as a marker of relapse during withdrawal of therapy in recovered dilated cardiomyopathy. JACC: Heart Failure, 9, pp. 509-517. (doi: 10.1016/j.jchf.2021.03.010)

Gupta, P., Voors, A. A., Patel, P., Lane, D., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G., Lang, C.C., Veldhuisen, D. J., Metra, M., Zannad, F., Samani, N. J., Jones, D. J.L., Squire, I. B., Ng, L. L. (2021) Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study) European Journal of Heart Failure, 23, pp. 1182-1190. (doi: 10.1002/ejhf.2160)

Krzemień, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., Windak, A., Mastej, M., Catapano, A., Ray, K., Mikhailidis, D., Toth, P., Howard, G., Lip, G., Tomaszewski, M., Charchar, F., Sattar, N., Williams, B., MacDonald, T., Penson, P., Jóźwiak, J. (2021) Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies. Archives of Medical Science, 19, (doi: 10.5114/aoms/139313)

Diaz-Navarro, R., Urrútia, G., Cleland, J. G.F., Poloni, D., Villagran, F., Acosta-Dighero, R., Bangdiwala, S. I., Rada, G., Madrid, E. (2021) Stem cell therapy for dilated cardiomyopathy. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.cd013433.pub2)

Markousis-Mavrogenis, G., Tromp, J., Mentz, R. J., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2021) The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. Journal of Cardiac Failure, 27, pp. 808-811. (doi: 10.1016/j.cardfail.2021.01.008)

Rush, C. J., Cleland, J. G.F., Veldtman, G. (2021) The emerging burden of heart failure in adults with congenital heart disease. International Journal of Cardiology Congenital Heart Disease, 4, (doi: 10.1016/j.ijcchd.2021.100171)

Pellicori, P., Fitchett, D., Kosiborod, M. N., Ofstad, A. P., Seman, L., Zinman, B., Zwiener, I., Wanner, C., George, J., Inzucchi, S. E., Testani, J. M., Cleland, J. G.F. (2021) Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. European Journal of Heart Failure, 23, pp. 1085-1093. (doi: 10.1002/ejhf.2220)

Gerstein, H. C., Sattar, N., Rosenstock, J., Ramasundarahettige, C., Pratley, R., Lopes, R. D., Lam, C. S.P., Khurmi, N. S., Heenan, L., Del Prato, S., Dyal, L., Branch, K. (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes. New England Journal of Medicine, (doi: 10.1056/NEJMoa2108269)

Cleland, J. G.F., Pfeffer, M. A., Clark, A. L., Januzzi, J. L., McMurray, J. J.V., Mueller, C., Pellicori, P., Richards, M., Teerlink, J. R., Zannad, F., Bauersachs, J. (2021) The struggle towards a universal definition of heart failure—how to proceed? European Heart Journal, 42, pp. 2331-2343. (doi: 10.1093/eurheartj/ehab082)

Livingstone, K. M., Celis-Morales, C., Navas-Carretero, S., San-Cristobal, R., Forster, H., Woolhead, C., O’Donovan, C. B., Moschonis, G., Manios, Y., Traczyk, I., Gundersen, T. E., Drevon, C. A., Marsaux, C. F. M., Fallaize, R., Macready, A. L., Daniel, H., Saris, W. H. M., Lovegrove, J. A., Gibney, M., Gibney, E. R., Walsh, M., Brennan, L., Martinez, J. A., Mathers, J. C. (2021) Personalised nutrition advice reduces intake of discretionary foods and beverages: findings from the Food4Me randomised controlled trial. International Journal of Behavioral Nutrition and Physical Activity, 18, (doi: 10.1186/s12966-021-01136-5)

Brosnahan, N., Leslie, W., McCombie, L., Barnes, A., Thom, G., McConnachie, A., Messow, C. M., Sattar, N., Taylor, R., Lean, M. E.J. (2021) Brief formula low‐energy‐diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT) Journal of Human Nutrition and Dietetics, 34, pp. 472-479. (doi: 10.1111/jhn.12839)

Sattar, N., Januzzi, J. L. (2021) Can biomarkers help find the ‘sweet spot’ for treating patients with diabetes? European Journal of Heart Failure, 23, pp. 1037-1039. (doi: 10.1002/ejhf.2175)

Butt, J. H., Docherty, K. F., Petrie, M. C., Schou, M., Kosiborod, M. N., O’Meara, E., Katova, T., Ljungman, C. E.A., Diez, M., Ogunniyi, M. O., Langkilde, A. M., Sjöstrand, M., Lindholm, D., Bengtsson, O., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Jhund, P. S., McMurray, J. J.V., Køber, L. (2021) Efficacy and safety of dapagliflozin in men and women with heart failure with reduced ejection fraction: results from the DAPA-HF trial. JAMA Cardiology, 6, pp. 678-689. (doi: 10.1001/jamacardio.2021.0379)

Eastwood, S. V., Mathur, R., Sattar, N., Smeeth, L., Bhaskaran, K., Chaturvedi, N. (2021) Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006–2019: a cohort study. PLoS Medicine, 18, (doi: 10.1371/journal.pmed.1003672)

Murray, E., Rossitto, G., Delles, C. (2021) Haemodynamic assessment in hypertension: the soloists and the orchestra. Journal of Hypertension, 39, pp. 1109-1111. (doi: 10.1097/HJH.0000000000002796)

Sierpinski, R., Josiak, K., Suchocki, T., Wojtas‐Polc, K., Mazur, G., Butrym, A., Rozentryt, P., Meer, P., Comin‐Colet, J., Haehling, S., Kosmala, W., Przewlocka‐Kosmala, M., Banasiak, W., Nowak, J., Voors, A. A., Anker, S. D., Cleland, J. G.F., Ponikowski, P., Jankowska, E. A. (2021) High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. European Journal of Heart Failure, 23, pp. 919-932. (doi: 10.1002/ejhf.2036)

Timmons, J. G., Greenlaw, N., Boyle, J. G., Chaturvedi, N., Ford, I., Brouwers, M. C.G.J., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E.K., Klein, R., Ooi, T. C., Rossing, P., Stehouwer, C. D.A., Sattar, N., Colhoun, H. M., Petrie, J. R. (2021) Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: the REMOVAL trial. Diabetes, Obesity and Metabolism, 23, pp. 1371-1378. (doi: 10.1111/dom.14350)

Mary, S., Small, H., Herse, F., Carrick, E., Flynn, A., Mullen, W., Dechend, R., Delles, C. (2021) Pre-existing hypertension and pregnancy induced hypertension reveal molecular differences in placental proteome in rodents. Physiological Genomics, 53, pp. 259-268. (doi: 10.1152/physiolgenomics.00160.2020)

Espersen, C., Campbell, R. T., Claggett, B., Lewis, E. F., Groarke, J. D., Docherty, K. F., Lee, M. M.Y., Lindner, M., Biering‐Sørensen, T., Solomon, S. D., McMurray, J. J.V., Platz, E. (2021) Sex differences in congestive markers in patients hospitalized for acute heart failure. ESC Heart Failure, 8, pp. 1784-1795. (doi: 10.1002/ehf2.13300)

Höhn, A., Jeyam, A., Caparrotta, T. M., McGurnaghan, S. J., O’Reilly, J. E., Blackbourn, L. A. K., McCrimmon, R. J., Leese, G. P., McKnight, J. A., Kennon, B., Lindsay, R. S., Sattar, N., Wild, S. H., McKeigue, P. M., Colhoun, H. M. (2021) The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes. Diabetologia, 64, pp. 1309-1319. (doi: 10.1007/s00125-021-05394-7)

Chen, J. et al. (2021) The trans-ancestral genomic architecture of glycemic traits. Nature Genetics, 53, pp. 840-860. (doi: 10.1038/s41588-021-00852-9)

Pandhi, P., Streng, K. W., Anker, S. D., Cleland, J. G., Damman, K., Dickstein, K., Pellicori, P., Lang, C. C., Ng, L., Samani, N. J., Metra, M., Rossignol, P., Filippatos, G., van Veldhuisen, D. J., Voors, A. A., ter Maaten, J. M. (2021) The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. Journal of Cachexia, Sarcopenia and Muscle, 12, pp. 555-567. (doi: 10.1002/jcsm.12690)

Maznyczka, A. M., Carrick, D., Oldroyd, K. G., James-Rae, G., McCartney, P., Greenwood, J. P., Good, R., McEntegart, M., Eteiba, H., Lindsay, M., Cotton, J. M., Petrie, M. C., Berry, C. (2021) Thermodilution-derived temperature recovery time, a novel predictor of microvascular reperfusion and prognosis after myocardial infarction. EuroIntervention, 17, pp. 220-228. (doi: 10.4244/EIJ-D-19-00904)

Jhund, P. S., Ponikowski, P., Docherty, K. F., Gasparyan, S. B., Böhm, M., Chang, C.-E., Desai, A. S., Howlett, J., Kitakaze, M., Petrie, M. C., Verma, S., Bengtsson, O., Langkilde, A.-M., Sjöstrand, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Sabatine, M. S., Solomon, S. D., McMurray, J. J.V. (2021) Dapagliflozin and recurrent heart failure hospitalizations in heart failure with reduced ejection fraction: an analysis of DAPA-HF. Circulation, 143, pp. 1962-1972. (doi: 10.1161/CIRCULATIONAHA.121.053659)

Schunk, S. J. et al. (2021) Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. European Heart Journal, 42, pp. 1742-1756. (doi: 10.1093/eurheartj/ehab107)

Emmens, J. E., Jia, C., Ng, L. L., van Veldhuisen, D. J., Dickstein, K., Anker, S. D., Lang, C. C., Filippatos, G., Cleland, J. G.F., Metra, M., Voors, A. A., de Boer, R. A., Tietge, U. J.F. (2021) Impaired high-density lipoprotein function in patients with heart failure. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019123)

Rossitto, G., Maiolino, G., Lerco, S., Ceolotto, G., Blackburn, G., Mary, S., Antonelli, G., Berton, C., Bisogni, V., Cesari, M., Seccia, T. M., Lenzini, L., Pinato, A., Montezano, A., Touyz, R. M., Petrie, M. C., Daly, R., Welsh, P., Plebani, M., Rossi, G. P., Delles, C. (2021) High sodium intake, glomerular hyperfiltration and protein catabolism in patients with essential hypertension. Cardiovascular Research, 117, pp. 1372-1381. (doi: 10.1093/cvr/cvaa205)

Lee, M. M.Y., Ghouri, N., McGuire, D. K., Rutter, M. K., Sattar, N. (2021) Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2i and GLP-1RA in Asian vs. White patients with and without type 2 diabetes. Diabetes Care, 44, pp. 1236-1241. (doi: 10.2337/dc20-3007)

Wolsk, E., Kaye, D. M., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Cleland, J. G., Hasenfuß, G., Hassager, C., Møller, J. E., Gustafsson, F. (2021) Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 23, pp. 754-764. (doi: 10.1002/ejhf.2146)

Tromp, J., Ouwerkerk, W., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Teng, K. T.-H., Bamadhaj, S., Ertl, G., Hassanein, M., Perrone, S. V., Ghandanfar, M., Schweizer, A., Obergfell, A., Filippatos, G., Collins, S. P., Lam, C. S.P., Dickstein, K. (2021) Global differences in burden and treatment of ischemic heart disease in acute heart failure: REPORT-HF. JACC: Heart Failure, 9, pp. 349-359. (doi: 10.1016/j.jchf.2020.12.015)

Mutambudzi, M., Niedzwiedz, C. L., Macdonald, E. B., Leyland, A. H., Mair, F. S., Anderson, J. J., Celis-Morales, C. A., Cleland, J. G., Forbes, J., Gill, J. M.R., Hastie, C. E., Ho, F. K., Jani, B. D., Mackay, D. F., Nicholl, B. I., O'Donnell, C. A., Sattar, N., Welsh, P., Pell, J. P., Katikireddi, S. V., Demou, E. (2021) Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78, pp. 307-314. (doi: 10.1136/oemed-2020-106731)

Khunti, K., Knighton, P., Zaccardi, F., Bakhai, C., Barron, E., Holman, N., Kar, P., Meace, C., Sattar, N., Sharp, S., Wareham, N. J., Weaver, A., Woch, E., Young, B., Valabhji, J. (2021) Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes and Endocrinology, 9, pp. 293-303. (doi: 10.1016/S2213-8587(21)00050-4)

Petermann-Rocha, F., Yang, S., Gray, S. R., Pell, J. P., Celis-Morales, C., Ho, F. K. (2021) Sarcopenic obesity and its association with respiratory disease incidence and mortality – Authors’ reply. Clinical Nutrition, 40, pp. 2520. (doi: 10.1016/j.clnu.2021.03.030)

Ferreira, J. P., Claggett, B. L., Liu, J., Desai, A. S., Pfeffer, M. A., Anand, I. S., Van Veldhuisen, D. J., Kober, L., Cleland, J. G.F., Rouleau, J. L., Packer, M., Zile, M. R., Shi, V. C., Lefkowitz, M. P., Shah, S. J., Vardeny, O., Zanannd, F., Solomon, S. D., McMurray, J. J.V. (2021) Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial. European Journal of Heart Failure, 23, pp. 776-784. (doi: 10.1002/ejhf.2134)

Rawshani, A., Kjölhede, E. A., Rawshani, A., Sattar, N., Eeg-Olofsson, K., Adiels, M., Ludvigsson, J., Lindh, M., Gisslén, M., Hagberg, E., Lappas, G., Eliasson, B., Rosengren, A. (2021) Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study. Lancet Regional Health - Europe, 4, (doi: 10.1016/j.lanepe.2021.100105)

Zhang, J., Pellicori, P., Schutte, R., Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289, pp. 747-748. (doi: 10.1111/joim.13226)

Campbell, E., Petermann-Rocha, F., Welsh, P., Celis-Morales, C., Pell, J. P., Ho, F. K., Gray, S. R. (2021) The effect of exercise on quality of life and activities of daily life in frail older adults: a systematic review of randomised control trials. Experimental Gerontology, 147, (doi: 10.1016/j.exger.2021.111287)

Connelly, P. J., Azizi, Z., Alipour, P., Delles, C., Pilote, L., Raparelli, V. (2021) The importance of gender to understand sex differences in cardiovascular disease. Canadian Journal of Cardiology, 37, pp. 699-710. (doi: 10.1016/j.cjca.2021.02.005)

Pellicori, P., Platz, E., Dauw, J., ter Maaten, J. M., Martens, P., Pivetta, E., Cleland, J. G.F., McMurray, J. J.V., Mullens, W., Solomon, S. D., Zannad, F., Gargani, L., Girerd, N. (2021) Ultrasound imaging of congestion in heart failure – examinations beyond the heart. European Journal of Heart Failure, 23, pp. 703-712. (doi: 10.1002/ejhf.2032)

Foster, H. M.E., Polz, P., Mair, F. S., Gill, J. M.R., O'Donnell, C. A. (2021) Understanding the influence of socioeconomic status on the association between combinations of lifestyle factors and adverse health outcomes: a systematic review protocol. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-042212)

Sattar, N., Forouhi, N. G. (2021) More evidence for 5-a-day for fruit and vegetables and a greater need for translating dietary research evidence to practice. Circulation, 143, pp. 1655-1658. (doi: 10.1161/CIRCULATIONAHA.121.053293)

Höskuldsdóttir, G., Sattar, N., Miftaraj, M., Näslund, I., Ottosson, J., Franzén, S., Svensson, A.-M., Eliasson, B. (2021) Potential effects of bariatric surgery on the incidence of heart failure and atrial fibrillation in patients with type 2 diabetes mellitus and obesity and on mortality in patients with preexisting heart failure: a nationwide, matched, observational cohort study. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019323)

Coats, A. J. et al. (2021) The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European Heart Journal, 42, pp. 1254-1269. (doi: 10.1093/eurheartj/ehab086)

Mooney, L., Goodyear, C. S., Chandra, T., Kirschner, K., Copland, M., Petrie, M. C., Lang, N. N. (2021) Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure. Clinical Science, 135, pp. 991-1007. (doi: 10.1042/CS20200306)

Vlahou, A. et al. (2021) Data sharing under the General Data Protection Regulation: time to harmonize law and research ethics? Hypertension, 77, pp. 1029-1035. (doi: 10.1161/HYPERTENSIONAHA.120.16340)

Scott, K., Morgan, H. L., Delles, C., Fisher, S., Graham, D., McBride, M. W. (2021) Distinct uterine artery gene expression profiles during early gestation in the stroke-prone spontaneously hypertensive rat. Physiological Genomics, 53, pp. 160-171. (doi: 10.1152/physiolgenomics.00159.2020)

Dewan, P., Docherty, K. F., Bengtsson, O., de Boer, R. A., Desai, A. S., Drozdz, J., Hawkins, N. M., Inzucchi, S. E., Kitakaze, M., Køber, L., Kosiborod, M. N., Langkilde, A. M., Lindholm, D., Martinez, F. A., Merkely, B., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Sjöstrand, M., Solomon, S. D., Verma, S., Jhund, P. S., McMurray, J. J.V. (2021) Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA-HF. European Journal of Heart Failure, 23, pp. 632-643. (doi: 10.1002/ejhf.2083)

Butt, J. H., Nicolau, J. C., Verma, S., Docherty, K. F., Petrie, M. C., Inzucchi, S. E., Schou, M., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D., Bengtsson, O., Jhund, P. S., McMurray, J., Køber, L. (2021) Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial. European Journal of Heart Failure, 23, pp. 601-613. (doi: 10.1002/ejhf.2124)

Mbakwem, A. C., Bauersachs, J., Viljoen, C., Hoevelmann, J., Meer, P., Petrie, M. C., Mebazaa, A., Goland, S., Karaye, K., Laroche, C., Sliwa, K. (2021) Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. ESC Heart Failure, 8, pp. 879-889. (doi: 10.1002/ehf2.13172)

Ferreira, J. P., Lam, C. S. P., Anker, S. D., Mehra, M. R., van Veldhuisen, D. J., Byra, W. M., La Police, D. A., Cleland, J. G.F., Greenberg, B., Zannad, F. (2021) Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial. European Journal of Heart Failure, 23, pp. 648-656. (doi: 10.1002/ejhf.2003)

Ferreira, J. P. et al. (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC: Heart Failure, 9, pp. 268-277. (doi: 10.1016/j.jchf.2020.11.010)

Ferguson, L. D., Linge, J., Leinhard, O. D., Woodward, R., Hall Barrientos, P., Roditi, G., Radjenovic, A., McInnes, I. B., Siebert, S., Sattar, N. (2021) Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity – a cross-sectional study. Rheumatology, 60, pp. 1858-1862. (doi: 10.1093/rheumatology/keaa604)

Sliwa, K. et al. (2021) Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 23, pp. 527-540. (doi: 10.1002/ejhf.2133)

Petermann-Rocha, F., Gray, S. R., Pell, J. P., Ho, F. K., Celis-Morales, C. (2021) The joint association of sarcopenia and frailty with incidence and mortality health outcomes: a prospective study. Clinical Nutrition, 40, pp. 2427-2434. (doi: 10.1016/j.clnu.2020.10.044)

Packer, M., Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Pocock, S. J., Sattar, N., Brueckmann, M., Jamal, W., Cotton, D., Iwata, T., Zannad, F. (2021) Empagliflozin in patients with heart failure, reduced ejection fraction, and volume overload EMPEROR-Reduced trial. Journal of the American College of Cardiology, 77, pp. 1381-1392. (doi: 10.1016/j.jacc.2021.01.033)

Petermann-Rocha, F., Parra-Soto, S., Gray, S., Anderson, J., Welsh, P., Gill, J., Sattar, N., Ho, F. K., Celis-Morales, C., Pell, J. P. (2021) Vegetarians, fish, poultry and meat-eaters: who has higher risk of CVD incidence and mortality? A prospective study from UK Biobank. European Heart Journal, 42, pp. 1136-1143. (doi: 10.1093/eurheartj/ehaa939)

Bos, M. M. et al. (2021) Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses. BMC Medicine, 19, pp. 69. (doi: 10.1186/s12916-021-01939-0)

Uijl, A., Vaartjes, I., Denaxas, S., Hemingway, H., Shah, A. D., Cleland, J., Grobbee, D. E., Hoes, A. W., Asselbergs, F. W., Koudstaal, S. (2021) Temporal trends in heart failure medication prescription in a population-based cohort study. BMJ Open, 11, (doi: 10.1136/bmjopen-2020-043290)

Pellicori, P., Doolub, G., Wong, C. M., Lee, K. S., Mangion, K., Ahmad, M., Berry, C., Squire, I., Lambiase, P., Lyon, A. R., McConnachie, A., Taylor, R. S., Cleland, J. G.F. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021, (doi: 10.1002/14651858.CD013879)

Smart, N. A., Pearson, M. J., Taylor, R. S., Cleland, J. (2021) Exercise training for heart failure with preserved ejection fraction (ExTraMATCH III): protocol for an individual patient data meta-analysis. Journal of Clinical Exercise Physiology, 10, pp. 3-11. (doi: 10.31189/2165-7629-10.1.3)

Mordi, I. R., Ouwerkerk, W., Anker, S. D., Cleland, J. G., Dickstein, K., Metra, M., Ng, L. L., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Voors, A. A., Lang, C. C. (2021) Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. European Journal of Heart Failure, 23, pp. 436-444. (doi: 10.1002/ejhf.1799)

Ferreira, J. P., Cleland, J. G.F., Lam, C. S.P., van Veldhuisen, D., Byra, W. M., La Police, D. A., Anker, S. D., Mehra, M. R., Leroy, C., Eschwege, V., Toussaint-Hacquard, M., Rossignol, P., Greenberg, B., Zannad, F. (2021) Impact of geographic region on the COMMANDER-HF Trial. JACC: Heart Failure, 9, pp. 201-211. (doi: 10.1016/j.jchf.2020.11.007)

Crouch, S. H., Botha-Le Roux, S., Delles, C., Graham, L. A., Schutte, A. E. (2021) Inflammation and salt in young adults: the African-PREDICT study. European Journal of Nutrition, 60, pp. 873-882. (doi: 10.1007/s00394-020-02292-3)

Ferguson, L. D., Sattar, N., McInnes, I. B. (2021) Managing cardiovascular risk in patients with rheumatic disease. Medical Clinics of North America, 105, pp. 247-262. (doi: 10.1016/j.mcna.2020.09.010)

Neves, K. B., Morris, H., Alves-Lopes, R., Muir, K. W., Moreton, F., Delles, C., Montezano, A. C., Touyz, R. M. (2021) Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO∕sGC∕cGMP pathway. Clinical Science, 135, pp. 753-773. (doi: 10.1042/CS20201412)

Tomasoni, D., Petrie, M. C., Adamo, M., Metra, M. (2021) Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. European Journal of Heart Failure, 23, pp. 486-488. (doi: 10.1002/ejhf.2098)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2021) The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. American Journal of Clinical Nutrition, 113, pp. 695-705. (doi: 10.1093/ajcn/nqaa311)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8, (doi: 10.1136/openhrt-2020-001453)

Ehteshami-Afshar, S., Mooney, L., Dewan, P., Desai, A. S., Lang, N. N., Lefkowitz, M. P., Petrie, M. C., Rizkala, A. R., Rouleau, J. L., Solomon, S. D., Swedberg, K., Shi, V. C., Zile, M. R., Packer, M., McMurray, J. J.V., Jhund, P. S., Hawkins, N. M. (2021) Clinical characteristics and outcomes of patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: insights from PARADIGM-HF. Journal of the American Heart Association, 10, (doi: 10.1161/JAHA.120.019238)

Thom, G., McIntosh, A., Messow, C.-M., Leslie, W. S., Barnes, A. C., Brosnahan, N., McCombie, L., Malkova, D., Al-Mrabeh, A., Zhyzhneuskaya, S., Welsh, P., Sattar, N., Taylor, R., Lean, M. E.J. (2021) Weight loss induced increase in fasting ghrelin concentration is a predictor of weight regain: evidence from the Diabetes Remission Clinical Trial. Diabetes, Obesity and Metabolism, 23, pp. 711-719. (doi: 10.1111/dom.14274)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) Circulation, 143, pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186)

Petrie, M. C., Lee, M. M., Lang, N. N. (2021) EMPEROR-REDUCED reigns while EMPERIAL whimpers. European Heart Journal, 42, pp. 711-714. (doi: 10.1093/eurheartj/ehaa965)

Cleland, J. G.F. et al. (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European Heart Journal, 42, pp. 684-696. (doi: 10.1093/eurheartj/ehaa758)

Parra Soto, S. L., Petermann-Rocha, F., Boonpor, J., Gray, S. R., Pell, J. P., Celis-Morales, C., Ho, F. K. (2021) Combined association of general and central obesity with incidence and mortality of cancers in 22 sites. American Journal of Clinical Nutrition, 113, pp. 401-409. (doi: 10.1093/ajcn/nqaa335)

Gerstein, H. C., Branch, K., Heenan, L., Del Prato, S., Khurmi, N. S., Lam, C. S.P., Pratley, R., Rosenstock, J., Sattar, N. (2021) Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonist. Diabetes, Obesity and Metabolism, 23, pp. 318-323. (doi: 10.1111/dom.14223)

Chiesa, S. T., Charakida, M., Georgiopoulos, G., Dangardt, F., Wade, K. H., Rapala, A., Bhowruth, D. J., Nguyen, H. C., Muthurangu, V., Shroff, R., Davey Smith, G., Lawlor, D. A., Sattar, N., Timpson, N. J., Hughes, A. D., Deanfield, J. E. (2021) Determinants of intima-media thickness in the young: the ALSPAC Study. JACC: Cardiovascular Imaging, 14, pp. 468-478. (doi: 10.1016/j.jcmg.2019.08.026)

Bhopal, R., Douglas, A., Sheikh, A., Wild, S.H., Gill, J.M.R., Sattar, N., Lean, M.E.J., McKnight, J., Tuomilehto, J., Wallia, S., Cezard, G. (2021) Diabetes incidence in a high-risk UK population at 7 years: linkage of the Prevention of Diabetes and Obesity in South Asians (PODOSA) trial to the Scottish Diabetes Register. Diabetic Medicine, 38, (doi: 10.1111/dme.14369)

Maznyczka, A. M., McCartney, P., Duklas, P., McEntegart, M., Oldroyd, K., Greenwood, J., Muir, D., Chowdhary, S., Gershlick, A. H., Eteiba, H., Cotton, J., Wragg, A., Curzen, N., Tait, R., Macfarlane, P., Welsh, P., Sattar, N., Petrie, M., Ford, I., Fox, K., McConnachie, A., Berry, C. (2021) Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial. Heart, 107, pp. 299-312. (doi: 10.1136/heartjnl-2020-317828)

Felker, G. M. et al. (2021) Effects of a novel nitroxyl donor in acute heart failure: the STAND-UP AHF Study. JACC: Heart Failure, 9, pp. 146-157. (doi: 10.1016/j.jchf.2020.10.012)

Inzucchi, S. E., Davies, M. J., Khunti, K., Trivedi, P., George, J. T., Zwiener, I., Johansen, O. E., Sattar, N. (2021) Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 23, pp. 425-433. (doi: 10.1111/dom.14234)

Donin, A. S., Nightingale, C. M., Perkin, M. R., Ussher, M., Jebb, S. A., Landberg, R., Welsh, P., Sattar, N., Adab, P., Owen, C. G., Rudnicka, A. R., Cook, D. G., Whincup, P. H. (2021) Evaluating an intervention to increase cereal fiber intake in children: a randomized controlled feasibility trial. Journal of Nutrition, 151, pp. 379-386. (doi: 10.1093/jn/nxaa347)

Halliday, B. P., Owen, R., Gregson, J., Vassiliou, V., Chen, X., Wage, R., Lota, A. S., Khalique, Z., Tayal, U., Hammersley, D. J., Jones, R. E., Baksi, A. J., Cowie, M. R., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2021) Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy – insights from TRED‐HF. European Journal of Heart Failure, 23, pp. 293-301. (doi: 10.1002/ejhf.2063)

Docherty, K. F., Campbell, R. T., Brooksbank, K. J.M., Godeseth, R. L., Forsyth, P., McConnachie, A., Roditi, G., Stanley, B., Welsh, P., Jhund, P. S., Petrie, M. C., McMurray, J. J.V. (2021) Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling. ESC Heart Failure, 8, pp. 129-138. (doi: 10.1002/ehf2.13137)

McGurnaghan, S. J. et al. (2021) Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes and Endocrinology, 9, pp. 82-93. (doi: 10.1016/S2213-8587(20)30405-8)

Al Ozairi, E., Alroudhan, D., Alsaeed, D., Voase, N., Hasan, A., Gill, J. M.R., Sattar, N., Welsh, P., Gray, C. M., Boonpor, J., Celis-Morales, C., Gray, S. R. (2021) Skeletal muscle and metabolic health – how do we increase muscle mass and function in people with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 106, pp. 309-317. (doi: 10.1210/clinem/dgaa835)

Connelly, P. J., Clark, A., Touyz, R. M., Delles, C. (2021) Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review. Journal of Hypertension, 39, pp. 223-230. (doi: 10.1097/HJH.0000000000002632)

Hastie, C., Pell, J., Sattar, N. (2021) Vitamin D and COVID-19 infection and mortality in UK Biobank. European Journal of Nutrition, 60, pp. 545-548. (doi: 10.1007/s00394-020-02372-4)

Samuel, N. A., Cuthbert, J. J., Brown, O. I., Kazmi, S., Cleland, J. G.F., Rigby, A. S., Clark, A. L. (2021) Relation between thyroid function and mortality in patients with chronic heart failure. American Journal of Cardiology, 139, pp. 57-63. (doi: 10.1016/j.amjcard.2020.10.034)

Teerlink, J. R. et al. (2021) Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. New England Journal of Medicine, 384, pp. 105-116. (doi: 10.1056/NEJMoa2025797)

Parra-Soto, S., Cowley, E. S., Rezende, L. F.M., Ferreccio, C., Mathers, J. C., Pell, J. P., Ho, F. K., Celis-Morales, C. (2021) Associations of six adiposity-related markers with incidence and mortality from 24 cancers – findings from the UK Biobank prospective cohort study. BMC Medicine, 19, (doi: 10.1186/s12916-020-01848-8)

Lyall, D. M., Ward, J., Banach, M., Smith, G. D., Gill, J. G., Pell, J. P., Holmes, M. V., Sattar, N. (2021) PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study. Archives of Medical Science, 17, pp. 241-244. (doi: 10.5114/aoms/127226)

Lagou, V. et al. (2021) Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nature Communications, 12, (doi: 10.1038/s41467-020-19366-9)

Bekfani, T., Fudim, M., Cleland, J. G.F., Jorbenadze, A., Haehling, S., Lorber, A., Rothman, A. M.‐K., Stein, K., Abraham, W. T., Sievert, H., Anker, S. D. (2021) A current and future outlook on upcoming technologies in the remote monitoring of patients with heart failure. European Journal of Heart Failure, 23, pp. 175-185. (doi: 10.1002/ejhf.2033)

Moreton, F. C., Cullen, B., Dickie, D. A., Lopez Gonzalez, R., Santosh, C., Delles, C., Muir, K. W. (2021) Brain imaging factors associated with progression of subcortical hyperintensities in CADASIL over two year follow up. European Journal of Neurology, 28, pp. 220-228. (doi: 10.1111/ene.14534)

Dobbin, S. J.H., Petrie, M. C., Myles, R. C., Touyz, R. M., Lang, N. N. (2021) Cardiotoxic effects of angiogenesis inhibitors. Clinical Science, 135, pp. 71-100. (doi: 10.1042/CS20200305)

Davison, B. A., Senger, S., Sama, I. E., Koch, G. G., Mebazaa, A., Dickstein, K., Samani, N. J., Metra, M., Anker, S. D., Cleland, J. G., Ng, L. L., Mordi, I. R., Zannad, F., Filippatos, G. S., Hillege, H. L., Ponikowski, P., Veldhuisen, D. J., Lang, C. C., Meer, P., Núñez, J., Bayés‐Genís, A., Edwards, C., Voors, A. A., Cotter, G. (2021) Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF. European Journal of Heart Failure, 23, pp. 43-57. (doi: 10.1002/ejhf.2077)

He, T., Melgarejo, J. D., Clark, A. L., Yu, Y.‐L., Thijs, L., Díez, J., López, B., González, A., Cleland, J. G., Schanstra, J. P., Vlahou, A., Latosinska, A., Mischak, H., Staessen, J. A., Zhang, Z.‐Y., Jankowski, V. (2021) Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure. Clinical and Translational Medicine, 11, (doi: 10.1002/ctm2.267)

Sattar, N., Boyle, J. G., Al-Ozairi, E. (2021) Testosterone replacement to prevent type 2 diabetes? Not just yet. Lancet Diabetes and Endocrinology, 9, pp. 5-6. (doi: 10.1016/S2213-8587(20)30373-9)

Anderson, A. S., Chong, H. Y., Craigie, A. M., Donnan, P. T., Gallant, S., Hickman, A., McAdam, C., McKell, J., McNamee, P., Macaskill, E. J., Mutrie, N., O’Carroll, R. E., Rauchhaus, P., Sattar, N., Stead, M., Treweek, S. (2021) A novel approach to increasing community capacity for weight management a volunteer-delivered programme (ActWELL) initiated within breast screening clinics: a randomised controlled trial. International Journal of Behavioral Nutrition and Physical Activity, 18, (doi: 10.1186/s12966-021-01099-7)

Ho, F. K., Celis-Morales, C., Petermann-Rocha, F., Parra-Soto, S. L., Lewsey, J., Mackay, D., Pell, J. P. (2021) Changes over 15 years in the contribution of adiposity and smoking to deaths in England and Scotland. BMC Public Health, 21, (doi: 10.1186/s12889-021-10167-3)

Anderson, J. J., Welsh, P., Ho, F. K., Ferguson, L. D., Welsh, C. E., Pellicori, P., Cleland, J. G.F., Forbes, J., Iliodromiti, S., Boyle, J., Lindsay, R., Celis-Morales, C., Gray, S. R., Katikireddi, S. V., Gill, J. M. R., Pell, J. P., Sattar, N. (2021) Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening. BMJ Open Diabetes Research and Care, 9, (doi: 10.1136/bmjdrc-2021-002176)

Small, H. Y., Delles, C. (2021) Letter to the Editor regarding Cunningham et al. 2020. Hypertension in Pregnancy, 40, pp. 133. (doi: 10.1080/10641955.2021.1899201)

Shoaib, A., Van Spall, H. G.C., Wu, J., Cleland, J. G.F., McDonagh, T. A., Rashid, M., Mohamed, M. O., Ahmed, F. Z., Deanfield, J., de Belder, M., Gale, C. P., Mamas, M. A. (2021) Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal: Quality of Care and Clinical Outcomes, 7, pp. 378-387. (doi: 10.1093/ehjqcco/qcab040)

Shah, P., Pellicori, P., Hanning, I., Zhang, J., Clark, A. L., Bhandari, S. (2021) The effect of digoxin on renal function in patients with heart failure. BMC Nephrology, 22, (doi: 10.1186/s12882-021-02562-0)

Edqvist, J., Rawshani, A., Rawshani, A., Adiels, M., Franzén, S., Bjorck, L., Svensson, A.-M., Lind, M., Sattar, N., Rosengren, A. (2021) Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset. BMJ Open Diabetes Research and Care, 9, (doi: 10.1136/bmjdrc-2021-002187)

2020

Brown, R., Welsh, P., Logue, J. (2020) Systematic review of clinical guidelines for lipid-lowering in the secondary prevention of cardiovascular disease events. Open Heart, 7, (doi: 10.1136/openhrt-2020-001396)

Rossitto, G., Mary, S., McAllister, C., Neves, K. B., Haddow, L., Rocchiccioli, J. P., Lang, N. N., Murphy, C. L., Touyz, R. M., Petrie, M. C., Delles, C. (2020) Reduced lymphatic reserve in heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 76, pp. 2817-2829. (doi: 10.1016/j.jacc.2020.10.022)

Lee, M. (2020) Studies of Empagliflozin and its Cardiovascular, Renal and Metabolic Effects in Patients With Diabetes Mellitus (or Prediabetes) and Heart Failure: a Randomized Controlled Trial (SUGAR-DM-HF) (doi: 10.1161/CIR.0000000000000940)

Goncalves Soares, A., Kilpi, F., Fraser, A., Nelson, S. M., Sattar, N., Welsh, P. I., Tilling, K., Lawlor, D. A. (2020) Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC) Scientific Reports, 10, (doi: 10.1038/s41598-020-77871-9)

Purcell, C., Daw, P., Kerr, C., Cleland, J., Cowie, A., Dalal, H., Ibbotson, T., Murphy, C., Taylor, R. (2020) Protocol for an implementation study of an evidence-based home cardiac rehabilitation programme for people with heart failure and their caregivers in Scotland (SCOT:REACH-HF) BMJ Open, 10, (doi: 10.1136/bmjopen-2020-040771)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116, pp. 2185-2196. (doi: 10.1093/cvr/cvaa209)

Al-Mrabeh, A., Hollingsworth, K. G., Shaw, J. A.M., McConnachie, A., Sattar, N., Lean, M. E.J., Taylor, R. (2020) 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes and Endocrinology, 8, pp. 939-948. (doi: 10.1016/S2213-8587(20)30303-X)

Ferguson, A. C., Tank, R., Lyall, L. M., Ward, J., Welsh, P., Celis-Morales, C., McQueenie, R., Strawbridge, R. J., Mackay, D. F., Pell, J. P., Smith, D. J., Sattar, N., Cavanagh, J., Lyall, D. M. (2020) Association of SBP and BMI with cognitive and structural brain phenotypes in UK Biobank. Journal of Hypertension, 38, pp. 2482-2489. (doi: 10.1097/HJH.0000000000002579)

Kelly, P., Williamson, C., Baker, G., Davis, A., Broadfield, S., Coles, A., Logan, G., Connell, H., Pell, J. P., Gray, C., Gill, J. M.R. (2020) Beyond cycle lanes and large-scale infrastructure: a scoping review of initiatives that groups and organisations can implement to promote cycling for the Cycle Nation Project. British Journal of Sports Medicine, 54, pp. 1405-1415. (doi: 10.1136/bjsports-2019-101447)

Petermann-Rocha, F., Gray, S. R., Pell, J. P., Celis-Morales, C., Ho, F. K. (2020) Biomarkers profile of people with sarcopenia: a cross-sectional analysis from UK Biobank. Journal of the American Medical Directors Association, 21, pp. 2017.e1-2017.e9. (doi: 10.1016/j.jamda.2020.05.005)

Surendran, P. et al. (2020) Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nature Genetics, 52, pp. 1314-1332. (doi: 10.1038/s41588-020-00713-x)

Mangion, K., Loughrey, C., Auger, D. A., McComb, C., Lee, M. M., Corcoran, D., McEntegart, M., Davie, A., Good, R., Lindsay, M., Eteiba, H., Rocchiccioli, J. P., Watkins, S., Hood, S., Shaukat, A., Haig, C., Epstein, F. H., Berry, C. (2020) Displacement encoding with stimulated echoes enables the identification of infarct transmurality early postmyocardial infarction. Journal of Magnetic Resonance Imaging, 52, pp. 1722-1731. (doi: 10.1002/jmri.27295)

Pellicori, P., Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., Zinman, B., Brueckmann, M., Lindenfeld, J. (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7, pp. 3401-3407. (doi: 10.1002/ehf2.12891)

Felker, G. M., Solomon, S. D., McMurray, J. J.V., Cleland, J. G.F., Abbasi, S. A., Malik, F. I., Zhang, H., Globe, G., Teerlink, J. R. (2020) Effects of omecamtiv mecarbil on symptoms and health-related quality of life in patients with chronic heart failure: results from the COSMIC-HF study. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.120.007814)

Ferreira, J. P., Docherty, K. F., Stienen, S., Jhund, P. S., Claggett, B. L., Solomon, S. D., Petrie, M. C., Gregsone, J., Pocock, S. L., Zannad, F., McMurray, J. (2020) Estimating the lifetime benefits of treatments for heart failure. JACC: Heart Failure, 8, pp. 984-995. (doi: 10.1016/j.jchf.2020.08.004)

Zamai, N., Cortie, C. H., Jarvie, E. M., Onyiaodike, C. C., Alrehaili, A., Francois, M., Freeman, D. J., Meyer, B. J. (2020) In pregnancy, maternal HDL is specifically enriched in, and carries the highest proportion of, DHA in plasma. Prostaglandins, Leukotrienes and Essential Fatty Acids, 163, (doi: 10.1016/j.plefa.2020.102209)

Steell, L., Johnston, B. A., Dewantoro, D., Foster, J. E., Gaya, D. R., Macdonald, J., McMillan, M., Russell, R. K., Seenan, J. P., Ahmed, S. F., Gray, S. R., Wong, S. C. (2020) Muscle deficits with normal bone microarchitecture and geometry in young adults with well controlled childhood onset Crohn’s disease. European Journal of Gastroenterology and Hepatology, 32, pp. 1497-1506. (doi: 10.1097/MEG.0000000000001838)

Brown, O., Costanzo, P., Clark, A. L., Condorelli, G., Cleland, J. G.F., Sathyapalan, T., Hepburn, D., Kilpatrick, E. S., Atkin, S. L. (2020) Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus. Cardiovascular Endocrinology and Metabolism, 9, pp. 177-182. (doi: 10.1097/XCE.0000000000000202)

Angwin, C., Jenkinson, C., Jones, A., Jennison, C., Henley, W., Farmer, A., Sattar, N., Holman, R. R., Pearson, E., Shields, B., Hattersley, A. (2020) TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. BMJ Open, 10, (doi: 10.1136/bmjopen-2020-042784)

Mackenzie, I. S. et al. (2020) Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet, 396, pp. 1745-1757. (doi: 10.1016/S0140-6736(20)32234-0)

Beazer, J. D., Patanapirunhakit, P., Gill, J. M.R., Graham, D., Karlsson, H., Ljunggren, S., Mulder, M., Freeman, D. J. (2020) High-density lipoprotein’s vascular protective functions in metabolic and cardiovascular disease - could extracellular vesicles be at play? Clinical Science, 134, pp. 2977-2986. (doi: 10.1042/CS20200892)

Ho, F. K., Celis-Morales, C. A., Gray, S. R., Katikireddi, S. V., Niedzwiedz, C. L., Hastie, C., Ferguson, L. D., Berry, C., Mackay, D. F., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P. (2020) Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open, 10, (doi: 10.1136/bmjopen-2020-040402)

Psotka, M. A. et al. (2020) Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel. Journal of the American College of Cardiology, 76, pp. 2368-2378. (doi: 10.1016/j.jacc.2020.09.544)

Petermann-Rocha, F., Hanlon, P., Gray, S. R., Welsh, P., Gill, J. M.R., Foster, H., Katikireddi, S. V., Lyall, D., Mackay, D. F., O'Donnell, C., Sattar, N., Nicholl, B. I., Pell, J. P., Jani, B. D., Ho, F. K., Mair, F. S., Celis-Morales, C. (2020) Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC Medicine, 18, (doi: 10.1186/s12916-020-01822-4)

Ho, F. K., Petermann-Rocha, F., Gray, S. R., Jani, B. D., Katikireddi, S. V., Niedzwiedz, C. L., Foster, H., Hastie, C. E., Mackay, D. F., Gill, J. M.R., O'Donnell, C., Welsh, P., Mair, F., Sattar, N., Celis-Morales, C. A., Pell, J. P. (2020) Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE, 15, (doi: 10.1371/journal.pone.0241824)

McEwan, P., Darlington, O., McMurray, J. J.V., Jhund, P. S., Docherty, K. F., Böhm, M., Petrie, M. C., Bergenheim, K., Qin, L. (2020) Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF. European Journal of Heart Failure, 22, pp. 2147-2156. (doi: 10.1002/ejhf.1978)

Ferreira, J. P., Dewan, P., Jhund, P., Lorenzo-Almorós, A., Duarte, K., Petrie, M., Carson, P. E., McKelvie, R., Komajda, M., Zile, M., Zannad, F., McMurray, J. J.V. (2020) Covariate adjusted reanalysis of the I-Preserve trial. Clinical Research in Cardiology, 109, pp. 1358-1365. (doi: 10.1007/s00392-020-01632-x)

Seferović, P. M. et al. (2020) Heart Failure Association of the European Society of Cardiology update on sodium glucose co‐transporter‐2 inhibitors in heart failure (an update on the Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. The position paper of the Heart Failure Association of the European Society of Cardiology) European Journal of Heart Failure, 22, pp. 1984-1986. (doi: 10.1002/ejhf.2026)

Petermann-Rocha, F., Ulloa, N., Martínez-Sanguinetti, M. A., Leiva, A. M., Martorell, M., Villagrán, M., Troncoso-Pantoja, C., Ho, F. K., Celis-Morales, C., Pizarro, A. (2020) Is waist-to-height ratio a better predictor of hypertension and type 2 diabetes than body mass index and waist circumference in the Chilean population? Nutrition, 79, (doi: 10.1016/j.nut.2020.110932)

McCartney, P. J. et al. (2020) Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT. Efficacy and Mechanism Evaluation, 7, (doi: 10.3310/eme07050)

Teerlink, J. R. et al. (2020) Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials. European Journal of Heart Failure, 22, pp. 2160-2171. (doi: 10.1002/ejhf.2015)

Petermann-Rocha, F., Martínez-Sanguinetti, M. A., Ho, F. K., Celis-Morales, C., Pizarro, A. (2020) Optimal cut-off points for waist circumference in the definition of metabolic syndrome in Chile. Public Health Nutrition, 23, pp. 2898-2903. (doi: 10.1017/S1368980020001469)

Morrow, A. J. et al. (2020) Rationale and design of the Medical Research Council precision medicine with Zibotentan in microvascular angina (PRIZE) trial. American Heart Journal, 229, pp. 70-80. (doi: 10.1016/j.ahj.2020.07.007)

Petermann-Rocha, F., Yang, S., Gray, S. R., Pell, J. P., Celis-Morales, C., Ho, F. K. (2020) Sarcopenic obesity and its association with respiratory disease incidence and mortality. Clinical Nutrition, 39, pp. 3461-3466. (doi: 10.1016/j.clnu.2020.03.006)

Selvaraj, S., Claggett, B. L., Pfeffer, M. A., Desai, A. S., McCausland, F. R., McGrath, M. M., Anand, I. S., van van Veldhuisen, D. J., Kober, L., Janssens, S., Cleland, J. G.F., Pieske, B., Rouleau, J. L., Zile, M. R., Shi, V. C., Lefkowitz, M. P., McMurray, J. J.V., Solomon, S. D. (2020) Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. European Journal of Heart Failure, 22, pp. 2093-2101. (doi: 10.1002/ejhf.1984)

Dewan, P., Jackson, A., Jhund, P. S., Shen, L., Ferreira, J. P., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2020) The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. European Journal of Heart Failure, 22, pp. 2123-2133. (doi: 10.1002/ejhf.1832)

Palazzuoli, A., Ruocco, G., Franci, B., Evangelista, I., Lucani, B., Nuti, R., Pellicori, P. (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clinical Research in Cardiology, 109, pp. 1423-1433. (doi: 10.1007/s00392-020-01642-9)

Foster, H. M.E., Ho, F. K., Sattar, N., Welsh, P., Pell, J. P., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A. (2020) Understanding how much TV is too much: a non-linear analysis of the association between television viewing time and adverse health outcomes. Mayo Clinic Proceedings, 95, pp. 2429-2441. (doi: 10.1016/j.mayocp.2020.04.035)

Hrund Björnsdottir, H., Rawshani, A., Rawshani, A., Franzén, S., Svensson, A.-M., Sattar, N., Gudbjörnsdottir, S. (2020) A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time. Scientific Reports, 10, (doi: 10.1038/s41598-020-73668-y)

Packer, M. et al. (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. New England Journal of Medicine, 383, pp. 1413-1424. (doi: 10.1056/NEJMoa2022190)

Blackburn, G., Hay, J., Skagen, C., Paul, E., Achcar, F., Wilson, J., Best, C., Manson, E., Burgess, K., Barrett, M. P., Gill, J. (2020) Running on empty: a metabolomics approach to investigating changing energy metabolism during fasted exercise and rest. Metabolites, 10, (doi: 10.3390/metabo10100399)

Barron, E., Bakhai, C., Kar, P., Weaver, A., Bradley, D., Ismail, H., Knighton, P., Holman, N., Khunti, K., Sattar, N., Wareham, N. J., Young, B., Valabhji, J. (2020) Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes and Endocrinology, 8, pp. 813-822. (doi: 10.1016/S2213-8587(20)30272-2)

Holman, N., Knighton, P., Kar, P., O'Keefe, J., Curley, M., Weaver, A., Barron, E., Bakhai, C., Khunti, K., Wareham, N. J., Sattar, N., Young, B., Valabhji, J. (2020) Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes and Endocrinology, 8, pp. 823-833. (doi: 10.1016/S2213-8587(20)30271-0)

Lang, N. N., Dobbin, S. J.H., Petrie, M. C. (2020) Vericiguat in worsening heart failure – agonising over, or celebrating, agonism. Cardiovascular Research, 116, pp. e152-e155. (doi: 10.1093/cvr/cvaa247)

Lyall, D. M., Cox, S. R., Lyall, L. M., Celis Morales, C., Cullen, B., Mackay, D. F., Ward, J., Strawbridge, R., McIntosh, A. M., Sattar, N., Smith, D., Cavanagh, J., Deary, I. J., Pell, J. (2020) Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity. Brain Imaging and Behavior, 14, pp. 1468-1476. (doi: 10.1007/s11682-019-00069-9)

Rahimi, K., Nazarzadeh, M., Pinho-Gomes, A.-C., Woodward, M., Salimi-Khorshidi, G., Ohkuma, T., Fitzpatrick, R., Tarassenko, L., Denis, M., Cleland, J. (2020) Home monitoring with technology-supported management in chronic heart failure: a randomised trial. Heart, 106, pp. 1573-1578. (doi: 10.1136/heartjnl-2020-316773)

Erzurumluoglu, A. M. et al. (2020) Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. Molecular Psychiatry, 25, pp. 2392-2409. (doi: 10.1038/s41380-018-0313-0)

von Haehling, S., Garfias Macedo, T., Valentova, M., Anker, M. S., Ebner, N., Bekfani, T., Haarmann, H., Schefold, J. C., Lainscak, M., Cleland, J. G.F., Doehner, W., Hasenfuss, G., Anker, S. D. (2020) Muscle wasting as an independent predictor of survival in patients with chronic heart failure. Journal of Cachexia, Sarcopenia and Muscle, 11, pp. 1242-1249. (doi: 10.1002/jcsm.12603)

Butt, J. H., Fosbøl, E. L., Gerds, T. A., Andersson, C., McMurray, J. J.V., Petrie, M. C., Gustafsson, F., Madelaire, C., Kristensen, S. L., Gislason, G. H., Torp-Pedersen, C., Køber, L., Schou, M. (2020) Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort. European Journal of Heart Failure, 22, pp. 1777-1785. (doi: 10.1002/ejhf.1800)

Donnelly, L. A., Dennis, J. M., Coleman, R. L., Sattar, N., Hattersley, A. T., Holman, R. R., Pearson, E. R. (2020) Risk of anemia with metformin use in type 2 diabetes: a MASTERMIND study. Diabetes Care, 43, pp. 2493-2499. (doi: 10.2337/dc20-1104)

Martinez-Amezcua, P., Haque, W., Khera, R., Kanaya, A. M., Sattar, N., Lam, C. S.P., Harikrishnan, S., Shah, S. J., Kandula, N. R., Jose, P. O., Narayan, K.M. V., Agyemang, C., Misra, A., Jenum, A. K., Bilal, U., Nasir, K., Cainzos-Achirica, M. (2020) The upcoming epidemic of heart failure in South Asia. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.120.007218)

Borges, L., Gorjão, R., Gray, S., Martins, T. R., Santos, V. C., Momesso, C. M., Pithon-Curi, T. C., Hatanaka, E. (2020) Lymphocyte activation after a high-intensity street dance class. PLoS ONE, 15, (doi: 10.1371/journal.pone.0239516)

Dowsett, L., Higgins, E., Alanazi, S., Alshuwayer, N. A., Leiper, F. C., Leiper, J. (2020) ADMA: A key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. Journal of Clinical Medicine, 9, (doi: 10.3390/jcm9093026)

Parra Soto, S. L., Ho, F. K., Pell, J. P., Celis-Morales, C. (2020) Does insulin-like growth factor moderate the association between height and risk of cancer at 24 sites? British Journal of Cancer, 123, pp. 1697-1704. (doi: 10.1038/s41416-020-01059-1)

Ford, T. J., Corcoran, D., Padmanabhan, S., Aman, A., Rocchiccioli, P., Good, R., McEntegart, M., Maguire, J. J., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., Sattar, N., Hsu, L.-Y., Arai, A. E., Oldroyd, K. G., Touyz, R. M., Davenport, A. P., Berry, C. (2020) Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction. European Heart Journal, 41, pp. 3239-3252. (doi: 10.1093/eurheartj/ehz915)

Sattar, N., Ho, F. K., Gill, J. M.R., Ghouri, N., Gray, S. R., Celis-Morales, C. A., Katikireddi, S. V., Berry, C., Pell, J. P., McMurray, J. J.V., Welsh, P. (2020) BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, pp. 1149-1151. (doi: 10.1016/j.dsx.2020.06.060)

Cameron, A. C., McMahon, K., Hall, M., Neves, K. B., Rios, F. J., Montezano, A. C., Welsh, P., Waterston, A., White, J., Mark, P. B., Touyz, R. M., Lang, N. N. (2020) Comprehensive characterisation of the vascular effects of cisplatin-based chemotherapy in patients with testicular cancer. JACC: CardioOncology, 2, pp. 443-455. (doi: 10.1016/j.jaccao.2020.06.004)

Voors, A. A. et al. (2020) Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. European Journal of Heart Failure, 22, pp. 1649-1658. (doi: 10.1002/ejhf.1933)

Pellicori, P., Ferreira, J. P., Mariottoni, B., Brunner-La Rocca, H.-P., Ahmed, F. Z., Job, V., Collier, T., Cuthbert, J. J., Petutschnigg, J., Mujaj, B., Girerd, N., González, A., Clark, A. L., Cosmi, F., Staessen, J. A., Heymans, S., Latini, R., Rossignol, P., Zannand, F., Cleland, J. G.F. (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European Journal of Heart Failure, 22, pp. 1711-1723. (doi: 10.1002/ejhf.1716)

Gill, J. M.R. (2020) Linking volume and intensity of physical activity to mortality. Nature Medicine, 26, pp. 1332-1334. (doi: 10.1038/s41591-020-1019-9)

Ferrannini, E., Murthy, A. C., Lee, Y.-h., Muscelli, E., Weiss, S., Ostroff, R. M., Sattar, N., Williams, S. A., Ganz, P. (2020) Mechanisms of sodium-glucose cotransporter-2 inhibition: insights from large-scale proteomics. Diabetes Care, 43, pp. 2183-2189. (doi: 10.2337/dc20-0456)

Caparrotta, T. M., Blackbourn, L. A.K., McGurnaghan, S. J., Chalmers, J., Lindsay, R., McCrimmon, R., McKnight, J., Wild, S., Petrie, J. R., Philip, S., McKeigue, P. M., Webb, D. J., Sattar, N., Colhoun, H. M. (2020) Prescribing paradigm shift? Applying the 2019 European Society of Cardiology-led guidelines on diabetes, prediabetes, and cardiovascular disease to assess eligibility for sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide 1 receptor agonists as first-line monotherapy (or add-on to metformin monotherapy) in type 2 diabetes in Scotland. Diabetes Care, 43, pp. 2034-2041. (doi: 10.2337/dc20-0120)

Seferović, P. M. et al. (2020) Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 22, pp. 1495-1503. (doi: 10.1002/ejhf.1954)

Rossitto, G., Mary, S., Chen, J. Y., Bodder, P., Chew, K. S., Neves, K. B., Alves, R. L., Montezano, A. C., Welsh, P., Petrie, M. C., Graham, D., Touyz, R. M., Delles, C. (2020) Tissue sodium excess is not hypertonic and reflects extracellular volume expansion. Nature Communications, 11, (doi: 10.1038/s41467-020-17820-2)

McQueenie, R., Foster, H. M.E., Jani, B. D., Katikireddi, S. V., Sattar, N., Pell, J. P., Ho, F. K., Niedzwiedz, C. L., Hastie, C. E., Anderson, J., Mark, P. B., Sullivan, M., O'Donnell, C. A., Mair, F. S., Nicholl, B. I. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15, (doi: 10.1371/journal.pone.0238091)

Ferguson, A. C., Tank, R., Lyall, L. M., Strawbridge, R., Ward, J., Celis-Morales, C., Ho, F., Whelan, C. D., Gill, J., Welsh, P., Anderson, J. J., Mark, P. B., Smith, D. J., Pell, J. P., Cavanagh, J., Sattar, N., Lyall, D. M. (2020) Alzheimer’s disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769) Journal of Alzheimer's Disease, 76, pp. 1541-1551. (doi: 10.3233/JAD-200338)

Wright, A. K., Welsh, P., Gill, J. M.R., Kontopantelis, E., Emsley, R., Buchan, I., Ashcroft, D. M., Rutter, M. K., Sattar, N. (2020) Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia, 63, pp. 1542-1553. (doi: 10.1007/s00125-020-05169-6)

Cigarroa, I., Espinoza, M. J., Lasserre, N., Diaz-Martinez, X., Garrido-Mendez, A., Matus, C., Martinez-Sanguinetti, M. A., Leiva, A. M., Petermann-Rocha, F., Parra, S., Concha-Cisternas, Y., Troncoso-Pantoja, C., Martorell, M., Ulloa, N., Waddell, H., Celis-Morales, C. (2020) Association between walking pace and diabetes: findings from the Chilean National Health Survey 2016-2017. International Journal of Environmental Research and Public Health, 17, (doi: 10.3390/ijerph17155341)

Ouwerkerk, W., Teng, T.-H. K., Tromp, J., Ting Tay, W., Cleland, J. G., van Veldhuisen, D. J., Dickstein, K., Ng, L. L., Lang, C. C., Anker, S. D., Zannad, F., Hung, C.-L., Sawhney, J.P.S., Naik, A., Shimizu, W., Hagiwara, N., Singh Wander, G., Anand, I., Richards, A. M., Voors, A. A., Lam, C. S.P. (2020) Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. European Journal of Heart Failure, 22, pp. 1472-1482. (doi: 10.1002/ejhf.1869)

Lombardi, C. M., Ferreira, J. P., Carubelli, V., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Voors, A., Metra, M. (2020) Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clinical Research in Cardiology, 109, pp. 967-977. (doi: 10.1007/s00392-019-01588-7)

ter Maaten, J. M., Martens, P., Damman, K., Dickstein, K., Ponikowski, P., Lang, C. C., Ng, L. L., Anker, S. D., Samani, N. J., Filippatos, G., Cleland, J. G., Zannad, F., Hillege, H. L., van Veldhuisen, D. J., Metra, M., Voors, A. A., Mullens, W. (2020) Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clinical Research in Cardiology, 109, pp. 1048-1059. (doi: 10.1007/s00392-020-01598-w)

Petermann-Rocha, F., Ho, K. F., Welsh, P., Mackay, D., Brown, R., Gill, J. M.R., Sattar, N., Gray, S. R., Pell, J. P., Celis-Morales, C. A. (2020) Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: a prospective study from UK Biobank. Maturitas, 138, pp. 69-75. (doi: 10.1016/j.maturitas.2020.04.017)

Harris, K., Oshima, M., Sattar, N., Würtz, P., Jun, M., Welsh, P., Hamet, P., Harrap, S., Poulter, N., Chalmers, J., Woodward, M. (2020) Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study. Diabetologia, 63, pp. 1637-1647. (doi: 10.1007/s00125-020-05162-z)

Bomer, N., Grote Beverborg, N., Hoes, M. F., Streng, K. W., Vermeer, M., Dokter, M. M., IJmker, J., Anker, S. D., Cleland, J. G.F., Hillege, H. L., Lang, C. C., Ng, L. L., Samani, N. J., Tromp, J., Veldhuisen, D. J., Touw, D. J., Voors, A. A., Meer, P. (2020) Selenium and outcome in heart failure. European Journal of Heart Failure, 22, pp. 1415-1423. (doi: 10.1002/ejhf.1644)

Connelly, P. J., Jandeleit-Dahm, K. A.M., Delles, C. (2020) Sex and gender aspects in vascular pathophysiology. Clinical Science, 134, pp. 2203-2207. (doi: 10.1042/CS20200876)

Campbell, R. T., Jasilek, A., Mischak, H., Nkuipou-Kenfack, E., Latosinska, A., Welsh, P. I., Jackson, C. E., Cannon, J., McConnachie, A., Delles, C., McMurray, J. J.V. (2020) The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure. ESC Heart Failure, 7, pp. 1595-1604. (doi: 10.1002/ehf2.12708)

O’Reilly, J. E., Blackbourn, L. A. K., Caparrotta, T. M., Jeyam, A., Kennon, B., Leese, G. P., Lindsay, R. S., McCrimmon, R. J., McGurnaghan, S. J., McKeigue, P. M., McKnight, J. A., Petrie, J. R., Philip, S., Sattar, N., Wild, S. H., Colhoun, H. M. (2020) Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017. Diabetologia, 63, pp. 1626-1636. (doi: 10.1007/s00125-020-05173-w)

Demin, A., Løge, B., Zhiteneva, O., Nishida, C., Whiting, S., Rippin, H., Delles, C., Karymbaeva, S., Wickramasinghe, K., Breda, J. (2020) Trans fatty acid elimination policy in member states of the Eurasian Economic Union: implementation challenges and capacity for enforcement. Journal of Clinical Hypertension, 22, pp. 1328-1337. (doi: 10.1111/jch.13945)

Shi, C., van der Wal, H. H., Silljé, H. H.W., Dokter, M. M., van den Berg, F., Huizinga, L., Vriesema, M., Post, J., Anker, S. D., Cleland, J. G., Ng, L. L., Samani, N. J., Dickstein, K., Zannad, F., Lang, C. C., van Haelst, P. L., Gietema, J. A., Metra, M., Ameri, P., Canepa, M., van Veldhuisen, D. J., Voors, A. A., de Boer, R. A. (2020) Tumor biomarkers: association with heart failure outcomes. Journal of Internal Medicine, 288, pp. 207-218. (doi: 10.1111/joim.13053)

Tarar, O. M., Ahmed, K. M., Nishtar, N. A., Achakzai, A. B. K., Gulzar, Y., Delles, C., Al-Jawaldeh, A. (2020) Understanding the complexities of prevalence of trans fat and its control in food supply in Pakistan. Journal of Clinical Hypertension, 22, pp. 1338-1346. (doi: 10.1111/jch.13943)

Dobbie, L. J., Mackin, S. T., Hogarth, K., Lonergan, F., Kannenkeril, D., Brooksbank, K., Delles, C. (2020) Validation of semi-automated flow mediated dilation measurement in healthy volunteers. Blood Pressure Monitoring, 25, pp. 216-223. (doi: 10.1097/MBP.0000000000000448)

Rezende, L. F. M., Murata, E., Giannichi, B., Tomita, L. Y., Wagner, G. A., Sanchez, Z. M., Celis-Morales, C., Ferrari, G. (2020) Cancer cases and deaths attributable to lifestyle risk factors in Chile. BMC Cancer, 20, (doi: 10.1186/s12885-020-07187-4)

Bulluck, H., Carberry, J., Carrick, D., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Mahrous, A., Ford, I., Oldroyd, K. G., Berry, C. (2020) Redefining adverse and reverse left ventricular remodeling by cardiovascular magnetic resonance following ST-segment elevation myocardial infarction and their implications on long-term prognosis. Circulation: Cardiovascular Imaging, 13, (doi: 10.1161/CIRCIMAGING.119.009937)

Sattar, N., Welsh, P. (2020) The obesity paradox in secondary prevention: a weighty intervention or a wait for more evidence? European Heart Journal, 41, pp. 2678-2680. (doi: 10.1093/eurheartj/ehaa398)

Boal, A. H., Gill, J. M.R., Sattar, N. (2020) Shorter sleep: a new potential target to address cardiovascular and metabolic risk? Cardiovascular Research, 116, pp. 1407-1409. (doi: 10.1093/cvr/cvz330)

Cleland, J. G.F., Li, C., Jones, Y. (2020) Artificial intelligence needs clinical intelligence to succeed. JACC: Heart Failure, 8, pp. 588-591. (doi: 10.1016/j.jchf.2020.06.002)

Dobbin, S. J.H., Mangion, K., Berry, C., Roditi, G., Basak, S., Sourbron, S., White, J., Venugopal, B., Touyz, R. M., Jones, R. J., Petrie, M. C., Lang, N. N. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22, pp. 1276-1277. (doi: 10.1002/ejhf.1847)

Pan, D., Pellicori, P., Walklett, C., Green, A., Masse, A. R., Wood, J., Purdy, J., Clark, A. L. (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26, pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002)

Docherty, K. F., Jhund, P. S., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., DeMets, D. L., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Desai, A. S., Diez, M., Howlett, J. G., Katova, T., Ljungman, C. E. A., O’Meara, E., Petrie, M. C., Schou, M., Verma, S., Vinh, P. N., Solomon, S. D., McMurray, J. J.V. (2020) Effects of dapagliflozin in DAPA-HF according to background heart failure therapy. European Heart Journal, 41, pp. 2379-2392. (doi: 10.1093/eurheartj/ehaa183)

Currie, G., Mary, S., Delles, C. (2020) Is there a role for proteomics in diabetic renal disease? NDT Plus, 35, pp. 1133-1135. (doi: 10.1093/ndt/gfz017)

Sattar, N., McInnes, I. B., McMurray, J. J.V. (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142, pp. 4-6. (doi: 10.1161/CIRCULATIONAHA.120.047659)

Taya, U., Wage, R., Newsome, S., Manivarmane, R., Izgi, C., Muthumala, A., Dungu, J. N., Assomull, R., Hatipoglu, S., Halliday, B. P., Lota, A. S., Ware, J. S., Gregson, J., Frenneaux, M., Cook, S. A., Pennell, D. J., Scott, A. D., Cleland, J. G.F., Prasad, S. K. (2020) Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study. European Journal of Heart Failure, 22, pp. 1160-1170. (doi: 10.1002/ejhf.1734)

Hastie, C. E., Mackay, D. F., Ho, F., Celis-Morales, C. A., Katikireddi, S. V., Niedzwiedz, C. L., Jani, B. D., Welsh, P., Mair, F. S., Gray, S. R., O'Donnell, C. A., Gill, J. M.R., Sattar, N., Pell, J. P. (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, pp. 561-565. (doi: 10.1016/j.dsx.2020.04.050)

Cleland, J. G.F., Lyon, A. R., McDonagh, T., McMurray, J. J.V. (2020) The year in cardiology 2019: heart failure. Romanian Journal of Cardiology, 30, pp. 185-204. (doi: 10.47803/rjc.2020.30.2.185)

Livingstone, K. M., Celis-Morales, C., Navas-Carretero, S., San-Cristobal, R., Forster, H., Woolhead, C., O'Donovan, C. B., Moschonis, G., Manios, Y., Traczyk, I., Gundersen, T. E., Drevon, C. A., Marsaux, C. F.M., Fallaize, R., Macready, A. L., Daniel, H., Brennan, L., Martinez, J. A., Mathers, J. C. (2020) Characteristics of participants who benefit most from personalised nutrition: findings from the pan-European Food4Me randomized controlled trial. British Journal of Nutrition, 123, pp. 1396-1405. (doi: 10.1017/S0007114520000653)

Al Ozairi, E., Alsaeed, D., Taliping, D., Jalali, M., El Samad, A., Mashankar, A., Taghadom, E., Guess, N., Gill, J. M.R., Sattar, N., Gray, C., Welsh, P., Gray, S. R. (2020) Protocol for a randomised controlled trial to investigate the effect of home and gym-based resistance exercise training on glycaemic control, body composition and muscle strength. Trials, 21, (doi: 10.1186/s13063-020-04480-2)

Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215)

Ho, F. K., Celis-Morales, C., Gray, S. R., Petermann-Rocha, F., Lyall, D., Mackay, D., Sattar, N., Minnis, H., Pell, J. P. (2020) Child maltreatment and cardiovascular disease: quantifying mediation pathways using UK Biobank. BMC Medicine, 18, (doi: 10.1186/s12916-020-01603-z)

Anker, S. D. et al. (2020) Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) European Heart Journal, 41, pp. 2109-2117. (doi: 10.1093/eurheartj/ehaa461)

Katus, H. A., Cleland, J. G.F., Jaffe, A. S. (2020) Myocardial injury in severe COVID-19 infection. European Heart Journal, 41, pp. 2080-2082. (doi: 10.1093/eurheartj/ehaa447)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. (2020) Agreement and classification performance of malnutrition tools in patients with chronic heart failure. Current Developments in Nutrition, 4, (doi: 10.1093/cdn/nzaa071)

Derakhshan, A. et al. (2020) Association of maternal thyroid function with birth weight: a systematic review and individual-participant data meta-analysis. Lancet Diabetes and Endocrinology, 8, pp. 501-510. (doi: 10.1016/S2213-8587(20)30061-9)

Gedmantaite, A., Celis-Morales, C. A., Ho, F., Pell, J. P., Ratkevicius, A., Gray, S. R. (2020) Associations between diet and handgrip strength: a cross-sectional study from UK Biobank. Mechanisms of Ageing and Development, 189, (doi: 10.1016/j.mad.2020.111269)

Cleland, J. G.F., Clark, R. A., Pellicori, P., Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22, pp. 995-998. (doi: 10.1002/ejhf.1864)

Picone, D. S., Deshpande, R. A., Schultz, M. G., Fonseca, R., Campbell, N. R.C., Delles, C., Hecht-Olsen, M., Schutte, A. E., Stergiou, G., Padwal, R., Zhang, X.-H., Sharman, J. E. (2020) Nonvalidated home blood pressure devices dominate the online marketplace in Australia: major implications for cardiovascular risk management. Hypertension, 75, pp. 1593-1599. (doi: 10.1161/hypertensionaha.120.14719)

Henson, J., Edwardson, C. L., Celis-Morales, C. A., Davies, M. J., Dunstan, D. W., Esliger, D. W., Gill, J., Kazi, A., Khunti, K., King, J., McCarthy, M., Sattar, N., Stensel, D. J., Velayudhan, L., Zaccardi, F., Yates, T. (2020) Predictors of the acute postprandial response to breaking up prolonged sitting. Medicine and Science in Sports and Exercise, 52, pp. 1385-1393. (doi: 10.1249/MSS.0000000000002249)

Niedzwiedz, C. L., O'Donnell, C. A., Jani, B. D., Demou, E., Ho, F. K., Celis-Morales, C., Nicholl, B. I., Mair, F. S., Welsh, P., Sattar, N., Pell, J. P., Katikireddi, S. V. (2020) Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Medicine, 18, (doi: 10.1186/s12916-020-01640-8)

Sama, I. E., Woolley, R. J., Nauta, J. F., Romaine, S. P.R., Tromp, J., ter Maaten, J. M., van der Meer, P., Lam, C. S.P., Samani, N. J., Ng, L. L., Metra, M., Dickstein, K., Anker, S. D., Zannad, F., Lang, C. C., Cleland, J. G.F., van Veldhuisen, D. J., Hillege, H. L., oors, A. A.V. (2020) A network analysis to identify pathophysiological pathways distinguishing ischemic from non-ischemic heart failure. European Journal of Heart Failure, 22, pp. 821-833. (doi: 10.1002/ejhf.1811)

McGovern, A. P., Hogg, M., Shields, B. M., Sattar, N. A., Holman, R. R., Pearson, E. R., Hattersley, A. T., Jones, A. G., Dennis, J. M., MASTERMIND consortium, , Henley, W. E., Lonergan, M., Rodgers, L. R., Hamilton, W. T., Angwin, C., Cruickshank, K. J., Farmer, A. J., Gough, S. C. L., Gray, A. M., Hyde, C., Jennison, C., Walker, M. (2020) Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation. BMJ Open Diabetes Research and Care, 8, (doi: 10.1136/bmjdrc-2020-001238)

Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41, pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415)

Voors, A. A., van Veldhuisen, D. J., Metra, M., Ponikowski, P., Anker, S. D., Filippatos, G., Lang, C. C., Dickstein, K., Ng, L. L., Samani, N. J., Friedrich, A. W., Rienstra, M., Cleland, J. G.F., ter Maaten, J. M., van Goor, H., Santema, B. T., Ravera, A., Sama, I. E. (2020) Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. European Heart Journal, 41, pp. 1810-1817. (doi: 10.1093/eurheartj/ehaa373)

Delles, C., Olfert, M. (2020) Electronic cigarettes: how bad are they for your health? Cardiovascular Research, 116, pp. e64-e66. (doi: 10.1093/cvr/cvaa041)

Welsh, C. E., Celis-Morales, C. A., Ho, F. K., Brown, R., Mackay, D. F., Lyall, D. M., Anderson, J. J., Pell, J. P., Gill, J. M.R., Sattar, N., Welsh, P., Gray, S. R. (2020) Grip strength and walking pace and cardiovascular disease risk prediction in 406,834 UK Biobank participants. Mayo Clinic Proceedings, 95, pp. 879-888. (doi: 10.1016/j.mayocp.2019.12.032)

Medina, I., Petermann-Rocha, F., Waddell, H., Díaz-Martínez, X., Matus-Castillo, C., Cigarroa, I., Concha-Cisternas, Y., Salas-Bravo, C., Martínez-Sanguinetti, M. A., Celis-Morales, C. (2020) Association between different modes of travelling and adiposity in Chilean population: findings from the Chilean National Health Survey 2016–2017. International Journal of Environmental Research and Public Health, 17, (doi: 10.3390/ijerph17103731)

Hayes, S., Forbes, J. F., Celis-Morales, C., Anderson, J., Ferguson, L., Gill, J. M.R., Gray, S., Hastie, C., Iliodromoti, S., Lyall, D., Pellicori, P., Sattar, N., Welsh, C. E., Pell, J. (2020) Association between walking pace and stroke incidence: findings from the UK Biobank prospective cohort study. Stroke, 51, pp. 1388-1395. (doi: 10.1161/STROKEAHA.119.028064)

Sattar, N., McMurray, J. J.V., Cheng, A. (2020) Cardiorenal risk reduction guidance in diabetes: can we reach consensus? Lancet Diabetes and Endocrinology, 8, pp. 357-360. (doi: 10.1016/S2213-8587(20)30062-0)

Maznyczka, A. M., Oldroyd, K. G., Greenwood, J. P., McCartney, P. J., Cotton, J., Lindsay, M., McEntegart, M., Rocchiccioli, J. P., Good, R., Robertson, K., Eteiba, H., Watkins, S., Shaukat, A., Petrie, C. J., Murphy, A., Petrie, M. C., Berry, C. (2020) Comparative significance of invasive measures of microvascular injury in acute myocardial infarction. Circulation: Cardiovascular Interventions, 13, (doi: 10.1161/CIRCINTERVENTIONS.119.008505)

Stienen, S., Ferreira, J. P., Pitt, B., Cleland, J. G., Pellicori, P., Girerd, N., Rossignol, P., Zannad, F. (2020) Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure. European Journal of Heart Failure, 22, pp. 901-903. (doi: 10.1002/ejhf.1812)

Fudim, M., Dalgaard, F., Al-Khatib, S. M., J. Friedman, D., Lallinger, K., Abraham, W. T., Cleland, J. G.F., Curtis, A. B., Gold, M. R., Kutyifa, V., Linde, C., Schaber, D. E., Tang, A., Ali-Ahmed, F., Goldstein, S. A., Kaufman, B., Fortman, R., Davis, J. K., Inoue, L. Y.T., Sanders, G. D. (2020) Future research prioritization in cardiac resynchronization therapy. American Heart Journal, 223, pp. 48-58. (doi: 10.1016/j.ahj.2020.02.011)

Cosentino, F. et al. (2020) Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD) [2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD] Revista Española de Cardiología, 73, pp. 404.e1-404.e59. (doi: 10.1016/j.recesp.2019.11.024)

Hawkins, N. M., Osmanska, J., Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22, pp. 868-870. (doi: 10.1002/ejhf.1803)

Cunningham, J. W., Ferreira, J. P., Deng, H., Anker, S. D., Byra, W. M., Cleland, J. G.F., Gheorghiade, M., Lam, C. S.P., La Police, D., Mehra, M. R., Neaton, J. D., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B., Zannad, F. (2020) Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: insights from COMMANDER HF. JACC: Heart Failure, 8, pp. 359-368. (doi: 10.1016/j.jchf.2019.12.009)

Hennigan, B., Berry, C., Collison, D., Corcoran, D., Eteiba, H., Good, R., McEntegart, M., Watkins, S., McClure, J., Mangion, K., Ford, T., Petrie, M. C., Hood, S., Rocchiccioli, P., Shaukat, A., Lindsay, M., Oldroyd, K. G. (2020) Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial. Heart, 106, pp. 714-715. (doi: 10.1136/heartjnl-2019-316075)

Docherty, K. F., Ferreira, J. P., Sharma, A., Girerd, N., Gregson, J., Duarte, K., Petrie, M. C., Jhund, P. S., Dickstein, K., Pfeffer, M. A., Pitt, B., Rossignol, P., Zannad, F., McMurray, J. J.V. (2020) Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. European Journal of Heart Failure, 22, pp. 848-855. (doi: 10.1002/ejhf.1694)

Malik, M. E., Madelaire, C., D'Souza, M., Blanche, P., Kristensen, S. L., Kistorp, C., Gustafsson, F., Køber, L., Rørth, R., McMurray, J., Sattar, N., Gislason, G., Torp-Pedersen, C., Schou, M. (2020) Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease. European Journal of Heart Failure, 22, pp. 813-820. (doi: 10.1002/ejhf.1819)

Quint, J. K., Rajagopalan, S., Cleland, J. G.F., Simon, D. I., Banerjee, A., Briere, J.-B., Bowrin, K., Cohen, A., Halcox, J., Zakeri, R., Bloom, C., Sundaram, V. (2020) Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015. European Heart Journal, 41, pp. 1636-1649. (doi: 10.1093/eurheartj/ehz880)

Anderson, J. J., Gray, S. R., Welsh, P., Mackay, D. F., Celis-Morales, C. A., Lyall, D. M., Forbes, J., Sattar, N., Gill, J. M.R., Pell, J. P. (2020) The associations of sugar-sweetened, artificially sweetened and naturally sweet juices with all-cause mortality in 198,285 UK Biobank participants: a prospective cohort study. BMC Medicine, 18, (doi: 10.1186/s12916-020-01554-5)

Siedlinski, M., Jozefczuk, E., Xu, X., Teumer, A., Evangelou, E., Schnabel, R. B., Welsh, P., Maffia, P., Erdmann, J., Tomaszewski, M., Caulfield, M. J., Sattar, N., Holmes, M. V., Guzik, T. J. (2020) White blood cells and blood pressure: a Mendelian randomization study. Circulation, 141, pp. 1307-1317. (doi: 10.1161/CIRCULATIONAHA.119.045102)

Petrie, M. C., et al. (2020) Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes. JAMA: Journal of the American Medical Association, 323, pp. 1353-1368. (doi: 10.1001/jama.2020.1906)

White, S. L., Begum, S., Vieira, M. C., Seed, P., Lawlor, D. L., Sattar, N., Nelson, S. M., Welsh, P., Pasupathy, D., Poston, L., on behalf of UPBEAT Consortium, (2020) Metabolic phenotyping by treatment modality in obese women with gestational diabetes suggests diverse pathophysiology: An exploratory study. PLoS ONE, 15, (doi: 10.1371/journal.pone.0230658)

Sattar, N. (2020) Type 2 diabetes-related sex differences in cardiovascular risk: reasons, ramifications and clinical realities. European Heart Journal, 41, pp. 1354-1356. (doi: 10.1093/eurheartj/ehz914)

Delles, C., Li, H., Touyz, R. M. (2020) ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Clinical Science, 134, pp. 747-750. (doi: 10.1042/CS20200363)

Pandhi, P., Maaten, J. M., Emmens, J. E., Struck, J., Bergmann, A., Cleland, J. G., Givertz, M. M., Metra, M., O'Connor, C. M., Teerlink, J. R., Ponikowski, P., Cotter, G., Davison, B., Veldhuisen, D. J., Voors, A. A. (2020) Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. European Journal of Heart Failure, 22, pp. 683-691. (doi: 10.1002/ejhf.1693)

Tofte, N. et al. (2020) Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial. Lancet Diabetes and Endocrinology, 8, pp. 301-312. (doi: 10.1016/S2213-8587(20)30026-7)

Simpson, J., Jhund, P. S., Lund, L. H., Padmanabhan, S., Clagget, B. L., Shen, L., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Kober, L., Paker, M., Rouleau, J. L., Mueller-Velten, G., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2020) Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the Swedish Heart Failure Registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiology, 5, pp. 432-441. (doi: 10.1001/jamacardio.2019.5850)

Zhyzhneuskaya, S. V., Al-Mrabeh, A., Peters, C., Barnes, A., Aribisala, B., Hollingsworth, K. G., McConnachie, A., Sattar, N., Lean, M. E.J., Taylor, R. (2020) Time course of normalization of functional β-cell capacity in the Diabetes Remission Clinical Trial after weight loss in type 2 diabetes. Diabetes Care, 43, pp. 813-820. (doi: 10.2337/dc19-0371)

Wehner, G. J., Jing, L., Haggerty, C. M., Suever, J. D., Leader, J. B., Hartzel, D. N., Kirchner, H. L., Manus, J. N.A., James, N., Ayar, Z., Gladding, P., Good, C. W., Cleland, J. G.F., Fornwalt, B. K. (2020) Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? European Heart Journal, 41, pp. 1249-1257. (doi: 10.1093/eurheartj/ehz550)

Cleland, J. G.F., Lyon, A. R., McDonagh, T., McMurray, J. J.V. (2020) The year in cardiology: heart failure. European Heart Journal, 41, pp. 1232-1248. (doi: 10.1093/eurheartj/ehz949)

Welsh, C., Celis-Morales, C. A., Ho, F., Lyall, D. M., Mackay, D., Ferguson, L., Sattar, N., Gray, S. R., Gill, J. M.R., Pell, J. P., Welsh, P. (2020) Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study. British Medical Journal, 368, (doi: 10.1136/bmj.m336)

Zijlstra, L. E., Trompet, S., Mooijaart, S. P., van Buren, M., Sattar, N., Stott, D. J., Jukema, J. W. (2020) The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis. BMC Nephrology, 21, (doi: 10.1186/s12882-020-01745-5)

Kolovos, S., Finch, A. P., van der Ploeg, H. P., van Nassau, F., Broulikova, H. M., Baka, A., Treweek, S., Gray, C. M., Jelsma, J. G.M., Bunn, C., Roberts, G. C., Silva, M. N., Gill, J. M.R., Røynesdal, Ø., van Mechelen, W., Andersen, E., Hunt, K., Wyke, S., Bosmans, J. E. (2020) Five-year cost-effectiveness analysis of the European Fans in Training (EuroFIT) physical activity intervention for men versus no intervention. International Journal of Behavioral Nutrition and Physical Activity, 17, (doi: 10.1186/s12966-020-00934-7)

Ho, F. K., Gray, S. R., Welsh, P., Petermann-Rocha, F., Foster, H., Waddell, H., Anderson, J., Lyall, D., Sattar, N., Gill, J. M.R., Mathers, J. C., Pell, J. P., Celis-Morales, C. (2020) Associations of fat and carbohydrate intake with cardiovascular disease and mortality: prospective cohort study of UK Biobank participants. British Medical Journal, 368, (doi: 10.1136/bmj.m688)

Petermann-Rocha, F., Chen, M., Gray, S. R., Ho, F. K., Pell, J. P., Celis-Morales, C. (2020) Factors associated with sarcopenia: a cross-sectional analysis using UK Biobank. Maturitas, 133, pp. 60-67. (doi: 10.1016/j.maturitas.2020.01.004)

Lee, M. M.Y., Petrie, M. C., McMurray, J. J.V., Sattar, N. (2020) How do SGLT2 (sodium-glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists reduce cardiovascular outcomes? Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 506-522. (doi: 10.1161/atvbaha.119.311904)

Sattar, N., Gill, J. M.R., Alazawi, W. (2020) Improving prevention strategies for cardiometabolic disease. Nature Medicine, 26, pp. 320-325. (doi: 10.1038/s41591-020-0786-7)

Jarvie, E., Stewart, F., Ramsay, J. E., Brown, E. A., Meyer, B., Olivecrona, G., Griffin, B., Freeman, D. (2020) Maternal adipose tissue expansion, a missing link in the prediction of birth weight centile. Journal of Clinical Endocrinology and Metabolism, 105, pp. e814-e825. (doi: 10.1210/clinem/dgz248)

Petermann Rocha, F., Chen, M., Gray, S. R., Ho, F. K., Pell, J. P., Celis Morales, C. (2020) New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes? Age and Ageing, 49, pp. 300-304. (doi: 10.1093/ageing/afz126)

Tromp, J., Bamadhaj, S., Cleland, J. G.F., Angermann, C. E., Dahlstrom, U., Ouwerkerk, W., Tay, W. T., Dickstein, K., Ertl, G., Hassanein, M., Hu, D., Perrone, S. V., Ghadanfar, M., Schweizer, A., Obergfell, A., Lam, C. S.P., Filippatos, G., Collins, S. P. (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Global Health, 8, pp. e411-e422. (doi: 10.1016/S2214-109X(20)30004-8)

Docherty, K. F., Shen, L., Castagno, D., Petrie, M. C., Abraham, W. T., Böhm, M., Desai, A. S., Dickstein, K., Køber, L. V., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Vazir, A., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2020) Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. European Journal of Heart Failure, 22, pp. 528-538. (doi: 10.1002/ejhf.1682)

Ferrari, G. L. d. M., Kovalskys, I., Fisberg, M., Gómez, G., Rigotti, A., Cortés Sanabria, L. Y., Yépez García, M. C., Pareja Torres, R. G., Herrera-Cuenca, M., Zimberg, I. Z., Guajardo, V., Pratt, M., Gonçalves, P. B., Rosales-Salas, J., Cristi-Montero, C., Rodríguez-Rodríguez, F., Waddell, H., Petermann R., F., Celis-Morales, C. A., Chaput, J.-P., Scholes, S., Solé, D. (2020) Socio-demographic patterns of public, private and active travel in Latin America: cross-sectional findings from the ELANS study. Journal of Transport and Health, 16, (doi: 10.1016/j.jth.2019.100788)

Santema, B. T., Chan, M. M.Y., Tromp, J., Dokter, M., van der Wal, H. H., Emmens, J. E., Takens, J., Samani, N. J., Ng, L. L., Lang, C. C., van der Meer, P., ter Maaten, J. M., Damman, K., Dickstein, K., Cleland, J. G., Zannad, F., Anker, S. D., Metra, M., van der Harst, P., de Boer, R. A., van Veldhuisen, D. J., Rienstra, M., Lam, C. S.P., Voors, A. A. (2020) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clinical Research in Cardiology, 109, pp. 331-338. (doi: 10.1007/s00392-019-01513-y)

Serenelli, M., Jackson, A., Dewan, P., Jhund, P. S., Petrie, M. C., Rossignol, P., Campo, G., Pitt, B., Zannad, F., Ferreira, J. P., McMurray, J. J.V. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8, pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011)

Rorth, R., Jhund, P. S., Yilmaz, M. B., Kristensen, S. L., Welsh, P., Desai, A. S., Køber, L., Prescott, M. F., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., McMurray, J. J.V. (2020) Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction. Circulation: Heart Failure, 13, (doi: 10.1161/CIRCHEARTFAILURE.119.006541)

Maznyczka, A. M., McCartney, P. J., Oldroyd, K. G., Lindsay, M., McEntegart, M., Eteiba, H., Rocchiccioli, P., Good, R., Shaukat, A., Robertson, K., Kodoth, V., Greenwood, J. P., Cotton, J. M., Hood, S., Watkins, S., Macfarlane, P. W., Kennedy, J., Tait, C., Welsh, P., Sattar, N., Collison, D., Gillespie, L., McConnachie, A., Berry, C. (2020) Effects of intracoronary alteplase on microvascular function in acute myocardial infarction. Journal of the American Heart Association, 9, (doi: 10.1161/JAHA.119.014066)

Al-Mrabeh, A., Zhyzhneuskaya, S. V., Peters, C., Barnes, A. C., Melhem, S., Jesuthasan, A., Aribisala, B., Hollingsworth, K. G., Lietz, G., Mathers, J. C., Sattar, N., Lean, M. E.J., Taylor, R. (2020) Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metabolism, 31, pp. 233-249.e4. (doi: 10.1016/j.cmet.2019.11.018)

Cameron, A. C., Welsh, P., Neves, K. B., Newby, D., Touyz, R. M., Lang, N. (2020) Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation. Journal of Hypertension, 38, pp. 257-265. (doi: 10.1097/HJH.0000000000002230)

Garton, M., McInnes, I. B., Sattar, N. (2020) Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis. Rheumatology, 59, pp. 453-454. (doi: 10.1093/rheumatology/kez613)

Rankin, A. J., Allwood-Spiers, S., Lee, M. M.Y., Zhu, L., Woodward, R., Kuehn, B., Radjenovic, A., Sattar, N., Roditi, G., Mark, P. B., Gillis, K. A. (2020) Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients. Magnetic Resonance Materials in Physics, Biology and Medicine, 33, pp. 103-112. (doi: 10.1007/s10334-019-00809-4)

Crouch, S. H., Botha-Le Roux, S., Delles, C., Graham, L. A., Schutte, A. E. (2020) Distinct inflammatory mediator patterns in young black and white adults: The African-PREDICT study. Cytokine, 126, (doi: 10.1016/j.cyto.2019.154894)

Seferović, P. M. et al. (2020) European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure. European Journal of Heart Failure, 22, pp. 196-213. (doi: 10.1002/ejhf.1673)

Witard, O. C., Combet, E., Gray, S. R. (2020) Long-chain n-3 fatty acids as an essential link between musculoskeletal and cardio-metabolic health in older adults. Proceedings of the Nutrition Society, 79, pp. 47-55. (doi: 10.1017/S0029665119000922)

Bégué, C., Mörner, S., Brito, D., Hengstenberg, C., Cleland, J. G.F., Arbustini, E., Galve, E., Wichter, T., Richter, A., Golmard, J.-L., Bernard, M., Dubourg, O., Komajda, M., Charron, P., Isnard, R. (2020) Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy. Heart, 106, pp. 196-202. (doi: 10.1136/heartjnl-2019-314826)

Maznyczka, A. M. et al. (2020) One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention. The T-TIME randomized trial. Circulation: Cardiovascular Interventions, 13, (doi: 10.1161/CIRCINTERVENTIONS.119.008855)

Ford, T. J., Khan, A., Docherty, K. F., Jackson, A., Morrow, A., Sidik, N., Rocchiccioli, P., Good, R., Eteiba, H., Watkins, S., Shaukat, A., Lindsay, M., Robertson, K., Petrie, M., Berry, C., Oldroyd, K., McEntegart, M. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95, pp. 232-241. (doi: 10.1002/ccd.28373)

Sillars, A., Ho, F. K., Pell, J. P., Gill, J. M.R., Sattar, N., Gray, S., Celis-Morales, C. (2020) Sex differences in the association of risk factors for heart failure incidence and mortality. Heart, 106, pp. 203-212. (doi: 10.1136/heartjnl-2019-314878)

Schlosser, K., Kaur, A., Dayan, N., Stewart, D. J., Pilote, L., Delles, C. (2020) Circulating miR-206 and Wnt-signaling are associated with cardiovascular complications and a history of preeclampsia in women. Clinical Science, 134, pp. 87-101. (doi: 10.1042/CS20190920)

Welsh, C., Welsh, P., Celis Morales, C. A., Mark, P., Mackay, D., Ghouri, N., Ho, F., Ferguson, L. D., Brown, R., Lewsey, J., Cleland, J. G., Gray, S. R., Lyall, D. M., Anderson, J., Jhund, P. S., Pell, J., McGuire, D. K., Gill, J. M.R., Sattar, N. (2020) Glycated hemoglobin, prediabetes and the links to cardiovascular disease: data from UK Biobank. Diabetes Care, 43, pp. 440-445. (doi: 10.2337/dc19-1683)

Kosiborod, M. N., Jhund, P., Docherty, K. F., Diez, M., Petrie, M. C., Verma, S., Nicolau, J. C., Merkely, B., Kitakaze, M., DeMets, D. L., Inzucchi, S. E., Køeber, L., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., Bengtsson, O., Lindholm, D., Niklasson, A., Sjöstrand, M., Langkilde, A. M., McMurray, J. J.V. (2020) Effects of dapagliflozin on symptoms, function and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial. Circulation, 141, pp. 90-99. (doi: 10.1161/CIRCULATIONAHA.119.044138)

Martinez, F. A., Serenelli, M., Nicolau, J. C., Petrie, M. C., Chiang, C.-E., Tereshchenko, S., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Ponikowski, P., Sabatine, M. S., DeMets, D. L., Dutkiewicz-Piasecka, M., Bengtsson, O., Sjöstrand, M., Langkilde, A. M., Jhund, P., McMurray, J. J.V. (2020) Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age: insights from DAPA-HF. Circulation, 141, pp. 100-111. (doi: 10.1161/CIRCULATIONAHA.119.044133)

Ford, T. J., Stanley, B., Sidik, N., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., Yii, E., McCartney, P., Corcoran, D., Collison, D., Rush, C., Sattar, N., McConnachie, A., Touyz, R. M., Oldroyd, K. G., Berry, C. (2020) 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA) JACC: Cardiovascular Interventions, 13, pp. 33-45. (doi: 10.1016/j.jcin.2019.11.001)

Shah, S. et al. (2020) Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nature Communications, 11, (doi: 10.1038/s41467-019-13690-5)

Filippatos, G., Angermann, C. E., Cleland, J. G.F., Lam, C. S.P., Dahlström, U., Dickstein, K., Ertl, G., Hassanein, M., Hart, K. W., Lindsell, C. J., Perrone, S. V., Guerin, T., Ghadanfar, M., Schweizer, A., Obergfell, A., Collins, S. P. (2020) Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiology, 5, pp. 401-410. (doi: 10.1001/jamacardio.2019.5108)

Wheeler, D. C. et al. (2020) 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal, 41, pp. 255-323. (doi: 10.1093/eurheartj/ehz486)

Shivakumar, O., Sattar, N., Wheeler, D. C. (2020) Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease. Nephrology Dialysis Transplantation, 35, pp. i43-i47. (doi: 10.1093/ndt/gfz292)

Ferreira, J. P., Ouwerkerk, W., Tromp, J., Ng, L., Dickstein, K., Anker, S., Filippatos, G., Cleland, J. G., Metra, M., van Veldhuisen, D. J., Voors, A. A., Zannad, F. (2020) Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study. European Journal of Heart Failure, 22, pp. 81-89. (doi: 10.1002/ejhf.1654)

Giles, J. T., Sattar, N., Gabriel, S., Ridker, P. M., Gay, S., Warne, C., Musselman, D., Brockwell, L., Shittu, E., Klearman, M., Fleming, T. R. (2020) Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis and Rheumatology, 72, pp. 31-40. (doi: 10.1002/art.41095)

Pellicori, P., Cleland, J. G.F., Clark, A. L. (2020) Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Failure Clinics, 16, pp. 33-44. (doi: 10.1016/j.hfc.2019.08.003)

Muilwijk, M., Goorden, S. M.I., Celis-Morales, C., Hof, M. H., Ghauharali-van der Vlugt, K., Beers-Stet, F. S., Gill, J. M.R., Vaz, F. M., van Valkengoed, I. G.M. (2020) Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults. BMJ Open Diabetes Research and Care, 8, (doi: 10.1136/bmjdrc-2019-001003)

Lim, S., Oh, T. J., Dawson, J., Sattar, N. (2020) Diabetes drugs and stroke risk: intensive versus conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trials. Diabetes, Obesity and Metabolism, 22, pp. 6-15. (doi: 10.1111/dom.13850)

Nikolaidou, T., Samuel, N. A., Marincowitz, C., Fox, D. J., Cleland, J. G.F., Clark, A. L. (2020) Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: a systematic review and meta‐analysis. Annals of Noninvasive Electrocardiology, 25, (doi: 10.1111/anec.12710)

Kobayashi, M., Voors, A. A., Girerd, N., Billotte, M., Anker, S. D., Cleland, J. G., Lang, C. C., Ng, L. L., van Veldhuisen, D. J., Dickstein, K., Metra, M., Duarte, K., Rossignol, P., Zannad, F., Ferreira, J. P. (2020) Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. European Journal of Internal Medicine, 71, pp. 62-69. (doi: 10.1016/j.ejim.2019.10.017)

Pellicori, P., Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L., Cleland, J. G.F. (2020) High sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116, pp. 91-100. (doi: 10.1093/cvr/cvz198)

Yates, T., Edwardson, C. L., Celis-Morales, C., Biddle, S. J.H., Bodicoat, D., Davies, M. J., Esliger, D., Henson, J., Kazi, A., Khunti, K., Sattar, N., Sinclair, A. J., Rowlands, A., Velayudhan, L., Zaccardi, F., Gill, J. M.R. (2020) Metabolic effects of breaking prolonged sitting with standing or light walking in older South Asians and White Europeans: a randomized acute study. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 75, pp. 139-146. (doi: 10.1093/gerona/gly252)

Pellicori, P., Khan, M. J. I., Graham, F. J., Cleland, J. G.F. (2020) New perspectives and future directions in the treatment of heart failure. Heart Failure Reviews, 25, pp. 147-159. (doi: 10.1007/s10741-019-09829-7)

Cao, T. H., Jones, D. J.L., Voors, A. A., Quinn, P. A., Sandhu, J. K., Chan, D. C.S., Parry, H. M., Mohan, M., Mordi, I. R., Sama, I. E., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Lang, C. C., Ng, L. L. (2020) Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. European Journal of Heart Failure, 22, pp. 70-80. (doi: 10.1002/ejhf.1608)

Anker, M. S., Hülsmann, M., Cleland, J. G. (2020) What do patients with heart failure die from? A single assassin or a conspiracy? European Journal of Heart Failure, 22, pp. 26-28. (doi: 10.1002/ejhf.1689)

Robertson, J., Lindgren, M., Schaufelberger, M., Adiels, M., Björck, L., Lundberg, C. E., Sattar, N., Rosengren, A., Åberg, M. (2020) Body Mass Index in young women and risk of cardiomyopathy: a long-term follow-up study in Sweden. Circulation, 141, pp. 520-529. (doi: 10.1161/CIRCULATIONAHA.119.044056)

Mary, S., Currie, G., Schutte, A. E., Delles, C. (2020) Cardiovascular proteomics. Academic Press

Heggie, R., Wu, O., Boyd, K., Lee, M. M.Y., Petrie, M. C., McEntegart, M., Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes.

Rey-Lopez, J. P., Ho, F. K.W., Foster, H. M.E., Petermann-Rocha, F., Sattar, N., Pell, J. P., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A. (2020) Does the association between physical capability and mortality differ by deprivation? Findings from the UK Biobank population-based cohort study. Journal of Sports Sciences, 38, pp. 2732-2739. (doi: 10.1080/02640414.2020.1797438)

Marshall-Mckenna, R., Campbell, E., Ho, F., Banger, M., Rowe, P., McAlpine, C., McArthur, K., Quinn, T. J., Gray, S. R. (2020) Feasibility of resistance exercise to failure at different loads in frail and healthy older adults?

Coll, A. P. et al. (2020) GDF15 mediates the effects of metformin on body weight and energy balance. Nature, 578, pp. 444-448. (doi: 10.1038/s41586-019-1911-y)

Israr, M. Z. et al. (2020) Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF. European Journal of Heart Failure, 22, pp. 1486-1490. (doi: 10.1002/ejhf.1951)

McCartney, P. J., Maznyczka, A. M., Eteiba, H., McEntegart, M., Oldroyd, K. G., Greenwood, J. P., Mareida, N., Schmitt, M., McCann, G. P., Fairbairn, T., McAlindon, E., Tait, C., Welsh, P., Sattar, N., Orchard, V., Corcoran, D., Ford, T. J., Radjenovic, A., Ford, I., McConnachie, A., Berry, C. (2020) Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time. Journal of the American College of Cardiology, 75, pp. 1406-1421. (doi: 10.1016/j.jacc.2020.01.041)

Henson, J., Edwardson, C. L., Davies, M. J., Gill, J. M.R., Heaney, L. M., Khunti, K., Ng, L., Sattar, N., Zaccardi, F., Yates, T. (2020) Physical activity and lipidomics in a population at high risk of type 2 diabetes mellitus. Journal of Sports Sciences, 38, pp. 1150-1160. (doi: 10.1080/02640414.2020.1744836)

Donnachie, C., Hunt, K., Mutrie, N., Gill, J. M.R., Kelly, P. (2020) Responsiveness of device-based and self-report measures of physical activity to detect behaviour change in men taking part in the Football Fans in Training (FFIT) programme. Journal for the Measurement of Physical Behaviour, 3, pp. 67-77. (doi: 10.1123/jmpb.2019-0018)

Ferrari, G. L. d. M., Kovalskys, I., Fisberg, M., Gómez, G., Rigotti, A., Sanabria, L. Y. C., García, M. C. Y., Torres, R. G. P., Herrera-Cuenca, M., Zimberg, I. Z., Guajardo, V., Pratt, M., Cristi-Montero, C., Rodríguez-Rodríguez, F., Scholes, S., Celis-Morales, C. A., Chaput, J.-P., Solé, D. (2020) Socio-demographic patterning of objectively measured physical activity and sedentary behaviours in eight Latin American countries: findings from the ELANS study. European Journal of Sport Science, 20, pp. 670-681. (doi: 10.1080/17461391.2019.1678671)

Thom, G., Gerasimidis, K., Rizou, E., Alfheeaid, H., Barwell, N., Manthou, E., Fatima, S., Gill, J. M.R., Lean, M. E.J., Malkova, D. (2020) Validity of predictive equations to estimate RMR in females with varying BMI. Journal of Nutritional Science, 9, (doi: 10.1017/jns.2020.11)

2019

Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J.V., Wikstrand, J., Anker, S. D., van Veldhuisen, D. J., Manzano, L., von Lueder, T. G., Rigby, A. S., Andersson, B., Kjekshus, J., Wedel, H., Ruschitzka, F., Cleland, J. G.F., Damman, K., Redon, J., Coats, A. J.S. (2019) Impact of renal impairment on beta-blocker efficacy in patients with heart failure. Journal of the American College of Cardiology, 74, pp. 2893-2904. (doi: 10.1016/j.jacc.2019.09.059)

Dewan, P., Rorth, R., Raparelli, V., Campbell, R. T., Shen, L., Jhund, P. S., Petrie, M. C., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Køber, L., Komajda, M., McKelvie, R. S., O'Meara, E., Pfeffer, M. A., Pitt, B., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Sex-related differences in heart failure with preserved ejection fraction. Circulation: Heart Failure, 12, (doi: 10.1161/CIRCHEARTFAILURE.119.006539)

Neves, K. B., Harvey, A. P., Moreton, F., Montezano, A. C., Rios, F. J., Alves-Lopes, R., Nguyen Dinh Cat, A., Rocchiccioli, P., Delles, C., Joutel, A., Muir, K., Touyz, R. M. (2019) ER stress and Rho kinase activation underlie the vasculopathy of CADASIL. JCI Insight, 4, (doi: 10.1172/jci.insight.131344)

Ferguson, L. D., Brown, R., Celis-Morales, C., Welsh, P., Lyall, D. M., Pell, J. P., McInnes, I. B., Siebert, S., Sattar, N. (2019) Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank. Rheumatology, 58, pp. 2137-2142. (doi: 10.1093/rheumatology/kez192)

Badjatiya, A., Merrill, P., Buse, J. B., Goodman, S. G., Katona, B., Iqbal, N., Pagidipati, N. J., Sattar, N., Holman, R. R., Hernandez, A. F., Mentz, R. J., Patel, M. R., Jones, W. S. (2019) Clinical outcomes in patients with type 2 diabetes mellitus and peripheral artery disease. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.008018)

Connelly, P. J., Freel, E. M., Perry, C., Ewan, J., Touyz, R. M., Currie, G., Delles, C. (2019) Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults. Hypertension, 74, pp. 1266-1274. (doi: 10.1161/HYPERTENSIONAHA.119.13080)

Eastwood, S. V., Chaturvedi, N., Sattar, N., Welsh, P. I., Hughes, A. D., Tillin, T. (2019) Impact of kidney function on cardiovascular risk and mortality: a comparison of South Asian and European cohorts. American Journal of Nephrology, 50, pp. 425-433. (doi: 10.1159/000503873)

Ford, T. J., Yii, E., Sidik, N., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., Eteiba, H., Shaukat, A., Lindsay, M., Robertson, K., Hood, S., McGeoch, R., McDade, R., McCartney, P., Corcoran, D., Collison, D., Rush, C., Stanley, B., McConnachie, A., Sattar, N., Touyz, R. M., Oldroyd, K. G., Berry, C. (2019) Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.008126)

Cheung, S. M., Keenan, K., Senn, N., Hutcheon, G., Chan, K., Erwig, L., Schrepf, A., Dospinescu, P., Gray, S., Waiter, G., He, J., Basu, N. (2019) Metabolic and structural skeletal muscle health in systemic lupus erythematosus related fatigue: a multi-modal magnetic resonance imaging study. Arthritis Care and Research, 71, pp. 1640-1646. (doi: 10.1002/acr.23833)

Johnson, M. J., Cockayne, S., Currow, D. C., Bell, K., Hicks, K., Fairhurst, C., Gabe, R., Torgerson, D., Jefferson, L., Oxberry, S., Ghosh, J., Hogg, K. J., Murphy, J., Allgar, V., Cleland, J. G.F., Clark, A. L. (2019) Oral modified release morphine for breathlessness in chronic heart failure: a randomised placebo-controlled trial. ESC Heart Failure, 6, pp. 1149-1160. (doi: 10.1002/ehf2.12498)

Cameron, A. C., Lang, N. N., Dominiczak, A. F., Jennings, G. L.R., Batlle, D., Bursztyn, M., Chugh, A. R., Floras, J. S., Taler, S. J., Touyz, R. M., Delles, C. (2019) Progressive hypertension and severe left ventricular outflow tract obstruction. Hypertension, 74, pp. 1216-1225. (doi: 10.1161/hypertensionaha.119.13343)

Sharma, V. et al. (2019) Report from the Annual Conference of the British Society of Echocardiography, November 2017, Edinburgh International Conference Centre, Edinburgh. Echo Research and Practice, 6, pp. M1-M2. (doi: 10.1530/ERP-19-0056)

Sillars, A., Sattar, N. (2019) Management of lipid abnormalities in patients with diabetes. Current Cardiology Reports, 21, (doi: 10.1007/s11886-019-1246-1)

Mehra, M. R., Vaduganathan, M., Fu, M., Ferreira, J. P., Anker, S. A., Cleland, J. G.F., Lam, C. S.P., van Veldhuisen, D. J., Byra, W. M., Spiro, T., Deng, H., Zannad, F., Greenberg, B. (2019) A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. European Heart Journal, 40, pp. 3593-3602. (doi: 10.1093/eurheartj/ehz427)

McMurray, J. J.V. et al. (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine, 381, pp. 1995-2008. (doi: 10.1056/NEJMoa1911303)

Tillin, T., Tuson, C., Sowa, B., Chattopadhyay, K., Sattar, N., Welsh, P., Roberts, I., Ebrahim, S., Kinra, S., Hughes, A., Chaturvedi, N. (2019) Yoga and Cardiovascular Health Trial (YACHT): a UK-based randomised mechanistic study of a yoga intervention plus usual care versus usual care alone following an acute coronary event. BMJ Open, 9, (doi: 10.1136/bmjopen-2019-030119)

Sillars, A., Celis-Morales, C. A., Ho, F., Petermann, F., Welsh, P., Iliodromiti, S., Ferguson, L. D., Lyall, D. M., Anderson, J., Mackay, D., Pellicori, P., Cleland, J., Pell, J. P., Gill, J. M.R., Gray, S. R., Sattar, N. (2019) Association of fitness and grip-strength with heart failure: findings from the UK Biobank population-based study. Mayo Clinic Proceedings, 94, pp. 2230-2240. (doi: 10.1016/j.mayocp.2019.04.041)

Steell, L., Ho, F. K., Sillars, A., Petermann, F., Li, H., Lyall, D. M., Iliodromiti, S., Welsh, P., Anderson, J., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R., Celis-Morales, C. A. (2019) Dose-response associations of cardiorespiratory fitness with all-cause mortality and incidence and mortality of cancer and cardiovascular and respiratory diseases: the UK Biobank cohort study. British Journal of Sports Medicine, 53, pp. 1371-1378. (doi: 10.1136/bjsports-2018-099093)

Ferguson, L., Welsh, P., Brown, R., Tindell, A., Kerrigan, S., Sattar, N., McInnes, I., Siebert, S. (2019) Effect of Phosphodiesterase 4 Inhibition with Apremilast on Cardiometabolic Outcomes in Psoriatic Arthritis – Initial Results from the Immune Metabolic Associations in Psoriatic Arthritis (IMAPA) Study.

Lees, J. S., Welsh, C. E., Celis-Morales, C. A., Mackay, D., Lewsey, J., Gray, S. R., Lyall, D. M., Cleland, J. G., Gill, J. M.R., Jhund, P. S., Pell, J., Sattar, N., Welsh, P., Mark, P. B. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8)

Beusekamp, J. C., Tromp, J., Cleland, J. G.F., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Ouwerkerk, W., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2019) Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality. JACC: Heart Failure, 7, pp. 970-979. (doi: 10.1016/j.jchf.2019.07.010)

Pellicori, P., Urbinati, A., Kaur, K., Zhang, J., Shah, P., Kazmi, S., Capucci, A., Cleland, J. G.F., Clark, A. L. (2019) Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. American Journal of Cardiology, 124, pp. 1554-1560. (doi: 10.1016/j.amjcard.2019.08.018)

Sattar, N., Preiss, D. (2019) Research digest: new horizons in heart failure therapy. Lancet Diabetes and Endocrinology, 7, pp. 832. (doi: 10.1016/S2213-8587(19)30315-8)

Conrad, N., Judge, A., Canoy, D., Tran, J., Pinho-Gomes, A. C., Millett, E. R.C., Salimi-Khorshidi, G., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2019) Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86 000 individuals. JAMA Cardiology, 4, pp. 1102-1111. (doi: 10.1001/jamacardio.2019.3593)

Beldhuis, I. E., Streng, K. W., van der Meer, P., Ter Maaten, J. M., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Cotter, G., Cleland, J. G.F., Davison, B. A., Givertz, M. M., Teerlink, J. R., Bloomfield, D. M., Voors, A. A., Damman, K. (2019) Trajectories of changes in renal function in patients with acute heart failure. Journal of Cardiac Failure, 25, pp. 866-874. (doi: 10.1016/j.cardfail.2019.07.004)

Clark, D. W. et al. (2019) Associations of autozygosity with a broad range of human phenotypes. Nature Communications, 10, (doi: 10.1038/s41467-019-12283-6)

Schmidt, A. F. et al. (2019) Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovascular Disorders, 19, (doi: 10.1186/s12872-019-1187-z)

Solomon, S. D. et al. (2019) Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction. New England Journal of Medicine, 381, pp. 1609-1620. (doi: 10.1056/NEJMoa1908655)

Alexander, M., Loomis, A. K., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., Avillach, P., Egger, P., Dhalwani, N. N., Kendrick, S., Celis-Morales, C., Waterworth, D. M., Alazawi, W., Sattar, N. (2019) Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. British Medical Journal, 367, (doi: 10.1136/bmj.l5367)

Santema, B. T. et al. (2019) Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet, 394, (doi: 10.1016/S0140-6736(19)31792-1)

Stirrat, C. G., Alam, S., MacGillivray, T. J., Gray, C., Dweck, M. R., Jones, V., Wallace, W., Payne, J. R., Prasad, S. K., Gardner, R. S., Petrie, M. C., Mirsadraee, S., Henriksen, P., Newby, D. E., Semple, S. (2019) Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation. Open Heart, 6, (doi: 10.1136/openhrt-2019-001115)

Howlett, J. G., Stebbins, A., Petrie, M. C., Jhund, P. S., Castelvecchio, S., Cherniavsky, A., Sueta, C. A., Roy, A., Piña, I. L., Wurm, R., Drazner, M. H., Andersson, B., Batlle, C., Senni, M., Chrzanowski, L., Merkely, B., Carson, P., Desvigne-Nickens, P. M., Lee, K. L., Velazquez, E. J., Al-Khalidi, H. R. (2019) CABG improves outcomes in patients with ischemic cardiomyopathy 10-year follow-up of the STICH trial. JACC: Heart Failure, 7, pp. 878-887. (doi: 10.1016/j.jchf.2019.04.018)

Seferovic, P. M. et al. (2019) Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 21, pp. 1169-1186. (doi: 10.1002/ejhf.1531)

Muilwijk, M., Ho, F., Waddell, H., Sillars, A., Welsh, P., Iliodromiti, S., Brown, R., Ferguson, L., Stronks, K., van Valkengoed, I., Pell, J. P., Gray, S. R., Gill, J. M. R., Sattar, N., Celis-Morales, C. (2019) Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study. BMJ Open Diabetes Research and Care, 7, (doi: 10.1136/bmjdrc-2019-000765)

Packer, M. et al. (2019) Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial. European Journal of Heart Failure, 21, pp. 1270-1278. (doi: 10.1002/ejhf.1536)

Anker, S. D. et al. (2019) Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial. European Journal of Heart Failure, 21, pp. 1279-1287. (doi: 10.1002/ejhf.1596)

Yazaki, Y., Salzano, A., Nelson, C. P., Voors, A. A., Anker, S. D., Cleland, J. G., Lang, C. C., Metra, M., Samani, N. J., Ng, L. L., Suzuki, T. (2019) Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis. European Journal of Heart Failure, 21, pp. 1291-1294. (doi: 10.1002/ejhf.1550)

Platz, E., Campbell, R. T., Claggett, B., Lewis, E. F., Groarke, J. D., Docherty, K. F., Lee, M. M.Y., Merz, A. A., Silverman, M., Swamy, V., Lindner, M., Rivero, J., Solomon, S. D., McMurray, J. J.V. (2019) Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short- and long-term outcomes. JACC: Heart Failure, 7, pp. 849-858. (doi: 10.1016/j.jchf.2019.07.008)

Lee, M. M.Y., Sattar, N., McMurray, J. J.V., Packard, C. J. (2019) Statins in the prevention and treatment of heart failure: a review of the evidence. Current Atherosclerosis Reports, 21, (doi: 10.1007/s11883-019-0800-z)

Ochs, A., McGurnaghan, S., Black, M. W., Leese, G. P., Philip, S., Sattar, N., Styles, C., Wild, S. H., McKeigue, P. M., Colhoun, H. M. (2019) Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: a retrospective cohort study. PLoS Medicine, 16, (doi: 10.1371/journal.pmed.1002945)

Nicolau, J. C., Stevens, S. R., Al-Khalidi, H. R., Jatene, F. B., Furtado, R. H.M., Dallan, L. A.O., Lisboa, L. A.F., Desvigne-Nickens, P., Haddad, H., Jolicoeur, E. M., Petrie, M. C., Doenst, T., Michler, R. E., Ohman, E. M., Maddury, J., Ali, I., Deja, M. A., Rouleau, J. L., Velazquez, E. J., Hill, J. A. (2019) Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. International Journal of Cardiology, 291, pp. 36-41. (doi: 10.1016/j.ijcard.2019.03.029)

Mazidi, M., Katsiki, N., Mikhailidis, D. P., Sattar, N., Banach, M. (2019) Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies. European Heart Journal, 40, pp. 2870-2879. (doi: 10.1093/eurheartj/ehz174)

Kitas, G. D. et al. (2019) A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis. Arthritis and Rheumatology, 71, pp. 1437-1449. (doi: 10.1002/art.40892)

Kristensen, S. L., Rorth, R., Jhund, P. S., Docherty, K., Sattar, N., Preiss, D., Kober, L., Petrie, M. C., McMurray, J. J.V. (2019) Cardiovascular, mortality and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes and Endocrinology, 7, pp. 776-785. (doi: 10.1016/S2213-8587(19)30249-9)

Sattar, N. (2019) Diabetes management gains: teaching old dogs new tricks. Diabetic Medicine, 36, pp. 1072-1074. (doi: 10.1111/dme.14068)

Iliodromiti, S., Sattar, N., Delles, C., Nelson, S. M., Gill, J. M.R., Lumsden, M. (2019) Menopausal hot flashing and endothelial function in two vascular beds: findings from a cross-sectional study of postmenopausal women. Menopause, 26, pp. 1002-1009. (doi: 10.1097/GME.0000000000001386)

Tromp, J., Lim, S. L., Tay, W. T., Teng, T.-H. K., Chandramouli, C., Ouwerkerk, W., Wander, G. S., Sawhney, J. P.S., Yap, J., MacDonald, M. R., Ling, L. H., Sattar, N., McMurray, J. J.V., Richards, A. M., Anand, I., Lam, C. S.P. (2019) Microvascular disease in patients with diabetes with heart failure and reduced ejection versus preserved ejection fraction. Diabetes Care, 42, pp. 1792-1799. (doi: 10.2337/dc18-2515)

Waddell, H., Rodriguez Rodríguez, F., Garrido Mendez, A., Diaz Martinez, X., Poblete Valderrama, F., Petermann Rocha, F., Celis Morales, C. (2019) Prevalence and patterns of active commuting according to socio-demographic factors in the Chilean population. Journal of Transport and Health, 14, (doi: 10.1016/j.jth.2019.100615)

Sadarangani, K. P., Cabanas-Sánchez, V., Von Oetinger, A., Cristi-Montero, C., Celis-Morales, C., Aguilar-Farías, N., Higueras-Fresnillo, S., De la Cámara, M. A., Suarez-Villadat, B., Martínez-Gómez, D. (2019) Substituting sedentary time with physical activity domains: an isotemporal substitution analysis in Chile. Journal of Transport and Health, 14, (doi: 10.1016/j.jth.2019.100593)

Mackay, A., Mackay, D.F., Celis-Morales, C.A., Lyall, D.M., Gray, S.R., Sattar, N., Gill, J.M.R., Pell, J.P., Anderson, J.J. (2019) The association between driving time and unhealthy lifestyles: a cross-sectional, general population study of 386 493 UK Biobank participants. Journal of Public Health, 41, pp. 527-534. (doi: 10.1093/pubmed/fdy155)

Ho, F. K.W., Celis-Morales, C. A., Petermann, F., Sillars, A., Welsh, P., Welsh, C., Anderson, J., Lyall, D. M., Mackay, D. F., Sattar, N., Gill, J. M.R., Pell, J. P., Gray, S. R. (2019) The association between handgrip strength and future health outcomes does not differ if grip strength is used in absolute or relative terms: a prospective cohort study. Age and Ageing, 48, pp. 683-691. (doi: 10.1093/ageing/afz068)

Metra, M. et al. (2019) Effects of serelaxin in patients with acute heart failure. New England Journal of Medicine, 381, pp. 716-726. (doi: 10.1056/NEJMoa1801291)

Deelen, J. et al. (2019) A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nature Communications, 10, (doi: 10.1038/s41467-019-11311-9)

Täger, T., Fröhlich, H., Grundtvig, M., Seiz, M., Schellberg, D., Goode, K., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Clark, A. L., Frankenstein, L. (2019) Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure – a multicenter propensity score matched analysis. International Journal of Cardiology, 289, pp. 83-90. (doi: 10.1016/j.ijcard.2019.01.109)

Welsh, C., Celis-Morales, C. A., Brown, R., Mackay, D. F., Lewsey, J., Mark, P. B., Gray, S. R., Ferguson, L. D., Anderson, J. J., Lyall, D. M., Cleland, J. G., Jhund, P. S., Gill, J. M.R., Pell, J. P., Sattar, N., Welsh, P. (2019) Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease: data from UK Biobank. Circulation, 140, pp. 542-552. (doi: 10.1161/CIRCULATIONAHA.119.041149)

Cleland, J. G.F., Pellicori, P. (2019) Myocardial dysfunction and coronary artery disease as therapeutic targets in heart failure. Circulation, 140, pp. 538-541. (doi: 10.1161/CIRCULATIONAHA.119.041523)

Varsou, O., Gray, S. R., Alkhedhairi, S., McDonald, S., Quondamatteo, F. (2019) Evaluating the Educational Use of Ultrasound and Custom-Made Imaging Phantoms in Anatomy Teaching.

Korevaar, T. I. M. et al. (2019) Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. JAMA: Journal of the American Medical Association, 322, pp. 632-641. (doi: 10.1001/jama.2019.10931)

Gray, S., Celis-Morales, C. A., Lyall, D. M., Petermann, F., Anderson, J., Ward, J., Iliodromiti, S., Mackay, D. F., Welsh, P., Bailey, M. E.S., Pell, J., Sattar, N., Gill, J. M.R., Gray, S. R. (2019) Do physical activity, commuting mode, cardiorespiratory fitness and sedentary behaviours modify the genetic predisposition to higher BMI? Findings from a UK Biobank study. International Journal of Obesity, 43, pp. 1526-1538. (doi: 10.1038/s41366-019-0381-5)

Jenum, A. K., Brekke, I., Mdala, I., Muilwijk, M., Ramachandran, A., Kjøllesdal, M., Andersen, E., Richardsen, K. R., Douglas, A., Cezard, G., Sheikh, A., Celis-Morales, C. A., Gill, J. M.R., Sattar, N., Bhopal, R. S., Beune, E., Stronks, K., Vandvik, P. O., van Valkengoed, I. G.M. (2019) Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials. Diabetologia, 62, pp. 1337-1348. (doi: 10.1007/s00125-019-4905-2)

Rørth, R., Dewan, P., Kristensen, S. L., Jhund, P. S., Petrie, M. C., Køber, L., McMurray, J. J.V. (2019) Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction. Clinical Research in Cardiology, 108, pp. 868-877. (doi: 10.1007/s00392-019-01415-z)

Fröhlich, H., Rosenfeld, N., Täger, T., Goode, K., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Clark, A. L., Frankenstein, L., Grundtvig, M. (2019) Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart, 105, pp. 1252-1259. (doi: 10.1136/heartjnl-2018-314256)

Celis-Morales, C., Livingstone, K. M., Petermann-Rocha, F., Navas-Carretero, S., San-Cristobal, R., O'Donovan, C. B., Moschonis, G., Manios, Y., Traczyk, I., Drevon, C. A., Daniel, H., Marsaux, C. F.M., Saris, W. H.M., Fallaize, R., Macready, A. L., Lovegrove, J. A., Gibney, M., Gibney, E. R., Walsh, M., Brennan, L., Martinez, J. A., Mathers, J. C. (2019) Frequent nutritional feedback, personalized advice, and behavioral changes: findings from the European Food4Me internet-based RCT. American Journal of Preventive Medicine, 57, pp. 209-219. (doi: 10.1016/j.amepre.2019.03.024)

Mair, C., Wulaningsih, W., Jeyam, A., McGurnaghan, S., Blackbourn, L., Kennon, B., Leese, G., Lindsay, R., McCrimmon, R. J., McKnight, J., Petrie, J. R., Sattar, N., Wild, S. H., Conway, N., Craigie, I., Robertson, K., Bath, L., McKeigue, P. M., Colhoun, H. M. (2019) Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016. Diabetologia, 62, pp. 1375-1384. (doi: 10.1007/s00125-019-4900-7)

Shen, L., Rørth, R., Cosmi, D., Kristensen, S. L., Petrie, M. C., Cosmi, F., Latini, R., Køber, L., Anand, I. S., Carson, P. E., Granger, C. B., Komajda, M., McKelvie, R. S., Solomon, S. D., Staszewsky, L., Swedberg, K., Huynh, T., Zile, M. R., Jhund, P. S., McMurray, J. J.V. (2019) Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. European Journal of Heart Failure, 21, pp. 974-984. (doi: 10.1002/ejhf.1535)

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12, (doi: 10.1161/CIRCINTERVENTIONS.119.007830)

Halliday, B. P., Baksi, A. J., Gulati, A., Ali, A., Newsome, S., Izgi, C., Arzanauskaite, M., Lota, A., Tayal, U., Vassiliou, V. S., Gregson, J., Alpendurada, F., Frenneaux, M. P., Cook, S. A., Cleland, J. G.F., Pennell, D. J., Prasad, S. K. (2019) Outcome in dilated cardiomyopathy related to the extent, location and pattern of late gadolinium enhancement. JACC: Cardiovascular Imaging, 12, pp. 1645-1655. (doi: 10.1016/j.jcmg.2018.07.015)

Felker, G. M., Borentain, M., Cleland, J. G.F., DeSouza, M. M., Kessler, P. D., O'Connor, C. M., Seiffert, D., Teerlink, J. R., Voors, A. A., McMurray, J. J.V. (2019) Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. European Journal of Heart Failure, 21, pp. 1022-1031. (doi: 10.1002/ejhf.1504)

Welsh, C. E., Welsh, P., Jhund, P., Sattar, N., Mark, P. B. (2019) Response by Welsh et al to letter regarding article “Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease” Hypertension, 74, pp. e27-e28. (doi: 10.1161/HYPERTENSIONAHA.119.13349)

Petermann-Rocha, F., Sillars, A., Brown, R., Sweeney, L., Troncoso, C., García-Hermoso, A., Leiva, A. M., Martínez, M. A., Diaz-Martínez, X., Poblete-Valderrama, F., Garrido-Mendez, A., Cataldo, X., Gonzalez, J. I., Salas, C., Lara, J., Gray, S. R., Celis-Morales, C. (2019) Sociodemographic patterns of urine sodium excretion and its association with hypertension in Chile: a cross-sectional analysis. Public Health Nutrition, 22, pp. 2012-2021. (doi: 10.1017/S1368980018003889)

Markousis-Mavrogenis, G., Tromp, J., Ouwerkerk, W., Devalaraja, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Zannad, F., Zwinderman, A. H., Hillege, H. L., van Veldhuisen, D. J., Kakkar, R., Voors, A. A., van der Meer, P. (2019) The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF Study. European Journal of Heart Failure, 21, pp. 965-973. (doi: 10.1002/ejhf.1482)

Halliday, B. P., Cleland, J. G.F., Prasad, S. K. (2019) When can heart failure treatment be stopped safely? – Authors' reply. Lancet, 394, pp. 217-218. (doi: 10.1016/S0140-6736(19)30499-4)

Rankin, J., Rowen, D., Howe, A., Cleland, J. G.F., Whitty, J. A. (2019) Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses. Heart Failure Reviews, 24, pp. 549-563. (doi: 10.1007/s10741-019-09780-7)

Varsou, O., Ferguson, E., Saleh, A., Gray, S. R. (2019) Let’s Do Some Ultrasound-Guided Pasta Cannulation.

Dangardt, F., Charakida, M., Georgiopoulos, G., Chiesa, S. T., Rapala, A., Wade, K. H., Hughes, A. D., Timpson, N. J., Pateras, K., Finer, N., Sattar, N., Davey Smith, G., Lawlor, D. A., Deanfield, J. E. (2019) Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children. Lancet Child and Adolescent Health, 3, pp. 474-481. (doi: 10.1016/S2352-4642(19)30105-1)

Suzuki, T., Yazaki, Y., Voors, A. A., Jones, D. J.L., Chan, D. C.S., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., Ng, L. L. (2019) Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure (from BIOSTAT‐CHF) European Journal of Heart Failure, 21, pp. 877-886. (doi: 10.1002/ejhf.1338)

Edqvist, J., Rawshani, A., Adiels, M., Björck, L., Lind, M., Svensson, A.-M., Gudbjörnsdottir, S., Sattar, N., Rosengren, A. (2019) BMI, mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox. Diabetes Care, 42, pp. 1297-1304. (doi: 10.2337/dc18-1446)

Nuzzi, V., Pellicori, P., Nikolaidou, T., Kallvikbacka-Bennett, A., Torromeo, C., Barilla, F., Damien, S., Kaur, K., Monzo, L., Cleland, J. G.F., Clark, A. L. (2019) Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine, 20, pp. 442-449. (doi: 10.2459/JCM.0000000000000802)

Beverborg, N. G., van der Wal, H., Klip, I. T., Anker, S. D., Cleland, J. G.F., Dickstein, K., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2019) Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies. JAMA Cardiology, 4, pp. 696-701. (doi: 10.1001/jamacardio.2019.1739)

Robertson, J., Schaufelberger, M., Lindgren, M., Adiels, M., Schiöler, L., Torén, K., McMurray, J., Sattar, N., Åberg, M., Rosengren, A. (2019) Higher body mass index in adolescence predicts cardiomyopathy risk in midlife: long-term follow-up among Swedish men. Circulation, 140, pp. 117-125. (doi: 10.1161/circulationaha.118.039132)

Bauersachs, J., König, T., Meer, P., Petrie, M. C., Hilfiker‐Kleiner, D., Mbakwem, A., Hamdan, R., Jackson, A. M., Forsyth, P., Boer, R. A., Mueller, C., Lyon, A. R., Lund, L. H., Piepoli, M. F., Heymans, S., Chioncel, O., Anker, S. D., Ponikowski, P., Seferovic, P. M., Johnson, M. R., Mebazaa, A., Sliwa, K. (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21, pp. 827-843. (doi: 10.1002/ejhf.1493)

Pellicori, P., Shah, P., Cuthbert, J., Urbinati, A., Zhang, J., Kallvikbacka-Bennett, A., Clark, A. L., Cleland, J. G.F. (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. European Journal of Heart Failure, 21, pp. 904-916. (doi: 10.1002/ejhf.1383)

Mordi, I. R., Santema, B. T., Kloosterman, M., Choy, A.-M., Rienstra, M., van Gelder, I., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Metra, M., Ng, L. L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Voors, A. A., Lang, C. C. (2019) Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. Clinical Research in Cardiology, 108, pp. 797-805. (doi: 10.1007/s00392-018-1409-x)

Cleland, J. G.F., Hindricks, G., Petrie, M. (2019) The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization. European Heart Journal, 40, pp. 2128-2130. (doi: 10.1093/eurheartj/ehz409)

Dennis, J. M., Henley, W. E., McGovern, A. P., Farmer, A. J., Sattar, N., Holman, R. R., Pearson, E. R., Hattersley, A. T., Shields, B. M., Jones, A. G. (2019) Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010–2017. Diabetes, Obesity and Metabolism, 21, pp. 1576-1584. (doi: 10.1111/dom.13687)

Shoaib, A., Mamas, M. A., Ahmad, Q. S., McDonagh, T. M., Hardman, S. M.C., Rashid, M., Butler, R., Duckett, S., Satchithananda, D., Nolan, J., Dargie, H. J., Clark, A. L., Cleland, J. G.F. (2019) Characteristics and outcome of acute heart failure patients according to the severity of peripheral oedema. International Journal of Cardiology, 285, pp. 40-46. (doi: 10.1016/j.ijcard.2019.03.020)

Lyall, D. M., Celis-Morales, C., Lyall, L. M., Graham, C., Graham, N., Mackay, D. F., Strawbridge, R. J., Ward, J., Gill, J. M., Sattar, N., Cavanagh, J., Smith, D. J., Pell, J. P. (2019) Assessing for interaction between APOE ε4, sex and lifestyle on cognitive abilities. Neurology, 92, pp. e2691-e2698. (doi: 10.1212/WNL.0000000000007551)

Malik, R. et al. (2019) Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics, (doi: 10.1038/s41588-019-0449-0)

Brazel, D. M. et al. (2019) Exome chip meta-analysis fine maps causal variants and elucidates the genetic architecture of rare coding variants in smoking and alcohol use. Biological Psychiatry, 85, pp. 946-955. (doi: 10.1016/j.biopsych.2018.11.024)

Greenberg, B., Neaton, J. D., Anker, S. D., Byra, W. M., Cleland, J. G.F., Deng, H., Fu, M., La Police, D. A., Lam, C. S. P., Mehra, M. R., Nessel, C. C., Spiro, T. E., van Veldhuisen, D. J., Vanden Boom, C. M., Zannad, F. (2019) Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial. JAMA Cardiology, 4, pp. 515-523. (doi: 10.1001/jamacardio.2019.1049)

ter Maaten, J. M., Kremer, D., Demissei, B. G., Struck, J., Bergmann, A., Anker, S. D., Ng, L. L., Dickstein, K., Metra, M., Samani, N. J., Romaine, S. P.R., Cleland, J., Girerd, N., Lang, C. C., van Veldhuisen, D. J., Voors, A. A. (2019) Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure. European Journal of Heart Failure, 21, pp. 732-743. (doi: 10.1002/ejhf.1437)

Welsh, P., Preiss, D., Hayward, C., Shah, A. S.V., McAllister, D., Briggs, A., Boachie, C., McConnachie, A., Padmanabhan, S., Welsh, C., Woodward, M., Campbell, A., Porteous, D., Mills, N. L., Sattar, N. (2019) Cardiac troponin T and troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes. Circulation, 139, pp. 2754-2764. (doi: 10.1161/CIRCULATIONAHA.118.038529)

Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I., Mamas, M. A., Sattar, N., Ashcroft, D. M., Rutter, M. K. (2019) Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities. Circulation, 139, pp. 2742-2753. (doi: 10.1161/CIRCULATIONAHA.118.039100)

Clark, A. L., Kalra, P. R., Petrie, M. C., Mark, P. B., Tomlinson, L. A., Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105, pp. 904-910. (doi: 10.1136/heartjnl-2018-314158)

Bagot, C.N., Leishman, E., Onyiaodike, C.C., Jordan, F., Gibson, V.B., Freeman, D.J. (2019) Changes in laboratory markers of thrombotic risk early in the first trimester of pregnancy may be linked to an increase in estradiol and progesterone. Thrombosis Research, 178, pp. 47-53. (doi: 10.1016/j.thromres.2019.03.015)

Haig, C., Carrick, D., Carberry, J., Mangion, K., Maznyczka, A., Wetherall, K., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ahmed, N., May, V. T. Y., Ford, I., Radjenovic, A., Welsh, P., Sattar, N., Oldroyd, K. G., Berry, C. (2019) Current smoking and prognosis after acute ST-segment elevation myocardial infarction: new pathophysiological insights. JACC: Cardiovascular Imaging, 12, pp. 993-1003. (doi: 10.1016/j.jcmg.2018.05.022)

Lean, M. E.J., Sattar, N. (2019) Da Qing 30 years on: more reasons to extend diabetes prevention. Lancet Diabetes and Endocrinology, 7, pp. 417-419. (doi: 10.1016/S2213-8587(19)30138-X)

Rita, P., Serenelli, M., Celis-Morales, C., Gray, S. R., Izawa, K. P., Watanabe, S., Colin-Ramirez, E., Castillo-Martínez, L., Izumiya, Y., Hanatani, S., Onoue, Y., Tsujita, K., Macdonald, P. S., Jha, S. R., Roger, V. L., Manemann, S. M., Sanchis, J., Ruiz, V., Bugani, G., Tonet, E., Ferrari, R., Volpato, S., Campo, G. (2019) Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis. Heart, 105, pp. 834-841. (doi: 10.1136/heartjnl-2018-313816)

Mueller, C., McDonald, K., deBoer, R. A., Maisel, A., Cleland, J. G.F., Kozhuharov, N., Coats, A. J.S., Metra, M., Mebazaa, A., Ruschitzka, F., Lainscak, M., Filippatos, G., Seferovic, P. M., Meijers, W. C., Bayes-Genis, A., Mueller, T., Richards, M., Januzzi, J. L. (2019) Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure, 21, pp. 715-731. (doi: 10.1002/ejhf.1494)

House, A. A. et al. (2019) Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies conference. Kidney International, 95, pp. 1304-1317. (doi: 10.1016/j.kint.2019.02.022)

Ahmad, F. A., Petrie, M. C., McMurray, J. J.V., Lang, N. N. (2019) Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it. European Journal of Heart Failure, 21, pp. 699-702. (doi: 10.1002/ejhf.1463)

Welsh, C., Welsh, P., Jhund, P., Delles, C., Celis-Morales, C., Lewsey, J., Gray, S., Lyall, D., Iliodromiti, S., Gill, J., Sattar, N., Mark, P. (2019) Urinary sodium excretion, blood pressure and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease. Hypertension, 73, pp. 1202-1209. (doi: 10.1161/HYPERTENSIONAHA.119.12726)

Raber, I., McCarthy, C. P., Vaduganathan, M., Bhatt, D. L., Wood, D. A., Cleland, J. G.F., Blumenthal, R. S., McEvoy, J. W. (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet, 393, pp. 2155-2167. (doi: 10.1016/S0140-6736(19)30541-0)

Cleland, J. G.F., Pellicori, P., Clark, A. L. (2019) Prevention or procrastination for heart failure?: Why we need a universal definition of heart failure. Journal of the American College of Cardiology, 73, pp. 2398-2400. (doi: 10.1016/j.jacc.2019.03.471)

Alexander, M., Loomis, A. K., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., Waterworth, D. M., Kendrick, S., Sattar, N., Alazawi, W. (2019) Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Medicine, 17, (doi: 10.1186/s12916-019-1321-x)

Schanstra, J. P., Luong, T. T.D., Makridakis, M., Van Linthout, S., Lygirou, V., Latosinska, A., Alesutan, I., Boehme, B., Schelski, N., Von Lewinski, D., Mullen, W., Nicklin, S., Delles, C., Feuillet, G., Denis, C., Lang, F., Pieske, B., Bascands, J.-L., Mischak, H., Saulnier-Blache, J.-S., Voelkl, J., Vlahou, A., Klein, J. (2019) Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment. JCI Insight, 4, (doi: 10.1172/jci.insight.125638)

Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., Gudbjörnsdottir, S. (2019) Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks findings from the Swedish National Diabetes Registry. Circulation, 139, pp. 2228-2237. (doi: 10.1161/CIRCULATIONAHA.118.037885)

Small, H. Y., McNeilly, S., Mary, S., Sheikh, A. M., Delles, C. (2019) Resistin mediates sex-dependent effects of perivascular adipose tissue on vascular function in the SHRSP. Scientific Reports, 9, (doi: 10.1038/s41598-019-43326-z)

McMurray, J. J.V. et al. (2019) A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF) European Journal of Heart Failure, 21, pp. 665-675. (doi: 10.1002/ejhf.1432)

Conrad, N., Judge, A., Canoy, D., Tran, J., O’Donnell, J., Nazarzadeh, M., Salimi-Khorshidi, G., Hobbs, F.D. R., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2019) Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: a cohort study of 93,000 UK patients. PLoS Medicine, 16, (doi: 10.1371/journal.pmed.1002805)

Lean, M. E.J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K., Rodrigues, A. M., Rehackova, L., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., Ross, H. M., McIlvenna, Y., Welsh, P., Kean, S., Ford, I., McConnachie, A., Messow, C.-M., Sattar, N., Taylor, R. (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes and Endocrinology, 7, pp. 344-355. (doi: 10.1016/S2213-8587(19)30068-3)

Dewan, P. et al. (2019) Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. European Journal of Heart Failure, 21, pp. 577-587. (doi: 10.1002/ejhf.1347)

Shoaib, A., Farag, M., Nolan, J., Rigby, A., Patwala, A., Rashid, M., Kwok, C.S., Perveen, R., Clark, A.L., Komajda, M., Cleland, J.G.F. (2019) Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from The First Euro Heart Failure Survey. Clinical Research in Cardiology, 108, pp. 510-519. (doi: 10.1007/s00392-018-1380-6)

Shen, L., Jhund, P. S., Docherty, K. F., Petrie, M. C., Anand, I. S., Carson, P. E., Desai, A. S., Granger, C. B., Komajda, M., McKelvie, R. S., Pfeffer, M. A., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Prior pacemaker implantation and clinical outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 7, pp. 418-427. (doi: 10.1016/j.jchf.2018.12.006)

Ferreira, J. P. et al. (2019) Proteomic bioprofiles and mechanistic pathways of progression to heart failure: the HOMAGE study. Circulation, 12, (doi: 10.1161/CIRCHEARTFAILURE.118.005897)

Currie, G., Delles, C. (2019) Vascular biomedicine in an era of chronic disease and multimorbidity. Clinical Science, 133, pp. 1137-1143. (doi: 10.1042/CS20180764)

Shah, P., Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Pan, D., Clark, A. L. (2019) Warm water immersion in patients with chronic heart failure: a pilot study. Clinical Research in Cardiology, 108, pp. 468-476. (doi: 10.1007/s00392-018-1376-2)

Rawshani, A., Rawshani, A., Sattar, N., Franzén, S., McGuire, D. K., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., Rosengren, A., Gudbjörnsdottir, S. (2019) Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation, 139, pp. 1900-1912. (doi: 10.1161/CIRCULATIONAHA.118.037454)

McGovern, A. P., Dennis, J. M., Shields, B. M., Hattersley, A. T., Pearson, E. R., Jones, A. G., , (2019) What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study. BMC Medicine, 17, (doi: 10.1186/s12916-019-1307-8)

Anderson, S. G., Shoaib, A., Myint, P. K., Cleland, J. G., Hardman, S. M., McDonagh, T. A., Dargie, H., Keavney, B., Garratt, C. J., Mamas, M. A. (2019) Does rhythm matter in Acute Heart Failure? An insight from the British Society for Heart Failure National Audit. Clinical Research in Cardiology, (doi: 10.1007/s00392-019-01463-5)

Patel, R. S. et al. (2019) Association of chromosome 9p21 with subsequent coronary heart disease events: a GENUIS-CHD study of individual participant data. Circulation: Genomic and Precision Medicine, 12, (doi: 10.1161/CIRCGEN.119.002471)

Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S.P., van Veldhuisen, D. J., Ponikowski, P., Petrie, M. C., Hassager, C., Møller, J. E., Gustafsson, F. (2019) Central and peripheral determinants of exercise capacity in heart failure patients with preserved ejection fraction. JACC: Heart Failure, 7, pp. 321-332. (doi: 10.1016/j.jchf.2019.01.006)

Welsh, P., Papacosta, O., Ramsay, S., Whincup, P., McMurray, J., Wannamethee, G., Sattar, N. (2019) High sensitivity troponin T and incident heart failure in older men: British Regional Heart Study. Journal of Cardiac Failure, 25, pp. 230-237. (doi: 10.1016/j.cardfail.2018.08.002)

Sze, S., Pellicori, P., Zhang, J., Weston, J., Clark, A. L. (2019) Identification of frailty in chronic heart failure. JACC: Heart Failure, 7, pp. 291-302. (doi: 10.1016/j.jchf.2018.11.017)

Maznyczka, A. M., Carrick, D., Carberry, J., Mangion, K., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Ford, I., Welsh, P., Sattar, N., Oldroyd, K. G., Berry, C. (2019) Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction. Open Heart, 6, (doi: 10.1136/openhrt-2018-000979)

Kuh, D., Cooper, R., Sattar, N., Welsh, P., Hardy, R., Ben-Shlomo, Y. (2019) Systemic inflammation and cardio-renal organ damage biomarkers in middle age are associated with physical capability up to 9 years later: findings from a British birth cohort study. Circulation, 139, pp. 1988-1999. (doi: 10.1161/CIRCULATIONAHA.118.037332)

Celis-Morales, C. A., Lyall, D. M., Bailey, M. E.S., Petermann-Rocha, F., Anderson, J., Ward, J., Mackay, D. F., Welsh, P., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R. (2019) The combination of physical activity and sedentary behaviors modifies the genetic predisposition to obesity. Obesity, 27, pp. 653-661. (doi: 10.1002/oby.22417)

McGurnaghan, S. J., Brierley, L., Caparrotta, T. M., McKeigue, P. M., Blackbourn, L. A.K., Wild, S. H., Leese, G. P., McCrimmon, R. J., McKnight, J. A., Pearson, E. R., Petrie, J. R., Sattar, N., Colhoun, H. M. (2019) The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study. Diabetologia, 62, pp. 621-632. (doi: 10.1007/s00125-018-4806-9)

Ismail, A. D., Aba Alkhayl, F. F. A., Wilson, J., Johnston, L., Gill, J. M.R., Gray, S. R. (2019) The effect of short duration resistance training on insulin sensitivity and muscle adaptations in overweight men. Experimental Physiology, 104, pp. 540-545. (doi: 10.1113/EP087435)

Pettit, S. J., Petrie, M. C. (2019) Transplantation of hearts donated after circulatory-determined death: a song of fire and ice. Circulation: Heart Failure, 12, (doi: 10.1161/CIRCHEARTFAILURE.119.005991)

Patel, R. et al. (2019) Subsequent event risk in individuals with established coronary heart disease: design and rationale of the GENIUS-CHD Consortium. Circulation: Genomic and Precision Medicine, (doi: 10.1161/CIRCGEN.119.002470)

Rankin, N. J., Burgess, K., Weidt, S., Wannamethee, G., Sattar, N., Welsh, P. (2019) High-throughput quantification of carboxymethyl lysine in serum and plasma using high-resolution accurate mass Orbitrap mass spectrometry. Annals of Clinical Biochemistry, 56, pp. 397-407. (doi: 10.1177/0004563219830432)

Alhindi, Y., Vaanholt, L. M., Al-Tarrah, M., Gray, S. R., Speakman, J. R., Hambly, C., Alanazi, B. S., Gabriel, B. M., Lionikas, A., Ratkevicius, A. (2019) Low citrate synthase activity is associated with glucose intolerance and lipotoxicity. Journal of Nutrition and Metabolism, 2019, (doi: 10.1155/2019/8594825)

Sokoreli, I., Cleland, J.G., Pauws, S.C., Steyerberg, E.W., de Vries, J.J.G., Riistama, J.M., Dobbs, K., Bulemfu, J., Clark, A.L. (2019) Added value of frailty and social support in predicting risk of 30-day unplanned re-admission or death for patients with heart failure: an analysis from OPERA-HF. International Journal of Cardiology, 278, pp. 167-172. (doi: 10.1016/j.ijcard.2018.12.030)

Steell, L., Sillars, A., Welsh, P., Iliodromiti, S., Wong, S.C., Pell, J.P., Sattar, N., Gill, J.M.R., Celis, C., Gray, S.R. (2019) Associations of dietary protein intake with bone mineral density: an observational study in 70,215 UK Biobank participants. Bone, 120, pp. 38-43. (doi: 10.1016/j.bone.2018.10.003)

Januzzi, J., Ferreira, J. P., Böhm, M., Kaul, S., Wanner, C., Brueckmann, M., Petrie, M., Ofstad, A.-P., Zeller, C., George, J., Fitchett, D., Zannad, F. (2019) Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline. European Journal of Heart Failure, 21, pp. 386-388. (doi: 10.1002/ejhf.1419)

Mangion, K., Carrick, D., Clerfond, G., Rush, C., McComb, C., Oldroyd, K. G., Petrie, M. C., Eteiba, H., Lindsay, M., McEntegart, M., Hood, S., Watkins, S., Davie, A., Auger, D. A., Zhong, X., Epstein, F. H., Haig, C. E., Berry, C. (2019) Predictors of segmental myocardial functional recovery in patients after an acute ST-elevation myocardial infarction. European Journal of Radiology, 112, pp. 121-129. (doi: 10.1016/j.ejrad.2019.01.010)

Loader, J., Chan, Y.-K., A Hawley, J., Moholdt, T., McDonald, C. F., Jhund, P., Petrie, M. C., McMurray, J. J., Scuffham, P. A., Ramchand, J., Burrell, L. M., Stewart, S. (2019) Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: analysis of 1598 patients and 4588 patient-years follow-up. International Journal of Cardiology, 279, pp. 126-132. (doi: 10.1016/j.ijcard.2018.12.060)

Lucas-Herald, A. K., Zürbig, P., Mason, A., Kinning, E., Brown, C. E., Mansoorian, B., Mullen, W., Ahmed, S. F., Delles, C. (2019) Proteomic evidence of biological aging in a child with a compound heterozygous ZMPSTE24 mutation. Proteomics Clinical Applications, 13, (doi: 10.1002/prca.201800135)

de Boer, R. A. et al. (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. European Journal of Heart Failure, 21, pp. 272-285. (doi: 10.1002/ejhf.1406)

Read, S. H., Fischbacher, C. M., Colhoun, H. M., Gasevic, D., Kerssens, J. J., McAllister, D. A., Sattar, N., Wild, S. H. (2019) Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015. Diabetologia, 62, pp. 418-425. (doi: 10.1007/s00125-018-4796-7)

Mamet, H., Petrie, M. C., Rocchiccioli, P. (2019) Type 1 diabetes mellitus and coronary revascularization. Cardiovascular Endocrinology and Metabolism, 8, pp. 35-38. (doi: 10.1097/XCE.0000000000000166)

Celis-Morales, C. A., Gray, S., Petermann, F., Iliodromiti, S., Welsh, P., Lyall, D. M., Anderson, J., Pellicori, P., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R. (2019) Walking pace is associated with lower risk of all-cause and cause-specific mortality. Medicine and Science in Sports and Exercise, 51, pp. 472-480. (doi: 10.1249/MSS.0000000000001795)

Sattar, N. (2019) Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the future. BMC Medicine, 17, (doi: 10.1186/s12916-019-1281-1)

Larsson, S. C., Traylor, M., Burgess, S., Boncoraglio, G. B., Jern, C., Michaëlsson, K., Markus, H. S., Walters, M., Ford, I., Sattar, N., Stott, D. J. (2019) Serum magnesium and calcium levels in relation to ischemic stroke. Neurology, 92, pp. e944-e950. (doi: 10.1212/WNL.0000000000007001)

Cleland, J. G.F., van Veldhuisen, D. J., Ponikowski, P. (2019) The year in cardiology 2018: heart failure. European Heart Journal, 40, pp. 651-661. (doi: 10.1093/eurheartj/ehz010)

Drozdowska, B. A., Celis-Morales, C. A., Lyall, D. M., Quinn, T. J. (2019) Social engagement after stroke – is it relevant to cognitive function? A cross-sectional analysis of UK Biobank data. AMRC Open Research, 1, (doi: 10.12688/amrcopenres.12862.2)

Pennells, L. et al. (2019) Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. European Heart Journal, 40, pp. 621-631. (doi: 10.1093/eurheartj/ehy653)

Wyke, S. et al. (2019) The effect of a programme to improve men's sedentary time and physical activity: the European Fans in Training (EuroFIT) randomised controlled trial. PLoS Medicine, 16, (doi: 10.1371/journal.pmed.1002736)

Armitage, J. et al. (2019) Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet, 393, pp. 407-415. (doi: 10.1016/S0140-6736(18)31942-1)

Avtaar Singh, S. S., Das De, S., Nappi, F., Al-Adhami, A., Hegazy, Y., Dalzell, J., Doshi, H., Sinclair, A., Curry, P., Petrie, M., Berry, C., Al-Attar, N. (2019) Mechanical circulatory support for refractory cardiogenic shock post-acute myocardial infarction-a decade of lessons. Journal of Thoracic Disease, 11, pp. 542-548. (doi: 10.21037/jtd.2019.01.21)

Palazzuoli, A., Ruocco, G., Pellicori, P., Incampo, E., Di Tommaso, C., Favilli, R., Evangelista, I., Nuti, R., Testani, J. M. (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. International Journal of Cardiology, 276, pp. 198-203. (doi: 10.1016/j.ijcard.2018.11.108)

Zhang, J., Begley, A., Jackson, R., Harrison, M., Pellicori, P., Clark, A. L., Cleland, J. G.F. (2019) Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis. Clinical Research in Cardiology, 108, pp. 119-132. (doi: 10.1007/s00392-018-1302-7)

Mangion, K., Carrick, D., Carberry, J., Mahrous, A., McComb, C., Oldroyd, K. G., Eteiba, H., Lindsay, M., McEntegart, M., Hood, S., Petrie, M. C., Watkins, S., Davie, A., Zhong, X., Epstein, F. H., Haig, C. E., Berry, C. (2019) Circumferential strain predicts major adverse cardiovascular events following an acute ST-segment-elevation myocardial infarction. Radiology, 290, pp. 329-337. (doi: 10.1148/radiol.2018181253)

Ferreira, J. P., Metra, M., Anker, S. D., Dickstein, K., Lang, C. C., Ng, L., Samani, N. J., Cleland, J. G., van Veldhuisen, D. J., Voors, A. A., Zannad, F. (2019) Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. European Journal of Heart Failure, 21, pp. 218-226. (doi: 10.1002/ejhf.1380)

Petrie, J. R., Sattar, N. (2019) Excess cardiovascular risk in type 1 diabetes mellitus. Circulation, 139, pp. 744-747. (doi: 10.1161/circulationaha.118.038137)

Kaye, D. M., Petrie, M. C., McKenzie, S., Hasenfuβ, G., Malek, F., Post, M., Doughty, R. N., Trochu, J.-N., Gustafsson, F., Lang, I., Kolodziej, A., Westenfeld, R., Penicka, M., Rosenberg, M., Hausleiter, J., Raake, P., Jondeau, G., Bergmann, M. W., Spelman, T., Aytug, H., Ponikowski, P., Hayward, C. (2019) Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Failure, 6, pp. 62-69. (doi: 10.1002/ehf2.12350)

Bekfani, T., Pellicori, P., Morris, D., Ebner, N., Valentova, M., Sandek, A., Doehner, W., Cleland, J. G., Lainscak, M., Schulze, P. C., Anker, S. D., von Haehling, S. (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clinical Research in Cardiology, 108, pp. 203-211. (doi: 10.1007/s00392-018-1344-x)

Sze, S., Pellicori, P., Zhang, J., Clark, A. L. (2019) Malnutrition, congestion and mortality in ambulatory patients with heart failure. Heart, 105, pp. 297-306. (doi: 10.1136/heartjnl-2018-313312)

Combet, E., Gray, S. R. (2019) Nutrient–nutrient interactions: competition, bioavailability, mechanism and function in health and diseases. Proceedings of the Nutrition Society, 78, pp. 1-3. (doi: 10.1017/S0029665118002732)

Ferreira, J. P., Rossignol, P., Pizard, A., Machu, J.-L., Collier, T., Girerd, N., Huby, A.-C., Gonzalez, A., Diez, J., López, B., Sattar, N., Cleland, J. G., Sever, P. S., Zannad, F. (2019) Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Heart, 105, pp. 307-314. (doi: 10.1136/heartjnl-2018-313182)

Budu-Aggrey, A. et al. (2019) Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS Medicine, 16, (doi: 10.1371/journal.pmed.1002739)

Ambrosy, A. P., Stevens, S. R., Al-Khalidi, H. R., Rouleau, J. L., Bouabdallaoui, N., Carson, P. E., Adlbrecht, C., Cleland, J. G.F., Dabrowski, R., Golba, K. S., Pina, I. L., Sueta, C. A., Roy, A., Sopko, G., Bonow, R. O., Velazquez, E. J. (2019) Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. European Journal of Heart Failure, 21, pp. 373-381. (doi: 10.1002/ejhf.1404)

Lee, M. M.Y., Campbell, R. T., Kelly, R., Petrie, M. C., Sonecki, P. (2019) Does “Scar” at Rest Echocardiography Predict Lack of Contractility Reserve at Dobutamine Stress Echocardiography. (doi: 10.1093/ehjci/jey266)

Mills, H. L., Patel, N., White, S. L., Pasupathy, D., Briley, A. L., Santos Ferreira, D. L., Seed, P. T., Nelson, S. M., Sattar, N., Tilling, K., Poston, L., Lawlor, D. A. (2019) The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK Pregnancies Better Eating and Activity Trial (UPBEAT) randomised controlled trial. BMC Medicine, 17, (doi: 10.1186/s12916-018-1248-7)

Keeble, T. R., Karamasis, G. V., Rothman, M. T., Ricksten, S.-E., Ferrari, M., Hullin, R., Scherstén, F., Reitan, O., Kirking, S. T., Cleland, J. G.F., Smith, E. J. (2019) Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP) International Journal of Cardiology, 275, pp. 53-58. (doi: 10.1016/j.ijcard.2018.09.085)

Dewan, P., Rørth, R., Jhund, P. S., Shen, L., Raparelli, V., Petrie, M. C., Abraham, W. T., Desai, A. S., Dickstein, K., Køber, L., Mogensen, U. M., Packer, M., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J.V. (2019) Differential impact of heart failure with reduced ejection fraction on men and women. Journal of the American College of Cardiology, 73, pp. 29-40. (doi: 10.1016/j.jacc.2018.09.081)

Halliday, B. P. et al. (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet, 393, pp. 61-73. (doi: 10.1016/S0140-6736(18)32484-X)

McCartney, P. J. et al. (2019) Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA: Journal of the American Medical Association, 321, pp. 56-68. (doi: 10.1001/jama.2018.19802)

Kerr, D. M.I., Brooksbank, K. J.M., Taylor, R. G., Pinel, K., Rios, F. J., Touyz, R. M., Delles, C. (2019) Acute effects of electronic and tobacco cigarettes on vascular and respiratory function in healthy volunteers: a cross-over study. Journal of Hypertension, 37, pp. 154-166. (doi: 10.1097/HJH.0000000000001890)

Lee, M. M. Y., McMurray, J. J.V., Lorenzo-Almorós, A., Kristensen, S. L., Sattar, N., Jhund, P. S., Petrie, M. C. (2019) Diabetic cardiomyopathy. Heart, 105, pp. 337-345. (doi: 10.1136/heartjnl-2016-310342)

Sabater-Lleal, M. et al. (2019) Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels. Circulation, 139, pp. 620-635. (doi: 10.1161/CIRCULATIONAHA.118.034532)

Martin, K. R., Bachmair, E.-M., Aucott, L., Dures, E., Emsley, R., Gray, S. R., Hewlett, S., Kumar, V., Lovell, K., Macfarlane, G. J., MacLennan, G., McNamee, P., Norrie, J., Paul, L., Ralston, S., Siebert, S., Wearden, A., White, P. D., Basu, N. (2019) Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT) BMJ Open, 9, (doi: 10.1136/bmjopen-2018-026793)

Concha-Cisternas, Y., Lanuza, F., Waddell, H., Sillars, A., Leiva, A.M., Troncoso, C., Martinez, M.A., Villagrán, M., Mardones, L., Martorell, M., Nazar, G., Ulloa, N., Labraña, A.M., Diaz-Martinez, X., Sadarangani, K., Alvarez, C., Ramirez-Campillo, R., Garrido-Mendez, A., Luarte, C., Ho, F., Gray, S. R., Petermann-Rocha, F., Celis-Morales, C. (2019) Association between adiposity levels and cognitive impairment in the Chilean older adult population. Journal of Nutritional Science, 8, (doi: 10.1017/jns.2019.24)

Petermann, F., Brown, R. E., Diaz-Martínez, X., Leiva, A. M., Martinez, M. A., Poblete-Valderrama, F., Garrido-Méndez, A., Matus-Castillo, C., Luarte-Rocha, C., Salas-Bravo, C., Troncoso-Pantoja, C., García-Hermoso, A., Ramírez-Vélez, R., Vásquez-Gómez, J. A., Rodríguez-Rodríguez, F., Alvarez, C., Celis-Morales, C. (2019) Association of leisure time and occupational physical activity with obesity and cardiovascular risk factors in Chile. Journal of Sports Sciences, 37, pp. 2549-2559. (doi: 10.1080/02640414.2019.1647738)

Ravassa, S., Delles, C., Currie, G., Díez, J. (2019) Biomarkers of cardiovascular disease. Springer

Ferguson, L. D., Siebert, S., McInnes, I. B., Sattar, N. (2019) Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. Nature Reviews Rheumatology, 15, pp. 461-474. (doi: 10.1038/s41584-019-0256-0)

Stefanaki, D.G.A., Dzulkarnain, A., Gray, S.R. (2019) Comparing the effects of low and high load resistance exercise to failure on adaptive responses to resistance exercise in young women. Journal of Sports Sciences, 37, pp. 1375-1380. (doi: 10.1080/02640414.2018.1559536)

Borges, L., Passos, M. E.P., Silva, M. B.B., Santos, V. C., Momesso, C. M., Pithon-Curi, T. C., Gorajao, R., Gray, S. R., Lima, K. C.A., de Freitas, P. B., Hatanaka, E. (2019) Dance training improves cytokine secretion and viability of neutrophils in diabetic patients. Mediators of Inflammation, 2019, (doi: 10.1155/2019/2924818)

Hawari, N. S.A., Wilson, J., Gill, J. M.R. (2019) Effects of breaking up sedentary time with "chair squats" on postprandial metabolism. Journal of Sports Sciences, 37, pp. 331-338. (doi: 10.1080/02640414.2018.1500856)

Small, H. Y., Currie, G., Delles, C. (2019) Endothelial dysfunction. Springer

Welsh, P., Iliodromiti, S. (2019) Epidemiology of vascular diseases. Springer

Rush, C. J., Petrie, M. C. (2019) Heart failure with preserved ejection fraction. Springer

Logue, J., Sattar, N., Freeman, D. (2019) Obesity. Springer

(2019) Textbook of Vascular Medicine. (doi: 10.1007/978-3-030-16481-2)

2018

Burri, L., Wyse, C., Gray, S. R., Harris, W. S., Lazzerini, K. (2018) Effects of dietary supplementation with krill meal on serum pro-inflammatory markers after the iditarod sled dog race. Research in Veterinary Science, 121, pp. 18-22. (doi: 10.1016/j.rvsc.2018.10.002)

Jamil, N.A., Yew, M.H., Noor Hafizah, Y., Gray, S.R., Poh, B.K., Macdonald, H.M. (2018) Estimated vitamin D synthesis and dietary vitamin D intake among Asians in two distinct geographical locations (Kuala Lumpur, 3°N versus Aberdeen, 57°N) and climates. Public Health Nutrition, 21, pp. 3118-3124. (doi: 10.1017/S1368980018002057)

Rossitto, G., Touyz, R. M., Petrie, M. C., Delles, C. (2018) Much Ado about N...atrium: modelling tissuesodium as a highly sensitive marker of subclinicaland localized oedema. Clinical Science, 132, pp. 2609-2613. (doi: 10.1042/CS20180575)

Tromp, J., Ouwerkerk, W., Demissei, B.G., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H.L., Lang, C.C., Metra, M., Ng, L.L., Ponikowski, P., Samani, N.J., van Veldhuisen, D.J., Zannad, F., Zwinderman, A.H., Voors, A.A., van der Meer, P. (2018) Novel endotypes in heart failure: effects on guideline-directed medical therapy. European Heart Journal, 39, pp. 4269-4276. (doi: 10.1093/eurheartj/ehy712)

Shiraishi, Y., Nagai, T., Kohsaka, S., Goda, A., Nagatomo, Y., Mizuno, A., Kohno, T., Rigby, A., Fukuda, K., Yoshikawa, T., Clark, A. L., Cleland, J. G.F. (2018) Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide. Clinical Research in Cardiology, 107, pp. 1103-1110. (doi: 10.1007/s00392-018-1283-6)

Salas, C., Petermann-Rocha, F., Celis-Morales, C., Martínez-López, E. J. (2018) Parental support for physical activity in schoolchildren and its influence on nutritional status and fitness = Apoyo parental para realizar actividad física en escolares de 6 años de edad: influencia sobre el estado nutricional y fitness. Revista Chilena de Pediatría, 89, pp. 732-740. (doi: 10.4067/S0370-41062018005000906)

Abuosa, A. M., Elshiekh, A. H., Qureshi, K., Abrar, M. B., Kholeif, M. A., Kinsara, A. J., Andejani, A., Ahmed, A. H., Cleland, J. G.F. (2018) Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin. Indian Heart Journal, 70, pp. S96-S100. (doi: 10.1016/j.ihj.2018.06.011)

Hills, A. P., Misra, A., Gill, J. M.R., Byrne, N. M., Soares, M. J., Ramachandran, A., Palaniappan, L., Street, S. J., Jayawardena, R., Khunti, K., Arena, R. (2018) Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia. Lancet Diabetes and Endocrinology, 6, pp. 992-1002. (doi: 10.1016/S2213-8587(18)30203-1)

Campbell, R. T., Petrie, M. C., McMurray, J. J.V. (2018) Redefining heart failure phenotypes based on ejection fraction. European Journal of Heart Failure, 20, pp. 1634-1635. (doi: 10.1002/ejhf.1325)

Chauhan, A. et al. (2018) Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland. QJM: An International Journal of Medicine, 111, pp. 920-924. (doi: 10.1093/qjmed/hcy193)

Campbell, R. T., Petrie, M. C., McMurray, J. J.V. (2018) Talking to patients with heart failure about end of life. European Journal of Heart Failure, 20, pp. 1763-1765. (doi: 10.1002/ejhf.1321)

Foster, H. M.E., Celis-Morales, C. A., Nicholl, B. I., Petermann, F., Pell, J. P., Gill, J. M.R., O'Donnell, C. A., Mair, F. S. (2018) The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. Lancet Public Health, 3, pp. e576-e585. (doi: 10.1016/S2468-2667(18)30200-7)

Dobbin, S. J.H., Cameron, A. C., Petrie, M. C., Jones, R. J., Touyz, R. M., Lang, N. N. (2018) Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart, 104, pp. 1995-2002. (doi: 10.1136/heartjnl-2018-313726)

Mentz, R. J., Thompson, V. P., Aguilar, D., Choi, J., Gustavson, S. M., Iqbal, N., Kong, A. P., Öhman, P., Sattar, N., Scott, R. S., Wong, Y. W., Holman, R. R., Hernandez, A. F. (2018) Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCEL. Circulation, 138, pp. 2576-2578. (doi: 10.1161/CIRCULATIONAHA.118.036811)

Streng, K. W., Nauta, J. F., Hillege, H. L., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Voors, A. A. (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology, 271, pp. 132-139. (doi: 10.1016/j.ijcard.2018.04.001)

Santema, B. T., Kloosterman, M., Van Gelder, I. C., Mordi, I., Lang, C. C., Lam, C. S.P., Anker, S., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Ter Maaten, J. M., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Rienstra, M., Voors, A. A. (2018) Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. European Heart Journal, 39, pp. 3867-3875. (doi: 10.1093/eurheartj/ehy421)

Wade, K. H., Chiesa, S. T., Hughes, A. D., Chaturvedi, N., Charakida, M., Rapala, A., Muthurangu, V., Khan, T., Finer, N., Sattar, N., Howe, L. D., Fraser, A., Lawlor, D. A., Davey Smith, G., Deanfield, J. E., Timpson, N. J. (2018) Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses. Circulation, 138, pp. 2187-2201. (doi: 10.1161/CIRCULATIONAHA.117.033278)

Cao, T. H., Jones, D. J. L., Quinn, P. A., Chan, D. C. S., Hafid, N., Parry, H. M., Mohan, M., Sandhu, J. K., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Metra, M., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Voors, A. A., Lang, C. C., Ng, L. L. (2018) Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clinical Proteomics, 15, (doi: 10.1186/s12014-018-9213-1)

Ligthart, S. et al. (2018) Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. American Journal of Human Genetics, 103, pp. 691-706. (doi: 10.1016/j.ajhg.2018.09.009)

Celis-Morales, C.A., Petermann, F., Steell, L., Anderson, J., Welsh, P., Mackay, D.F., Iliodromiti, S., Lyall, D.M., Lean, M.E., Pell, J.P., Sattar, N., Gill, J.M.R., Gray, S.R. (2018) Associations of dietary protein intake with fat free mass and grip strength: cross-sectional study in 146,816 UK Biobank participants. American Journal of Epidemiology, 187, pp. 2405-2414. (doi: 10.1093/aje/kwy134)

Wade, K. H., Carslake, D., Sattar, N., Davey Smith, G., Timpson, N. J. (2018) BMI and mortality in UK Biobank: revised estimates using Mendelian randomization. Obesity, 26, pp. 1796-1806. (doi: 10.1002/oby.22313)

Welsh, P., Preiss, D., Shah, A. S.V., McAllister, D., Briggs, A., Boachie, C., McConnachie, A., Hayward, C., Padmanabhan, S., Welsh, C., Woodward, M., Campbell, A., Porteous, D., Mills, N. L., Sattar, N. (2018) Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clinical Chemistry, 64, pp. 1607-1616. (doi: 10.1373/clinchem.2018.292086)

Mahajan, A. et al. (2018) Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nature Genetics, 50, pp. 1505-1513. (doi: 10.1038/s41588-018-0241-6)

Ramírez-Vélez, R., Saavedra, J. M., Lobelo, F., Celis-Morales, C. A., Pozo-Cruz, B. d., García-Hermoso, A. (2018) Ideal cardiovascular health and incident cardiovascular disease among adults: a systematic review and meta-analysis. Mayo Clinic Proceedings, 93, pp. 1589-1599. (doi: 10.1016/j.mayocp.2018.05.035)

Sliz, E. et al. (2018) Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment. Circulation, 138, pp. 2499-2512. (doi: 10.1161/CIRCULATIONAHA.118.034942)

Kristensen, S. L., Rørth, R., Jhund, P. S., Shen, L., Lee, M. M.Y., Petrie, M. C., Køber, L., McMurray, J. J.V. (2018) Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial. European Journal of Heart Failure, 20, pp. 1549-1556. (doi: 10.1002/ejhf.1201)

Troncoso, C., Petermann, F., Brown, R., Leiva, A. M., Martinez, M. A., Diaz-Martinez, X., Garrido-Mendez, A., Poblete-Valderrama, F., Iturra-Gonzalez, J. A., Villagran, M., Mardones, L., Salas-Bravo, C., Ulloa, N., Garcia-Hermoso, A., Ramírez-Vélez, R., Gómez, J. V., Celis-Morales, C. (2018) Patterns of healthy lifestyle behaviours in older adults: findings from the Chilean National Health Survey 2009–2010. Experimental Gerontology, 113, pp. 180-185. (doi: 10.1016/j.exger.2018.09.026)

Narang, R., Saxena, A., Desai, A., Ramakrishnan, S., Thangjam, R. S., Kulkarni, S., Narvencar, K., Jacques' e Costa, A. K., Dias, A., Sukharamwala, R., Cleland, J. (2018) Prevalence and determinants of hypertension in apparently healthy schoolchildren in India: a multi-center study. European Journal of Preventive Cardiology, 25, pp. 1775-1784. (doi: 10.1177/2047487318790056)

Anderson, A. S., Craigie, A. M., Gallant, S., McAdam, C., Macaskill, E. J., Mutrie, N., Neilson, A. R., O'Carroll, R. E., Rauchhaus, P., Sattar, N., Stead, M., Treweek, S. (2018) Randomised controlled trial to assess the impact of a lifestyle intervention (ActWELL) in women invited to NHS breast screening. BMJ Open, 8, (doi: 10.1136/bmjopen-2018-024136)

Zhang, J., Pellicori, P., Pan, D., Dierckx, R., Clark, A.L., Cleland, J.G.F. (2018) Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology, 269, pp. 196-200. (doi: 10.1016/j.ijcard.2018.06.070)

Taylor, R., Adamson, A. J., Sattar, N., Lean, M. E.J., Mathers, J. C. (2018) VLCD for weight loss and remission of type 2 diabetes? - Authors' reply. Lancet, 392, pp. 1307. (doi: 10.1016/S0140-6736(18)31892-0)

Maack, C. et al. (2018) Treatments targeting inotropy. European Heart Journal, (doi: 10.1093/eurheartj/ehy600)

Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G.F., Fu, M., Gheorghiade, M., Lam, C. S.P., Mehra, M. R., Neaton, J. D., Nessel, C. C., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B. (2018) Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. New England Journal of Medicine, 379, pp. 1332-1342. (doi: 10.1056/NEJMoa1808848)

Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J., Sattar, N., Lean, M. E.J. (2018) Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for beta cell recovery. Cell Metabolism, 28, pp. 1-10. (doi: 10.1016/j.cmet.2018.07.003)

Rush, C. J., Campbell, R. T., Jhund, P. S., Petrie, M. C., McMurray, J. J.V. (2018) Association is not causation: treatment effects cannot be estimated from observational data in heart failure. European Heart Journal, 39, pp. 3417-3438. (doi: 10.1093/eurheartj/ehy407)

Shah, P., Pellicori, P., Rimmer, S., Rigby, A. S., Clark, A. L. (2018) Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction. International Journal of Cardiology, 268, pp. 166-169. (doi: 10.1016/j.ijcard.2018.05.029)

Tofte, N. et al. (2018) Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. Diabetic Medicine, 35, pp. 1375-1382. (doi: 10.1111/dme.13669)

Dayan, N., Schlosser, K., Stewart, D. J., Delles, C., Kaur, A., Pilote, L. (2018) Circulating microRNAs implicate multiple atherogenic abnormalities in the long-term cardiovascular sequelae of preeclampsia. American Journal of Hypertension, 31, pp. 1093-1097. (doi: 10.1093/ajh/hpy069)

Cusi, K., Sattar, N., García-Pérez, L.-E., Pavo, I., Yu, M., Robertson, K. E., Karanikas, C. A., Haupt, A. (2018) Dulaglutide decreases plasma aminotransferases in people with type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme. Diabetic Medicine, 35, pp. 1434-1439. (doi: 10.1111/dme.13697)

Sattar, N., Fitchett, D., Hantel, S., George, J. T., Zinman, B. (2018) Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial. Diabetologia, 61, pp. 2155-2163. (doi: 10.1007/s00125-018-4702-3)

Cuthbert, J. J., Pellicori, P., Rigby, A., Pan, D., Kazmi, S., Shah, P., Clark, A. L. (2018) Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. European Journal of Heart Failure, 20, pp. 1426-1435. (doi: 10.1002/ejhf.1247)

Shah, S. J. et al. (2018) One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial. JAMA Cardiology, 3, pp. 968-977. (doi: 10.1001/jamacardio.2018.2936)

Rutter, M. K., Sattar, N. (2018) Personalised blood pressure ranges in type 2 diabetes? Lancet Diabetes and Endocrinology, 6, pp. 761-763. (doi: 10.1016/S2213-8587(18)30002-0)

Wyse, C. A., Celis Morales, C. A., Ward, J., Lyall, D., Smith, D. J., Mackay, D., Curtis, A. M., Bailey, M. E., Biello, S., Gill, J. M.R., Pell, J.P. (2018) Population-level seasonality in cardiovascular mortality, blood pressure, BMI and inflammatory cells in UK Biobank. Annals of Medicine, 50, pp. 410-419. (doi: 10.1080/07853890.2018.1472389)

Keene, D., Arnold, A., Shun-Shin, M. J., Howard, J. P., Sohaib, S. A., Moore, P., Tanner, M., Quereshi, N., Muthumala, A., Chandresekeran, B., Foley, P., Leyva, F., Adhya, S., Falaschetti, E., Tsang, H., Vijayaraman, P., Cleland, J. G.F., Stegemann, B., Francis, D. P., Whinnett, Z. I. (2018) Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. ESC Heart Failure, 5, pp. 965-976. (doi: 10.1002/ehf2.12315)

Halliday, B. P., Gulati, A., Ali, A., Newsome, S., Lota, A., Tayal, U., Vassiliou, V. S., Arzanauskaite, M., Izgi, C., Krishnathasan, K., Singhal, A., Chiew, K., Gregson, J., Frenneaux, M. P., Cook, S. A., Pennell, D. J., Collins, P., Cleland, J. G.F., Prasad, S. K. (2018) Sex and age-based differences in the natural history and outcome of dilated cardiomyopathy. European Journal of Heart Failure, 20, pp. 1392-1400. (doi: 10.1002/ejhf.1216)

Cleland, J. G.F., Clark, R. A. (2018) Telehealth: delivering high-quality care for heart failure. Lancet, 392, pp. 990-991. (doi: 10.1016/S0140-6736(18)31995-0)

Nagai, T., Sundaram, V., Rothnie, K., Quint, J. K., Shoaib, A., Shiraishi, Y., Kohsaka, S., Piper, S., McDonagh, T. A., Hardman, S. M. C., Goda, A., Mizuno, A., Kohno, T., Rigsby, A. S., Yoshikawa, T., Clark, A. L., Anzai, T., Cleland, J. G.F. (2018) Mortality after admission for heart failure in the United Kingdom compared to Japan. Open Heart, 5, (doi: 10.1136/openhrt-2018-000811)

Paul, L., Campbell, E., Gray, C., Brewster, S., Ramsay, A., Gill, J. M.R., McFadyen, A., Dybus, A. (2018) Increasing physical activity in stroke survivors using STARFISH, an interactive smartphone application: protocol for a randomised controlled trial. Technology and Disability, 30, pp. 77-82. (doi: 10.3233/tad-180196)

Tromp, J., Westenbrink, B. D., Oowerkerk, W., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Lang, C. C., Ng, L. L., Zannad, F., Zwinderman, A. H., Hillege, H. L., van der Meer, P., Voors, A. A. (2018) Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. Journal of the American College of Cardiology, 72, pp. 1081-1090. (doi: 10.1016/j.jacc.2018.06.050)

Williams, B. et al. (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39, pp. 3021-3104. (doi: 10.1093/eurheartj/ehy339)

Jenkins, D. A., Bowden, J., Robinson, H. A., Sattar, N., Loos, R. J.F., Rutter, M. K., Sperrin, M. (2018) Adiposity-mortality relationships in type 2 diabetes, coronary heart disease and cancer subgroups in the UK Biobank, and their modification by smoking. Diabetes Care, 41, pp. 1878-1886. (doi: 10.2337/dc17-2508)

Panahi, M., Papanikolaou, A., Torabi, A., Zhang, J.-G., Khan, H., Vazir, A., Hasham, M. G., Cleland, J. G.F., Rosenthal, N. A., Harding, S. E., Sattler, S. (2018) Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition. Cardiovascular Research, 114, pp. 1445-1461. (doi: 10.1093/cvr/cvy145)

Read, S. H., van Diepen, M., Colhoun, H. M., Halbesma, N., Lindsay, R. S., McKinght, J. A., McAllister, D. A., Pearson, E. R., Petrie, J. R., Philip, S., Sattar, N., Woodward, M., Wild, S. H. (2018) Performance of cardiovascular disease risk scores in people diagnosed with type 2 diabetes: external validation using data from the national Scottish diabetes register. Diabetes Care, 41, pp. 2010-2018. (doi: 10.2337/dc18-0578)

Gulati, A., Japp, A. G., Raza, S., Halliday, B. P., Jones, D. A., Newsome, S., Ismail, N. A., Morarji, K., Khwaja, J., Spath, N., Shakespeare, C., Kalra, P. R., Lloyd, G., Mathur, A., Cleland, J. G.F., Cowie, M. R., Assomull, R. G., Pennell, D. J., Ismail, T. F., Prasad, S. K. (2018) Absence of myocardial fibrosis predicts favorable long-term survival in new-onset heart failure: a cardiovascular magnetic resonance study. Circulation: Cardiovascular Imaging, 11, (doi: 10.1161/CIRCIMAGING.118.007722)

Steell, L., Garrido-Méndez, A., Petermann, F., Díaz-Martínez, X., Martínez, M. A., Leiva, A. M., Salas-Bravo, C., Alvarez, C., Ramirez-Campillo, R., Cristi-Montero, C., Rodríguez, F., Poblete-Valderrama, F., Floody, P. D., Aguilar-Farias, N., Willis, N. D., Celis-Morales, C. A. (2018) Active commuting is associated with a lower risk of obesity, diabetes and metabolic syndrome in Chilean adults. Journal of Public Health, 40, pp. 508-516. (doi: 10.1093/pubmed/fdx092)

Ravassa, S., Trippel, T., Bach, D., Bachran, D., González, A., López, B., Wachter, R., Hasenfuss, G., Delles, C., Dominiczak, A. F., Pieske, B., Díez, J., Edelmann, F. (2018) Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial. European Journal of Heart Failure, 20, pp. 1290-1299. (doi: 10.1002/ejhf.1194)

McDowell, K., Petrie, M. C., Raihan, N. A., Logue, J. (2018) Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obesity Reviews, 19, pp. 1189-1204. (doi: 10.1111/obr.12707)

van der Laan, S. W., Siemelink, M. A., Haitjema, S., Foroughi Asl, H., Perisic, L., Mokry, M., van Setten, J., Malik, R., Dichgans, M., Worrall, B. B., Samani, N. J., Schunkert, H., Erdmann, J., Hedin, U., Paulsson-Berne, G., Björkegrenn, J. L.M., de Borst, G. J., Asselbergs, F. W., den Ruijter, F. W., de Bakker, P. I.W., Pasterkamp, G., Ford, I., Sattar, N., Stott, D. J. (2018) Genetic susceptibility loci for cardiovascular disease and their impact on atherosclerotic plaques. Circulation: Genomic and Precision Medicine, 11, (doi: 10.1161/CIRCGEN.118.002115)

Díaz-Martínez, X., Steell, L., Martinez, M. A., Leiva, A. M., Salas-Bravo, C., Labraña, A. M., Duran, E., Cristi-Montero, C., Livingstone, K. M., Garrido-Méndez, A., Alvarez, C., Poblete-Valderrama, F., Luisa Zagalaz, M., Valdivia-Moral, P., Cuadra, L., Ulloa, N., Willis, N. D., Celis-Morales, C. A. (2018) Higher levels of self-reported sitting time is associated with higher risk of type 2 diabetes independent of physical activity in Chile. Journal of Public Health, 40, pp. 501-507. (doi: 10.1093/pubmed/fdx091)

Carrick, D., Haig, C., Maznyczka, A. M., Carberry, J., Mangion, K., Ahmed, N., May, V. T. Y., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ford, I., Radjenovic, A., Welsh, P., Sattar, N., Wetherall, K., Oldroyd, K. G., Berry, C. (2018) Hypertension, microvascular pathology and prognosis after an acute myocardial infarction. Hypertension, 72, pp. 720-730. (doi: 10.1161/HYPERTENSIONAHA.117.10786)

McEntegart, M. B., Corcoran, D., Carrick, D., Clerfond, G., Sidik, N., Collison, D., Robertson, K. R., Shaukat, A., Watkins, S., Rocchicholi, P. R., Eteiba, H., Petrie, M. P., Lindsay, M. M., Oldroyd, K. G., Berry, C. (2018) Incidence of procedural myocardial infarction and cardiac magnetic resonance imaging-detected myocardial injury following percutaneous coronary intervention with rotational atherectomy. EuroIntervention, 14, pp. 819-823. (doi: 10.4244/EIJ-D-17-01077)

Álvarez, C., Ramírez-Vélez, R., Ramírez-Campillo, R., Shigenori, I., Celis-Morales, C., García-Hermoso, A., Rodriguez-Mañas, L., Lucia, A., Izquierdo, M. (2018) Interindividual responses to different exercise stimuli among insulin-resistant women. Scandinavian Journal of Medicine and Science in Sports, 28, pp. 2052-2065. (doi: 10.1111/sms.13213)

Cristi-Montero, C., Steell, L., Petermann, F., Garrido-Méndez, A., Díaz-Martínez, X., Salas-Bravo, C., Ramirez-Campillo, R., Alvarez, C., Rodriguez, F., Aguilar-Farias, N., Martinez, M. A., Leiva, A. M., Poblete-Valderrama, F., Willis, N. D., Celis-Morales, C. (2018) Joint effect of physical activity and sedentary behaviour on cardiovascular risk factors in Chilean adults. Journal of Public Health, 40, pp. 485-492. (doi: 10.1093/pubmed/fdx134)

Carberry, J., Carrick, D., Haig, C., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2018) Persistent iron within the infarct core after ST-segment elevation myocardial infarction: implications for left ventricular remodeling and health outcomes. JACC: Cardiovascular Imaging, 11, pp. 1248-1256. (doi: 10.1016/j.jcmg.2017.08.027)

Boakye, D., Wyse, C.A., Morales-Celis, C.A., Biello, S.M., Bailey, M.E.S., Dare, S., Ward, J., Gill, J.M.R., Pell, J.P., Mackay, D.F. (2018) Tobacco exposure and sleep disturbance in 498 208 UK Biobank participants. Journal of Public Health, 40, pp. 517-526. (doi: 10.1093/pubmed/fdx102)

Streng, K. W., Voors, A. A., Hillege, H. L., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhusen, D. J., Zwinderman, A. H., Zannad, F., Damman, K., van der Meer, P., Lang, C. C. (2018) Waist-to-hip ratio and mortality in heart failure. European Journal of Heart Failure, 20, pp. 1269-1277. (doi: 10.1002/ejhf.1244)

Campbell, R. T., Petrie, M. C., Jackson, C. E., Jhund, P. S., Wright, A., Gardner, R. S., Sonecki, P., Pozzi, A., McSkimming, P., McConnachie, A., Finlay, F., Davidson, P., Denvir, M. A., Johnson, M. J., Hogg, K. J., McMurray, J. J.V. (2018) Which patients with heart failure should receive specialist palliative care? European Journal of Heart Failure, 20, pp. 1338-1347. (doi: 10.1002/ejhf.1240)

Rawshani, A., Rawshani, A., Franzén, S., Sattar, N., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., McGuire, D. K., Rosengren, A., Gudbjörnsdottir, S. (2018) Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 379, pp. 633-644. (doi: 10.1056/NEJMoa1800256)

Alexander, M., Loomis, A. K., Fairburn-Beech, J., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., Avillach, P., Egger, P., Kendrick, S., Waterworth, D. M., Sattar, N., Alazawi, W. (2018) Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Medicine, 16, (doi: 10.1186/s12916-018-1103-x)

Rawshani, A., Sattar, N., Franzén, S., Rawshani, A., Hattersley, A. T., Svensson, A.-M., Eliasson, B., Gudbjörnsdottir, S. (2018) Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet, 392, pp. 477-486. (doi: 10.1016/S0140-6736(18)31506-X)

Muilwijk, M., Vaz, F. M., Celis-Morales, C., Peters, R. J.G., van Valkengoed, I. G.M. (2018) The association of acylcarnitines and amino acids with age in Dutch and South-Asian Surinamese living in Amsterdam. Journal of Clinical Endocrinology and Metabolism, 103, pp. 3783-3791. (doi: 10.1210/jc.2018-00809)

Sze, S., Pellicori, P., Kamzi, S., Anton, A., Clark, A. L. (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. International Journal of Cardiology, 264, pp. 104-112. (doi: 10.1016/j.ijcard.2018.03.089)

Bodde, M. C., Welsh, P., Bergheanu, S. C., Lijfering, W. M., Mertens, B., Liem, A.-H., van der Laarse, A., Sattar, N., Jukema, J.W. (2018) A rapid (differential) effect of rosuvastatin and atorvastatin on high-sensitivity cardiac Troponin-I in subjects with stable cardiovascular disease. Clinical Pharmacology and Therapeutics, 104, pp. 311-316. (doi: 10.1002/cpt.1095)

Gillis, K., Stevens, K. K., Bell, E., Patel, R. K., Jardine, A. G., Morris, S. T.W., Schneider, M. P., Delles, C., Mark, P. B. (2018) Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease. Clinical Kidney Journal, 11, pp. 532-539. (doi: 10.1093/ckj/sfx158)

Yew, S. N., Carrick, D., Corcoran, D., Ahmed, N., Carberry, J., May, V. T. Y., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davie, A., Mahrous, A., Mordi, I., Ford, I., Oldroyd, K. G., Berry, C. (2018) Coronary thermodilution waveforms after acute reperfused ST‐segment–elevation myocardial infarction: relation to microvascular obstruction and prognosis. Journal of the American Heart Association, 7, (doi: 10.1161/JAHA.118.008957)

Wessler, J., Kaye, D., Gustafsson, F., Petrie, M. C., Hasenfuβ, G., Lam, C. S.P., Borlaug, B. A., Komtebedde, J., Feldman, T., Shah, S. J., Burkhoff, D. (2018) Impact of baseline hemodynamics on the effects of a transcatheter interatrial shunt device in heart failure with preserved ejection fraction. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004540)

Jenkins, A. J., Welsh, P., Petrie, J. R. (2018) Metformin, lipids and atherosclerosis prevention. Current Opinion in Lipidology, 29, pp. 346-353. (doi: 10.1097/MOL.0000000000000532)

Bennett-Britton, I., Teyhan, A., Macleod, J., Sattar, N., Davey Smith, G., Ben-Shlomo, Y. (2018) Response to: 'On the approach for determining association between changes in marital quality and cardiovascular disease risk factors' by MM Pike. Journal of Epidemiology and Community Health, 72, pp. 759-760. (doi: 10.1136/jech-2018-210797)

Nagai, T., Sundaram, V., Shoaib, A., Shiraishi, Y., Kohsaka, S., Rothnie, K. J., Piper, S., McDonagh, T. A., Hardman, S. M.C., Goda, A., Mizuno, A., Sawano, M., Rigby, A. S., Quint, J. K., Yoshikawa, T., Clark, A. L., Anzai, T., Cleland, J. G.F. (2018) Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan. European Journal of Heart Failure, 20, pp. 1179-1190. (doi: 10.1002/ejhf.1210)

Muilwijk, M., Nicolaou, M., Qureshi, S. A., Celis-Morales, C., Gill, J. M.R., Sheikh, A., Sattar, N., Beune, E., Jenum, A. K., Stronks, K., van Valkengoed, I. G.M. (2018) Dietary and physical activity recommendations to prevent type 2 diabetes in South Asian adults: a systematic review. PLoS ONE, 13, (doi: 10.1371/journal.pone.0200681)

Borges, L., Dermargos, A., Gray, S., Barros Silva, M. B., Santos, V., Pithon-Curi, T. C., Gorjão, R., Hatanaka, E. (2018) Neutrophil migration and adhesion molecule expression after acute high-intensity street dance exercise. Journal of Immunology Research, 2018, (doi: 10.1155/2018/1684013)

Colombo, M., Looker, H. C., Farran, B., Agakov, F., Brosnan, M.J., Welsh, P., Sattar, N., Livingstone, S., Durrington, P. N., Betteridge, D.J., McKeigue, P. M., Colhoun, H. M. (2018) Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. Atherosclerosis, 274, pp. 182-190. (doi: 10.1016/j.atherosclerosis.2018.05.014)

Burgess, S. et al. (2018) Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies. JAMA Cardiology, 3, pp. 619-627. (doi: 10.1001/jamacardio.2018.1470)

Solomon, S. D. et al. (2018) Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.118.004962)

Welsh, P., Rankin, N., Li, Q., Mark, P. B., Würtz, P., Ala-Korpela, M., Marre, M., Poulter, N., Hamet, P., Chalmers, J., Woodward, M., Sattar, N. (2018) Circulating amino acids and the risk of macrovascular, microvascular, and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. Diabetologia, 61, pp. 1581-1591. (doi: 10.1007/s00125-018-4619-x)

Palazzuoli, A., Ruocco, G., Beltrami, M., Nuti, R., Cleland, J. G. (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clinical Research in Cardiology, 107, pp. 586-596. (doi: 10.1007/s00392-018-1221-7)

Ghouri, N., Hussain, S., Mohammed, R., Beshyah, S. A., Chowdhury, T. A., Sattar, N., Sheikh, A. (2018) Diabetes, driving and fasting during Ramadan: the interplay between secular and religious law. BMJ Open Diabetes Research and Care, 6, (doi: 10.1136/bmjdrc-2018-000520)

Nichols, S., Gleadall-Siddall, D.O., Antony, R., Clark, A.L., Cleland, J.G.F., Carroll, S., Ingle, L. (2018) Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation? Clinical Physiology and Functional Imaging, 38, pp. 681-688. (doi: 10.1111/cpf.12468)

Pellicori, P., Cleland, J. G.F., Clark, A. L. (2018) Losing track by tracking speckles. JACC: Cardiovascular Imaging, 11, pp. 1038-1039. (doi: 10.1016/j.jcmg.2018.04.027)

Sartor, F., Papini, G., Cox, L. G. E., Cleland, J. (2018) Methodological shortcomings of wrist-worn heart rate monitors validations. Journal of Medical Internet Research, 20, (doi: 10.2196/10108)

Ford, T. J., Corcoran, D., Oldroyd, K. G., McEntegart, M., Rocchiccioli, P., Watkins, S., Brooksbank, K., Padmanabhan, S., Sattar, N., Briggs, A., McConnachie, A., Touyz, R., Berry, C. (2018) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. American Heart Journal, 201, pp. 86-94. (doi: 10.1016/j.ahj.2018.03.010)

West, J., Lawlor, D. A., Santorelli, G., Collings, P., Whincup, P. H., Sattar, N. A., Farrar, D., Wright, J. (2018) Associations of social and economic and pregnancy exposures with blood pressure in UK White British and Pakistani children age 4/5. Scientific Reports, 8, (doi: 10.1038/s41598-018-27316-1)

Rørth, R., Jhund, P. S., Mogensen, U. M., Kristensen, S. L., Petrie, M. C., Køber, L., McMurray, J. J.V. (2018) Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction. Diabetes Care, 41, pp. 1285-1291. (doi: 10.2337/dc17-2583)

Petermann, F., Villagrán, M., Troncoso, C., Mardones, L., Leiva, A. M., Martínez, M. A., Garrido-Méndez, A., Poblete-Valderrama, F., Salas-Bravo, C., Ramírez-Vélez, R., Ulloa, N., Pérez-Bravo, F., Celis-Morales, C. (2018) Asociación entre el polimorfismo rs9939609 del gen FTO y marcadores de adiposidad en población adulta chilena = Association between FTO (ns9939609) genotype and adiposity markers in Chilean adults. Revista Medica de Chile, 146, pp. 717-726. (doi: 10.4067/s0034-98872018000600717)

Lyall, L. M., Wyse, C. A., Graham, N., Ferguson, A., Lyall, D. M., Cullen, B., Celis Morales, C. A., Biello, S. M., Mackay, D., Ward, J., Strawbridge, R. J., Gill, J. M.R., Bailey, M. E.S., Pell, J. P., Smith, D. J. (2018) Association of disrupted circadian rhythmicity with mood disorders, subjective wellbeing, and cognitive function: a cross-sectional study of 91 105 participants from the UK Biobank. Lancet Psychiatry, 5, pp. 507-514. (doi: 10.1016/S2215-0366(18)30139-1)

Welsh, C., Welsh, P., Mark, P. B., Celis-Morales, C. A., Lewsey, J., Gray, S. R., Lyall, D. M., Iliodromiti, S., Gill, J. M.R., Pell, J., Jhund, P. S., Sattar, N. (2018) Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, pp. 1415-1423. (doi: 10.1161/ATVBAHA.118.310945)

Dickstein, K. et al. (2018) CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? European Journal of Heart Failure, 20, pp. 1039-1051. (doi: 10.1002/ejhf.1142)

García-Hermoso, A., Ramírez-Vélez, R., Celis-Morales, C. A., Olloquequi, J., Izquierdo, M. (2018) Can physical activity attenuate the negative association between sitting time and cognitive function among older adults? A mediation analysis. Experimental Gerontology, 106, pp. 173-177. (doi: 10.1016/j.exger.2018.03.002)

Ginsberg, H. N., Farnier, M., Robinson, J. G., Cannon, C. P., Sattar, N., Baccara-Dinet, M. T., Letierce, A., Bujas-Bobanovic, M., Louie, M. J., Colhoun, H. M. (2018) Efficacy and safety of alirocumab in individuals with Diabetes Mellitus: pooled analyses from five placebo-controlled phase 3 studies. Diabetes Therapy, 9, pp. 1317-1334. (doi: 10.1007/s13300-018-0439-8)

Zymliński, R., Biegus, J., Sokolski, M., Siwołowski, P., Nawrocka-Millward, S., Todd, J., Jankowska, E. A., Banasiak, W., Cotter, G., Cleland, J. G., Ponikowski, P. (2018) Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion. European Journal of Heart Failure, 20, pp. 1011-1018. (doi: 10.1002/ejhf.1156)

Sliwa, K., Petrie, M. C., Hilfiker-Kleiner, D., Mebazaa, A., Jackson, A., Johnson, M. R., van der Meer, P., Mbakwem, A., Bauersachs, J. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 20, pp. 951-962. (doi: 10.1002/ejhf.1178)

Perera, D., Clayton, T., Petrie, M. C., Greenwood, J. P., O'Kane, P. D., Evans, R., Sculpher, M., Mcdonagh, T., Gershlick, A., de Belder, M., Redwood, S., Carr-White, G., Marber, M. (2018) Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy. JACC: Heart Failure, 6, pp. 517-526. (doi: 10.1016/j.jchf.2018.01.024)

Sze, S., Pellicori, P., Kazmi, S., Rigby, A., Cleland, J. G.F., Wong, K., Clark, A. L. (2018) Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index. JACC: Heart Failure, 6, pp. 476-486. (doi: 10.1016/j.jchf.2018.02.018)

Corcoran, D., Ford, T. J., Hsu, L.-Y., Chiribiri, A., Orchard, V., Mangion, K., McEntegart, M., Rocchiccioli, P., Watkins, S., Good, R., Brooksbank, K., Padmanabhan, S., Sattar, N., McConnachie, A., Oldroyd, K. G., Touyz, R. M., Arai, A., Berry, C. (2018) Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study. Open Heart, 5, (doi: 10.1136/openhrt-2018-000924)

Ambrosy, A. P., Mentz, R. J., Fiuzat, M., Cleland, J. G.F., Greene, S. J., O'Connor, C. M., Teerlink, J. R., Zannad, F., Solomon, S. D. (2018) The role of angiotensin receptor–neprilysin inhibitors in cardiovascular disease—existing evidence, knowledge gaps, and future directions. European Journal of Heart Failure, 20, pp. 963-972. (doi: 10.1002/ejhf.1159)

Moreton, F. C., Cullen, B., Delles, C., Santosh, C., Lopez Gonzalez, R., Dani, K., Muir, K. W. (2018) Vasoreactivity in CADASIL: comparison to structural MRI and neuropsychology. Journal of Cerebral Blood Flow and Metabolism, 38, pp. 1085-1095. (doi: 10.1177/0271678X17710375)

Celis-Morales, C., Lyall, D. M., Steell, L., Gray, S. R., Iliodromiti, S., Anderson, J., Mackay, D. F., Welsh, P., Yates, T., Pell, J. P., Sattar, N., Gill, J. M.R. (2018) Associations of discretionary screen time with mortality, cardiovascular disease and cancer are attenuated by strength, fitness and physical activity: findings from the UK Biobank study. BMC Medicine, 16, (doi: 10.1186/s12916-018-1063-1)

Celis-Morales, C. A., Welsh, P., Lyall, D. M., Steell, L., Petermann, F., Anderson, J., Iliodromiti, S., Sillars, A., Graham, N., Mackay, D. F., Pell, J. P., Gill, J. M.R., Sattar, N., Gray, S. R. (2018) Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. British Medical Journal, 361, (doi: 10.1136/bmj.k1651)

Rubio-Gracia, J., Demissei, B. G., ter Maaten, J. M., Cleland, J. G., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., Dittrich, H., Damman, K., Pérez-Calvo, J. I., Voors, A. A. (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. International Journal of Cardiology, 258, pp. 185-191. (doi: 10.1016/j.ijcard.2018.01.067)

Iliodromiti, S., Celis-Morales, C. A., Lyall, D. M., Anderson, J., Gray, S. R., Mackay, D. F., Nelson, S. M., Welsh, P., Pell, J. P., Gill, J. M.R., Sattar, N. (2018) The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. European Heart Journal, 39, pp. 1514-1520. (doi: 10.1093/eurheartj/ehy057)

Ferrari, R., Bueno, H., Chioncel, O., Cleland, J. G., Stough, W. G., Lettino, M., Metra, M., Parissis, J. T., Pinto, F., Ponikowski, P., Ruschitzka, F., Tavazzi, L. (2018) Acute heart failure: lessons learned, roads ahead. European Journal of Heart Failure, 20, pp. 842-850. (doi: 10.1002/ejhf.1169)

Salvi, D., Ottaviano, M., Muuraiskangas, S., Martınez-Romero, A., Vera-Munoz, C., Triantafyllidis, A., Cabrera Umpierrez, M. F., Arredondo Waldmeyer, M. T., Skobel, E., Knackstedt, C., Liedes, H., Honka, A., Luprano, J., Cleland, J. G.F., Stut, W., Deighan, C. (2018) An m-health system for education and motivation in cardiac rehabilitation: the experience of heartcycle guided exercise. Journal of Telemedicine and Telecare, 24, pp. 303-316. (doi: 10.1177/1357633X17697501)

Petermann, F., Díaz-Martínez, X., Garrido-Méndez, Á., Leiva, A. M., Martínez, M. A., Salas, C., Poblete-Valderrama, F., Celis-Morales, C. (2018) Asociación entre diabetes mellitus tipo 2 y actividad física en personas con antecedentes familiares de diabetes = Association between type 2 diabetes and physical activity in individuals with family history of diabetes. Gaceta Sanitaria, 32, pp. 230-235. (doi: 10.1016/j.gaceta.2017.09.008)

Vaucher, J., Keating, B.J., Lasserre, A.M., Gan, W., Lyall, D.M., Ward, J., Smith, D.J., Pell, J.P., Sattar, N., Paré, G., Holmes, M.V. (2018) Cannabis use and risk of schizophrenia: a Mendelian randomization study. Molecular Psychiatry, 23, pp. 1287-1292. (doi: 10.1038/mp.2016.252)

Díaz-Martínez, X., Petermann, F., Leiva, A. M., Garrido-Méndez, A., Salas-Bravo, C., Martínez, M. A., Labraña, A. M., Duran, E., Valdivia-Moral, P., Zagalaz, M. L., Poblete-Valderrama, F., Alvarez, C., Celis-Morales, C. (2018) No cumplir con las recomendaciones de actividad física se asocia a mayores niveles de obesidad, diabetes, hipertensión y síndrome metabólico en población chilena = Association of physical inactivity with obesity, diabetes, hypertension and metabolic syndrome in the chilean population. Revista Medica de Chile, 146, pp. 585-595. (doi: 10.4067/s0034-98872018000500585)

Jackson, A. M., Dalzell, J. R., Walker, N. L., Coats, C. J., Jhund, P. S., Petrie, M. C. (2018) Peripartum cardiomyopathy: diagnosis and management. Heart, 104, pp. 779-786. (doi: 10.1136/heartjnl-2016-310599)

Beusekamp, J. C., Tromp, J., van der Wal, H. H., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Rossignol, P., Zannad, F., Voors, A. A., van der Meer, P. (2018) Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction. European Journal of Heart Failure, 20, pp. 923-930. (doi: 10.1002/ejhf.1079)

Metra, M., Cotter, G., Senger, S., Edwards, C., Cleland, J. G., Ponikowski, P., Cursack, G. C., Milo, O., Teerlink, J. R., Givertz, M. M., O’Connor, C. M., Dittrich, H. C., Bloomfield, D. M., Voors, A. A., Davison, B. A. (2018) Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion. Circulation: Heart Failure, 11, (doi: 10.1161/CIRCHEARTFAILURE.117.004644)

Cosmi, F. et al. (2018) Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. European Journal of Heart Failure, 20, pp. 888-895. (doi: 10.1002/ejhf.1146)

Seferović, P. M. et al. (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 20, pp. 853-872. (doi: 10.1002/ejhf.1170)

Lygirou, V., Latosinska, A., Makridakis, M., Mullen, W., Delles, C., Schanstra, J. P., Zoidakis, J., Pieske, B., Mischak, H., Vlahou, A. (2018) Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease. Journal of Translational Medicine, 16, (doi: 10.1186/s12967-018-1476-9)

Wood, A. M. et al. (2018) Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet, 391, pp. 1513-1523. (doi: 10.1016/S0140-6736(18)30134-X)

Dontje, M. L., Dall, P. M., Skelton, D. A., Gill, J. M.R., Chastin, S. F.M. (2018) Reliability, minimal detectable change and responsiveness to change: Indicators to select the best method to measure sedentary behaviour in older adults in different study designs. PLoS ONE, 13, (doi: 10.1371/journal.pone.0195424)

Currie, G. E., von Scholten, B. J., Mary, S., Flores Guerrero, J.-L., Lindhardt, M., Reinhard, H., Jacobsen, P. K., Mullen, W., Parving, H.-H., Mischak, H., Rossing, P., Delles, C. (2018) Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria. Cardiovascular Diabetology, 17, (doi: 10.1186/s12933-018-0697-9)

Delles, C., Currie, G. (2018) Sex differences in hypertension and other cardiovascular diseases. Journal of Hypertension, 36, pp. 768-770. (doi: 10.1097/HJH.0000000000001655)

Fröhlich, H., Henning, F., Täger, T., Schellberg, D., Grundtvig, M., Goode, K., Corletto, A., Kazmi, S., Hole, T., Katus, H. A., Atar, D., Cleland, J. G.F., Agewall, S., Frankenstein, L., Clark, A. L. (2018) Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study. European Heart Journal: Cardiovascular Pharmacotherapy, 4, pp. 82-92. (doi: 10.1093/ehjcvp/pvx013)

Petrie, M. C., Rocchiccioli, P. (2018) Coronary angiography in heart failure: when and why? Uncertainty reigns. Heart, 104, pp. 548-549. (doi: 10.1136/heartjnl-2017-312200)

Ferreira, J. P., Rossignol, P., Demissei, B., Sharma, A., Girerd, N., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Voors, A., Zannad, F. (2018) Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart, 104, pp. 606-613. (doi: 10.1136/heartjnl-2017-311750)

Griffin, S. J., Bethel, M. A., Holman, R. R., Khunti, K., Wareham, N., Brierley, G., Davies, M., Dymond, A., Eichenberger, R., Evans, P., Gray, A., Greaves, C., Harrington, K., Hitman, G., Irving, G., Lessels, S., Millward, A., Petrie, J. R., Rutter, M., Sampson, M., Sattar, N., Sharp, S. (2018) Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Health Technology Assessment, 22, (doi: 10.3310/hta22180)

Malik, R. et al. (2018) Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics, 50, pp. 524-537. (doi: 10.1038/s41588-018-0058-3)

Delles, C., Rankin, N. J., Boachie, C., McConnachie, A., Ford, I., Kangas, A., Soininen, P., Trompet, S., Mooijaart, S. P., Jukema, J. W., Zannad, F., Ala-Korpela, M., Salomaa, V., Havulinna, A. S., Welsh, P., Würtz, P., Sattar, N. (2018) Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. European Journal of Heart Failure, 20, pp. 663-673. (doi: 10.1002/ejhf.1076)

Dennis, J. M., Shields, B. M., Hill, A. V., Knight, B. A., McDonald, T. J., Rodgers, L. R., Weedon, M. N., Henley, W. E., Sattar, N., Holman, R. R., Pearson, E. R., Hattersley, A. T., Jones, A. G. (2018) Precision medicine in type 2 diabetes: clinical markers of insulin resistance are associated with altered short- and long-term glycemic response to DPP-4 inhibitor therapy. Diabetes Care, 41, pp. 705-712. (doi: 10.2337/dc17-1827)

Sokoreli, I., Pauws, S. C., Steyerberg, E. W., de Vries, G.-J., Riistama, J. M., Tesanovic, A., Kazmi, S., Pellicori, P., Cleland, J. G., Clark, A. L. (2018) Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study. European Journal of Heart Failure, 20, pp. 689-696. (doi: 10.1002/ejhf.1112)

Mahajan, A. et al. (2018) Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nature Genetics, 50, pp. 559-571. (doi: 10.1038/s41588-018-0084-1)

Da Boit, M., Tommasi, S., Elliott, D., Zinellu, A., Sotgia, S., Sibson, R., Meakin, J.R., Aspden, R.M., Carru, C., Mangoni, A.A., Gray, S.R. (2018) Sex differences in the associations between L-arginine pathway metabolites, skeletal muscle mass and function, and their responses to resistance exercise, in old age. Journal of Nutrition, Health and Aging, 22, pp. 534-540. (doi: 10.1007/s12603-017-0964-6)

Botha, S., Forde, L., MacNaughton, S., Shearer, R., Lindsay, R., Sattar, N., Morrison, D., Welsh, P., Logue, J. (2018) The effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: a comparison of interventional and non-interventional outcomes at three years. Diabetes, Obesity and Metabolism, 20, pp. 879-888. (doi: 10.1111/dom.13171)

Linde, C., Cleland, J. G.F., Gold, M. R., Daubert, J. C., Tang, A. S.L., Young, J. B., Sherfesee, L., Abraham, W. T. (2018) The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis. European Journal of Heart Failure, 20, pp. 780-791. (doi: 10.1002/ejhf.1133)

Lyall, L. M., Wyse, C. A., Celis Morales, C. A., Lyall, D. M., Cullen, B., Mackay, D., Ward, J., Graham, N., Strawbridge, R. J., Gill, J. M.R., Ferguson, A., Bailey, M. E.S., Pell, J. P., Curtis, A. M., Smith, D. J. (2018) Seasonality of depressive symptoms in women but not in men: a cross-sectional study in the UK Biobank cohort. Journal of Affective Disorders, 229, pp. 296-305. (doi: 10.1016/j.jad.2017.12.106)

von Birgelen, C., Kok, M. M., Sattar, N., Zocca, P., Doelman, C., Kant, G. D., Löwik, M. M., van der Heijden, L. C., Sen, H., van Houwelingen, K. G., Stoel, M. G., Louwerenburg, J. H. W., Hartmann, M., de Man, F. H.A.F., Linssen, G. C.M., Doggen, C. J.M., Tandjung, K. (2018) "Silent" diabetes and clinical outcome after treatment with contemporary drug-eluting stents: the BIO-RESORT silent diabetes study. JACC: Cardiovascular Interventions, 11, pp. 448-459. (doi: 10.1016/j.jcin.2017.10.038)

Lee, M. M.Y. et al. (2018) Non-Invasive Versus Invasive Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: Comparisons Between the Randomized Controlled Pilot Trial and Registry. (doi: 10.1016/S0735-1097(18)30586-2)

Čukić, I., Shaw, R., Der, G., Chastin, S. F.M., Dontje, M. L., Gill, J. M.R., Starr, J. M., Skelton, D. A., Radaković, R., Cox, S. R., Dall, P. M., Gale, C. R., Deary, I. J. (2018) Cognitive ability does not predict objectively measured sedentary behaviour: evidence from three older cohorts. Psychology and Aging, 33, pp. 288-296. (doi: 10.1037/pag0000221)

Leiva, A. M., Martínez, M. A., Petermann, F., Garrido-Méndez, A., Poblete-Valderrama, F., Díaz-Martínez, X., Celis-Morales, C. (2018) Factores asociados al desarrollo de diabetes mellitus tipo 2 en Chile = Risk factors associated with type 2 diabetes in Chile. Nutricion Hospitalaria, 35, pp. 400-407. (doi: 10.20960/nh.1434)

Feng, Y.-M., Thijs, L., Zhang, Z.-Y., Yang, W.-Y., Huang, Q.-F., Wei, F.-F., Kuznetsova, T., Jennings, A.-M., Delles, C., Lennox, R., Verhamme, P., Dominiczak, A., Staessen, J. A. (2018) Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population. Nephrology Dialysis Transplantation, 33, pp. 426-435. (doi: 10.1093/ndt/gfx256)

Parsons, T. J., Sartini, C., Welsh, P., Sattar, N., Ash, S., Lennon, L. T., Wannamethee, S. G., Lee, I.-M., Whincup, P. H., Jefferis, B. J. (2018) Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men. International Journal of Cardiology, 254, pp. 322-327. (doi: 10.1016/j.ijcard.2017.11.003)

Gho, J. M.I.H., Schmidt, A. F., Pasea, L., Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Shah, A. D., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G., Hemingway, H., Asselbergs, F. W. (2018) An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors. BMJ Open, 8, (doi: 10.1136/bmjopen-2017-018331)

Edqvist, J., Rawshani, A., Adiels, M., Björck, L., Lind, M., Svensson, A.-M., Gudbjörnsdottir, S., Sattar, N., Rosengren, A. (2018) BMI and mortality in patients with new-onset type 2 diabetes: a comparison with age- and sex-matched control subjects from the general population. Diabetes Care, 41, pp. 458-493. (doi: 10.2337/dc17-1309)

Taylor, R., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Sattar, N., Welsh, P., Peters, C., Zhyzhneuskaya, S., Hollingsworth, K. G., Al-Mrabeh, A., Rodrigues, A. M., Rehackova, L., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., Ross, H. M., McIlvenna, Y., Kean, S., Ford, I., McConnachie, A., Lean, M. E.J. (2018) Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort. Diabetologia, 61, pp. 589-598. (doi: 10.1007/s00125-017-4503-0)

Gray, S. R., Mittendorfer, B. (2018) Fish oil-derived n-3 polyunsaturated fatty acids for the prevention and treatment of sarcopenia. Current Opinion in Clinical Nutrition and Metabolic Care, 21, pp. 104-109. (doi: 10.1097/MCO.0000000000000441)

Carru, C., Da Boit, M., Paliogiannis, P., Zinellu, A., Sotgia, S., Sibson, R., Meakin, J. R., Aspden, R. M., Mangoni, A. A., Gray, S. R. (2018) Markers of oxidative stress, skeletal muscle mass and function, and their responses to resistance exercise training in older adults. Experimental Gerontology, 103, pp. 101-106. (doi: 10.1016/j.exger.2017.12.024)

Greene, S. J., Vaduganathan, M., Khan, M. S., Bakris, G. L., Weir, M. R., Seltzer, J. H., Sattar, N., McGuire, D. K., Januzzi, J. L., Stockbridge, N., Butler, J. (2018) Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes. Journal of the American College of Cardiology, 71, pp. 1379-1390. (doi: 10.1016/j.jacc.2018.01.047)

Steinarsson, A. O., Rawshani, A., Gudbjörnsdottir, S., Franzén, S., Svensson, A.-M., Sattar, N. (2018) Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register. Diabetologia, 61, pp. 599-606. (doi: 10.1007/s00125-017-4532-8)

Stewart, R. A.H., Szalewska, D., Stebbins, A., Al-Khalidi, H. R., Cleland, J. G.H., Rynkiewicz, A., Drazner, M. H., White, H. D., Mark, D. B., Roy, A., Kosevic, D., Rajda, M., Jasinski, M., Leng, C. Y., Tungsubutra, W., Desvigne-Nickens, P., Velazquez, E. J., Petrie, M. C. (2018) Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy. Open Heart, 5, (doi: 10.1136/openhrt-2017-000752)

Gill, J. M.R., Hawari, N. S.A., Maxwell, D. J., Louden, D., Mourselas, N., Bunn, C., Gray, C. M., van der Ploeg, H. P., Hunt, K., Martin, A., Wyke, S., Mutrie, N. (2018) Validation of a novel device to measure and provide feedback on sedentary behavior. Medicine and Science in Sports and Exercise, 50, pp. 525-532. (doi: 10.1249/MSS.0000000000001458)

Petrie, M. C., Connelly, D. T., Gardner, R. S. (2018) Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISH. European Journal of Heart Failure, 20, pp. 413-416. (doi: 10.1002/ejhf.1135)

Velazquez, E. J., Petrie, M. C. (2018) CABG or PCI for diabetic patients with left ventricular dysfunction: closing in on the truth? Journal of the American College of Cardiology, 71, pp. 828-831. (doi: 10.1016/j.jacc.2018.01.014)

Chastin, S.F.M., Dontje, M.L., Skelton, D.A., Čukić, I., Shaw, R.J., Gill, J.M.R., Greig, C.A., Gale, C.R., Deary, I., Der, G., Dall, P.M. (2018) Systematic comparative validation of self-report measures of sedentary time against an objective measure of postural sitting (activPAL) International Journal of Behavioral Nutrition and Physical Activity, 15, (doi: 10.1186/s12966-018-0652-x)

Nelson, S. M., Haig, C., McConnachie, A., Sattar, N., Ring, S. M., Smith, G. D., Lawlor, D. A., Lindsay, R. S. (2018) Maternal thyroid function and child educational attainment: prospective cohort study. British Medical Journal, 360, (doi: 10.1136/bmj.k452)

ter Maaten, J. M., Voors, A. A., Damman, K., van der Meer, P., Anker, S. D., Cleland, J. G.F., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., Metra, M., Navis, G., Ng, L., Ouwerkerk, W., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., de Borst, M. H. (2018) Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. International Journal of Cardiology, 253, pp. 84-90. (doi: 10.1016/j.ijcard.2017.10.010)

Lean, M. E.J. et al. (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet, 391, pp. 541-551. (doi: 10.1016/S0140-6736(17)33102-1)

Conrad, N., Judge, A., Tran, J., Mohseni, H., Hedgecott, D., Crespillo, A. P., Allison, M., Hemingway, H., Cleland, J. G., McMurray, J. J.V., Rahimi, K. (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet, 391, pp. 10-16. (doi: 10.1016/S0140-6736(17)32520-5)

Wang, Q., Ferreira, D. L. S., Nelson, S. M., Sattar, N., Ala-Korpela, M., Lawlor, D. A. (2018) Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Medicine, 16, (doi: 10.1186/s12916-018-1008-8)

Chavan-Gautam, P., Rani, A., Freeman, D. J. (2018) Distribution of fatty acids and lipids during pregnancy. Elsevier

Corcoran, D., Young, R., Cialdella, P., McCartney, P., Bajrangee, A., Hennigan, B., Collison, D., Carrick, D., Shaukat, A., Good, R., Watkins, S., McEntegart, M., Watt, J., Welsh, P., Sattar, N., McConnachie, A., Oldroyd, K.G., Berry, C. (2018) The effects of remote ischaemic preconditioning on coronary artery function in patients with stable coronary artery disease. International Journal of Cardiology, 252, pp. 24-30. (doi: 10.1016/j.ijcard.2017.10.082)

Currie, G., Delles, C. (2018) Blood pressure targets in the elderly. Journal of Hypertension, 36, pp. 234-236. (doi: 10.1097/HJH.0000000000001576)

Wild, S. H., Walker, J. J., Morling, J. R., McAllister, D. A., Colhoun, H. M., Farran, B., McGurnaghan, S., McCrimmon, R., Read, S. H., Sattar, N., Byrne, C. D. (2018) Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care, 41, pp. 341-347. (doi: 10.2337/dc17-1590)

Welsh, P. (2018) Correlating changes in metabolic status with arterial health: modest associations but any clinical implications? Hypertension, 71, pp. 227-228. (doi: 10.1161/HYPERTENSIONAHA.117.10595)

Toth, P. P., Sattar, N., Blom, D. J., Martin, S. S., Jones, S. R., Monsalvo, M. L., Elliott, M., Davis, M., Somaratne, R., Preiss, D. (2018) Effect of evolocumab on lipoprotein particles. American Journal of Cardiology, 121, pp. 308-314. (doi: 10.1016/j.amjcard.2017.10.028)

Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Numé, A.-k., Gislason, G. H.,, Jhund, P. S., Petrie, M. C., McMurray, J. J.V., Torp-Pedersen, C., Køber, L., Kristensen, S. L. (2018) Employment status at time of first hospitalization for heart failure is associated with death and rehospitalization for heart failure. European Journal of Heart Failure, 20, pp. 240-247. (doi: 10.1002/ejhf.1046)

Ferguson, L.D., Ntuk, U.E., Celis-Morales, C., Mackay, D.F., Pell, J.P., Gill, J.M.R., Sattar, N. (2018) Men across a range of ethnicities have a higher prevalence of diabetes: findings from a cross-sectional study of 500000 UK Biobank participants. Diabetic Medicine, 35, pp. 270-276. (doi: 10.1111/dme.13551)

Cleland, J. G.F. (2018) Physicians Addicted to Prescribing Aspirin-a Disorder Of Cardiologists (PAPA-DOC) Syndrome: the headache of nonevidence-based medicine for ischemic heart disease? JACC: Heart Failure, 6, pp. 168-171. (doi: 10.1016/j.jchf.2017.11.014)

Nikolaidou, T., Pellicori, P., Zhang, J., Kazmi, S., Goode, K. M., Cleland, J. G., Clark, A. L. (2018) Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure. Clinical Research in Cardiology, 107, pp. 108-119. (doi: 10.1007/s00392-017-1162-6)

Welsh, P., Kou, L., Yu, C., Anand, I., van Veldhuisen, D. J., Maggioni, A. P., Desai, A. S., Solomon, S. D., Pfeffer, M. A., Cheng, S., Gullestad, L., Aukrust, P., Ueland, T., Swedberg, K., Young, J. B., Kattan, M. W., Sattar, N., McMurray, J. J.V. (2018) Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. European Journal of Heart Failure, 20, pp. 268-277. (doi: 10.1002/ejhf.988)

Emmens, J. E., Jones, D. J.L., Cao, T. H., Chan, D. C.S., Romaine, S. P.R., Quinn, P. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., de Boer, R. A., Voors, A. A., Ng, L. L. (2018) Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. European Journal of Heart Failure, 20, pp. 260-267. (doi: 10.1002/ejhf.1101)

Anderson, J. J., Darwis, N. D.M., Mackay, D. F., Celis-Morales, C., Lyall, D. M., Sattar, N., Gill, J. M.R., Pell, J. P. (2018) Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis. European Journal of Cancer, 90, pp. 73-82. (doi: 10.1016/j.ejca.2017.11.022)

Cotter, G., Metra, M., Davison, B. A., Jondeau, G., Cleland, J. G.F., Bourge, R. C., Milo, O., O'Connor, C. M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Kobrin, I., Rainisio, M., Senger, S., Edwards, C., McMurray, J. J.V., Teerlink, J. R. (2018) Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? European Journal of Heart Failure, 20, pp. 317-322. (doi: 10.1002/ejhf.889)

Stoumpos, S., Lees, J., Welsh, P., Hund, M., Geddes, C. C., Nelson, S. M., Mark, P. B. (2018) The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reproductive BioMedicine Online, 36, pp. 219-226. (doi: 10.1016/j.rbmo.2017.11.003)

Ouwerkerk, W., Zwinderman, A. H., Ng, L. L., Demissei, B., Hillege, H. L., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Metra, M., ter Maaten, J. M., Lang, C. C., van der Harst, P., Filippatos, G., Dickstein, K., Cleland, J. G., Anker, S. D., Voors, A. A. (2018) Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF. Journal of the American College of Cardiology, 71, pp. 386-398. (doi: 10.1016/j.jacc.2017.11.041)

Feldman, T., Mauri, L., Kahwash, R., Litwin, S., Ricciardi, M. J., van der Harst, P., Penicka, M., Fail, P. S., Kaye, D. M., Petrie, M. C., Basuray, A., Hummel, S. L., Forde-McLean, R., Nielsen, C. D., Lilly, S., Massaro, J. M., Burkhoff, D., Shah, S. J. (2018) Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A phase 2, randomized, sham-controlled trial. Circulation, 137, pp. 364-375. (doi: 10.1161/CIRCULATIONAHA.117.032094)

Onyiaodike, C. C., Murray, H. M., Zhang, R., Meyer, B. J., Jordan, F., Brown, E. A., Nibbs, R. J.B., Lyall, H., Sattar, N., Nelson, S. M., Freeman, D. J. (2018) Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer. Scientific Reports, 8, (doi: 10.1038/s41598-018-19500-0)

Jiang, X. et al. (2018) Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nature Communications, 9, (doi: 10.1038/s41467-017-02662-2)

Gale, C. R. et al. (2018) The epigenetic clock and objectively measured sedentary and walking behavior in older adults: the Lothian Birth Cohort 1936. Clinical Epigenetics, 10, (doi: 10.1186/s13148-017-0438-z)

Cleland, J. G.F., Flather, M. D., Altman, D. G., Kotecha, D. (2018) Reply: an incomplete story. Journal of the American College of Cardiology, 71, pp. 105. (doi: 10.1016/j.jacc.2017.10.078)

Cleland, J. G.F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J.S., Manzano, L., McMurray, J. J.V., Ruschitzka, F., van Veldhuisen, D. J., von Lueder, T. G., Böhm, M., Andersson, B., Kjekshus, J., Packer, M., Rigby, A. S., Rosano, G., Wedel, H., Hjalmarson, Å., Wikstrand, J., Kotecha, D. (2018) Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. European Heart Journal, 39, pp. 26-35. (doi: 10.1093/eurheartj/ehx564)

Fallaize, R., Livingstone, K. M., Celis-Morales, C., Macready, A. L., San-Cristobal, R., Navas-Carretero, S., Marsaux, C. F.M., O'Donovan, C. B., Kolossa, S., Moschonis, G., Walsh, M. C., Gibney, E. R., Brennan, L., Bouwman, J., Manios, Y., Jarosz, M., Martinez, J. A., Daniel, H., Saris, W. H.M., Gundersen, T. E., Drevon, C. A., Gibney, M. J., Mathers, J. C., Lovegrove, J. A. (2018) Association between diet-quality scores, adiposity, total cholesterol and markers of nutritional status in European adults: findings from the Food4Me study. Nutrients, 10, (doi: 10.3390/nu10010049)

West, J., Santorelli, G., Whincup, P. H., Smith, L., Sattar, N. A., Cameron, N., Farrar, D., Collings, P., Wright, J., Lawlor, D. A. (2018) Association of maternal exposures with adiposity at age 4/5 years in white British and Pakistani children: findings from the Born in Bradford study. Diabetologia, 61, pp. 242-252. (doi: 10.1007/s00125-017-4457-2)

Pellicori, P., Urbinati, A., Zhang, J., Joseph, A. C., Costanzo, P., Lukaschuk, E., Capucci, A., Cleland, J. G.F., Clark, A. L. (2018) Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study. Clinical Cardiology, 41, pp. 20-27. (doi: 10.1002/clc.22840)

Patel, N., Hellmuth, C., Uhl, O., Godfrey, K., Briley, A., Welsh, P., Pasupathy, D., Seed, P., Koletzko, B., Poston, L. (2018) Cord metabolic profiles In obese pregnant women; insights into offspring growth and body composition. Journal of Clinical Endocrinology and Metabolism, 103, pp. 346-355. (doi: 10.1210/jc.2017-00876)

Rørth, R., Fosbøl, E. L., Mogensen, U. M., Kragholm, K., Jhund, P. S., Petrie, M. C., Schou, M., Gislason, G. H., McMurray, J. J.V., Torp-Pedersen, C., Køber, L., Kristensen, S. L. (2018) Evidence based therapy and its association with workforce detachment following first hospitalization for heart failure. JACC: Heart Failure, 6, pp. 41-48. (doi: 10.1016/j.jchf.2017.09.019)

Martínez, M. A., Leiva, A. M., Petermann, F., Garrido, A., Díaz, X., Álvarez, C., Salas, C., Cristi, C., Rodríguez, F., Aguilar, N., Ramírez, R., Celis, C. (2018) Factores asociados a sedentarismo en Chile: evidencia de la Encuesta Nacional de Salud 2009-2010 = Correlates of sedentary behaviors in Chile: evidence from the National Health Survey 2009-2010. Revista Medica de Chile, 146, pp. 22-31. (doi: 10.4067/s0034-98872018000100022)

Read, S.H., McAllister, D.A., Colhoun, H.M., Farran, B., Fischbacher, C., Kerssens, J.J., Leese, G.P., Lindsay, R.S., McCrimmon, R.J., McGurnaghan, S., Philip, S., Sattar, N., Wild, S.H. (2018) Incident ischaemic stroke and Type 2 diabetes: trends in incidence and case fatality in Scotland 2004–2013. Diabetic Medicine, 35, pp. 99-106. (doi: 10.1111/dme.13528)

Gray, S. R., Aird, T. P., Farquharson, A. J., Horgan, G. W., Fisher, E., Wilson, J., Hopkins, G. E., Anderson, B., Ahmad, S. A., Davis, S. R., Drew, J. E. (2018) Inter-individual responses to sprint interval training, a pilot study investigating interactions with the sirtuin system. Applied Physiology, Nutrition and Metabolism, 43, pp. 84-93. (doi: 10.1139/apnm-2017-0224)

Floyd, J.S. et al. (2018) Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics Journal, 18, pp. 127-135. (doi: 10.1038/tpj.2016.90)

Muilwijk, M., Celis-Morales, C., Nicolaou, M., Snijder, M. B., Gill, J. M.R., van Valkengoed, I. G.M. (2018) Plasma cholesteryl ester fatty acids do not mediate the association of ethnicity with type 2 diabetes: results from the HELIUS study. Molecular Nutrition and Food Research, 62, (doi: 10.1002/mnfr.201700528)

Lee, M. M.Y. et al. (2018) Routine Non-invasive vs Invasive Management in Patients With Prior CABG With a NSTE-ACS: a Randomised Controlled Trial. (doi: 10.1136/heartjnl-2018-BCIS.9)

Walker, J., Colhoun, H., Livingstone, S., McCrimmon, R., Petrie, J., Sattar, N., Wild, S. (2018) Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study. Diabetologia, 61, pp. 108-116. (doi: 10.1007/s00125-017-4478-x)

Celis-Morales, C. et al. (2018) Correlates of overall and central obesity in adults from seven European countries: findings from the Food4Me Study. European Journal of Clinical Nutrition, 72, pp. 207-219. (doi: 10.1038/s41430-017-0004-y)

Davison, G., Aldred, S., Nikolaidis, M. G., Gray, S. (2018) From physiology and nutrition to biological sciences, and back again! Journal of Sports Sciences, 36, pp. 1195-1195. (doi: 10.1080/02640414.2018.1429559)

Tommasi, S., Elliot, D.J., Da Boit, M., Gray, S.R., Lewis, B.C., Mangoni, A.A. (2018) Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance. Scientific Reports, 8, (doi: 10.1038/s41598-018-22099-x)

Noonan, J., Asiala, S. M., Grassia, G., MacRitchie, N., Gracie, K., Carson, J., Moores, M., Girolami, M., Bradshaw, A. C., Guzik, T. J., Meehan, G. R., Scales, H. E., Brewer, J. M., McInnes, I. B., Sattar, N., Faulds, K., Garside, P., Graham, D., Maffia, P. (2018) In vivo multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopy. Theranostics, 8, pp. 6195-6209. (doi: 10.7150/thno.28665)

Petermann, F., Leiva, A. M., Martínez, M. A., Salas, C., Garrido-Méndez, A., Luarte-Rocha, C., Díaz, X., Cuadrado, C., Celis-Morales, C. (2018) Inactividad física y obesidad ¿cuál es su repercusión en el gasto económico de diabetes mellitus 2 en Chile? = Physical inactivity and obesity: What are the implications for diabetes expenditures in Chile? Revista Chilena de Nutrición, 45, pp. 91-92. (doi: 10.4067/s0717-75182018000100091)

McAllister, D. A., Read, S., Kerssens, J., Livingstone, S., McGurnaghan, S., Jhund, P., Petrie, J., Sattar, N., Fischbacher, C., Kristensen, S. L., McMurray, J., Colhoun, H. M., Wild, S. (2018) Incidence of hospitalisation for heart failure and case-fatality among 3.25 million people with and without diabetes. Circulation, 138, pp. 2774-2785. (doi: 10.1161/CIRCULATIONAHA.118.034986)

Rørth, R., Fosbøl, E. L., Kragholm, K., Mogensen, U. M., Jhund, P. S., Petrie, M. C., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2018) Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure: a nationwide cohort study. Clinical Epidemiology, 10, pp. 917-930. (doi: 10.2147/CLEP.S164795)

Petermann, F., Labraña, A. M., Durán, E., Martínez, M. A., Leiva, A., Garrido-Méndez, A., Celis-Morales, C. (2018) Repetido, pero cierto: una alimentación saludable es la clave para una mejor salud = Repeated but true: healthy eating is the key to better health. Revista Chilena de Nutrición, 45, pp. 89-90. (doi: 10.4067/s0717-75182018000100089)

Layland, J., Tong, D., Lee, M., Berry, C. (2018) ST and T-Wave Abnormality as Footprint of Myocardial Oedema in Non–ST-Elevation Myocardial Infarction. (doi: 10.1016/j.hlc.2018.06.515)

Bouabdallaoui, N. et al. (2018) Society of Thoracic Surgeons risk score and EuroSCORE-2 appropriately assess 30-day postoperative mortality in the STICH trial and a contemporary cohort of patients with left ventricular dysfunction undergoing surgical revascularization. Circulation: Heart Failure, 11, (doi: 10.1161/circheartfailure.118.005531)

Delles, C., Carrick, E., Graham, D., Nicklin, S. A. (2018) Utilising proteomics to understand and define hypertension: where are we and where do we go? Expert Review of Proteomics, 15, pp. 581-592. (doi: 10.1080/14789450.2018.1493927)

2017

Grimaldi, K. A. et al. (2017) Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice. Genes and Nutrition, 12, (doi: 10.1186/s12263-017-0584-0)

Dybus, A., Paul, L., Wyke, S., Brewster, S., Gill, J. M.R., Ramsay, A., Campbell, E. (2017) Validation of smartphone step count algorithm used in STARFISH smartphone application. Technology and Health Care, 25, pp. 1157-1162. (doi: 10.3233/thc-170970)

Celis-Morales, C. A., Petermann, F., Hui, L., Lyall, D. M., Iliodromiti, S., McLaren, J., Anderson, J., Welsh, P., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R., Gray, S. R. (2017) Associations between diabetes and both cardiovascular disease and all-cause mortality are modified by grip strength: evidence from UK Biobank, a prospective population-based cohort study. Diabetes Care, 40, pp. 1710-1718. (doi: 10.2337/dc17-0921)

San-Cristobal, R. et al. (2017) Capturing health and eating status through a nutritional perception screening questionnaire (NPSQ9) in a randomised internet-based personalised nutrition intervention: the Food4Me study. International Journal of Behavioral Nutrition and Physical Activity, 14, (doi: 10.1186/s12966-017-0624-6)

Kaye, D. M., Silvestry, F. E., Gustafsson, F., Cleland, J. G., van Veldhuisen, D. J., Ponikowski, P., Komtebedde, J., Nanayakkara, S., Burkhoff, D., Shah, S. J. (2017) Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction. European Journal of Heart Failure, 19, pp. 1690-1697. (doi: 10.1002/ejhf.930)

Hilfiker-Kleiner, D., Haghikia, A., Masuko, D., Nonhoff, J., Held, D., Libhaber, E., Petrie, M. C., Walker, N. L., Podewski, E., Berliner, D., Bauersachs, J., Sliwa, K. (2017) Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. European Journal of Heart Failure, 19, pp. 1723-1728. (doi: 10.1002/ejhf.808)

Carberry, J., Carrick, D., Haig, C., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2017) Persistence of infarct zone T2 hyperintensity at 6 months after acute ST-elevation myocardial infarction: incidence, pathophysiology and prognostic implications. Circulation: Cardiovascular Imaging, 10, (doi: 10.1161/CIRCIMAGING.117.006586)

Kristensen, S. L., Jhund, P. S., Lee, M. M.Y., Køber, L., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., McMurray, J. J.V. (2017) Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes. Cardiovascular Drugs and Therapy, 31, pp. 545-549. (doi: 10.1007/s10557-017-6754-x)

Yates, T., Zaccardi, F., Dhalwani, N. N., Davies, M. J., Bakrania, K., Celis-Morales, C. A., Gill, J. M.R., Franks, P. W., Khunti, K. (2017) Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK biobank observational study. European Heart Journal, 38, pp. 3232-3240. (doi: 10.1093/eurheartj/ehx449)

Krochmal, M., Kontostathi, G., Magalhães, P., Makridakis, M., Klein, J., Husi, H., Leierer, J., Mayer, G., Bascands, J.-L., Denis, C., Zoidakis, J., Zürbig, P., Delles, C., Schanstra, J. P., Mischak, H., Vlahou, A. (2017) Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy. Scientific Reports, 7, (doi: 10.1038/s41598-017-15359-9)

Vieira, M. C., White, S. L., Patel, N., Seed, P. T., Briley, A. L., Sandall, J., Welsh, P., Sattar, N., Nelson, S. M., Lawlor, D. A., Poston, L., Pasupathy, D. (2017) Prediction of uncomplicated pregnancies in obese women: a prospective multicentre study. BMC Medicine, 15, (doi: 10.1186/s12916-017-0956-8)

Gabriel, B. M., Al-Tarrah, M., Alhindi, Y., Kilikevicius, A., Venckunas, T., Gray, S. R., Lionikas, A., Ratkevicius, A. (2017) H55N polymorphism is associated with low citrate synthase activity which regulates lipid metabolism in mouse muscle cells. PLoS ONE, 12, (doi: 10.1371/journal.pone.0185789)

Sartini, C., Whincup, P. H., Wannamethee, S. G., Jefferis, B. J., Lennon, L., Lowe, G. D.O., Welsh, P., Sattar, N., Morris, R. W. (2017) Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study. BMJ Open, 7, (doi: 10.1136/bmjopen-2017-018264)

Bennett-Britton, I., Teyhan, A., Macleod, J., Sattar, N., Davey Smith, G., Ben-Shlomo, Y. (2017) Changes in marital quality over 6 years and its association with cardiovascular disease risk factors in men: findings from the ALSPAC prospective cohort study. Journal of Epidemiology and Community Health, 71, pp. 1094-1100. (doi: 10.1136/jech-2017-209178)

Díaz-Martínez, X., Petermann, F., Salas-Bravo, C., Garrido-Méndez, A., Martínez, M. A., Leiva, A. M., Alvarez, C., Valdivia-Moral, P., Zagalaz, M. L., Durán, E., Labraña, A. M., Poblete-Valderrama, F., Celis-Morales, C. (2017) Efectos de la actividad física sobre la asociación entre obesidad y diabetes mellitus tipo 2: resultados de la Encuesta Nacional de Salud 2009-2010 = The association between adiposity and diabetes is modified by physical activity. Revista Medica de Chile, 145, pp. 1394-1402. (doi: 10.4067/s0034-98872017001101394)

Sattar, N., Toth, P. P., Blom, D. J., Koren, M. J., Soran, H., Uhart, M., Elliott, M., Cyrille, M., Somaratne, R., Preiss, D. (2017) Effect of the proprotein convertase subtilisin/kexin type 9 inhibitor evolocumab on glycemia, body weight, and new-onset diabetes mellitus. American Journal of Cardiology, 120, pp. 1521-1527. (doi: 10.1016/j.amjcard.2017.07.047)

Shah, P., Pellicori, P., Macnamara, A., Urbinati, A., Clark, A. L. (2017) Is swimming safe in heart failure? A systematic review. Cardiology in Review, 25, pp. 321-325. (doi: 10.1097/CRD.0000000000000154)

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., McMurray, J. J., Rydén, L., Schröder, S., Sun, Y., Theodorakis, M. J., Tendera, M., Tucker, L., Tuomilehto, J., Wei, Y., Yang, W., Wang, D., Hu, D., Pan, C., ACE Study Group, (2017) Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes and Endocrinology, 5, pp. 877-886. (doi: 10.1016/S2213-8587(17)30309-1)

Wong, C. M., Hawkins, N. M., Ezekowitz, J. A., Jhund, P. S., Savu, A., MacDonald, M. R., Kristensen, S. L., Petrie, M. C., McMurray, J. J.V., McAlister, F. A., Kaul, P. (2017) Heart failure in young adults is associated with high mortality: a contemporary population-level analysis. Canadian Journal of Cardiology, 33, pp. 1472-1477. (doi: 10.1016/j.cjca.2017.05.009)

Rodríguez-Rodríguez, F., Cristi-Montero, C., Celis-Morales, C., Escobar-Gómez, D., Chillón, P. (2017) Impact of distance on mode of active commuting in Chilean children and adolescents. International Journal of Environmental Research and Public Health, 14, (doi: 10.3390/ijerph14111334)

Pontillo, C. et al. (2017) Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker. Kidney International Reports, 2, pp. 1066-1075. (doi: 10.1016/j.ekir.2017.06.004)

Welsh, P., Grassia, G., Botha, S., Sattar, N., Maffia, P. (2017) Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? British Journal of Pharmacology, 174, pp. 3898-3913. (doi: 10.1111/bph.13818)

Schmieder, R. E., Wagner, F., Mayr, M., Delles, C., Ott, C., Keicher, C., Hrabak-Paar, M., Heye, T., Aichner, S., Khder, Y., Yates, D., Albrecht, D., Langenickel, T., Freyhardt, P., Janka, R., Bremerich, J. (2017) The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. European Heart Journal, 38, pp. 3308-3317. (doi: 10.1093/eurheartj/ehx525)

Butler, J. et al. (2017) The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. European Journal of Heart Failure, 19, pp. 1390-1400. (doi: 10.1002/ejhf.933)

O’Donovan, C. B. et al. (2017) Metabotyping for the development of tailored dietary advice solutions in a European population: the Food4Me study. British Journal of Nutrition, 118, pp. 561-569. (doi: 10.1017/S0007114517002069)

Rutherford, E., Mangion, K., Mccomb, C., Bell, E., Cockburn, S., Talle, M., Roditi, G., Welsh, P., Woodward, R., Radjenovic, A., Struthers, A. D., Jardine, A., Berry, C., Patel, R. K., Mark, P. B. (2017) Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study. Scientific Reports, 7, (doi: 10.1038/s41598-017-14481-y)

Bayes-Genis, A., Núñez, J., Zannad, F., Ferreira, J. P., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Lang, C. C., Ng, L. L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Metra, M., Lupón, J., Voors, A. A. (2017) The PCSK9-LDL receptor axis and outcomes in heart failure: BIOSTAT-CHF subanalysis. Journal of the American College of Cardiology, 70, pp. 2128-2136. (doi: 10.1016/j.jacc.2017.08.057)

Joshi, P. K. et al. (2017) Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity. Nature Communications, 8, (doi: 10.1038/s41467-017-00934-5)

Díaz-Martínez, X., Garrido, A., Martínez, M. A., Leiva, A. M., Álvarez, C., Ramírez-Campillo, R., Cristi-Montero, C., Rodríguez, F., Salas-Bravo, C., Durán, E., Abraña, A. M., Valdivia-Moral, P., Zagalaz, M. L., Aguilar-Farías, N., Celis-Morales, C. A. (2017) Factores asociados a inactividad física en Chile: resultados de la Encuesta Nacional de Salud 2009-2010 = Correlates of physical inactivity: Findings from the Chilean National Health Survey 2009-2010. Revista Medica de Chile, 145, pp. 1259-1267. (doi: 10.4067/S0034-98872017001001259)

Kohli-Lynch, C.N., Boyd, K., Briggs, A., Delles, C. (2017) A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease. (doi: 10.1016/j.jval.2017.08.040)

Sharma, A., Demissei, B. G., Tromp, J., Hillege, H. L., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Davison, B. A., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van Veldhuisen, D. J., Cotter, G., Ezekowitz, J. A., Khan, M. A.F., Voors, A. A. (2017) A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. European Journal of Heart Failure, 19, pp. 1310-1320. (doi: 10.1002/ejhf.912)

Celis-Morales, C., Leiva, A., Martínez, M. A., Durán, E., Labraña, A. M., Petermann, F., Garrido-Mendez, A., Díaz, X., Salas, C., Poblete-Valderrama, F. (2017) Aumento del índice de masa corporal durante las últimas cuatro décadas en la población chilena: de la desnutrición a la obesidad = Increase in body mass index during the last four decades in Chile: from undernutrition to obesity. Revista Medica de Chile, 145, pp. 1363-1364. (doi: 10.4067/S0034-98872017001001363)

Johns, E., Sattar, N. (2017) Cardiovascular and mortality risks in migrant South Asians with type 2 diabetes: are we winning the battle? Current Diabetes Reports, 17, (doi: 10.1007/s11892-017-0929-5)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B., Kettlewell, S., Smith, G. L., Clancy, M. J., Delles, C., Jardine, A. G. (2017) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, 32, pp. 1617-1627. (doi: 10.1093/ndt/gfw252)

Roberts, C. E., Phillips, L. H., Cooper, C. L., Gray, S., Allan, J. L. (2017) Effect of different types of physical activity on activities of daily living in older adults: systematic review and meta-analysis. Journal of Aging and Physical Activity, 25, pp. 653-670. (doi: 10.1123/japa.2016-0201)

Zhao, W. et al. (2017) Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nature Genetics, 49, pp. 1450-1457. (doi: 10.1038/ng.3943)

San-Cristobal, R. et al. (2017) Mediterranean diet adherence and genetic background roles within a web-based nutritional intervention: The Food4Me study. Nutrients, 9, (doi: 10.3390/nu9101107)

White, S. L., Pasupathy, D., Sattar, N., Nelson, S. M., Lawlor, D. A., Briley, A. L., Seed, P. T., Welsh, P., Poston, L. (2017) Metabolic profiling of gestational diabetes in obese women during pregnancy. Diabetologia, 60, pp. 1903-1912. (doi: 10.1007/s00125-017-4380-6)

Ferreira, J. P., Rossignol, P., Machu, J.-L., Sharma, A., Girerd, N., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ter Maaten, J., Metra, M., Ng, L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zwinderman, A. H., Voors, A., Zannad, F. (2017) Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. European Journal of Heart Failure, 19, pp. 1284-1293. (doi: 10.1002/ejhf.900)

Nassif, M. E., Tang, Y., Cleland, J. G.F., Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Daubert, J. C., Sherfesee, L., Schaber, D., Tang, A. S.L., Jones, P. G., Arnold, S. V., Spertus, J. A. (2017) Precision medicine for cardiac resynchronization: predicting quality of life benefits for individual patients-an analysis from 5 clinical trials. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.117.004111)

Toth, P. P., Worthy, G., Gandra, S. R., Sattar, N., Bray, S., Cheng, L.-I., Bridges, I., Worth, G. M., Dent, R., Forbes, C. A., Deshpande, S., Ross, J., Kleijnen, J., Stroes, E. S.G. (2017) Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.005367)

Jayabalan, N., Nair, S., Nuzhat, Z., Rice, G. E., Zúñiga, F. A., Sobrevia, L., Leiva, A., Sanhueza, C., Agustin Gutierrez, J., Lappas, M., Freeman, D. J., Salomon, C. (2017) Cross talk between adipose tissue and placenta in obese and gestational diabetes mellitus pregnancies via exosomes. Frontiers in Endocrinology, 8, (doi: 10.3389/fendo.2017.00239)

Robertson, J., Porter, D., Sattar, N., Packard, C. J., Caslake, M., McInnes, I., McCarey, D. (2017) Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis. Annals of the Rheumatic Diseases, 76, pp. 1949-1952. (doi: 10.1136/annrheumdis-2017-211708)

McCombie, L., Leslie, W., Taylor, R., Kennon, B., Sattar, N., Lean, M. E.J. (2017) Beating type 2 diabetes into remission. British Medical Journal, 358, (doi: 10.1136/bmj.j4030)

Cleland, J. G.F., Halliday, B. P., Prasad, S. K. (2017) Selecting patients with nonischemic dilated cardiomyopathy for ICDs. Journal of the American College of Cardiology, 70, pp. 1228-1231. (doi: 10.1016/j.jacc.2017.07.748)

Ridker, P. M. et al. (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377, pp. 1119-1131. (doi: 10.1056/NEJMoa1707914)

Fröhlich, H., Torres, L., Täger, T., Schellberg, D., Corletto, A., Kazmi, S., Goode, K., Grundtvig, M., Hole, T., Katus, H. A., Cleland, J. G.F., Atar, D., Clark, A. L., Agewall, S., Frankenstein, L. (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clinical Research in Cardiology, 106, pp. 711-721. (doi: 10.1007/s00392-017-1115-0)

Wannamethee, S. G., Welsh, P., Papacosta, O., Ellins, E. A., Halcox, J. P.J., Whincup, P. H., Sattar, N. (2017) Circulating soluble receptor for advanced glycation end product: cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis, 264, pp. 36-43. (doi: 10.1016/j.atherosclerosis.2017.07.008)

Sliwa, K., Mebazaa, A., Hilfiker-Kleiner, D., Petrie, M. C., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., van der Meer, P., Roos-Hesselink, J. W., Seferovic, P., van Spandonck-Zwarts, K., Mbakwem, A., Böhm, M., Mouquet, F., Pieske, B., Hall, R., Ponikowski, P., Bauersachs, J. (2017) Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) European Journal of Heart Failure, 19, pp. 1131-1141. (doi: 10.1002/ejhf.780)

Price, A. H., Weir, C. J., Welsh, P., McLachlan, S., Strachan, M. W.J., Sattar, N., Price, J. F. (2017) Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Atherosclerosis, 264, pp. 67-73. (doi: 10.1016/j.atherosclerosis.2017.07.009)

Cleland, J. G.F. (2017) Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! European Journal of Heart Failure, 19, pp. 1086-1088. (doi: 10.1002/ejhf.697)

Bagot, C.N., Leishman, E., Onyiaodike, C.C., Jordan, F., Freeman, D.J. (2017) Normal pregnancy is associated with an increase in thrombin generation from the very early stages of the first trimester. Thrombosis Research, 157, pp. 49-54. (doi: 10.1016/j.thromres.2017.06.027)

Koudstaal, S., Pujades-Rodriguez, M., Denaxas, S., Gho, J. M.I.H., Shah, A. D., Yu, N., Patel, R. S., Gale, C. P., Hoes, A. W., Cleland, J. G.F., Asselbergs, F. W., Hemingway, H. (2017) Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. European Journal of Heart Failure, 19, pp. 1119-1127. (doi: 10.1002/ejhf.709)

Rudnicka, A. R., Nightingale, C. M., Donin, A. S., Sattar, N., Cook, D. G., Whincup, P. H., Owen, C. G. (2017) Sleep duration and risk of type 2 diabetes. Pediatrics, 140, (doi: 10.1542/peds.2017-0338)

Ferguson, L. D., Sattar, N. (2017) Impact of obesity on cardiovascular disease. Springer International Publishing

Krochmal, M., Cisek, K., Filip, S., Markoska, K., Orange, C., Zoidakis, J., Gakiopoulou, C., Spasovski, G., Mischak, H., Delles, C., Vlahou, A., Jankowski, J. (2017) Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis. Scientific Reports, 7, (doi: 10.1038/s41598-017-09393-w)

Gao, X., Salomon, C., Freeman, D. J. (2017) Extracellular vesicles from adipose tissue - a potential role in obesity and type 2 diabetes? Frontiers in Endocrinology, 8, (doi: 10.3389/fendo.2017.00202)

Januzzi, J. L., Butler, J., Jarolim, P., Sattar, N., Vijapurkar, U., Desai, M., Davies, M. J. (2017) Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. Journal of the American College of Cardiology, 70, pp. 704-712. (doi: 10.1016/j.jacc.2017.06.016)

Willeit, P., Welsh, P., Evans, J. D.W., Tschiderer, L., Boachie, C., Jukema, J. W., Ford, I., Trompet, S., Stott, D. J., Kearney, P. M., Mooijaart, S. P., Kiechl, S., Di Angelantonio, E., Sattar, N. (2017) High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes: literature-based meta-analysis involving 154,052 participants. Journal of the American College of Cardiology, 70, pp. 558-568. (doi: 10.1016/j.jacc.2017.05.062)

Ntuk, U.E., Celis-Morales, C.A., Mackay, D.F., Sattar, N., Pell, J.P., Gill, J.M.R. (2017) Association between grip strength and diabetes prevalence in black, South Asian, and white European ethnic groups: a cross-sectional study of 418,656 UK Biobank participants. Diabetic Medicine, 34, pp. 1120-1128. (doi: 10.1111/dme.13323)

Lyall, D. M., Celis-Morales, C., Ward, J., Iliodromiti, S., Anderson, J. J., Gill, J. M.R., Smith, D. J., Ntuk, U. E., Mackay, D. F., Holmes, M. V., Sattar, N., Pell, J. P. (2017) Association of body mass index with cardiometabolic disease in the UK Biobank: a Mendelian randomization study. JAMA Cardiology, 2, pp. 882-889. (doi: 10.1001/jamacardio.2016.5804)

Petrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C.G.J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E.K., Klein, R., Ooi, T. C., Rossing, P., Stehouwer, C. D.A., Sattar, N., Colhoun, H. M. (2017) Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes and Endocrinology, 5, pp. 597-609. (doi: 10.1016/S2213-8587(17)30194-8)

Jenks, S. J., Conway, B. R., McLachlan, S., Teoh, W. L., Williamson, R. M., Webb, D. J., Welsh, P., Sattar, N., Strachan, M. W.J., Price, J. F. (2017) Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes. Diabetologia, 60, pp. 1400-1408. (doi: 10.1007/s00125-017-4297-0)

Gimpelewicz, C., Metra, M., Cleland, J. G.F., Szecsödy, P., Chang Wun, C.-C., Boer-Martins, L., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Pang, P., Ponikowski, P., Severin, T., Voors, A. A., Teerlink, J. R. (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. American Heart Journal, 190, pp. 113-122. (doi: 10.1016/j.ahj.2017.05.012)

Currie, G., Delles, C. (2017) Healthy vascular ageing. Hypertension, 70, pp. 229-231. (doi: 10.1161/HYPERTENSIONAHA.117.09122)

Small, H. Y., Cornelius, D. C., Guzik, T. J., Delles, C. (2017) Natural killer cells in placentation and cancer: Implications for hypertension during pregnancy. Placenta, 56, pp. 59-64. (doi: 10.1016/j.placenta.2017.03.003)

Zhang, Z.‐Y., Ravassa, S., Nkuipou‐Kenfack, E., Yang, W.-Y., Kerr, S. M., Koeck, T., Campbell, A., Kuznetsova, T., Mischak, H., Padmanabhan, S., Dominiczak, A. F., Delles, C., Staessen, J. A. (2017) Novel urinary peptidomic classifier predicts incident heart failure. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.005432)

Linde, C., Abraham, W. T., Gold, M. R., Daubert, C., Tang, A. S.L., Young, J. B., Sherfesee, L., Hudnall, H., Fagan, D. H., Cleland, J. G. (2017) Predictors of short-term clinical response to cardiac resynchronization therapy. European Journal of Heart Failure, 19, pp. 1056-1063. (doi: 10.1002/ejhf.795)

Gajjala, P. R., Jankowski, V., Heinze, G., Bilo, G., Zanchetti, A., Noels, H., Liehn, E., Perco, P., Schulz, A., Delles, C., Kork, F., Biessen, E., Narkiewicz, K., Kawecka-Jaszcz, K., Floege, J., Soranna, D., Zidek, W., Jankowski, J. (2017) Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human plasma. Hypertension, 70, pp. 412-419. (doi: 10.1161/HYPERTENSIONAHA.116.08906)

Cleland, J. G.F. (2017) What do cardiology and homeopathy have in common? : A belief in aspirin? JACC: Heart Failure, 5, pp. 611-614. (doi: 10.1016/j.jchf.2017.06.009)

Knez, J., Marrachelli, V. G., Cauwenberghs, N., Winckelmans, E., Zhang, Z., Thijs, L., Brguljan-Hitij, J., Plusquin, M., Delles, C., Monleon, D., Redón, J., Staessen, J. A., Nawrot, T. S., Kuznetsova, T. (2017) Peripheral blood mitochondrial DNA content in relation to circulating metabolites and inflammatory markers: a population study. PLoS ONE, 12, (doi: 10.1371/journal.pone.0181036)

Halliday, B. P., Cleland, J. G.F., Goldberger, J. J., Prasad, S. K. (2017) Personalizing sudden death risk stratification in dilated cardiomyopathy: past, present and future. Circulation, 136, pp. 215-231. (doi: 10.1161/CIRCULATIONAHA.116.027134)

Damman, K., Valente, M. A.E., van Veldhuisen, D. J., Cleland, J. G.F., O’Connor, C. M., Metra, M., Ponikowski, P., Cotter, G., Davison, B., Givertz, M. M., Bloomfield, D. M., Hillege, H. L., Voors, A. A. (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. International Journal of Molecular Sciences, 18, (doi: 10.3390/ijms18071470)

Ohkuma, T., Jun, M., Woodward, M., Zoungas, S., Cooper, M. E., Grobbee, D. E., Hamet, P., Mancia, G., Williams, B., Welsh, P., Sattar, N., Shaw, J. E., Rahimi, K., Chalmers, J. (2017) Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial. Diabetes Care, 40, pp. 1203-1209. (doi: 10.2337/dc17-0509)

Shen, L., Jhund, P. S., Petrie, M. C., Claggett, B. L., Barlera, S., Cleland, J. G.F., Dargie, H. J., Granger, C. B., Kjekshus, J., Køber, L., Latini, R., Maggioni, A. P., Packer, M., Pitt, B., Solomon, S. D., Swedberg, K., Tavazzi, L., Wikstrand, J., Zannad, F., Zile, M. R., McMurray, J. J.V. (2017) Declining risk of sudden death in heart failure. New England Journal of Medicine, 377, pp. 41-51. (doi: 10.1056/NEJMoa1609758)

Fröhlich, H., Raman, N., Täger, T., Schellberg, D., Goode, K. M., Kazmi, S., Grundtvig, M., Hole, T., Cleland, J. G.F., Katus, H. A., Agewall, S., Clark, A. L., Atar, D., Frankenstein, L. (2017) Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. International Journal of Cardiology, 238, pp. 97-104. (doi: 10.1016/j.ijcard.2017.03.028)

Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2017) Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC: Heart Failure, 5, pp. 507-517. (doi: 10.1016/j.jchf.2017.04.007)

Martin, A., Adams, J. M., Bunn, C., Gill, J. M.R., Gray, C. M., Hunt, K., Maxwell, D. J., van der Ploeg, H. P., Wyke, S., Mutrie, N. (2017) Feasibility of a real-time self-monitoring device for sitting less and moving more: a randomised controlled trial. BMJ Open Sport and Exercise Medicine, 3, (doi: 10.1136/bmjsem-2017-000285)

Patel, N., Godfrey, K.M., Pasupathy, D., Levin, J., Flynn, A.C., Hayes, L., Briley, A.L., Bell, R., Lawlor, D.A., Oteng-Ntim, E., Nelson, S.M., Robson, S.C., Sattar, N., Singh, C., Wardle, J., White, S., Seed, P.T., Poston, L. (2017) Infant adiposity following a randomised controlled trial of a behavioural intervention in obese pregnancy. International Journal of Obesity, 41, pp. 1018-1026. (doi: 10.1038/ijo.2017.44)

Garrido-Méndez, A., Díaz, X., Martínez, M. A., Leiva, A. M., Álvarez, C., Ramírez Campillo, R., Cristi-Montero, C., Rodríguez, F., Salas-Bravo, C., Durán, E., Labraña, A. M., Aguilar-Farías, N., Celis-Morales, C. (2017) Mayores niveles de transporte activo se asocian a un menor nivel de adiposidad y menor riesgo de obesidad: resultados de la Encuesta Nacional de Salud 2009-2010 = Association of active commuting with obesity: findings from the Chilean National Health Survey 2009-2010. Revista Medica de Chile, 145, pp. 837-844. (doi: 10.4067/s0034-98872017000700837)

Pellicori, P., Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D., Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19, pp. 883-892. (doi: 10.1002/ejhf.825)

Sze, S., Zhang, J., Pellicori, P., Morgan, D., Hoye, A., Clark, A.L. (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clinical Research in Cardiology, 106, pp. 533-541. (doi: 10.1007/s00392-017-1082-5)

Zewinger, S. et al. (2017) Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes and Endocrinology, 5, pp. 534-543. (doi: 10.1016/S2213-8587(17)30096-7)

Nightingale, C. M., Rudnicka, A. R., Donin, A. S., Sattar, N., Cook, D. G., Whincup, P. H., Owen, C. G. (2017) Screen time is associated with adiposity and insulin resistance in children. Archives of Disease in Childhood, 102, pp. 612-616. (doi: 10.1136/archdischild-2016-312016)

Cleland, J. G.F., Pellicori, P., Clark, A. L., Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5, pp. 538-540. (doi: 10.1016/j.jchf.2017.04.003)

Huda, S. S., Jordan, F., Bray, J., Love, G., Payne, R., Sattar, N., Freeman, D. J. (2017) Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancy. Clinical Science, 131, pp. 1529-1540. (doi: 10.1042/CS20160832)

Ouwerkerk, W., Voors, A.A., Anker, S.D., Cleland, J.G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H.L., Lang, C.C., ter Maaten, J.M., Ng, L.L., Ponikowski, P., Samani, N.J., van Veldhuisen, D.J., Zannad, F., Metra, M., Zwinderman, A.H. (2017) Determinants and clinical outcome of uptitration of ACE-inhibitor and beta-blocker in patients with heart failure: a prospective European study. European Heart Journal, 38, pp. 1883-1890. (doi: 10.1093/eurheartj/ehx026)

Kotecha, D., Flather, M. D., Altman, D. G., Holmes, J., Rosano, G., Wikstrand, J., Packer, M., Coats, A. J.S., Manzano, L., Böhm, M., van Veldhuisen, D. J., Andersson, B., Wedel, H., von Lueder, T. G., Rigby, A. S., Hjalmarson, Å., Kjekshus, J., Cleland, J. G.F. (2017) Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis. Journal of the American College of Cardiology, 69, pp. 2885-2896. (doi: 10.1016/j.jacc.2017.04.001)

van den Berg, M. E. et al. (2017) Discovery of novel heart rate-associated loci using the Exome Chip. Human Molecular Genetics, 26, pp. 2346-2363. (doi: 10.1093/hmg/ddx113)

Dale, C. E. et al. (2017) Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation, 135, pp. 2373-2388. (doi: 10.1161/CIRCULATIONAHA.116.026560)

Sattar, N., Preiss, D. (2017) Reverse causality in cardiovascular epidemiological research: more common than imagined? Circulation, 135, pp. 2369-2372. (doi: 10.1161/CIRCULATIONAHA.117.028307)

Muilwijk, M., Stronks, K., Qureshi, S. A., Beune, E., Celis-Morales, C., Gill, J., Sheikh, A., Jenum, A. K., van Valkengoed, I. G. (2017) Dietary and physical activity strategies to prevent type 2 diabetes in South Asian adults: protocol for a systematic review. BMJ Open, 7, (doi: 10.1136/bmjopen-2016-012783)

Ritchie, J., Green, D., Chrysochou, T., Hegarty, J., Handley, K., Ives, N., Wheatley, K., Houston, G., Wright, J., Neyses, L., Chalmers, N., Mark, P., Patel, R., Moss, J., Roditi, G., Eadington, D., Lukaschuk, E., Cleland, J., Kalra, P. A. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32, pp. 1006-1013. (doi: 10.1093/ndt/gfw107)

Liu, L. C.Y., Valente, M. A.E., Postmus, D., O’Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., van der Meer, P., Voors, A. A. (2017) Identifying subpopulations with distinct response to treatment using plasma biomarkers in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, 31, pp. 281-293. (doi: 10.1007/s10557-017-6726-1)

Cleland, J. G.F., Teerlink, J. R., Davison, B. A., Shoaib, A., Metra, M., Senger, S., Milo, O., Cotter, G., Bourge, R. C., Parker, J. D., Jondeau, G., Krum, H., O'Connor, C. M., Torre-Amione, G., van Veldhuisen, D. J., McMurray, J. J.V. (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS) European Journal of Heart Failure, 19, pp. 739-747. (doi: 10.1002/ejhf.786)

McCoy, J., Bates, M., Eggett, C., Siervo, M., Cassidy, S., Newman, J., Moore, S. A., Gorman, G., Trenell, M. I., Velicki, L., Seferovic, P. M., Cleland, J. G.F., MacGowan, G. A., Turnbull, D. M., Jakovljevic, D. G. (2017) Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients. Open Heart, 4, (doi: 10.1136/openhrt-2017-000632)

Shah, P., Pellicori, P., Cuthbert, J., Clark, A. L. (2017) Pharmacological and non-pharmacological treatment for decompensated heart failure: what is new? Current Heart Failure Reports, 14, pp. 147-157. (doi: 10.1007/s11897-017-0328-x)

Demissei, B. G., Postmus, D., Cleland, J. G.F., O’Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Dittrich, H., Hillege, H. L., Voors, A. A. (2017) Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission. European Journal of Heart Failure, 19, pp. 728-738. (doi: 10.1002/ejhf.766)

Stott, D. J. et al. (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. New England Journal of Medicine, 376, pp. 2534-2544. (doi: 10.1056/NEJMoa1603825)

Pellicori, P., Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F., Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, 19, pp. 768-778. (doi: 10.1002/ejhf.788)

Halliday, B. P. et al. (2017) Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, 135, pp. 2106-2115. (doi: 10.1161/CIRCULATIONAHA.116.026910)

Sattar, N., Petrie, M. C., Zinman, B., Januzzi Jr., J. L. (2017) Novel diabetes drugs and the cardiovascular specialist. Journal of the American College of Cardiology, 69, pp. 2646-2656. (doi: 10.1016/j.jacc.2017.04.014)

Natarajan, P., Young, R., Stitziel, N. O., Padmanabhan, S., Baber, U., Mehran, R., Sartori, S., Fuster, V., Reilly, D. F., Butterworth, A. S., Rader, D. J., Ford, I., Sattar, N., Kathiresan, S. (2017) Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation, 135, pp. 2091-2101. (doi: 10.1161/CIRCULATIONAHA.116.024436)

Neisius, U., Olson, E., Rossi, S. H., Ibrahim, H. A., Currie, G., Dominiczak, A., Delles, C. (2017) Evaluation of the systemic micro- and macrovasculature in stable angina: a case-control study. PLoS ONE, 12, (doi: 10.1371/journal.pone.0178412)

Gill, J. M.R., Celis-Morales, C. A., Sattar, N., Pell, J. P. (2017) Authors' reply to Colquhoun and Buchinsky. British Medical Journal, 357, (doi: 10.1136/bmj.j2447)

Bell, S., Farran, B., McGurnaghan, S., McCrimmon, R. J., Leese, G. P., Petrie, J. R., McKeigue, P., Sattar, N., Wild, S., McKnight, J., Lindsay, R., Colhoun, H. M., Looker, H. (2017) Risk of acute kidney injury and survival in patients treated with metformin: an observational cohort study. BMC Nephrology, 18, (doi: 10.1186/s12882-017-0579-5)

Packer, M., O'Connor, C., McMurray, J. J.V., Wittes, J., Abraham, W. T., Anker, S. D., Dickstein, K., Filippatos, G., Holcomb, R., Krum, H., Maggioni, A. P., Mebazaa, A., Peacock, W. F., Petrie, M. C., Ponikowski, P., Ruschitzka, F., van Veldhuisen, D. J., Kowarski, L. S., Schactman, M., Holzmeister, J. (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. New England Journal of Medicine, 376, pp. 1956-1964. (doi: 10.1056/NEJMoa1601895)

Toth, P. P., Descamps, O., Genest, J., Sattar, N., Preiss, D., Dent, R. E., Djedjos, C. S., Wu, Y., Geller, M., Uhart, M., Somaratne, R., Wasserman, S. M. (2017) Pooled safety analysis of evolocumab in over 6000 patients from double-blind and open-label extension studies. Circulation, 135, pp. 1819-1831. (doi: 10.1161/CIRCULATIONAHA.116.025233)

Noordam, R. et al. (2017) A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Journal of Medical Genetics, 54, pp. 313-323. (doi: 10.1136/jmedgenet-2016-104112)

Celis-Morales, C. et al. (2017) Can genetic-based advice help you lose weight? Findings from the Food4Me European randomized controlled trial. American Journal of Clinical Nutrition, 105, pp. 1204-1213. (doi: 10.3945/ajcn.116.145680)

Voors, A. A., Ouwerkerk, W., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P., Ng, L. L., Metra, M., ter Maaten, J. M., Lang, C. C., Hillege, H. L., van der Harst, P., Filippatos, G., Dickstein, K., Cleland, J. G.F., Anker, S. D., Zwinderman, A. H. (2017) Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. European Journal of Heart Failure, 19, pp. 627-634. (doi: 10.1002/ejhf.785)

Poston, L., Bell, R., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng-Ntim, E., Sandall, J., Sanders, T. A.B., Sattar, N., Seed, P. T., Robson, S. C., Trépel, D., Wardle, J. (2017) Improving pregnancy outcome in obese women: the UK pregnancies better eating and activity randomised controlled trial. Programme Grants for Applied Research, 5, (doi: 10.3310/pgfar05100)

Packer, M. et al. (2017) Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure : primary results of the ENABLE Trials. JACC: Heart Failure, 5, pp. 317-326. (doi: 10.1016/j.jchf.2017.02.021)

Meyer, B. J., Freeman, D. J. (2017) Maternal plasma docosahexaenoic acid (DHA) concentrations increase at the critical time of neural tube closure. Fats of Life,

Mary, S., Small, H. Y., Siwy, J., Mullen, W., Giri, A., Delles, C. (2017) Polymerization-incompetent uromodulin in the pregnant stroke-prone spontaneously hypertensive rat. Hypertension, 69, pp. 910-918. (doi: 10.1161/HYPERTENSIONAHA.116.08826)

Jacobs, L., Efremov, L., Ferreira, J. P., Thijis, L., Yang, W.-Y., Zhang, Z.-Y., Latini, R., Masson, S., Agabiti, N., Sever, P., Delles, C., Sattar, N., Butler, J., Cleland, J., Kuznetsova, T., Staessen, J. A., Zannad, F. (2017) Risk for incident heart failure: a subject-level meta-analysis from the Heart “OMics” in AGEing (HOMAGE) study. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.005231)

Futema, M., Cooper, J. A., Charakida, M., Boustred, C., Sattar, N., Deanfield, J., Lawlor, D. A., Timpson, N. J., Humphries, S. E., Hingorani, A. D. (2017) Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC) Atherosclerosis, 260, pp. 47-55. (doi: 10.1016/j.atherosclerosis.2017.03.007)

Zakeri, R., Van Wagoner, D. R., Calkins, H., Wong, T., Ross, H. M., Heist, E. K., Meyer, T. E., Kowey, P. R., Mentz, R. J., Cleland, J. G.F., Pitt, B., Zannad, F., Linde, C. (2017) The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm, 14, pp. 763-782. (doi: 10.1016/j.hrthm.2017.01.032)

Tigbe, W. W., Granat, M. H., Sattar, N., Lean, M. E.J. (2017) Time spent in sedentary posture is associated with waist circumference and cardiovascular risk. International Journal of Obesity, 41, pp. 689696. (doi: 10.1038/ijo.2017.30)

Justice, A. E. et al. (2017) Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. Nature Communications, 8, (doi: 10.1038/ncomms14977)

Celis-Morales, C. A., Lyall, D. M., Welsh, P., Anderson, J., Steell, L., Guo, Y., Maldonado, R., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R. (2017) Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study. British Medical Journal, 357, (doi: 10.1136/bmj.j1456)

Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., Gudbjörnsdottir, S. (2017) Range of risk factor levels: control, mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation, 135, pp. 1522-1531. (doi: 10.1161/CIRCULATIONAHA.116.025961)

Zhang, J., Wong, K. Y.-K., Clark, A. L., Cleland, J. G.F. (2017) Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling. International Journal of Cardiology, 233, pp. 67-72. (doi: 10.1016/j.ijcard.2017.01.127)

Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., Gudbjörnsdottir, S. (2017) Mortality and cardiovascular disease in type 1 and type 2 diabetes. New England Journal of Medicine, 376, pp. 1407-1418. (doi: 10.1056/NEJMoa1608664)

Misra, A., Tandon, N., Ebrahim, S., Sattar, N., Alam, D., Shrivastava, U., Narayan, K.M. V., Jafar, T. H. (2017) Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions. British Medical Journal, 357, (doi: 10.1136/bmj.j1420)

Bakrania, K., Yates, T., Edwardson, C. L., Bodicoat, D. H., Esliger, D. W., Gill, J. M.R., Kazi, A., Velayudhan, L., Sinclair, A. J., Sattar, N., Biddle, S. J.H., Hamer, M., Davies, M. J., Khunti, K. (2017) Associations of moderate-to-vigorous-intensity physical activity and body mass index with glycated haemoglobin within the general population: a cross-sectional analysis of the 2008 Health Survey for England. BMJ Open, 7, (doi: 10.1136/bmjopen-2016-014456)

McDiarmid, A. K., Pellicori, P., Cleland, J. G.F., Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38, pp. 942-954. (doi: 10.1093/eurheartj/ehw140)

Anderson, J.J., Celis, C.A., Mackay, D.F., Iliodromiti, S., Lyall, D.M., Sattar, N., Gill, J.M.R., Pell, J.P. (2017) Adiposity among 132 479 UK Biobank participants; contribution of sugar intake vs other macronutrients. International Journal of Epidemiology, 46, pp. 492-501. (doi: 10.1093/ije/dyw173)

Layland, J., Rauhalammi, S., Lee, M. M.Y., Ahmed, N., Carberry, J., Teng Yue May, V., Watkins, S., McComb, C., Mangion, K., McClure, J. D., Carrick, D., O'Donnell, A., Sood, A., McEntegart, M., Oldroyd, K. G., Radjenovic, A., Berry, C. (2017) Diagnostic accuracy of 3.0-T magnetic resonance T1 and T2 mapping and T2-weighted dark-blood imaging for the infarct-related coronary artery in Non-ST-segment elevation myocardial infarction. Journal of the American Heart Association, 6, (doi: 10.1161/JAHA.116.004759)

Cezard, G., Douglas, A., Gill, J.M.R., McKnight, J., Sheikh, A., Wallia, S., Bhopal, R. (2017) Did the weight loss in the Prevention of Diabetes and Obesity in South Asians (PODOSA) trial differ by sex? An exploratory analysis. Public Health, 145, pp. 67-69. (doi: 10.1016/j.puhe.2016.12.004)

Celis-Morales, C. et al. (2017) Effect of personalized nutrition on health-related behaviour change: evidence from the Food4me European randomized controlled trial. International Journal of Epidemiology, 46, pp. 578-588. (doi: 10.1093/ije/dyw186)

Leiva, A. M., Martínez, M. A., Cristi-Montero, C., Salas, C., Ramírez-Campillo, R., Díaz Martínez, X., Aguilar-Farías, N., Celis-Morales, C. (2017) El sedentarismo se asocia a un incremento de factores de riesgo cardiovascular y metabólicos independiente de los niveles de actividad física = Sedentary lifestyle is associated with metabolic and cardiovascular risk factors independent of physical activity. Revista Medica de Chile, 145, pp. 458-467. (doi: 10.4067/S0034-98872017000400006)

Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G.F., Colucci, W. S.,, Butler, J., Voors, A. A., Anker, S. D., Pitt, B., Pieske, B., Filippatos, G., Greene, S. J., Gheorghiade, M. (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 14, pp. 238-250. (doi: 10.1038/nrcardio.2016.203)

Dominiczak, A., Delles, C., Padmanabhan, S. (2017) Genomics and precision medicine for clinicians and scientists in hypertension. Hypertension, 69, pp. e10-e13. (doi: 10.1161/HYPERTENSIONAHA.116.08252)

Filippatos, G. S. et al. (2017) Independent academic data monitoring committees for clinical trials in cardiovascular and cardiometabolic diseases. European Journal of Heart Failure, 19, pp. 449-456. (doi: 10.1002/ejhf.761)

Skobel, E., Knackstedt, C., Martinez-Romero, A., Salvi, D., Vera-Munoz, C., Napp, A., Luprano, J., Bover, R., Glöggler, S., Bjarnason-Wehrens, B., Marx, N., Rigby, A., Cleland, J. G.F. (2017) Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels, 32, pp. 408-418. (doi: 10.1007/s00380-016-0897-8)

Nymo, S. H., Aukrust, P., Kjekshus, J., McMurray, J. J.V., Cleland, J. G.F., Wikstrand, J., Muntendam, P., Wienhues-Thelen, U., Latini, R., Tandberg Askevold, E., Gravning, J., Dahl, C. P., Broch, K., Yndestad, A., Gullestad, L., Ueland, T. (2017) Limited added value of circulating inflammatory biomarkers in chronic heart failure. JACC: Heart Failure, 5, pp. 256-264. (doi: 10.1016/j.jchf.2017.01.008)

Petrie, J.R., Chaturvedi, N., Ford, I., Hramiak, I., Hughes, A.D., Jenkins, A.J., Klein, B., Klein, R., Ooi, T.C., Rossing, P., Sattar, N., Stehouwer, C.D.A., Colhoun, H.M. (2017) Metformin in adults with type 1 diabetes: design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): an international multicentre trial. Diabetes, Obesity and Metabolism, 19, pp. 509-516. (doi: 10.1111/dom.12840)

Celis-Morales, C., Lyall, D. M., Guo, Y., Steell, L., Llamas, D., Ward, J., Mackay, D. F., Biello, S. M., Bailey, M. E.S., Pell, J. P., Gill, J. M.R. (2017) Sleep characteristics modify the association between genetic predisposition to obesity and anthropometric measurements in 119,679 UK Biobank participants. American Journal of Clinical Nutrition, 105, pp. 980-990. (doi: 10.3945/ajcn.116.147231)

Urbinati, A., Pellicori, P., Guerra, F., Capucci, A., Clark, A. L. (2017) Takotsubo syndrome in the paediatric population. Journal of Cardiovascular Medicine, 18, pp. 262-267. (doi: 10.2459/JCM.0000000000000446)

Jamil, N.A., Gray, S.R., Fraser, W.D., Fielding, S., MacDonald, H.M. (2017) The relationship between vitamin D status and muscle strength in young healthy adults from sunny climate countries currently living in the northeast of Scotland. Osteoporosis International, 28, pp. 1433-1443. (doi: 10.1007/s00198-016-3901-3)

Cleland, J. G.F., Mueller, C. (2017) What can we learn from SOCRATES: more questions than answers? European Heart Journal, 38, pp. 1128-1131. (doi: 10.1093/eurheartj/ehw561)

Layland, J. J., Carberry, J., May, V. T.Y., Lee, M., Eteiba, H., Lindsay, M., Petrie, M., McEntegart, M., Watkins, S., Shaukat, A., Oldroyd, K., Curzen, N., Sood, A., Balachandran, K., Das, R., Junejo, S., Hannah, A., Stewart, A., Henderson, R., McConnachie, A., Berry, C. (2017) Decision Making Using Fractional Flow Reserve is Associated With Lower Rates of Incomplete Revascularization Compared With Angiographic Guided Decision Making Amongst Patients With NSTEMI. (doi: 10.1016/s0735-1097(17)34446-7)

Rao, M. P., Al-Khatib, S. M., Pokorney, S., She, L., Romanov, A., Nicolau, J. C., Lee, K. L., Carson, P. E., Selzman, C. H., Stepinska, J., Cleland, J. G.F., Tungsubutra, W., Desvigne-Nickens, P. M., Sueta, C., Siepe, M., Lang, I. M., Feldman, A. M., Yii, M., Rouleau, J. L., Velazquez, E. J. (2017) Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure) Circulation, 135, pp. 1136-1144. (doi: 10.1161/CIRCULATIONAHA.116.026075)

Dovancescu, S., Pellicori, P., Mabote, T., Torabi, A., Clark, A. L., Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.748)

Htun, N. M., Magliano, D. J., Zhang, Z.-Y., Lyons, J., Petit, T., Nkuipou-Kenfack, E., Ramirez-Torres, A., von zur Muhlen, C., Maahs, D., Schanstra, J. P., Pontillo, C., Pejchinovski, M., Snell-Bergeon, J. K., Delles, C., Mischak, H., Staessen, J. A., Shaw, J. E., Koeck, T., Peter, K. (2017) Prediction of acute coronary syndromes by urinary proteome analysis. PLoS ONE, 12, (doi: 10.1371/journal.pone.0172036)

Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I., Sattar, N., Rutter, M. K., Ashcroft, D. M. (2017) Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups. Diabetes Care, 40, pp. 338-345. (doi: 10.2337/dc16-1616)

Matsue, Y., van der Meer, P., Damman, K., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Gansevoort, R. T., Bakker, S. J.L., van der Harst, P., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A. (2017) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart, 103, pp. 407-413. (doi: 10.1136/heartjnl-2016-310112)

Matsue, Y., ter Maaten, J. M., Struck, J., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., van Veldhuisen, D. J., van der Meer, P., Damman, K., Voors, A. A. (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. Journal of Cardiac Failure, 23, pp. 231-239. (doi: 10.1016/j.cardfail.2016.09.007)

Gregson, J. M. et al. (2017) Genetic invalidation of Lp-PLA2 as a therapeutic target: large-scale study of five functional Lp-PLA2-lowering alleles. European Journal of Preventive Cardiology, 24, pp. 492-504. (doi: 10.1177/2047487316682186)

Small, H. Y., Akehurst, C., Sharafetdinova, L., McBride, M. W., McClure, J. D., Robinson, S. W., Carty, D. M., Freeman, D. J., Delles, C. (2017) HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia. Physiological Genomics, 49, pp. 193-200. (doi: 10.1152/physiolgenomics.00106.2016)

Cuthbert, J. J., Pellicori, P., Shah, P., Clark, A. L. (2017) New pharmacological approaches in heart failure therapy: developments and possibilities. Future Cardiology, 13, pp. 173-188. (doi: 10.2217/fca-2016-0068)

Parsons, T. J., Sartini, C., Welsh, P., Sattar, N., Ash, S., Lennon, L. T., Wannamethee, S. G., Lee, I.-M., Whincup, P. H., Jefferis, B. J. (2017) Physical activity, sedentary behavior, and inflammatory and hemostatic markers in men. Medicine and Science in Sports and Exercise, 49, pp. 459-465. (doi: 10.1249/MSS.0000000000001113)

Sartini, C., Barry, S. J.E., Whincup, P. H., Wannamethee, S. G., Lowe, G. D.O., Jefferis, B. J., Lennon, L., Welsh, P., Ford, I., Sattar, N., Morris, R. W. (2017) Relationship between outdoor temperature and cardiovascular disease risk factors in older people. European Journal of Preventive Cardiology, 24, pp. 349-356. (doi: 10.1177/2047487316682119)

Masters, J., Morton, G., Anton, I., Szymanski, J., Greenwood, E., Grogono, J., Flett, A. S., Cleland, J. G.F., Cowburn, P. J. (2017) Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team. Open Heart, 4, (doi: 10.1136/openhrt-2016-000547)

Preiss, D., Dawed, A., Welsh, P., Heggie, A., Jones, A. G., Dekker, J., Koivula, R., Hansen, T. H., Stewart, C., Holman, R. R., Franks, P. W., Walker, M., Pearson, E. R., Sattar, N. (2017) Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. Diabetes, Obesity and Metabolism, 19, pp. 356-363. (doi: 10.1111/dom.12826)

Dierckx, R., Inglis, S. C., Clark, R. A., Prieto-Merino, D., Cleland, J. G.F. (2017) Telemedicine in heart failure: new insights from the Cochrane meta-analyses. European Journal of Heart Failure, 19, pp. 304-306. (doi: 10.1002/ejhf.759)

Currie, G., Delles, C. (2017) The future of "omics" in hypertension. Canadian Journal of Cardiology, 33, pp. 601-610. (doi: 10.1016/j.cjca.2016.11.023)

Carty, D. M., Doogan, F., Welsh, P., Dominiczak, A. F., Delles, C. (2017) Thyroid stimulating hormone (TSH) ≥2.5mU/l in early pregnancy: prevalence and subsequent outcomes. European Journal of Obstetrics and Gynecology and Reproductive Biology, 210, pp. 366-369. (doi: 10.1016/j.ejogrb.2017.01.048)

Lyall, D. M., Celis-Morales, C. A., Anderson, J., Gill, J. M.R., Mackay, D. F., McIntosh, A. M., Smith, D. J., Deary, I. J., Sattar, N., Pell, J. P. (2017) Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants. European Heart Journal, 38, pp. 577-583. (doi: 10.1093/eurheartj/ehw528)

Webb, T. R. et al. (2017) Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease. Journal of the American College of Cardiology, 69, pp. 823-836. (doi: 10.1016/j.jacc.2016.11.056)

Marouli, E. et al. (2017) Rare and low-frequency coding variants alter human adult height. Nature, 542, pp. 186-190. (doi: 10.1038/nature21039)

Stott, D. J. et al. (2017) Study protocol; thyroid hormone replacement for untreated older adults with subclinical hypothyroidism - a randomised placebo controlled trial (TRUST) BMC Endocrine Disorders, 17, (doi: 10.1186/s12902-017-0156-8)

Docherty, K. F., Campbell, R. T., Jhund, P., Petrie, M. C., McMurray, J. J.V. (2017) How robust are clinical trials in heart failure? European Heart Journal, 38, pp. 338-345. (doi: 10.1093/eurheartj/ehw427)

Simpson, J., Smith, A. D.A.C., Fraser, A., Sattar, N., Lindsay, R. S., Ring, S. M., Tilling, K., Smith, G. D., Lawlor, D. A., Nelson, S. M. (2017) Programming of adiposity in childhood and adolescence: associations with birth weight and cord blood adipokines. Journal of Clinical Endocrinology and Metabolism, 102, pp. 499-506. (doi: 10.1210/jc.2016-2342)

Emdin, C. A., Hsiao, A. J., Kiran, A., Conrad, N., Salimi-Khorshidi, G., Woodward, M., Anderson, S. G., Mohseni, H., McMurray, J. J.V., Cleland, J. G.F., Dargie, H., Hardman, S., McDonagh, T., Rahimi, K. (2017) Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales) American Journal of Cardiology, 119, pp. 440-444. (doi: 10.1016/j.amjcard.2016.10.021)

Freeman, D. J., Meyer, B. J. (2017) Brain food for babies. Biochemist, 39, pp. 26-29.

Schmidt, A. F. et al. (2017) PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes and Endocrinology, 5, pp. 97-105. (doi: 10.1016/S2213-8587(16)30396-5)

Gastelurrutia, P., Lupón, J., Domingo, M., Stut, W., Dovancescu, S., Cleland, J., Frankenstein, L., Bayes-Genis, A. (2017) Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Failure, 4, pp. 66-70. (doi: 10.1002/ehf2.12104)

Zhang, J., Dierckx, R., Mohee, K., Clark, A. L., Cleland, J. G.F. (2017) Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4, pp. 40-45. (doi: 10.1002/ehf2.12112)

Iliodromiti, S., Mackay, D. F., Smith, G. C.S., Pell, J. P., Sattar, N., Lawlor, D. A., Nelson, S. M. (2017) Customised and noncustomised birth weight centiles and prediction of stillbirth and infant mortality and morbidity: a cohort study of 979,912 term singleton pregnancies in Scotland. PLoS Medicine, 14, (doi: 10.1371/journal.pmed.1002228)

Delles, C., Husi, H. (2017) Systems biology approach in hypertension research. Springer

de Vries, P. S. et al. (2017) Comparison of HapMap and 1000 genomes reference panels in a large-scale genome-wide association study. PLoS ONE, 12, (doi: 10.1371/journal.pone.0167742)

Celis-Morales, C. A., Lyall, D. M., Anderson, J., Iliodromiti, S., Fan, Y., Ntuk, U. E., Mackay, D. F., Pell, J. P., Sattar, N., Gill, J. M.R. (2017) The association between physical activity and risk of mortality is modulated by grip strength and cardiorespiratory fitness: evidence from 498 135 UK-Biobank participants. European Heart Journal, 38, pp. 116-122. (doi: 10.1093/eurheartj/ehw249)

Paul, L., Brewster, S., Wyke, S., McFadyen, A. K., Sattar, N., Gill, J., Dybus, A., Gray, C. M. (2017) Increasing physical activity in older adults using STARFISH, an interactive smartphone application (app); a pilot study. Journal of Rehabilitation and Assistive Technologies Engineering, 4, (doi: 10.1177/2055668317696236)

Streng, K. W., ter Maaten, J. M., Cleland, J. G.F., O’Connor, C. M., Davison, B. A., Metra, M., Givertz, M. M., Teerlink, J. R., Ponikowski, P., Bloomfield, D. M., Dittrich, H. C., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., van der Meer, P. (2017) Associations of body mass index with laboratory and biomarkers in patients with acute heart failure. Circulation: Heart Failure, 10, (doi: 10.1161/CIRCHEARTFAILURE.116.003350)

Livingstone, K. M. et al. (2017) Characteristics of European adults who dropped out from the Food4Me Internet-based personalised nutrition intervention. Public Health Nutrition, 20, pp. 53-63. (doi: 10.1017/S1368980016002020)

Kristensen, S. L., Mogensen, U. M., Jhund, P. S., Petrie, M. C., Preiss, D., Win, S., Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Gottdiener, J. S., Carson, P. E., McMurray, J. J.V. (2017) Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-Preserve) Circulation, 135, pp. 724-735. (doi: 10.1161/CIRCULATIONAHA.116.024593)

Da Boit, M., Hunter, A. M., Gray, S. M. (2017) Fit with good fat? The role of n-3 polyunsaturated fatty acids on exercise performance. Metabolism, 66, pp. 45-54. (doi: 10.1016/j.metabol.2016.10.007)

Stam-Slob, M. C., Visseren, F. L.J., Wouter Jukema, J., van der Graaf, Y., Poulter, N. R., Gupta, A., Sattar, N., Macfarlane, P. W., Kearney, P. M., de Craen, A. J.M., Trompet, S. (2017) Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clinical Research in Cardiology, 106, pp. 58-68. (doi: 10.1007/s00392-016-1023-8)

Tromp, J., ter Maaten, J., Damman, K., O’Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van der Wal, M. H.L., Jaarsma, T., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2017) Serum potassium levels and outcome in acute heart failure (data from the PROTECT and COACH trials) American Journal of Cardiology, 119, pp. 290-296. (doi: 10.1016/j.amjcard.2016.09.038)

Da Boit, M., Sibson, R., Sivasubramaniam, S., Meakin, J. R., Greig, C. A., Aspden, R. M., Thies, F., Jeromson, S., Hamilton, D. L., Speakman, J. R., Hambly, C., Mangoni, A. A., Preston, T., Gray, S. R. (2017) Sex differences in the effect of fish-oil supplementation on the adaptive response to resistance exercise training in older people: a randomized controlled trial. American Journal of Clinical Nutrition, 105, pp. 151-158. (doi: 10.3945/ajcn.116.140780)

Wyse, C. A., Celis Morales, C. A., Graham, N., Fan, Y., Ward, J., Curtis, A. M., Mackay, D., Smith, D. J., Bailey, M. E.S., Biello, S., Gill, J. M.R., Pell, J. P. (2017) Adverse metabolic and mental health outcomes associated with shiftwork in a population-based study of 277,168 workers in UK biobank. Annals of Medicine, 49, pp. 411-420. (doi: 10.1080/07853890.2017.1292045)

Delles, C., Vanholder, R. (2017) Chronic kidney disease. Clinical Science, 131, pp. 225-226. (doi: 10.1042/CS20160624)

Petermann, F., Leiva, A. M., Martínez, M. A., Salas, C., Garrido-Méndez, A., Celis-Morales, C. (2017) Consumo de bebidas azúcaradas ayer y hoy: ¿cuál es el escenario para la población chilena? = Sugar-sweetened beverage consumption, what is the scenario for Chile? Revista Chilena de Nutrición, 44, pp. 400-401. (doi: 10.4067/s0717-75182017000400400)

Celis-Morales, C., Lyall, D. M., Gray, S., Steell, L., Anderson, J., Iliodromiti, S., Welsh, P., Guo, Y., Petermann, F., Mackay, D. F., Bailey, M. E.S., Pell, J., Gill, J. M.R., Sattar, N. (2017) Dietary fat and total energy intake modifies the association of genetic profile risk score on obesity: evidence from 48 170 UK Biobank participants. International Journal of Obesity, 41, pp. 1761-1768. (doi: 10.1038/ijo.2017.169)

Agca, R. et al. (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Annals of the Rheumatic Diseases, 76, pp. 17-28. (doi: 10.1136/annrheumdis-2016-209775)

Petermann Rocha, F., Durán Fernández, E., Labraña Torres, A. M., Celis-Morales, C. (2017) Efecto de una consulta nutricional protocolizada sobre el estado nutricional y hábitos alimentarios de adultos con sobrepeso y obesidad = Effect of a structured nutritional consultation on weight loss and eating habits in overweight and obese adults. Revista Chilena de Nutrición, 44, pp. 341-349. (doi: 10.4067/s0717-75182017000400341)

Liu, D. J. et al. (2017) Exome-wide association study of plasma lipids in >300,000 individuals. Nature Genetics, 49, pp. 1758-1766. (doi: 10.1038/ng.3977)

Petermann, F., Durán, E., Labraña, A. M., Martínez, M. A., Garrido-Méndez, A., Poblete-Valderrama, F., Díaz, X., Salas, C., Celis-Morales, C. (2017) Factores asociados al desarrollo de obesidad en Chile: resultados de la Encuesta Nacional de Salud 2009-2010 = Risk factors for obesity: analysis of the 2009-2010 Chilean Health Survey. Revista Medica de Chile, 145, pp. 716-722. (doi: 10.4067/s0034-98872017000600716)

Cuthbert, J. J., Pellicori, P., Clark, A. L. (2017) Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Medical Devices: Evidence and Research, 10, pp. 123-132. (doi: 10.2147/mder.s113105)

Skaaby, T. et al. (2017) Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium. Scientific Reports, 7, (doi: 10.1038/s41598-017-01977-w)

Mahinrad, S., Vriend, A. E., Jukema, J. W., van Heemst, D., Sattar, N., Blauw, G. J., Macfarlane, P. W., Clark, E. N., de Craen, A. J.M., Sabayan, B. (2017) Left ventricular hypertrophy and cognitive decline in old age. Journal of Alzheimer's Disease, 58, pp. 275-283. (doi: 10.3233/JAD-161150)

Arain, F., Gullestad, L., Nymo, S., Kjekshus, J., Cleland, J. G.F., Michelsen, A., McMurray, J. J.V., Wikstrand, J., Aukrust, P., Ueland, T. (2017) Low YKL-40 in Chronic Heart Failure may predict beneficial effects of statins: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) Biomarkers, 22, pp. 261-267. (doi: 10.1080/1354750X.2016.1204003)

Labraña, A. M., Durán, E., Martínez, M. A., Leiva, A. M., Garrido, A., Díaz, X., Salas, C., Celis-Morales, C. (2017) Menor peso corporal, de índice de masa corporal y de perímetro de cintura se asocian a una disminución en factores de riesgo cardiovascular en población chilena = Effects of a lower body weight or waist circumference on cardiovascular risk. Findings from the Chilean health survey. Revista Medica de Chile, 145, pp. 585-594.

Pellicori, P., Carubelli, V. (2017) Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives. Giornale Italiano di Cardiologia, 18, pp. 129-138. (doi: 10.1714/2663.27298)

Pellicori, P., Salekin, D., Pan, D., Clark, A. L. (2017) This patient is not breathing properly: is this COPD, heart failure, or neither? Expert Review of Cardiovascular Therapy, 15, pp. 389-396. (doi: 10.1080/14779072.2017.1317592)

2016

Torabi, A., Cleland, J. G.F., Sherwi, N., Atkin, P., Panahi, H., Kilpatrick, E., Thackray, S., Hoye, A., Alamgir, F., Goode, K., Rigby, A., Clark, A. L. (2016) Influence of case definition on incidence and outcome of acute coronary syndromes. Open Heart, 3, (doi: 10.1136/openhrt-2016-000487)

Ramirez-Campillo, R., Diaz, D., Martinez-Salazar, C., Valdés-Badilla, P., Delgado-Floody, P., Méndez-Rebolledo, G., Cañas-Jamet, R., Cristi-Montero, C., García-Hermoso, A., Celis-Morales, C., Moran, J., Buford, T. W., Rodriguez-Mañas, L., Alonso-Martinez, A. M., Izquierdo, M. (2016) Effects of different doses of high-speed resistance training on physical performance and quality of life in older women: a randomized controlled trial. Clinical Interventions in Aging, 2016, pp. 1797-1804. (doi: 10.2147/CIA.S121313)

Teerlink, J. R., Felker, G. M., McMurray, J. J.V., Solomon, S. D., Adams, Jr., K. F., Cleland, J. G.F., Ezekowitz, J. A., Goudev, A., Macdonald, P., Metra, M., Mitrovic, V., Ponikowski, P., Serpytis, P., Spinar, J., Tomcsányi, J., Vandekerckhove, H. J., Voors, A. A., Monsalvo, M. L., Johnston, J., Malik, F. I., Honarpour, N. (2016) Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet, 388, pp. 2895-2903. (doi: 10.1016/S0140-6736(16)32049-9)

White, S. L., Lawlor, D. A., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng-Ntim, E., Robson, S. C., Sattar, N., Seed, P. T., Vieira, M. C., Welsh, P., Whitworth, M., Poston, L., Pasupathy, D. (2016) Early antenatal prediction of gestational diabetes in obese women: development of prediction tools for targeted intervention. PLoS ONE, 11, (doi: 10.1371/journal.pone.0167846)

Carrick, D., Haig, C., Ahmed, N., Carberry, J., Teng Yue May, V., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Davies, A., Abouzaid, A. M., Mordi, I., Ford, I., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation, 134, pp. 1833-1847. (doi: 10.1161/CIRCULATIONAHA.116.022603)

Vegter, E. L., Schmitter, D., Hagemeijer, Y., Ovchinnikova, E. S., van der Harst, P., Teerlink, J. R., O'Connor, C. M., Metra, M., Davison, B. A., Bloomfield, D., Cotter, G., Cleland, J. G.F., Givertz, M. M., Ponikowski, P., van Veldhuisen, D. J., van der Meer, P., Berezikov, E., Voors, A. A., Khan, M. A.F. (2016) Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. International Journal of Cardiology, 224, pp. 231-239. (doi: 10.1016/j.ijcard.2016.09.010)

Pellicori, P., Cleland, J. G.F., Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30, pp. 599-609. (doi: 10.1007/s10557-016-6697-7)

Livingstone, K. M. et al. (2016) Clustering of adherence to personalised dietary recommendations and changes in healthy eating index within the Food4Me study. Public Health Nutrition, 19, pp. 3296-3305. (doi: 10.1017/S1368980016001932)

Simpson, J., Smith, A. D., Fraser, A., Sattar, N., Callaway, M., Lindsay, R. S., Lawlor, D. A., Nelson, S. M. (2016) Cord blood adipokines and lipids and adolescent non-alcoholic fatty liver disease. Journal of Clinical Endocrinology and Metabolism, 101, pp. 4661-4668. (doi: 10.1210/jc.2016-2604)

Hawari, N. S.A., Al-Shayji, I., Wilson, J., Gill, J. M.R. (2016) Frequency of breaks in sedentary time and postprandial metabolic responses. Medicine and Science in Sports and Exercise, 48, pp. 2495-2502. (doi: 10.1249/MSS.0000000000001034)

Collins, P. D., Sattar, N. (2016) Glycaemic effects of non-statin lipid-lowering therapies. Current Cardiology Reports, 18, (doi: 10.1007/s11886-016-0795-9)

Postmus, I. et al. (2016) Meta-analysis of genome-wide association studies of HDL cholesterol response to statins. Journal of Medical Genetics, 53, pp. 835-845. (doi: 10.1136/jmedgenet-2016-103966)

Kaye, D. M., Hasenfuß, G., Neuzil, P., Post, M. C., Doughty, R., Trochu, J.-N., Kolodziej, A., Westenfeld, R., Penicka, M., Rosenberg, M., Walton, A., Muller, D., Walters, D., Hausleiter, J., Raake, P., Petrie, M. C., Bergmann, M., Jondeau, G., Feldman, T., van Veldhuisen, D. J., Ponikowski, P., Silvestry, F. E., Burkhoff, D., Hayward, C. (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003662)

Flynn, A. C., Seed, P. T., Patel, N., Barr, S., Bell, R., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng-Ntim, E., Robinson, S. M., Sanders, T. A., Sattar, N., Wardle, J., Poston, L., Goff, L. M. (2016) Dietary patterns in obese pregnant women; influence of a behavioral intervention of diet and physical activity in the UPBEAT randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity, 13, (doi: 10.1186/s12966-016-0450-2)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., Cleland, J. G.F. (2016) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Heart, 103, pp. 255-257. (doi: 10.1136/heartjnl-2015-309191)

Demissei, B. G., Postmus, D., Liu, L. C.Y., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Edwards, C., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Voors, A. A., Hillege, H. L. (2016) Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial. International Journal of Cardiology, 223, pp. 967-975. (doi: 10.1016/j.ijcard.2016.08.271)

Ferreira, J. P., Girerd, N., Pellicori, P., Duarte, K., Girerd, S., Pfeffer, M. A., McMurray, J. J.V., Pitt, B., Dickstein, K., Jacobs, L., Staessen, J. A., Butler, J., Latini, R., Masson, S., Mebazaa, A., Rocca, H. P. B.-L., Delles, C., Heymans, S., Sattar, N., Jukema, J. W., Cleland, J. G.F., Zannad, F., Rossignol, P. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, (doi: 10.1186/s12916-016-0731-2)

Rutherford, C., Speirs, C., Williams, J. J.L., Ewart, M.-A., Mancini, S. J., Hawley, S. A., Delles, C., Viollet, B., Costa-Pereira, A. P., Baillie, G. S., Salt, I. P., Palmer, T. M. (2016) Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling. Science Signaling, 9, (doi: 10.1126/scisignal.aaf8566)

Bekfani, T., Pellicori, P., Morris, D. A., Ebner, N., Valentova, M., Steinbeck, L., Wachter, R., Elsner, S., Sliziuk, V., Schefold, J. C., Sandek, A., Doehner, W., Cleland, J. G.F., Lainscak, M., Anker, S. D., von Haehling, S. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi: 10.1016/j.ijcard.2016.07.135)

Petrie, M. C., Jhund, P. S., She, L., Adlbrecht, C., Doenst, T., Panza, J. A., Hill, J. A., Lee, K. L., Rouleau, J. L., Prior, D. L., Ali, I. S., Maddury, J., Golba, K. S., White, H. D., Carson, P., Chrzanowski, L., Romanov, A., Miller, A. B., Velazquez, E. J. (2016) Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure) Circulation, 134, pp. 1314-1324. (doi: 10.1161/CIRCULATIONAHA.116.024800)

Lyall, D. M., Celis-Morales, C., Ward, J., Iliodromiti, S., Anderson, J. J., Gill, J. M.R., Smith, D. J., Ntuk, U. E., Mackay, D. F., Holmes, M. V., Sattar, N., Pell, J. P. (2016) Body-mass index and cardiometabolic disease: a Mendelian randomisation study of UK Biobank Participants. Lancet, 388, pp. S9-S9. (doi: 10.1016/S0140-6736(16)32245-0)

Hennigan, B., Oldroyd, K. G., Berry, C., Johnson, N., McClure, J., McCartney, P., McEntegart, M. B., Eteiba, H., Petrie, M. C., Rocchiccioli, P., Good, R., Lindsay, M. M., Hood, S., Watkins, S. (2016) Discordance between resting and hyperemic indices of coronary stenosis severity: the VERIFY 2 study (a comparative study of resting coronary pressure gradient, instantaneous wave-free ratio and fractional flow reserve in an unselected population referred for invasive angiography) Circulation: Cardiovascular Interventions, 9, (doi: 10.1161/CIRCINTERVENTIONS.116.004016)

Welsh, P., Tuckwell, K., McInnes, I. B., Sattar, N. (2016) Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. Atherosclerosis, 254, pp. 167-171. (doi: 10.1016/j.atherosclerosis.2016.10.016)

Preiss, D., Rankin, N., Welsh, P., Holman, R.R., Kangas, A.J., Soininen, P., Würtz, P., Ala-Korpela, M., Sattar, N. (2016) Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study. Diabetic Medicine, 33, pp. 1569-1574. (doi: 10.1111/dme.13097)

Read, S. H., Kerssens, J. J., McAllister, D. A., Colhoun, H. M., Fischbacher, C. M., Lindsay, R. S., McCrimmon, R. J., McKnight, J. A., Petrie, J. R., Sattar, N., Wild, S. H. (2016) Erratum to: Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia, 59, pp. 2492. (doi: 10.1007/s00125-016-4089-y)

Preiss, D., Sattar, N. (2016) Research digest: cardiac biomarkers for risk prediction. Lancet Diabetes and Endocrinology, 4, pp. 890-890. (doi: 10.1016/S2213-8587(16)30293-5)

Salas, C., Cristi-Montero, C., Fan, Y., Durán, E., Labraña, A. M., Martínez, M. A., Leiva, A. M., Alvarez, C., Aguilar-Farías, N., Ramírez-Campillo, R., Martínez, X. D., Sanzana-Inzunza, R., Celis-Morales, C. (2016) Ser físicamente activo modifica los efectos nocivos del sedentarismo sobre marcadores de obesidad y cardiometabólicos en adultos = [Being physically active modifies the detrimental effect of sedentary behavior on obesity and cardiometabolic markers in adults] Revista Medica de Chile, 144, pp. 1400-1409. (doi: 10.4067/S0034-98872016001100005)

Small, H. Y., Nosalski, R., Morgan, H., Beattie, E., Guzik, T., Graham, D., Delles, C. (2016) The role of tumor necrosis factor-α and natural killer cells in uterine artery function and pregnancy outcome in the stroke prone spontaneously hypertensive rat. Hypertension, 68, pp. 1298-1307. (doi: 10.1161/HYPERTENSIONAHA.116.07933)

Currie, G., Delles, C. (2016) Urinary proteomics for diagnosis and monitoring of diabetic nephropathy. Current Diabetes Reports, 16, (doi: 10.1007/s11892-016-0798-3)

Tromp, J., Meyer, S., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., van der Meer, P. (2016) Acute heart failure in the young: clinical characteristics and biomarker profiles. International Journal of Cardiology, 221, pp. 1067-1072. (doi: 10.1016/j.ijcard.2016.06.339)

Sattar, N. (2016) PCSK9 inhibitors and diabetes risk: a question worth asking? European Heart Journal, 37, pp. 2990-2992. (doi: 10.1093/eurheartj/ehw346)

Lotta, L. A. et al. (2016) Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA: Journal of the American Medical Association, 316, pp. 1383-1391. (doi: 10.1001/jama.2016.14568)

Rørth, R., Wong, C., Kragholm, K., Fosbøl, E. L., Mogensen, U. M., Lamberts, M., Petrie, M. C., Jhund, P. S., Gerds, T. A., Torp-Pedersen, C., Gislason, G. H., McMurray, J. J.V., Køber, L., Kristensen, S. L. (2016) Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study. Circulation, 134, pp. 999-1009. (doi: 10.1161/CIRCULATIONAHA.116.021859)

Sokoreli, I., de Vries, J.J.G., Riistama, J.M., Pauws, S.C., Steyerberg, E.W., Tesanovic, A., Geleijnse, G., Goode, K.M., Crundall-Goode, A., Kazmi, S., Cleland, J.G.F., Clark, A.L. (2016) Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. International Journal of Cardiology, 220, pp. 202-207. (doi: 10.1016/j.ijcard.2016.06.068)

Hoes, A. W. et al. (2016) 2016 ESC guidelines on cardiovascular disease prevention in clinical practice = Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología, 69, pp. 939.e1-939.e87. (doi: 10.1016/j.recesp.2016.09.004)

Gabay, C., McInnes, I. B., Kavanaugh, A., Tuckwell, K., Klearman, M., Pulley, J., Sattar, N. (2016) Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 75, pp. 1806-1812. (doi: 10.1136/annrheumdis-2015-207872)

Rutherford, E., Talle, M. A., Mangion, K., Bell, E., Rauhalammi, S. M., Roditi, G., McComb, C., Radjenovic, A., Welsh, P., Woodward, R., Struthers, A. D., Jardine, A. G., Patel, R. K., Berry, C., Mark, P. B. (2016) Definition of myocardial tissue abnormalities in end stage renal failure with cardiac magnetic resonance imaging using T1 mapping. Kidney International, 90, pp. 845-852. (doi: 10.1016/j.kint.2016.06.014)

Gray, S. R., Ferguson, C., Birch, K., Forrest, L. J., Gill, J. M. R. (2016) High-intensity interval training: key data needed to bridge the gap from laboratory to public health policy. British Journal of Sports Medicine, 50, pp. 1231-1232. (doi: 10.1136/bjsports-2015-095705)

Willeit, P. et al. (2016) Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes and Endocrinology, 4, pp. 840-849. (doi: 10.1016/S2213-8587(16)30196-6)

Cleland, J. G.F., Pellicori, P. (2016) PARADIGM-HF: does dose matter? European Journal of Heart Failure, 18, pp. 1235-1237. (doi: 10.1002/ejhf.634)

Cotter, G., Davison, B. A., Milo, O., Bourge, R. C., Cleland, J. G.F., Jondeau, G., Krum, H., O'Connor, C. M., Metra, M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Kobrin, I., Rainisio, M., Senger, S., Edwards, C., McMurray, J. J.V., Teerlink, J. R. (2016) Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of Cardiac Failure, 22, pp. 815-822. (doi: 10.1016/j.cardfail.2015.12.017)

Jani, B. D., Cavanagh, J., Barry, S. J.E., Der, G., Sattar, N., Mair, F. S. (2016) Relationship between blood pressure values, depressive symptoms and cardiovascular outcomes in patients with cardiometabolic disease. Journal of Clinical Hypertension, 18, pp. 1027-1035. (doi: 10.1111/jch.12813)

Sattar, N., Logue, J., Preiss, D. (2016) Research digest: weight loss to prevent and treat diabetes. Lancet Diabetes and Endocrinology, 4, pp. 817-817. (doi: 10.1016/S2213-8587(16)30244-3)

Joseph, A. C., Prapa, M., Pellicori, P., Mabote, T., Nasir, M., Clark, A. L. (2016) Tachycardia-induced cardiomyopathy in pregnancy. Journal of Cardiovascular Medicine, 17, pp. 762-766. (doi: 10.2459/jcm.0000000000000209)

Surendran, P. et al. (2016) Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nature Genetics, 48, pp. 1151-1161. (doi: 10.1038/ng.3654)

Read, S. H., Kerssens, J. J., McAllister, D., Colhoun, H. M., Fischbacher, C. M., Lindsay, R. S., McCrimmon, R. J., McKnight, J. A., Petrie, J. R., Sattar, N., Wild, S. H. (2016) Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia, 59, pp. 2106-2113. (doi: 10.1007/s00125-016-4054-9)

Brown, S. H.J., Eather, S. R., Freeman, D. J., Meyer, B. J., Mitchell, T. W. (2016) A lipidomic analysis of placenta in preeclampsia: evidence for lipid storage. PLoS ONE, 11, (doi: 10.1371/journal.pone.0163972)

Currie, G., Matt, P., Delles, C. (2016) Clinical cardiovascular proteomics. Springer

Currie, G., Taylor, A. H.M., Fujita, T., Ohtsu, H., Lindhart, M., Rossing, P., Boesby, L., Edwards, N. C., Ferro, C. J., Townend, J. N., van den Meiracker, A. H., Saklayen, M. G., Oveisi, S., Jardine, A. G., Delles, C., Preiss, D. J., Mark, P. B. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, (doi: 10.1186/s12882-016-0337-0)

White, J., Swerdlow, D. I., Preiss, D., Fairhurst-Hunter, Z., Keating, B. J., Asselbergs, F. W., Sattar, N., Humphries, S. E., Hingorani, A. D., Holmes, M. V. (2016) Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiology, 1, pp. 629-699. (doi: 10.1001/jamacardio.2016.1884)

Bauersachs, J., Arrigo, M., Hilfiker-Kleiner, D., Veltmann, C., Coats, A. J.S., Crespo-Leiro, M. G., De Boer, R. A., van der Meer, P., Maack, C., Mouquet, F., Petrie, M. C., Piepoli, M. F., Regitz-Zagrosek, V., Schaufelberger, M., Seferovic, P., Tavazzi, L., Ruschitzka, F., Mebazaa, A., Sliwa, K. (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 18, pp. 1096-1105. (doi: 10.1002/ejhf.586)

Wijsman, L. W., de Craen, A. J.M., Trompet, S., Sabayan, B., Muller, M., Stott, D. J., Ford, I., Welsh, P., Westendorp, R. G.J., Jukema, J. W., Sattar, N., Mooijaart, S. P. (2016) High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk. European Journal of Preventive Cardiology, 23, pp. 1383-1392. (doi: 10.1177/2047487316632364)

Preiss, D., Sattar, N. (2016) Research digest: NAFLD in the spotlight. Lancet Diabetes and Endocrinology, 4, pp. 735-735. (doi: 10.1016/S2213-8587(16)30187-5)

Hawkins, N. M., Jhund, P. S., Pozzi, A., O'Meara, E., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., Petrie, M. C., Virani, S., McMurray, J. J.V. (2016) Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. European Journal of Heart Failure, 18, pp. 1162-1171. (doi: 10.1002/ejhf.614)

Roberto, G., Leal, I., Sattar, N., Loomis, A. K., Avillach, P., Egger, P., van Wijngaarden, R., Ansell, D., Reisberg, S., Tammesoo, M.-L., Alavere, H., Pasqua, A., Pedersen, L., Cunningham, J., Tramontan, L., Mayer, M. A., Herings, R., Coloma, P., Lapi, F., Sturkenboom, M., van der Lei, J., Schuemie, M. J., Rijnbeek, P., Gini, R. (2016) Identifying cases of type 2 diabetes in heterogeneous data sources: strategy from the EMIF project. PLoS ONE, 11, (doi: 10.1371/journal.pone.0160648)

van der Laan, S. W. et al. (2016) Cystatin C and cardiovascular disease: a mendelian randomization study. Journal of the American College of Cardiology, 68, pp. 934-945. (doi: 10.1016/j.jacc.2016.05.092)

Di Angelantonio, E. et al. (2016) Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet, 388, pp. 776-786. (doi: 10.1016/S0140-6736(16)30175-1)

Iliodromiti, S., Ghouri, N., Celis-Morales, C. A., Sattar, N., Lumsden, M. A., Gill, J. M.R. (2016) Should physical activity recommendations for South Asian adults be ethnicity-specific? Evidence from a cross-sectional study of South Asian and white European men and women. PLoS ONE, 11, (doi: 10.1371/journal.pone.0160024)

ter Maaten, J. M., Damman, K., Hanberg, J. S., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Cotter, G., Davison, B., Cleland, J. G.F., Bloomfield, D. M., Hillege, H. L., van Veldhuisen, D. J., Voors, A. A., Testani, J. M. (2016) Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003109)

Piepoli, M. F. et al. (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) European Heart Journal, 37, pp. 2315-2381. (doi: 10.1093/eurheartj/ehw106)

Livingstone, K. M. et al. (2016) Effect of an Internet-based, personalized nutrition randomized trial on dietary changes associated with the Mediterranean diet: the Food4Me Study. American Journal of Clinical Nutrition, 104, pp. 288-297. (doi: 10.3945/​ajcn.115.129049)

Yaghootkar, H. et al. (2016) Genetic evidence for a link between favorable adiposity and lower risk of type 2 diabetes, hypertension, and heart disease. Diabetes, 65, pp. 2448-2460. (doi: 10.2337/db15-1671)

Carberry, J., Carrick, D., Haig, C., Rauhalammi, S. M., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Davie, A., Mahrous, A., Ford, I., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, 68, pp. 385-391. (doi: 10.1161/HYPERTENSIONAHA.116.07222)

Bhattacharyya, S., Mittal, T., Abayalingam, M., Kabir, T., Dalby, M., Cleland, J. G.F., Baltabaeva, A., Rahman Haley, S. (2016) Classification of aortic stenosis by flow and gradient patterns provides insights into the pathophysiology of disease. Angiology, 67, pp. 664-669. (doi: 10.1177/0003319715611804)

Mordi, I., Mordi, N., Delles, C., Tzemos, N. (2016) Endothelial dysfunction in human essential hypertension. Journal of Hypertension, 34, pp. 1464-1472. (doi: 10.1097/hjh.0000000000000965)

Fröhlich, H., Nelges, C., Täger, T., Schwenger, V., Cebola, R., Schnorbach, J., Goode, K. M., Kazmi, S., Katus, H. A., Cleland, J. G.F., Clark, A. L., Frankenstein, L. (2016) Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. American Heart Journal, 178, pp. 28-36. (doi: 10.1016/j.ahj.2016.03.024)

Preiss, D., Welsh, P., Sattar, N. (2016) Metformin therapy and circulating NT-proBNP levels: the CAMERA trial. Diabetes Care, 39, pp. e114-e115. (doi: 10.2337/dc16-0887)

Davison, B. A., Metra, M., Senger, S., Edwards, C., Milo, O., Bloomfield, D. M., Cleland, J. G., Dittrich, H. C., Givertz, M. M., O'Connor, C. M., Massie, B. M., Ponikowski, P., Teerlink, J. R., Voors, A. A., Cotter, G. (2016) Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. European Journal of Heart Failure, 18, pp. 1041-1050. (doi: 10.1002/ejhf.540)

Cleland, J. G.F., Zhang, J., Pellicori, P., Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K., Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1, pp. 539-547. (doi: 10.1001/jamacardio.2016.1161)

Sattar, N., Preiss, D. (2016) Research digest. Lancet Diabetes and Endocrinology, 4, pp. 651-651. (doi: 10.1016/S2213-8587(16)30161-9)

Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., Zinman, B., EMPA-REG OUTCOME Investigators, (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine, 375, pp. 323-334. (doi: 10.1056/NEJMoa1515920)

van Nassau, F. et al. (2016) Study protocol of European Fans in Training (EuroFIT): a four-country randomised controlled trial of a lifestyle program for men delivered in elite football clubs. BMC Public Health, 16, (doi: 10.1186/s12889-016-3255-y)

Lyall, D. M., Ward, J., Ritchie, S. J., Davies, G., Cullen, B., Celis, C., Bailey, M. E.S., Anderson, J., Evans, J., Mackay, D., McIntosh, A. M., Sattar, N., Smith, D. J., Deary, I. J., Pell, J. P. (2016) Alzheimer disease genetic risk factor APOE e4, and cognitive abilities in 111,739 UK Biobank participants. Age and Ageing, 45, pp. 511-517. (doi: 10.1093/ageing/afw068)

Aucott, L. S., Philip, S., Avenell, A., Afolabi, E., Sattar, N., Wild, S. (2016) Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ Open, 6, pp. e010836. (doi: 10.1136/bmjopen-2015-010836)

Biegus, J., Hillege, H. L., Postmus, D., Valente, M. A.E., Bloomfield, D. M., Cleland, J. G.F., Cotter, G., Davison, B. A., Dittrich, H. C., Fiuzat, M., Givertz, M. M., Massie, B. M., Metra, M., Teerlink, J. R., Voors, A. A., O'Connor, C. M., Ponikowski, P. (2016) Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European Journal of Heart Failure, 18, pp. 830-839. (doi: 10.1002/ejhf.532)

Sattar, N., Preiss, D. (2016) Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. Lancet Diabetes and Endocrinology, 4, pp. 555-556. (doi: 10.1016/s2213-8587(16)30097-3)

Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., McMurray, J. J. (2016) Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59, pp. 1573-1574. (doi: 10.1007/s00125-016-3987-3)

Khamis, R. Y., Hughes, A. D., Caga-Anan, M., Chang, C. L., Boyle, J. J., Kojima, C., Welsh, P., Sattar, N., Johns, M., Sever, P., Mayet, J., Haskard, D. O. (2016) High serum immunoglobulin g and m levels predict freedom from adverse cardiovascular events in hypertension: a nested case-control substudy of the Anglo-Scandinavian cardiac outcomes trial. EBioMedicine, 9, pp. 372-380. (doi: 10.1016/j.ebiom.2016.06.012)

Poortvliet, R. K.E., van Peet, P. G., de Craen, A. J.M., Mertens, B. J.A., Mooijaart, S. P., Wijsman, L. W., Drewes, Y. M., Ford, I., Sattar, N., Jukema, J. W., Stott, D., de Ruijter, W., Gussekloo, J. (2016) Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: additive value of N-terminal pro-B-type natriuretic peptide. European Journal of Preventive Cardiology, 23, pp. 1104-1113. (doi: 10.1177/2047487315617908)

Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., McMurray, J. J.V. (2016) SGLT2 and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia, 59, pp. 1333-1339. (doi: 10.1007/s00125-016-3956-x)

Sattar, N., Preiss, D. (2016) Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. Lancet Diabetes and Endocrinology, 4, pp. 560-562. (doi: 10.1016/S2213-8587(16)00085-1)

Feldman, T., Komtebedde, J., Burkhoff, D., Massaro, J., Maurer, M. S., Leon, M. B., Kaye, D., Silvestry, F. E., Cleland, J. G.F., Kitzman, D., Kubo, S. H., Van Veldhuisen, D. J., Kleber, F., Trochu, J.-N., Auricchio, A., Gustafsson, F., Hasenfuβ, G., Ponikowski, P., Filippatos, G., Mauri, L., Shah, S. J. (2016) Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE elevated left atrial pressure in heart failure (REDUCE LAP-HF I) Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.116.003025)

Currie, G., Delles, C. (2016) Use of biomarkers in the evaluation and treatment of hypertensive patients. Current Hypertension Reports, 18, (doi: 10.1007/s11906-016-0661-6)

Wannamethee, S. G., Welsh, P., Lennon, L., Papacosta, O., Whincup, P., Sattar, N. (2016) Copeptin and risk of incident stroke, coronary heart disease and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study. Diabetologia, 59, pp. 1904-1912. (doi: 10.1007/s00125-016-4011-7)

Scott, R. A. et al. (2016) A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Science Translational Medicine, 8, (doi: 10.1126/scitranslmed.aad3744)

Voors, A. A., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., van der Harst, P., Hillege, H. L., Lang, C. C., ter Maaten, J. M., Ng, L., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M. (2016) A systems BIOlogy Study to TAilored treatment in chronic heart failure: rationale, design, and baseline characteristics of BIOSTAT-CHF. European Journal of Heart Failure, 18, pp. 716-726. (doi: 10.1002/ejhf.531)

Siervo, M., Lara, J., Celis-Morales, C., Vacca, M., Oggioni, C., Battezzati, A., Leone, A., Tagliabue, A., Spadafranca, A., Bertoli, S. (2016) Age-related changes in basal substrate oxidation and visceral adiposity and their association with metabolic syndrome. European Journal of Nutrition, 55, pp. 1755-1767. (doi: 10.1007/s00394-015-0993-z)

Welsh, P., Cezard, G., Gill, J.M., Wallia, S., Douglas, A., Sheikh, A., Wild, S.H., Tuomilehto, J., McKnight, J., Murray, G., Bhopal, R., Lean, M., Sattar, N. (2016) Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA Trial. International Journal of Obesity, 40, pp. 1005-1011. (doi: 10.1038/ijo.2016.35)

ter Maaten, J. M., Valente, M. A.E., Damman, K., Cleland, J. G., Givertz, M. M., Metra, M., O’Connor, C. M., Teerlink, J. R., Ponikowski, P., Bloomfield, D. M., Cotter, G., Davison, B., Subacius, H., van Veldhuisen, D. J., van der Meer, P., Hillege, H. L., Gheorghiade, M., Voors, A. A. (2016) Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002845)

Wannamethee, G., Shaper, G., Papacosta, O., Lennon, L., Welsh, P., Whincup, P. (2016) Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men—the British regional heart study. Thorax, 71, pp. 526-534. (doi: 10.1136/thoraxjnl-2014-206724)

Emmens, J. E., ter Maaten, J. M., Matsue, Y., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Todd, J., van Veldhuisen, D. J., Hillege, H. L., Damman, K., van der Meer, P., Voors, A. A. (2016) Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. European Journal of Heart Failure, 18, pp. 641-649. (doi: 10.1002/ejhf.426)

Da Boit, M., Sibson, R., Meakin, J. R., Aspden, R. M., Thies, F., Mangoni, A. A., Gray, S. R. (2016) Sex differences in the response to resistance exercise training in older people. Physiological Reports, 4, (doi: 10.14814/phy2.12834)

Da Boit, M., Sibson, R., Meakin, J. R., Aspden, R. M., Thies, F., Mangoni, A. A., Gray, S. R. (2016) Sex-differences in the effect of fish oil supplementation on the adaptive response to resistance exercise training in older people: a randomized control trial. American Journal of Clinical Nutrition, 4, (doi: 10.14814/phy2.12834)

Celis-Morales, C., Salas, C., Alduhishy, A., Sanzana, R., Martinez, M. A., Leiva, A., Diaz, X., Martinez, C., Alvarez, C., Leppe, J., Munro, C. A., Siervo, M., Willis, N. D. (2016) Socio-demographic patterns of physical activity and sedentary behaviour in Chile: results from the national health survey 2009-2010. Journal of Public Health, 38, pp. e98-e105. (doi: 10.1093/pubmed/fdv079)

Gregg, E. W., Sattar, N., Ali, M. K. (2016) The changing face of diabetes complications and its global implications. Lancet Diabetes and Endocrinology, 4, pp. 537-547. (doi: 10.1016/S2213-8587(16)30010-9)

Wild, S. H., Morling, J. R., McAllister, D. A., Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P. J., Sattar, N., Byrne, C. D. (2016) Type 2 diabetes and risk of hospital admission or death for chronic liver diseases. Journal of Hepatology, 64, pp. 1358-1364. (doi: 10.1016/j.jhep.2016.01.014)

Ballantyne, M. D., Pinel, K., Dakin, R., Vesey, A. T., Diver, L., MacKenzie, R., Garcia, R., Welsh, P., Sattar, N., Hamilton, G., Joshi, N., Dweck, M. R., Miano, J. M., McBride, M. W., Newby, D. E., McDonald, R. A., Baker, A. H. (2016) Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation, 133, pp. 2050-2065. (doi: 10.1161/circulationaha.115.021019)

Stitziel, N. O. et al. (2016) Correction: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. New England Journal of Medicine, 374, pp. 1898. (doi: 10.1056/NEJMxx160012)

Carrick, D., Haig, C., Carberry, J., Teng Tue May, V., Mccartney, P., Welsh, P., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Mahrous, A., Rauhalammi, S. M.O., Mordi, I., Ford, I., Radjenovic, A., Sattar, N., Oldroyd, K. G., Berry, C. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1, (doi: 10.1172/jci.insight.85768)

Pellicori, P., Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L., Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi: 10.1016/j.ijcard.2016.02.081)

Gheorghiade, M., Larson, C. J., Shah, S. J., Greene, S. J., Cleland, J. G.F., Colucci, W. S., Dunnmon, P., Epstein, S. E., Kim, R. J., Parsey, R. V., Stockbridge, N., Carr, J., Dinh, W., Krahn, T., Kramer, F., Wahlander, K., Deckelbaum, L. I., Crandall, D., Okada, S., Senni, M., Sikora, S., Sabbah, H. N., Butler, J. (2016) Developing new treatments for heart failure: focus on the heart. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002727)

Shoaib, A., Farag, M., Nasir, M., John, J., Gupta, S., Pellicori, P., Antony, R., Perveen, R., Rigby, A., Goode, K. M., Yassin, A., Clark, A. L., Cleland, J. G.F. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18, pp. 556-563. (doi: 10.1002/ejhf.505)

Pellicori, P., Cleland, J.G.F. (2016) New ways to visualize and combat congestion in heart failure = Nuevos modos de visualizar y combatir la congestión en la insuficiencia cardiaca. Revista Clínica Española, 216, pp. 202-204. (doi: 10.1016/j.rce.2016.03.007)

Campbell, R. T., Willox, G. P., Jhund, P. S., Hawkins, N. M., Huang, F., Petrie, M. C., McMurray, J. J. V. (2016) Reporting of lost to follow-up and treatment discontinuation in device and pharmacotherapy trials in chronic heart failure: a systematic review. Circulation: Heart Failure, 9, (doi: 10.1161/CIRCHEARTFAILURE.115.002842)

Velazquez, E. J., Lee, K. L., Jones, R. H., Al-Khalidi, H. R., Hill, J. A., Panza, J. A., Michler, R. E., Bonow, R. O., Doenst, T., Petrie, M. C., Oh, J. K., She, L., Moore, V. L., Desvigne-Nickens, P., Sopko, G., Rouleau, J. L. (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. New England Journal of Medicine, 374, pp. 1511-1520. (doi: 10.1056/NEJMoa1602001)

Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D. G., Collins, P. D., Packer, M., Wikstrand, J., Coats, A. J.S., Cleland, J. G.F., Kirchhof, P., von Lueder, T. G., Rigby, A. S., Andersson, B., Lip, G. Y.H., van Veldhuisen, D. J., Shibata, M. C., Wedel, H., Böhm, M., Flather, M. D. (2016) Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. British Medical Journal, 353, (doi: 10.1136/bmj.i1855)

Lee, M. M.Y., Petrie, M. C., Rocchiccioli, P., Simpson, J., Jackson, C., Brown, A., Corcoran, D., Mangion, K., McEntegart, M., Shaukat, A., Rae, A., Hood, S., Peat, E., Findlay, I., Murphy, C., Cormack, A., Bukov, N., Balachandran, K., Papworth, R., Ford, I., Briggs, A., Berry, C. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS) Open Heart, 3, (doi: 10.1136/openhrt-2015-000371)

Nissen, S. E., Stroes, E., Dent-Acosta, R. E., Rosenson, R. S., Lehman, S. J., Sattar, N., Preiss, D., Bruckert, E., Češka, R., Lepor, N., Ballantyne, C. M., Gouni-Berthold, I., Elliott, M., Brennan, D. M., Wasserman, S. M., Somaratne, R., Scott, R., Stein, E. A. (2016) Efficacy and tolerability of evolocumab vs. ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. JAMA: Journal of the American Medical Association, 315, pp. 1580-1590. (doi: 10.1001/jama.2016.3608)

Abdul-Rahim, A. H., MacIsaac, R. L., Jhund, P. S., Petrie, M. C., Lees, K. R., McMurray, J. J.V. (2016) Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial. International Journal of Cardiology, 209, pp. 310-316. (doi: 10.1016/j.ijcard.2016.02.074)

Wan Sulaiman, W.N., Caslake, M.J., Delles, C., Karlsson, H., Mulder, M.T., Graham, D., Freeman, D.J. (2016) Does high-density lipoprotein protect vascular function in healthy pregnancy? Clinical Science, 130, pp. 491-497. (doi: 10.1042/cs20150475)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Lindsay, M., Mahrous, A., Ford, I., Tzemos, N., Sattar, N., Welsh, P., Radjenovic, A., Oldroyd, K. G., Berry, C. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37, pp. 1044-1059. (doi: 10.1093/eurheartj/ehv372)

Martin, D. J., Ul-Haq, Z., Nicholl, B. I., Cullen, B., Evans, J., Gill, J. M. R., Roberts, B., Gallacher, J., Mackay, D., McIntosh, A., Hotopf, M., Craddock, N., Deary, I. J., Pell, J. P., Smith, D. J. (2016) Cardiometabolic disease and features of depression and bipolar disorder: population-based, cross-sectional study. British Journal of Psychiatry, 208, pp. 343-351. (doi: 10.1192/bjp.bp.114.157784)

Paul, L., Wyke, S., Brewster, S., Sattar, N., Gill, J. M.R., Alexander, G., Rafferty, D., McFadyen, A. K., Ramsay, A., Dybus, A. (2016) Increasing physical activity in stroke survivors using STARFISH, an interactive mobile phone application: a pilot study. Topics in Stroke Rehabilitation, 23, pp. 170-177. (doi: 10.1080/10749357.2015.1122266)

Trompet, S., Postmus, I., Slagboom, P.E., Heijmans, B.T., Smit, R.A.J., Maier, A.B., Buckley, B.M., Sattar, N., Stott, D.J., Ford, I., Westendorp, R.G.J., de Craen, A.J.M., Jukema, J.W. (2016) Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies. European Journal of Clinical Pharmacology, 72, pp. 431-437. (doi: 10.1007/s00228-015-1994-9)

Eisele, N., Albrecht, C., Mistry, H. D., Dick, B., Baumann, M., Surbek, D., Currie, G., Delles, C., Mohaupt, M. G., Escher, G., Gennari-Moser, C. (2016) Placental expression of the angiogenic placental growth factor is stimulated by both aldosterone and simulated starvation. Placenta, 40, pp. 18-24. (doi: 10.1016/j.placenta.2016.02.004)

Ovchinnikova, E. S. et al. (2016) Signature of circulating microRNAs in patients with acute heart failure. European Journal of Heart Failure, 18, pp. 414-423. (doi: 10.1002/ejhf.332)

Koshy, A., Pellicori, P., Clark, A. L. (2016) The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure. Heart, 102, pp. 597-601. (doi: 10.1136/heartjnl-2015-308932)

Neisius, U., Koeck, T., Mischak, H., Rossi, S. H., Olson, E., Carty, D. M., Dymott, J. A., Dominiczak, A. F., Berry, C., Oldroyd, K. G., Delles, C. (2016) Urine proteomics in the diagnosis of stable angina. BMC Cardiovascular Disorders, 16, (doi: 10.1186/s12872-016-0246-y)

Patel, S., Lawlor, D. A., Callaway, M., Macdonald-Wallis, C., Sattar, N., Fraser, A. (2016) Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. BMC Pediatrics, 16, (doi: 10.1186/s12887-016-0585-y)

Wu, W.-C. H., Murray, E. T., Jones, R., Thomas, C., Ghosh, A. K., Sattar, N., Deanfield, J., Hardy, R., Kuh, D., Hughes, A. D., Whincup, P. (2016) Life course socioeconomic position: associations with cardiac structure and function at age 60-64 years in the 1946 British birth cohort. PLoS ONE, 11, pp. e0152691. (doi: 10.1371/journal.pone.0152691)

Teerlink, J. R., Felker, G. M., McMurray, J. J.V., Ponikowski, P., Metra, M., Filippatos, G. S., Ezekowitz, J. A., Dickstein, K., Cleland, J. G.F., Kim, J. B., Lei, L., Knusel, B., Wolff, A. A., Malik, F. I., Wasserman, S. M. (2016) Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure. Journal of the American College of Cardiology, 67, pp. 1444-1455. (doi: 10.1016/j.jacc.2016.01.031)

Hasenfuß, G., Hayward, C., Burkhoff, D., Silvestry, F. E., McKenzie, S., Gustafsson, F., Malek, F., Van der Heyden, J., Lang, I., Petrie, M. C., Cleland, J. G.F., Leon, M., Kaye, D. M. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387, pp. 1298-1304. (doi: 10.1016/S0140-6736(16)00704-2)

Stitziel, N. O. et al. (2016) Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. New England Journal of Medicine, 374, pp. 1134-1144. (doi: 10.1056/NEJMoa1507652)

Würtz, P. et al. (2016) Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase. Journal of the American College of Cardiology, 67, pp. 1200-1210. (doi: 10.1016/j.jacc.2015.12.060)

Zanoni, P. et al. (2016) Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science, 351, pp. 1166-1171. (doi: 10.1126/science.aad3517)

Loomis, A. K., Kabadi, S., Preiss, D., Hyde, C., Bonato, V., St. Louis, M., Desai, J., Gill, J. M.R., Welsh, P., Waterworth, D., Sattar, N. (2016) Body mass index and risk of non-alcoholic fatty liver disease: two electronic health record prospective studies. Journal of Clinical Endocrinology and Metabolism, 101, pp. 945-952. (doi: 10.1210/jc.2015-3444)

Nissen, S. E., Dent-Acosta, R. E., Rosenson, R. S., Stroes, E., Sattar, N., Preiss, D., Mancini, G.B. J., Ballantyne, C. M., Catapano, A., Gouni-Berthold, I., Stein, E. A., Xue, A., Wasserman, S. M., Scott, R., Thompson, P. D. (2016) Comparison of PCSK9 inhibitor evolocumab vs ezetimibe in statin-intolerant patients: design of the goal achievement after utilizing an anti-PCSK9 antibody in statin-intolerant subjects 3 (GAUSS-3) trial. Clinical Cardiology, 39, pp. 137-144. (doi: 10.1002/clc.22518)

Sattar, N., McInnes, I. (2016) Editorial: Lipid changes with different antiinflammatory regimens in rheumatoid arthritis: developing a pragmatic approach to complex data. Arthritis and Rheumatology, 68, pp. 563-565. (doi: 10.1002/art.39510)

Mullan, A., Delles, C., Ferrell, W., Mullen, W., Edwards, C. A., McColl, J. H., Roberts, S. A., Lean, M. (2016) Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized trial. Atherosclerosis, 246, pp. 169-176. (doi: 10.1016/j.atherosclerosis.2016.01.004)

Donin, A.S., Dent, J.E., Nightingale, C.M., Sattar, N., Owen, C.G., Rudnicka, A.R., Perkin, M.R., Stephen, A.M., Jebb, S.A., Cook, D.G., Whincup, P.H. (2016) Fruit, vegetable and vitamin C intakes and plasma vitamin C: cross-sectional associations with insulin resistance and glycaemia in 9-10 year-old children. Diabetic Medicine, 33, pp. 307-315. (doi: 10.1111/dme.13006)

Damman, K., Kjekshus, J., Wikstrand, J., Cleland, J. G.F., Komajda, M., Wedel, H., Waagstein, F., McMurray, J. J.V. (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18, pp. 328-336. (doi: 10.1002/ejhf.462)

Demissei, B. G., Valente, M. A.E., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van der Meer, P., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A. (2016) Optimizing clinical use of biomarkers in high-risk acute heart failure patients. European Journal of Heart Failure, 18, pp. 269-280. (doi: 10.1002/ejhf.443)

Livingstone, K. M. et al. (2016) Profile of European adults interested in internet-based personalised nutrition: the Food4Me study. European Journal of Nutrition, 55, pp. 759-769. (doi: 10.1007/s00394-015-0897-y)

Cuba Gyllensten, I., Bonomi, A. G., Goode, K. M., Reiter, H., Habetha, J., Amft, O., Cleland, J. G.F. (2016) Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance. JMIR Medical Informatics, 4, (doi: 10.2196/medinform.4842)

Demissei, B. G., Cleland, J. G.F., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Davison, B., Givertz, M. M., Bloomfield, D. M., Dittrich, H., van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., Cotter, G. (2016) Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. International Journal of Cardiology, 204, pp. 164-171. (doi: 10.1016/j.ijcard.2015.11.141)

ter Maaten, J. M., Valente, M. A.E., Metra, M., Bruno, N., O’Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., van Veldhuisen, D. J., Hillege, H. L., Damman, K., Voors, A. A. (2016) A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clinical Research in Cardiology, 105, pp. 145-153. (doi: 10.1007/s00392-015-0896-2)

Currie, G., Delles, C., Touyz, R. M., Staessen, J. A., Dominiczak, A. F., Jennings, G. L. R., Wang, J.-G. (2016) A woman with treatment-resistant hypertension. Hypertension, 67, pp. 243-250. (doi: 10.1161/HYPERTENSIONAHA.115.06756)

Marsaux, C. F. et al. (2016) Changes in physical activity following a genetic-based internet-delivered personalized intervention: randomized controlled trial (Food4Me) Journal of Medical Internet Research, 18, (doi: 10.2196/jmir.5198)

Bhandari, S., Ives, N., Brettell, E. A., Valente, M., Cockwell, P., Topham, P. S., Cleland, J. G.F., Khwaja, A., El Nahas, M. (2016) Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology Dialysis Transplantation, 31, pp. 255-261. (doi: 10.1093/ndt/gfv346)

Welsh, P., Hart, C., Papacosta, O., Preiss, D., McConnachie, A., Murray, H., Ramsay, S., Upton, M., Watt, G., Whincup, P., Wannamethee, G., Sattar, N. (2016) Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? Hypertension, 2016, pp. 309-315. (doi: 10.1161/HYPERTENSIONAHA.115.06501)

Small, H. Y., Currie, G. E., Delles, C. (2016) Prostasin, proteases, and preeclampsia. Journal of Hypertension, 34, pp. 193-195. (doi: 10.1097/hjh.0000000000000828)

Carrick, D., Haig, C., Rauhalammi, S., Clerfond, G., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M. M., Mahrous, A., Welsh, P., Sattar, N., Ford, I., Oldroyd, K., Radjenovic, A., Berry, C. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, (doi: 10.1161/JAHA.115.002834)

Hoeller, U. et al. (2016) Application of dried blood spots to determine vitamin D status in a large nutritional study with unsupervised sampling: the Food4Me project. British Journal of Nutrition, 115, pp. 202-211. (doi: 10.1017/S0007114515004298)

Bruno, N., ter Maaten, J. M., Ovchinnikova, E. S., Vegter, E. L., Valente, M. A.E., van der Meer, P., de Boer, R. A., van der Harst, P., Schmitter, D., Metra, M., O'Connor, C. M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G.F., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Pinto, Y. M., van Veldhuisen, D. J., Hillege, H. L., Berezikov, E., Voors, A. A. (2016) MicroRNAs relate to early worsening of renal function in patients with acute heart failure. International Journal of Cardiology, 203, pp. 564-569. (doi: 10.1016/j.ijcard.2015.10.217)

Iliodromiti, S., Sassarini, J., Kelsey, T. W., Lindsay, R. S., Sattar, N., Nelson, S. M. (2016) Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis. Diabetologia, 59, pp. 692-699. (doi: 10.1007/s00125-015-3855-6)

Bakrania, K., Edwardson, C. L., Bodicoat, D. H., Esliger, D. W., Gill, J. M. R., Kazi, A., Velayudhan, L., Sinclair, A. J., Sattar, N., Biddle, S. J. H., Khunti, K., Davies, M., Yates, T. (2016) Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of the Health Survey for England. BMC Public Health, 16, (doi: 10.1186/s12889-016-2694-9)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P., Clark, A. L., Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi: 10.1016/j.ijcard.2015.09.076)

Ahmed, N., Layland, J., Carrick, D., Petrie, M. C., McEntegart, M., Eteiba, H., Hood, S., Lindsay, M., Watkins, S., Davie, A., Mahrous, A., Carberry, J., Teng, V., McConnachie, A., Curzen, N., Oldroyd, K. G., Berry, C. (2016) Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. International Journal of Cardiology, 202, pp. 305-310. (doi: 10.1016/j.ijcard.2015.09.014)

de Vries, P. et al. (2016) A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. Human Molecular Genetics, 25, pp. 358-370. (doi: 10.1093/hmg/ddv454)

Small, H. Y., Morgan, H., Beattie, E., Griffin, S., Indahl, M., Delles, C., Graham, D. (2016) Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. Placenta, 37, pp. 34-44. (doi: 10.1016/j.placenta.2015.10.022)

Anderson, E. L., Fraser, A., Howe, L. D., Callaway, M. P., Sattar, N., Day, C., Tilling, K., Lawlor, D. A. (2016) Physical activity is prospectively associated with adolescent nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition, 62, pp. 110-117. (doi: 10.1097/mpg.0000000000000904)

Cowie, M. R., Bax, J., Bruining, N., Cleland, J. G.F., Koehler, F., Malik, M., Pinto, F., van der Velde, E., Vardas, P. (2016) e-Health: a position statement of the European Society of Cardiology. European Heart Journal, 37, pp. 63-66. (doi: 10.1093/eurheartj/ehv416)

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G.F., Coats, A. J.S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M.C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., McMurray, J. J.V., Petrie, M. C. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37, pp. 2129-2200. (doi: 10.1093/eurheartj/ehw128)

Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J. A., Damasceno, A., Delles, C., Gimenez-Roqueplo, A.-P., Hering, D., López-Jaramillo, P., Martinez, F., Perkovic, V., Rietzschel, E. R., Schillaci, G., Schutte, A. E., Scuteri, A., Sharman, J. E., Wachtell, K., Wang, J. G. (2016) A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet, 388, pp. 2665-2712. (doi: 10.1016/S0140-6736(16)31134-5)

Rankin, N. J., Preiss, D., Welsh, P., Sattar, N. (2016) Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. International Journal of Epidemiology, 45, pp. 1351-1371. (doi: 10.1093/ije/dyw271)

Zhang, Z.-y., Ravassa, S., Yang, W.-Y., Petit, T., Pejchinovski, M., Zürbig, P., López, B., Wei, F.-F., Pontillo, C., Thijs, L., Jacobs, L., González, A., Koeck, T., Delles, C., Voigt, J.-U., Verhamme, P., Kuznetsova, T., Díez, J., Mischak, H., Staessen, J. A. (2016) Diastolic left ventricular function in relation to urinary and serum collagen biomarkers in a general population. PLoS ONE, 11, (doi: 10.1371/journal.pone.0167582)

Albani, V. et al. (2016) Exploring the association of diary product intake with the fatty acids C15:0 and C17:0 measured from dried blood spots in a multi-population cohort: findings from the Food4Me study. Molecular Nutrition and Food Research, 60, pp. 834-845. (doi: 10.1002/mnfr.201500483)

Livingstone, K. M. et al. (2016) FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. British Medical Journal, 354, (doi: 10.1136/bmj.i4707)

Stirrat, C. t., Alam, S. R., MacGillivray, T. J., Gray, C. D., Forsythe, R., Dweck, M. R., Payne, J. R., Prasad, S. K., Petrie, M. C., Gardner, R. S., Mirsadraee, S., Henriksen, P. A., Newby, D. E., Semple, S. I.K. (2016) Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. Journal of Cardiovascular Magnetic Resonance, 18, (doi: 10.1186/s12968-016-0261-2)

McCallum, J. E., Mackenzie, A. E., Divorty, N., Clarke, C., Delles, C., Milligan, G., Nicklin, S. A. (2016) G protein-coupled receptor 35 mediates human saphenous vein vascular smooth muscle cell migration and endothelial cell proliferation. Journal of Vascular Research, 52, pp. 383-395. (doi: 10.1159/000444754)

Mangion, K., Carrick, D., Hennigan, B. W., Payne, A. R., McClure, J., Mason, M., Das, R., Wilson, R., Edwards, R. J., Petrie, M. C., McEntegart, M., Eteiba, H., Oldroyd, K. G., Berry, C. (2016) Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention. Heart, 102, pp. 1980-1987. (doi: 10.1136/heartjnl-2015-308660)

Sattar, N., Preiss, D., Robinson, J. G., Djedjos, C. S., Elliott, M., Somaratne, R., Wasserman, S. M., Raal, F. J. (2016) Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab in patients with type 2 diabetes: a meta-analysis. Lancet Diabetes and Endocrinology, 4, pp. 403-410. (doi: 10.1016/S2213-8587(16)00003-6)

Meyer, B. J., Onyiaodike, C. C., Brown, E. A., Jordan, F., Murray, H., Nibbs, R. J. B., Sattar, N., Lyall, H., Nelson, S. M., Freeman, D. J. (2016) Maternal plasma DHA levels increase prior to 29 days post-LH surge in women undergoing frozen embryo transfer: a prospective, observational study of human pregnancy. Journal of Clinical Endocrinology and Metabolism, 101, pp. 1745-1753. (doi: 10.1210/jc.2015-3089)

Carrick, D., Haig, C., Watkins, S., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Hood, S., Watkins, S., Lindsay, M. M., Davie, A., Mahrous, A., Mordi, I., Rauhalammi, S., Sattar, N., Welsh, P., Radjenovic, A., Ford, I., Oldroyd, K., Berry, C. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9, (doi: 10.1161/CIRCIMAGING.115.004148)

Gillis, K. A., Mccomb, C., Patel, R. K., Stevens, K. K., Schneider, M. P., Radjenovic, A., Morris, S. T.W., Roditi, G. H., Delles, C., Mark, P. B. (2016) Non-contrast renal magnetic resonance imaging to assess perfusion and corticomedullary differentiation in health and chronic kidney disease. Nephron, 133, pp. 183-192. (doi: 10.1159/000447601)

O'Donovan, G., Bakrania, K., Ghouri, N., Yates, T., Gray, L. J., Hamer, M., Stamatakis, E., Khunti, K., Davies, M., Sattar, N., Gill, J. M.R. (2016) Non-exercise equations to estimate fitness in white European and South Asian men. Medicine and Science in Sports and Exercise, 48, pp. 854-859. (doi: 10.1249/MSS.0000000000000836)

Celis-Morales, C. et al. (2016) Physical activity attenuates the effect of the FTO genotype on obesity traits in European adults: The Food4Me study. Obesity, 24, pp. 962-969. (doi: 10.1002/oby.21422)

Lindhardt, M., Persson, F., Currie, G., Pontillo, C., Beige, J., Delles, C., von der Leyen, H., Mischak, H., Navis, G., Noutsou, M., Ortiz, A., Ruggenenti, P. L., Rychlik, I., Spasovski, G., Rossing, P. (2016) Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. BMJ Open, 6, (doi: 10.1136/bmjopen-2015-010310)

Marshall, S. J. et al. (2016) Reproducibility of the Online Food4Me Food-Frequency Questionnaire for estimating dietary intakes across Europe. Journal of Nutrition, 146, pp. 1068-1075. (doi: 10.3945/​jn.115.225078)

Sheikh, A. M., Small, H. Y., Currie, G., Delles, C. (2016) Systematic review of micro-RNA expression in pre-eclampsia identifies a number of common pathways associated with the disease. PLoS ONE, 11, (doi: 10.1371/journal.pone.0160808)

Leslie, W. S., Ford, I., Sattar, N., Hollingsworth, K. G., Adamson, A., Sniehotta, F. F., McCombie, L., Brosnahan, N., Ross, H., Mathers, J. C., Peters, C., Thom, G., Barnes, A., Kean, S., McIlvenna, Y., Rodrigues, A., Rehackova, L., Zhyzhneuskaya, S., Taylor, R., Lean, M. E.J. (2016) The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Family Practice, 17, (doi: 10.1186/s12875-016-0406-2)

Fallaize, R. et al. (2016) The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial. American Journal of Clinical Nutrition, 104, pp. 827-836. (doi: 10.3945/​ajcn.116.135012)

Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., Anker, S. D., Sattar, N., Petrie, M. C., Gardner, R. S., McMurray, J. J. V. (2016) The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. European Journal of Heart Failure, 18, pp. 1491-1498. (doi: 10.1002/ejhf.543)

Emdin, C. A., Conrad, N., Kiran, A., Salimi-Khorshidi, G., Woodward, M., Anderson, S. G., Mohseni, H., Dargie, H. J., Hardman, S. M.C., McDonagh, T., McMurray, J. J.V., Cleland, J. G.F., Rahimi, K. (2016) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart, 103, pp. 55-62. (doi: 10.1136/heartjnl-2016-309706)

2015

Cleland, J. G.F., Mareev, Y. (2015) CRT for heart failure and ESRD: more trials or more thought needed? Journal of the American College of Cardiology, 66, pp. 2630-2632. (doi: 10.1016/j.jacc.2015.10.022)

Oggioni, C., Cena, H., Wells, J.C.K., Lara, J., Celis-Morales, C., Siervo, M. (2015) Association between worldwide dietary and lifestyle patterns with total cholesterol concentrations and DALYs for infectious and cardiovascular diseases: an ecological analysis. Journal of Epidemiology and Global Health, 5, pp. 315-325. (doi: 10.1016/j.jegh.2015.02.002)

Henson, J., Davies, M. J., Bodicoat, D. H., Edwardson, C. L., Gill, J. M.R., Stensel, D. J., Tolfrey, K., Dunstan, D. W., Khunti, K., Yates, T. (2015) Breaking up prolonged sitting with standing or walking attenuates the postprandial metabolic response in postmenopausal women: a randomized acute study. Diabetes Care, (doi: 10.2337/dc15-1240)

Eastwood, S. V., Tillin, T., Sattar, N., Forouhi, N. G., Hughes, A. D., Chaturvedi, N. (2015) Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in South Asians and Europeans. Diabetes Care, 38, pp. 2325-2332. (doi: 10.2337/dc15-1078)

Linneberg, A. et al. (2015) Effect of smoking on blood pressure and resting heart rate: a Mendelian randomization meta-analysis in the CARTA Consortium. Circulation: Cardiovascular Genetics, 8, pp. 832-841. (doi: 10.1161/circgenetics.115.001225)

Nam, J., Briggs, A., Layland, J., Oldroyd, K. G., Curzen, N., Sood, A., Balachandran, K., Das, R., Junejo, S., Eteiba, H., Petrie, M. C., Lindsay, M., Watkins, S., Corbett, S., O'Rourke, B., O'Donnell, A., Stewart, A., Hannah, A., McConnachie, A., Henderson, R., Berry, C. (2015) Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods. Cost Effectiveness and Resource Allocation, 2015, (doi: 10.1186/s12962-015-0045-9)

Hallmann, J. et al. (2015) Predicting fatty acid profiles in blood based on food intake and the FADS1 rs174546 SNP. Molecular Nutrition and Food Research, 59, pp. 2565-2573. (doi: 10.1002/mnfr.201500414)

Sattar, N., Sorensen, T., Taylor, A. E., Morris, R., Munafò, M. R. (2015) Smoking and diabetes risk: building a causal case with clinical implications. Lancet Diabetes and Endocrinology, 3, pp. 918-920. (doi: 10.1016/s2213-8587(15)00341-1)

Sattar, N., Gill, J. M.R. (2015) Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Lancet Diabetes and Endocrinology, 3, pp. 1004-1016. (doi: 10.1016/S2213-8587(15)00326-5)

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., Broedl, U. C., Inzucchi, S. E., EMPA-REG OUTCOME Investigators, (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373, pp. 2117-2128. (doi: 10.1056/NEJMoa1504720)

Jolicœur, E. M., Dunning, A., Castelvecchio, S., Dabrowski, R., Waclawiw, M. A., Petrie, M. C., Stewart, R., Jhund, P. S., Desvigne-Nickens, P., Panza, J. A., Bonow, R. O., Sun, B., San, T. R., Al-Khalidi, H. R., Rouleau, J. L., Velazquez, E. J., Cleland, J. G.F. (2015) Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 66, pp. 2092-2100. (doi: 10.1016/j.jacc.2015.08.882)

San-Cristobal, R., Navas-Carretero, S., Celis-Morales, C., Brennan, L., Walsh, M., Lovegrove, J., Daniel, H., Saris, W., Traczyk, I., Manios, Y., Gibney, E., Gibney, M., Mathers, J., Martinez, J. (2015) Analysis of dietary pattern impact on weight status for personalised nutrition through on-line advice:: The Food4Me Spanish cohort. Nutrients, 7, pp. 9523-9537. (doi: 10.3390/nu7115482)

Simpson, J., Castagno, D., Doughty, R. N., Poppe, K. K., Earle, N., Squire, I., Richards, M., Andersson, B., Ezekowitz, J. A., Komajda, M., Petrie, M. C., McAlister, F. A., Gamble, G. D., Whalley, G. A., McMurray, J. J.V. (2015) Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis. European Journal of Heart Failure, 17, pp. 1182-1191. (doi: 10.1002/ejhf.346)

Pellicori, P., Joseph, A. C., Zhang, J., Lukaschuk, E., Sherwi, N., Bourantas, C. V., Loh, H., Clark, A. L., Cleland, J. G.F. (2015) The relationship of QRS morphology with cardiac structure and function in patients with heart failure. Clinical Research in Cardiology, 104, pp. 935-945. (doi: 10.1007/s00392-015-0861-0)

Celis, C., Salas, C., Álvarez, C., Aguilar Farías, N., Ramírez Campillos, R., Leppe, J., Cristi-Montero, C., Díaz Martínez, X., Duran, E., Labraña, A. M., Martínez, M. A., Leiva, A. M., Willis, N. (2015) Un mayor nivel de actividad física se asocia a una menor prevalencia de factores de riesgo cardiovascular en Chile: resultados de la Encuesta Nacional de Salud 2009-2010 = Higher physical activity levels are associated with lower prevalence of cardiovascular risk factors in Chile. Revista Medica de Chile, 143, pp. 1435-1443. (doi: 10.4067/S0034-98872015001100009)

Hofer, E. et al. (2015) White matter lesion progression: genome-wide search for genetic influences. Stroke, 46, pp. 3048-3057. (doi: 10.1161/STROKEAHA.115.009252)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., Cleland, J. G.F. (2015) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews, 2015, (doi: 10.1002/14651858.CD007228.pub3)

Farag, M., Mabote, T., Shoaib, A., Zhang, J., Nabhan, A. F., Clark, A. L., Cleland, J. G. (2015) Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systematic review. International Journal of Cardiology, 196, pp. 61-69. (doi: 10.1016/j.ijcard.2015.05.160)

Mareev, Y., Cleland, J. G.F. (2015) Should β-blockers be used in patients with heart failure and atrial fibrillation? Clinical Therapeutics, 37, pp. 2215-2224. (doi: 10.1016/j.clinthera.2015.08.017)

Winkler, T. W. et al. (2015) The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genetics, 11, (doi: 10.1371/journal.pgen.1005378)

Shadman, R., Poole, J. E., Dardas, T. F., Mozaffarian, D., Cleland, J. G.F., Swedberg, K., Maggioni, A. P., Anand, I. S., Carson, P. E., Miller, A. B., Levy, W. C. (2015) A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm, 12, pp. 2069-2077. (doi: 10.1016/j.hrthm.2015.06.039)

Butcher, C., Mareev, Y., Markides, V., Mason, M., Wong, T., Cleland, J.G.F. (2015) Cardiac resynchronization therapy update: evolving indications, expanding benefit? Current Cardiology Reports, 17, (doi: 10.1007/s11886-015-0641-5)

Akehurst, C., Small, H., Sharafetdinova, L., Forrest, R., Beattie, W., Brown, C. E., Robinson, S. W., McClure, J. D., Work, L. M., Carty, D. M., McBride, M. W., Freeman, D. J., Delles, C. (2015) Differential expression of microRNA-206 and its target genes in pre-eclampsia. Journal of Hypertension, 33, pp. 2068-2074. (doi: 10.1097/HJH.0000000000000656)

Poston, L., Bell, R., Croker, H., Flynn, A. C., Godfrey, K. M., Goff, L., Hayes, L., Khazaezadeh, N., Nelson, S. M., Oteng-Ntim, E., Pasupathy, D., Patel, N., Robson, S. C., Sandall, J., Sanders, T. A. B., Sattar, N., Seed, P. T., Wardle, J., Whitworth, M. K., Briley, A. L. (2015) Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes and Endocrinology, 3, pp. 767-777. (doi: 10.1016/s2213-8587(15)00227-2)

Marsaux, C. F. et al. (2015) Effects of a web-based personalized intervention on physical activity in European adults: a randomized controlled trial. Journal of Medical Internet Research, 17, (doi: 10.2196/jmir.4660)

Frankenstein, L., Fröhlich, H., Cleland, J. G.F. (2015) Multidisciplinary approach for patients hospitalized with heart failure. Revista Española de Cardiología (English Edition), 68, pp. 885-891. (doi: 10.1016/j.rec.2015.05.008)

Cleland, J. G.F., Freemantle, N. (2015) QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion? Heart, 101, pp. 1441-1443. (doi: 10.1136/heartjnl-2015-307553)

Wannamethee, S. G., Welsh, P., Papacosta, O., Lennon, L., Whincup, P. H., Sattar, N. (2015) Copeptin, insulin resistance, and risk of incident diabetes in older men. Journal of Clinical Endocrinology and Metabolism, 100, pp. 3332-3339. (doi: 10.1210/JC.2015-2362)

Lindsey, M. L., Mayr, M., Gomes, A. V., Delles, C., Arrell, D. K., Murphy, A. M., Lange, R. A., Costello, C. E., Jin, Y.-F., Laskowitz, D. T., Sam, F., Terzic, A., Van Eyk, J., Srinivas, P. R. (2015) Transformative impact of proteomics on cardiovascular health and disease: a scientific statement from the American Heart Association. Circulation, 132, pp. 852-872. (doi: 10.1161/CIR.0000000000000226)

Fisher, M., Petrie, M., Ambery, P., Donaldson, J., McMurray, J. J.V., Ye, J. (2015) Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis. Lancet Diabetes and Endocrinology, 3, pp. 697-703. (doi: 10.1016/s2213-8587(15)00233-8)

Pellicori, P., Clark, A. L. (2015) Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure. European Journal of Heart Failure, 17, pp. 979-983. (doi: 10.1002/ejhf.340)

Damy, T., Hobkirk, J., Walters, M., Ciobanu, A., Rigby, A. S., Kallvikbacka-Bennett, A., Guellich, A., Dubois-Randé, J.-L., Hittinger, L., Clark, A. L., Cleland, J. G.F. (2015) Development of a human model for the study of effects of hypoxia, exercise, and sildenafil on cardiac and vascular function in chronic heart failure. Journal of Cardiovascular Pharmacology, 66, pp. 229-238. (doi: 10.1097/FJC.0000000000000262)

Dierckx, R., Cleland, J. G.F., Pellicori, P., Zhang, J., Goode, K., Putzu, P., Boyalla, V., Clark, A. L. (2015) If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare, 21, pp. 331-339. (doi: 10.1177/1357633X15574947)

Stut, W., Deighan, C., Cleland, J. G., Jaarsma, T. (2015) Adherence to self-care in patients with heart failure in the HeartCycle study. Patient Preference and Adherence, 9, pp. 1195-1206. (doi: 10.2147/PPA.S88482)

Morris, R. W. et al. (2015) Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium: Table 1. BMJ Open, 5, (doi: 10.1136/bmjopen-2015-008808)

Livingstone, K.M., Celis-Morales, C., Lara, J., Ashor, A.W., Lovegrove, J.A., Martinez, J.A., Saris, W.H., Gibney, M., Manios, Y., Traczyk, I., Drevon, C.A., Daniel, H., Gibney, E.R., Brennan, L., Bouwman, J., Grimaldi, K.A., Mathers, J.C. (2015) Associations between FTO genotype and total energy and macronutrient intake in adults: a systematic review and meta-analysis. Obesity Reviews, 16, pp. 666-678. (doi: 10.1111/obr.12290)

Jackson, C. E., Haig, C., Welsh, P., Dalzell, J. R., Tsorlalis, I. K., McConnachie, A., Preiss, D., McInnes, I. B., Sattar, N., Petrie, M. C., Gardner, R. S., McMurray, J. J.V. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, 3, pp. 618-625. (doi: 10.1016/j.jchf.2015.03.014)

Schanstra, J.P. et al. (2015) Diagnosis and prediction of CKD progression by assessment of urinary peptides. Journal of the American Society of Nephrology, 26, pp. 1999-2010. (doi: 10.1681/asn.2014050423)

Rush, C. J., Campbell, R. T., Jhund, P. S., Connolly, E. C., Preiss, D., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) Falling cardiovascular mortality in heart failure with reduced ejection fraction and implications for clinical trials. JACC: Heart Failure, 3, pp. 603-614. (doi: 10.1016/j.jchf.2015.03.013)

Preiss, D., Thomas, L. E., Wojdyla, D. M., Haffner, S. M., Gill, J. M. R., Yates, T., Davies, M. J., Holman, R. R., McMurray, J. J., Califf, R. M., Kraus, W. E. (2015) Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study. BMJ Open, 5, (doi: 10.1136/bmjopen-2015-007901)

Cleland, J. G.F., Mareev, Y., Linde, C. (2015) Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT? European Heart Journal, 36, pp. 1948-1951. (doi: 10.1093/eurheartj/ehv264)

Sattar, N., McInnes, I. B. (2015) Rheumatoid arthritis: debunking the obesity–mortality paradox in RA. Nature Reviews Rheumatology, 11, pp. 445-446. (doi: 10.1038/nrrheum.2015.93)

Askevold, E. T., Gullestad, L., Nymo, S., Kjekshus, J., Yndestad, A., Latini, R., Cleland, J. G.F., McMurray, J. J.V., Aukrust, P., Ueland, T. (2015) Secreted frizzled related protein 3 in chronic heart failure: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA) PLoS ONE, 10, (doi: 10.1371/journal.pone.0133970)

Ross, R., Gray, C. M., Gill, J. M.R. (2015) The effects of an injected placebo on endurance running performance. Medicine and Science in Sports and Exercise, 47, pp. 1672-1681. (doi: 10.1249/MSS.0000000000000584)

Cristi-Montero, C., Celis-Morales, C., Ramírez-Campillo, R., Aguilar-Farías, N., Álvarez, C., Rodríguez-Rodríguez, F. (2015) ¡Sedentarismo e inactividad física no son lo mismo!: una actualización de conceptos orientada a la prescripción del ejercicio físico para la salud = Sedentary lifestyle and physical inactivity are not the same!: an update of concepts aimed at the prescription of physical exercise for health. Revista Medica de Chile, 143, pp. 1089-1090. (doi: 10.4067/S0034-98872015000800021)

Joshi, P. K. et al. (2015) Directional dominance on stature and cognition in diverse human populations. Nature, 523, pp. 459-462. (doi: 10.1038/nature14618)

Raphael, C. E., Finegold, J. A., Barron, A. J., Whinnett, Z. I., Mayet, J., Linde, C., Cleland, J. G.F., Levy, W. C., Francis, D. P. (2015) The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most? European Heart Journal, 36, pp. 1676-1688. (doi: 10.1093/eurheartj/ehv102)

Di Angelantonio, E. et al. (2015) Association of cardiometabolic multimorbidity with mortality. JAMA: Journal of the American Medical Association, 314, pp. 52-60. (doi: 10.1001/jama.2015.7008)

MacDonald, M. R., She, L., Doenst, T., Binkley, P. F., Rouleau, J. L., Tan, R.-S., Lee, K. L., Miller, A. B., Sopko, G., Szalewska, D., Waclawiw, M. A., Dabrowski, R., Castelvecchio, S., Adlbrecht, C., Michler, R. E., Oh, J. K., Velazquez, E. J., Petrie, M. C. (2015) Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. European Journal of Heart Failure, 17, pp. 725-734. (doi: 10.1002/ejhf.288)

Mentz, R. J., Metra, M., Cotter, G., Milo, O., McKendry, C., Chiswell, K., Davison, B. A., Cleland, J. G.F., Bloomfield, D. M., Dittrich, H. C., Fiuzat, M., Ponikowski, P., Givertz, M. M., Voors, A. A., Teerlink, J. R., O'Connor, C. M. (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. European Journal of Heart Failure, 17, pp. 697-706. (doi: 10.1002/ejhf.308)

Ferrari, R., Böhm, M., Cleland, J. G.F., Paulus, W. J.S., Pieske, B., Rapezzi, C., Tavazzi, L. (2015) Heart failure with preserved ejection fraction: uncertainties and dilemmas. European Journal of Heart Failure, 17, pp. 665-671. (doi: 10.1002/ejhf.304)

Cho, N.H., Kim, K.M., Choi, S.H., Park, K.S., Jang, H.C., Kim, S.S., Sattar, N., Lim, S. (2015) High blood pressure and its association with incident diabetes over 10 years in the Korean genome and epidemiology study (KoGES) Diabetes Care, 38, pp. 1333-1338. (doi: 10.2337/dc14-1931)

Mccallum, L., Panniyammakal, J., Hastie, C. E., Hewitt, J., Patel, R., Jones, G. C., Muir, S., Walters, M., Sattar, N., Dominiczak, A., Padmanabhan, S. (2015) Longitudinal blood pressure control, long-term mortality and predictive utility of serum liver enzymes and bilirubin in hypertensive patients. Hypertension, 66, pp. 37-43. (doi: 10.1161/HYPERTENSIONAHA.114.04915)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Lindsay, M., Watkins, S., Hood, S., Davie, A., Marous, A., Sattar, N., Welsh, P., Tzemos, N., Radjenovic, A., Ford, I., Oldroyd, K., Berry, C. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8, pp. 779-789. (doi: 10.1016/j.jcmg.2015.03.007)

Pellicori, P., Kallvikbacka-Bennett, A., Dierckx, R., Zhang, J., Putzu, P., Cuthbert, J., Boyalla, V., Shoaib, A., Clark, A. L., Cleland, J. G.F. (2015) Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure. Heart, 101, pp. 1149-1158. (doi: 10.1136/heartjnl-2015-307558)

Zannad, F., Greenberg, B., Cleland, J. G.F., Gheorghiade, M., van Veldhuisen, D. J., Mehra, M. R., Anker, S. D., Byra, W. M., Fu, M., Mills, R. M. (2015) Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. European Journal of Heart Failure, 17, pp. 735-742. (doi: 10.1002/ejhf.266)

Petrie, M.C., Boyle, J.G., McKay, G.A. (2015) Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base. Diabetic Medicine, 32, pp. 981-982. (doi: 10.1111/dme.12709)

Dowsett, L., Piper, S., Slaviero, A., Dufton, N., Wang, Z., Boruc, O., Delahaye, M., Colman, L., Kalk, E., Tomlinson, J., Birdsey, G., Randi, A. M., Leiper, J. (2015) Endothelial dimethylarginine dimethylaminohydrolase 1 is an important regulator of angiogenesis but does not regulate vascular reactivity or hemodynamic homeostasis. Circulation, 131, pp. 2217-2225. (doi: 10.1161/CIRCULATIONAHA.114.015064)

Al Halabi, S., Qintar, M., Hussein, A., Alraies, M. C., Jones, D. G., Wong, T., MacDonald, M. R., Petrie, M. C., Cantillon, D., Tarakji, K. G., Kanj, M., Bhargava, M., Varma, N., Baranowski, B., Wilkoff, B. L., Wazni, O., Callahan, T., Saliba, W., Chung, M. K. (2015) Catheter ablation for atrial fibrillation in heart failure patients. JACC: Clinical Electrophysiology, 1, pp. 200-209. (doi: 10.1016/j.jacep.2015.02.018)

Lambden, S., Kelly, P., Ahmetaj-Shala, B., Wang, Z., Lee, B., Nandi, M., Torondel, B., Delahaye, M., Dowsett, L., Piper, S., Tomlinson, J., Caplin, B., Colman, L., Boruc, O., Slaviero, A., Zhao, L., Oliver, E., Khadayate, S., Singer, M., Arrigoni, F., Leiper, J. (2015) Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, pp. 1382-1392. (doi: 10.1161/ATVBAHA.115.305278)

Ferguson, L., Sattar, N. (2015) Endothelial function measures: not for clinical prime time? International Journal of Clinical Practice, 69, pp. 624-625. (doi: 10.1111/ijcp.12642)

Inglis, S. C., Conway, A., Cleland, J. G.F., Clark, R. A. (2015) Is age a factor in the success or failure of remote monitoring in heart failure? Telemonitoring and structured telephone support in elderly heart failure patients. European Journal of Cardiovascular Nursing, 14, pp. 248-255. (doi: 10.1177/1474515114530611)

GHAFOURI, K., Cooney, J., Bedford, D. K., Wilson, J., Caslake, M. J., Gill, J. M.R. (2015) Moderate exercise increases affinity of large very low density lipoproteins for hydrolysis by lipoprotein lipase. Journal of Clinical Endocrinology and Metabolism, 100, pp. 2205-2213. (doi: 10.1210/jc.2015-1196)

Kristensen, S. L., Jhund, P. S., Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Cleland, J. G.F., Carson, P. E., McMurray, J. J.V. (2015) Relative importance of history of heart failure hospitalization and N-terminal pro–B-type natriuretic peptide level as predictors of outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 3, pp. 478-486. (doi: 10.1016/j.jchf.2015.01.014)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, 36, pp. 1536-1546. (doi: 10.1093/eurheartj/ehv072)

Dalzell, J. R., Rocchiccioli, J. P., Weir, R. A.P., Jackson, C. E., Padmanabhan, N., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) The emerging potential of the apelin-APJ system in heart failure. Journal of Cardiac Failure, 21, pp. 489-498. (doi: 10.1016/j.cardfail.2015.03.007)

Dakin, R. S., Parker, A. L., Delles, C., Nicklin, S. A., Baker, A. H. (2015) Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector. Human Gene Therapy, 26, pp. 312-319. (doi: 10.1089/hum.2015.019)

Fox, C. S., Hall, J. L., Arnett, D. K., Ashley, E. A., Delles, C., Engler, M. B., Freeman, M. W., Johnson, J. A., Lanfear, D. E., Liggett, S. B., Lusis, A. J., Loscalzo, J., MacRae, C. A., Musunuru, K., Newby, L. K., O'Donnell, C. J., Rich, S. S., Terzic, A. (2015) Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. Circulation, 131, pp. 1715-1736. (doi: 10.1161/CIR.0000000000000211)

Costanzo, P., Cleland, J. G.F., Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J., Atkin, S. L. (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of Internal Medicine, 162, pp. 610-618. (doi: 10.7326/M14-1551)

Anderson, E.L., Howe, L.D., Fraser, A., Macdonald-Wallis, C., Callaway, M.P., Sattar, N., Day, C., Tilling, K., Lawlor, D.A. (2015) Childhood energy intake is associated with nonalcoholic fatty liver disease in adolescents. Journal of Nutrition, 145, pp. 983-989. (doi: 10.3945/jn.114.208397)

Tillin, T., Hughes, A. D., Wang, Q., Würtz, P., Ala-Korpela, M., Sattar, N., Forouhi, N. G., Godsland, I. F., Eastwood, S. V., McKeigue, P. M., Chaturvedi, N. (2015) Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) study. Diabetologia, 58, pp. 968-979. (doi: 10.1007/s00125-015-3517-8)

Kukulski, T., She, L., Racine, N., Gradinac, S., Panza, J. A., Velazquez, E. J., Chan, K., Petrie, M. C., Lee, K. L., Pellikka, P. A., Romanov, A., Biernat, J., Rouleau, J. L., Batlle, C., Rogowski, J., Ferrazzi, P., Zembala, M., Oh, J. K. (2015) Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. Journal of Thoracic and Cardiovascular Surgery, 149, pp. 1312-1321. (doi: 10.1016/j.jtcvs.2014.09.117)

Filippatos, G., Khan, S. S., Ambrosy, A. P., Cleland, J. G.F., Collins, S. P., Lam, C. S.P., Angermann, C. E., Ertl, G., Dahlström, U., Hu, D., Dickstein, K., Perrone, S. V., Ghadanfar, M., Bermann, G., Noe, A., Schweizer, A., Maier, T., Gheorghiade, M. (2015) International REgistry to assess medical practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. European Journal of Heart Failure, 17, pp. 527-533. (doi: 10.1002/ejhf.262)

Celis-Morales, C., Lara, J., Mathers, J. C. (2015) Personalising nutritional guidance for more effective behaviour change. Proceedings of the Nutrition Society, 74, pp. 130-138. (doi: 10.1017/S0029665114001633)

Da Boit, M., Gabriel, B.M., Gray, P., Gray, S.R. (2015) The effect of fish oil, vitamin D and protein on URTI incidence in young active people. International Journal of Sports Medicine, 36, pp. 426-430. (doi: 10.1055/s-0034-1394464)

Davison, B. A., Metra, M., Cotter, G., Massie, B. M., Cleland, J. G.F., Dittrich, H. C., Edwards, C., Filippatos, G., Givertz, M. M., Greenberg, B., Ponikowski, P., Voors, A. A., O’Connor, C. M., Teerlink, J. R. (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC: Heart Failure, 3, pp. 395-403. (doi: 10.1016/j.jchf.2015.01.007)

Ravassa, S., Kuznetsova, T., Varo, N., Thijs, L., Delles, C., Dominiczak, A., Díez, J., Staessen, J. A. (2015) Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: a population-based study. International Journal of Cardiology, 185, pp. 177-185. (doi: 10.1016/j.ijcard.2015.03.046)

Malik, M. O., Govan, L., Petrie, J. R., Ghouri, N., Leese, G., Fischbacher, C., Colhoun, H., Philip, S., Wild, S., McCrimmon, R., Sattar, N., Lindsay, R. S. (2015) Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia, 58, pp. 716-725. (doi: 10.1007/s00125-015-3492-0)

Siervo, M., Oggioni, C., Lara, J., Celis-Morales, C., Mathers, J. C., Battezzati, A., Leone, A., Tagliabue, A., Spadafranca, A., Bertoli, S. (2015) Age-related changes in resting energy expenditure in normal weight, overweight and obese men and women. Maturitas, 80, pp. 406-413. (doi: 10.1016/j.maturitas.2014.12.023)

Ghouri, N., Purves, D., Deans, K. A., Logan, G., McConnachie, A., Wilson, J., Gill, J. M. R., Sattar, N. (2015) An investigation of two-dimensional ultrasound carotid plaque presence and intima media thickness in middle-aged South Asian and European men living in the United Kingdom. PLoS ONE, 10, (doi: 10.1371/journal.pone.0123317)

McInnes, I. B., Thompson, L., Giles, J. T., Bathon, J. M., Salmon, J. E., Beaulieu, A. D., Codding, C. E., Carlson, T. H., Delles, C., Lee, J. S., Sattar, N. (2015) Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Annals of the Rheumatic Diseases, 74, pp. 694-702. (doi: 10.1136/annrheumdis-2013-204345)

Santangeli, L., Sattar, N., Huda, S. H. (2015) Impact of maternal obesity on perinatal and childhood outcomes. Best Practice and Research: Clinical Obstetrics and Gynaecology, 29, pp. 438-448. (doi: 10.1016/j.bpobgyn.2014.10.009)

Mischak, H., Delles, C., Vlahou, A., Vanholder, R. (2015) Proteomic biomarkers in kidney disease: issues in development and implementation. Nature Reviews Nephrology, 11, pp. 221-232. (doi: 10.1038/nrneph.2014.247)

Cleland, J. G.F., Butcher, C. (2015) When is it appropriate to withdraw cardiac resynchronization therapy? Guesses and evidence. JACC: Heart Failure, 3, pp. 337-339. (doi: 10.1016/j.jchf.2015.01.003)

Pellicori, P., Zhang, J., Lukaschuk, E., Joseph, A. C., Bourantas, C. V., Loh, H., Bragadeesh, T., Clark, A. L., Cleland, J. G.F. (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. European Heart Journal, 36, pp. 733-742. (doi: 10.1093/eurheartj/ehu405)

Jankowska, E. A., Wojtas, K., Kasztura, M., Mazur, G., Butrym, A., Kalicinska, E., Rybinska, I., Skiba, J., von Haehling, S., Doehner, W., Anker, S. D., Banasiak, W., Cleland, J. G.F., Ponikowski, P. (2015) Bone marrow iron depletion is common in patients with coronary artery disease. International Journal of Cardiology, 182, pp. 517-522. (doi: 10.1016/j.ijcard.2014.10.006)

Metra, M., Cotter, G., El-Khorazaty, J., Davison, B. A., Milo, O., Carubelli, V., Bourge, R. C., Cleland, J. G., Jondeau, G., Krum, H., O'Connor, C. M., Parker, J. D., Torre-Amione, G., van Veldhuisen, D. J., Rainisio, M., Kobrin, I., McMurray, J. J., Teerlink, J. R. (2015) Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. Journal of Cardiac Failure, 21, pp. 179-88. (doi: 10.1016/j.cardfail.2014.12.012)

Nightingale, C. M., Rudnicka, A. R., Owen, C. G., Newton, S. L., Bales, J. L., Donin, A. S., McKay, C. M., Steer, P. J., Lawlor, D. A., Sattar, N., Cook, D. G., Whincup, P. H. (2015) Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the child heart and health study in England (CHASE) Diabetologia, 58, pp. 474-484. (doi: 10.1007/s00125-014-3474-7)

Eastwood, S. V., Tillin, T., Dehbi, H.-M., Wright, A., Forouhi, N. G., Godsland, I., Whincup, P., Sattar, N., Hughes, A. D., Chaturvedi, N. (2015) Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: The SABRE study. Obesity, 23, pp. 699-706. (doi: 10.1002/oby.20997)

Pellicori, P., Cleland, J. G.F. (2015) Is the epidemic of heart disease really over or just evolving? American Journal of Medicine, 128, pp. e17. (doi: 10.1016/j.amjmed.2014.09.018)

Wurtz, P. et al. (2015) Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation, 131, pp. 774-785. (doi: 10.1161/CIRCULATIONAHA.114.013116)

Campbell, R. T., Jackson, C., Wright, A., Gardner, R. S., Ford, I., Davidson, P. M., Denvir, M. A., Hogg, K. J., Johnson, M. J., Petrie, M. C., McMurray, J. J. V. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2, pp. 25-36. (doi: 10.1002/ehf2.12027)

Dierckx, R., Cleland, J. G.F., Parsons, S., Putzu, P., Pellicori, P., Dicken, B., Boyalla, V., Clark, A. L. (2015) Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. JACC: Heart Failure, 3, pp. 224-230. (doi: 10.1016/j.jchf.2014.11.003)

Patel, S., Lawlor, D. A., Ferreira, D. L.S., Hughes, A. D., Chaturvedi, N., Callaway, M., Day, C., Sattar, N., Fraser, A. (2015) The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence. Journal of Hypertension, 33, pp. 546-553. (doi: 10.1097/HJH.0000000000000445)

Khand, A. U., Chew, P. G., Douglas, H., Jones, J., Jan, A., Cleland, J.G.F. (2015) The effect of carvedilol on b-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation. Cardiology, 130, pp. 153-158. (doi: 10.1159/000368746)

Pellicori, P., Cleland, J. G.F. (2015) Update on management of heart failure with preserved ejection fraction. Current Opinion in Cardiology, 30, pp. 173-178. (doi: 10.1097/HCO.0000000000000152)

Jani, B. D., McLean, G., Nicholl, B. I., Barry, S. J.E., Sattar, N., Mair, F. S., Cavanagh, J. (2015) Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers. Frontiers in Human Neuroscience, 9, (doi: 10.3389/fnhum.2015.00018)

Rao, V. U., Pavlov, A., Klearman, M., Musselman, D., Giles, J. T., Bathon, J. M., Sattar, N., Lee, J. S. (2015) An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis and Rheumatology, 67, pp. 372-380. (doi: 10.1002/art.38920)

Preiss, D., Sattar, N. (2015) Classification of reported statin intolerance. Current Opinion in Lipidology, 26, pp. 65-66. (doi: 10.1097/MOL.0000000000000149)

Badar, A. A., Perez-Moreno, A. C., Hawkins, N. M., Brunton, A. P.T., Jhund, P. S., Wong, C. M., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) programme. European Journal of Heart Failure, 17, pp. 196-204. (doi: 10.1002/ejhf.221)

Kristensen, S. L., Jhund, P. S., Køber, L., Preiss, D., Kjekshus, J., McKelvie, R. S., Zile, M. R., Anand, I. S., Wikstrand, J. G.F., Wedel, H., Komajda, M., Carson, P. E., Cleland, J., McMurray, J. J.V. (2015) Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure, 17, pp. 169-176. (doi: 10.1002/ejhf.211)

Ashor, A. W., Lara, J., Siervo, M., Celis-Morales, C., Oggioni, C., Jakovljevic, D. G., Mathers, J. C. (2015) Exercise modalities and endothelial function: a systematic review and dose-response meta-analysis of randomized controlled trials. Sports Medicine, 45, pp. 279-296. (doi: 10.1007/s40279-014-0272-9)

Boyalla, V., Putzu, P., Dierckx, R., Clark, A. L., Pellicori, P. (2015) Patent Ductus Arteriosus in older adults: incidental finding or relevant pathology? Journal of the American Geriatrics Society, 63, pp. 409-411. (doi: 10.1111/jgs.13256)

Kristensen, S. L., McInnes, I., Sattar, N. (2015) Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Annals of the Rheumatic Diseases, 74, pp. 321-322. (doi: 10.1136/annrheumdis-2014-206617)

Layland, J. et al. (2015) Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. European Heart Journal, 36, pp. 100-111. (doi: 10.1093/eurheartj/ehu338)

Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., McKnight, J. A., Morris, A., Pearson, D. W. M., Petrie, J. R., Philip, S., Sattar, N. A., Traynor, J. P., Colhoun, H. M. (2015) Estimated life expectancy in a Scottish cohort With type 1 diabetes, 2008-2010. JAMA: Journal of the American Medical Association, 313, pp. 37-44. (doi: 10.1001/jama.2014.16425)

Wade, K. H., Forouhi, N. G., Cook, D. G., Johnson, P., McConnachie, A., Morris, R. W., Rodriguez, S., Ye, Z., Ebrahim, S., Padmanabhan, S., Watt, G., Bruckdorfer, K. R., Wareham, N. J., Whincup, P. H., Chanock, S., Sattar, N., Lawlor, D. A., Davey Smith, G., Timpson, N. J. (2015) Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with L-ascorbic acid. American Journal of Clinical Nutrition, 101, pp. 202-209. (doi: 10.3945/ajcn.114.092981)

Metra, M., Mentz, R. J., Chiswell, K., Bloomfield, D. M., Cleland, J. G.F., Cotter, G., Davison, B. A., Dittrich, H. C., Fiuzat, M., Givertz, M. M., Lazzarini, V., Mansoor, G. A., Massie, B. M., Ponikowski, P., Teerlink, J. R., Voors, A. A., O'Connor, C. M. (2015) Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. European Journal of Heart Failure, 17, pp. 109-118. (doi: 10.1002/ejhf.207)

Celis-Morales, C. et al. (2015) Design and baseline characteristics of the Food4Me study: a web-based randomised controlled trial of personalised nutrition in seven European countries. Genes and Nutrition, 10, (doi: 10.1007/s12263-014-0450-2)

Malkova, D., Gill, J. M.R., Manthou, E. (2015) Effect of exercise programmes with aerobic exercise sessions of similar intensity but different frequency and duration on health related measures in overweight women. Journal of Physical Activity and Health, 12, pp. 80-86. (doi: 10.1123/jpah.2013-0047)

Dickstein, K., Normand, C., Anker, S.D., Auricchio, A., Lundqvist Blomstrom, C., Bogale, N., Cleland, J., Filippatos, G., Gasparini, M., Gitt, A., Hindricks, G., Kuck, K.-H., Ponikowski, P., Stellbrink, C., Ruschitzka, F., Linde, C. (2015) European cardiac resynchronization therapy survey II: rationale and design. Europace, 17, pp. 137-141. (doi: 10.1093/europace/euu312)

Swerdlow, D. I. et al. (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet, 385, pp. 351-361. (doi: 10.1016/S0140-6736(14)61183-1)

Jones, R., Hardy, R., Sattar, N., Deanfield, J. E., Hughes, A., Kuh, D., Murray, E. T., Whincup, P. H., Thomas, C. (2015) Novel coronary heart disease risk factors at 60–64 years and life course socioeconomic position: the 1946 British birth cohort. Atherosclerosis, 238, pp. 70-76. (doi: 10.1016/j.atherosclerosis.2014.11.011)

McArthur, L., Johnston, L., Sattar, N., Logue, J., Welsh, P. (2015) Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze-thaw cycles. Annals of Clinical Biochemistry, 52, pp. 165-168. (doi: 10.1177/0004563214529550)

Dierckx, R., Pellicori, P., Cleland, J.G.F., Clark, A.L. (2015) Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews, 20, pp. 107-116. (doi: 10.1007/s10741-014-9449-4)

Layland, J., Rauhalammi, S., Watkins, S., Ahmed, N., McClure, J., Lee, M. M.Y., Carrick, D., O’Donnell, A., Sood, A., Petrie, M. C., Teng Yue May, V., Eteiba, H., Lindsay, M., McEntegart, M., Oldroyd, K. G., Radjenovic, A., Berry, C. (2015) Assessment of fractional flow reserve in patients with recent Non–ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 8, (doi: 10.1161/circinterventions.114.002207)

Musunuru, K., Hickey, K. T., Al-Khatib, S. M., Delles, C., Fornage, M., Fox, C. S., Frazier, L., Gelb, B. D., Herrington, D. M., Lanfear, D. E., Rosand, J. (2015) Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. Circulation: Cardiovascular Genetics, 8, pp. 216-242. (doi: 10.1161/HCG.0000000000000020)

Pellicori, P., Costanzo, P. (2015) Betabloccanti in pazienti con scompenso cardiaco e fibrillazione atriale = [Betablockers in patients with heart failure and atrial fibrillation] Giornale italiano di cardiologia, 16, pp. 613-616. (doi: 10.1714/2066.22428)

Poortvliet, R. K.E., Lloyd, S. M., Ford, I., Sattar, N., de Craen, A. J.M., Wijsman, L. W., Mooijaart, S. P., Westendorp, R. G.J., Jukema, J. W., de Ruijter, W., Gussekloo, J., Stott, D. J. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28, pp. 469-479. (doi: 10.1093/ajh/hpu181)

Welsh, P., Preiss, D., Touyz, R. M. (2015) Biomarkers of hypertension and cardiovascular disease. Royal Society of Chemistry

Welsh, P., Preiss, D., Tsiropoulou, S., Rios, F. J., Harvey, A., Dulak-Lis, M. G., Montezano, A. C., Touyz, R. M. (2015) Biomarkers of vascular inflammation and cardiovascular disease. Springer

Badar, A. A., Perez-Moreno, A. C., Hawkins, N. M., Jhund, P. S., Brunton, A. P.T., Anand, I. S., McKelvie, R. S., Komajda, M., Zile, M. R., Carson, P. E., Gardner, R. S., Petrie, M. C., McMurray, J. J.V. (2015) Clinical characteristics and outcomes of patients with coronary artery disease and angina. Circulation: Heart Failure, 8, pp. 717-724. (doi: 10.1161/CIRCHEARTFAILURE.114.002024)

Preiss, D., Sattar, N. (2015) Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA: Journal of the American Medical Association, 313, pp. 1016-1017. (doi: 10.1001/jama.2015.1275)

Bis, J. C. et al. (2015) Drug-gene interactions of antihypertensive medications and risk of incident cardiovascular disease: a pharmacogenomics study from the CHARGE consortium. PLoS ONE, 10, (doi: 10.1371/journal.pone.0140496)

Díaz Martínez, X., Bastías, C. M., Celis-Moralesl, C., Salas, C., Moral, P. V. (2015) Efecto de un programa de actividad física y alimentación saludable aplicado a hijos y padres para la prevención de la obesidad infantil = [Effect of a healthy eating and physical activity intervention program on chilhood obesity] Nutricion Hospitalaria, 32, pp. 110-117. (doi: 10.3305/nh.2015.32.1.9122)

Burska, A.N., Sakthiswary, R., Sattar, N. (2015) Effects of tumour necrosis factor antagonists on insulin sensitivity/resistance in rheumatoid arthritis: a systematic review and meta-analysis. PLoS ONE, 10, (doi: 10.1371/journal.pone.0128889)

Pellicori, P., Kaur, K., Clark, A. L. (2015) Fluid management in patients with chronic heart failure. Cardiac Failure Review, 1, pp. 90-95. (doi: 10.15420/cfr.2015.1.2.90)

Locke, A. E. et al. (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature, 518, pp. 197-206. (doi: 10.1038/nature14177)

van Leeuwen, E. M. et al. (2015) Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels. Nature Communications, 6, (doi: 10.1038/ncomms7065)

Mistry, H.D., Eisele, N., Escher, G., Dick, B., Surbek, D., Delles, C., Currie, G., Schlembach, D., Mohaupt, M.G., Gennari-Moser, C. (2015) Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum. Reproductive Biology and Endocrinology, 13, (doi: 10.1186/s12958-015-0100-6)

Escola-Gil, J.C., Julve, J., Griffin, B.A., Freeman, D.J., Blanco-Vaca, F. (2015) HDL and lifestyle interventions. Springer Open

Celis-Morales, C. et al. (2015) How reliable is internet-based self-reported identity, socio-demographic and obesity measures in European adults? Genes and Nutrition, 10, (doi: 10.1007/s12263-015-0476-0)

Dalzell, J. R., Cannon, J. A., Simpson, J., Gardner, R. S., Petrie, M. C. (2015) Improving outcomes in peripartum cardiomyopathy. Expert Review of Cardiovascular Therapy, 13, pp. 665-671. (doi: 10.1586/14779072.2015.1040767)

Mangion, K., Carrick, D., Payne, A., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K., Berry, C. (2015) Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-O9)

Mangion, K., Carrick, D., Payne, A. R., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K. G., Berry, C. (2015) Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-P104)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K., Berry, C. (2015) Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-Q52)

Paul, L., Brewster, S., Wyke, S., Gill, J. M.R., Alexander, G., Dybus, A., Rafferty, D. (2015) Physical activity profiles and sedentary behaviour in people following stroke: a cross-sectional study. Disability and Rehabilitation, (doi: 10.3109/09638288.2015.1041615)

Carrick, D., Haig, C., Rauhalammi, S. M., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K. G., Berry, C. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-O26)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K., Berry, C. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17, (doi: 10.1186/1532-429X-17-S1-O54)

Carrick, D., Haig, C., Rauhalammi, S., Ahmed, N., Mordi, I., McEntegart, M., Petrie, M., Eteiba, H., Hood, S., Watkins, S., Lindsay, M., Marous, A., Radjenovic, A., Ford, I., Tzemos, N., Oldroyd, K., Berry, C. (2015) Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 17, pp. O53. (doi: 10.1186/1532-429X-17-S1-O53)

Logue, J., Stewart, S., Munro, J., Bruce, J., Grieve, E., Lean, M., Lindsay, R. S., Bruce, D., Ali, A., Briggs, A., Sattar, N., Ford, I. (2015) SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in Scotland. BMJ Open, 5, (doi: 10.1136/bmjopen-2015-008106)

Da Boit, M., Mastalurova, I., Brazaite, G., McGovern, N., Thompson, K., Gray, S. (2015) The effect of krill oil supplementation on exercise performance and markers of immune function. PLoS ONE, 10, (doi: 10.1371/journal.pone.0139174)

Polyviou, T. P., Pitsiladis, Y. P., Celis-Morales, C., Brown, B., Speakman, J. R., Malkova, D. (2015) The effects of hyperhydrating supplements containing creatine and glucose on plasma lipids and insulin sensitivity in endurance-trained athletes. Journal of Amino Acids, 2015, (doi: 10.1155/2015/352458)

Sattar, N., Welsh, P., Preiss, D. (2015) The insulin resistance syndrome. John Wiley & Sons, Ltd

Badar, A. A., Brunton, A. P.T., Mahmood, A. H., Dobbin, S., Pozzi, A., McMinn, J. F., Sinclair, A. J.E., Gardner, R. S., Petrie, M. C., Curry, P. A., Al-Attar, N. H.K., Pettit, S. J. (2015) The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review. Expert Review of Cardiovascular Therapy, 13, pp. 915-922. (doi: 10.1586/14779072.2015.1067139)

Brown, C. E., McCarthy, N. S., Hughes, A. D.,, Sever, P., Stalmach, A., Mullen, W., Dominiczak, A. F., Sattar, N., Mischak, H., Thom, S., Mayet, J., Stanton, A. V., Delles, C. (2015) Urinary proteomic biomarkers to predict cardiovascular events. Proteomics Clinical Applications, 9, pp. 610-617. (doi: 10.1002/prca.201400195)

PGR Students

Nur Dania Rosaini

  • Postgraduate Research Student 
  • Research title: n/a

Anas Dighriri

  •  Postgraduate Research Student
  • Research title: Resistance training effects on young adults with diabetes

Our unit strives to better understand the links between metabolic and endocrine diseases including diabetes and cardiovascular diseases including atherosclerotic vascular disease and heart failure. We study general populations of interest and specific subgroups of interest to investigate the way that risk factors and mechanisms change in different people, including by ethnicity, gender, and socioeconomic deprivation.

Ongoing research topics include:

  • Epidemiology of diabetes and other metabolic conditions.
  • Biomarkers of cardiometabolic disease.
  • Imaging studies of cardiometabolic diseases.
  • Intervention studies including mechanistic randomized controlled clinical trials.

We use this knowledge both to develop and understand new cardiovascular therapies and target existing therapies to at risk groups more effectively.